Evidence-based Ayurveda

This groundbreaking work calls for an overhaul of traditional Ayurveda and its transformation into a progressive, evidence-based medicinal system.

This book begins by looking back at the research of the last three centuries, Indian medicinal plants, and Ayurveda in a twenty-first-century context. The first part of this book explores the limitations of contemporary Ayurvedic pharmacognosy and pharmacology, discussing the challenges the practice faces from research and clinical trials. It makes a compelling argument for the necessity of change. The second part of the book defines and elaborates upon a new, scientific path, taking the reader from identification of the herb through all stages of drug development.

An essential tool for herbal drug development, this text is designed for knowledgeable students, practitioners, and scholars of Ayurveda, pharmacy, and herbal medicine.

C. P. Khare is the founder president of the Society for New Age Herbals, a forum for promoting evidence-based herbal medicine, in New Delhi, India. He has been an herbalist, herbal drug consultant, and herbal historian for more than 60 years.





The Old Order Changeth

Yielding Place to New . . .





Evidence-based Ayurveda

Defining a New Scientific Path

Edited by

C. P. Khare





First published 2020

by Routledge

2 Park Square, Milton Park, Abingdon, Oxon OX14 4RN

and by Routledge

52 Vanderbilt Avenue, New York, NY 10017

Routledge is an imprint of the Taylor & Francis Group, an informa business

© 2020 selection and editorial matter, C. P. Khare; individual chapters, the contributors

The right of C. P. Khare to be identified as the author of the editorial material, and of the authors for their individual chapters, has been asserted in accordance with sections 77 and 78 of the Copyright, Designs and Patents Act 1988.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers.

Trademark notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe.

British Library Cataloguing-in-Publication Data

A catalogue record for this book is available from the British Library Library of Congress Cataloging-in-Publication Data

A catalog record for this book has been requested

ISBN: 978-0-367-35709-2 (hbk)

ISBN: 978-0-429-34126-7 (ebk)

Typeset in Times New Roman

by Apex CoVantage, LLC





Contents

List of contributors vii



Introduction: the thrust: why a new scientific path?

1

PART I

The legacy and logical steps for a new therapeutic regimen 5

1 The need for liberal regulations for promoting evidence-

based Ayurveda

7

2 Each and every step of AYUSH will have a far-reaching

impact

29

3 To move with the times: expand the knowledge base of

Ayurveda

33

4 The classical age in countries that are now leaders in

herbal medicine

39

5 Avoiding scientific inquiry is not possible now

57

6 Ayurvedic pharmacognosy and pharmacology: in modern

perspective

61

7 How classical procedures lost ground

67

8 Identification of proper herbs: a new scientific route

73

9 Pruning of classical formulations: suggested process

121

10 The pragmatic nature of Ayurveda: no restrictions on

revising old formulations

127

11 Basic steps: for restructuring Ayurvedic formulations

131

12 Hidden secrets of clinical success: super power of “Sacred

Word”

155

vi Contents

PART II

Defining a new scientific path by switching over to modern

pharmacognosy, pharmacology and research protocols

161

13 Identification of medicinal plants by voucher specimen

163

14 DNA barcoding: a breakthrough in authentication of

raw herbs

173

15 Modern extraction methods and standardization of

extracts

183

VIKRAM ANDREW NAHARWAR

16 Markers for quality control of herbal drugs

201

17 Pharmacological actions of chemical constituents

217

18 Pharmacological screening of Ayurvedic drugs by

experimental studies

231

R. C. SAXENA

19 An enigmatic approach in Ayurvedic Pharmacopoeia of

India: from holistic approach to disease-specific concepts

237

20 Unbiased research: lifeline of evidence-based Ayurveda

245

21 Threat to classical reputation by dubious herbs and

substitutes

261

22 Red list of medicinal plants: a threat to Ayurvedic

formulations

273

23 Ayurvedic education system: a path-breaking study

reflecting the elements of evidence-based Ayurveda

293

List of abbreviations

299

Index

301





Contributors

Vikram Andrew Nahaewar is a third-generation herbalist. For 23 years he has been Director of India’s first private-sector R&D laboratory, Amsar, which has been recognized by the Department of Scientific Industrial Research of India. He participated in the System of Conferences on Medicinal & Aromatic Plants, Vienna, 1997, organized by the United Nations Industrial Development Organization (UNIDO). Dr. Naharwar is Chief Scientific Officer at Integrated Clinical Research Sciences, an Indian CRO that has conducted clinical trials for global pharmaceutical companies, such as Pfizer, Aventis, GSK and Panacea Biotech. In 2001 he was nominated by the Central Drug Laboratory, Government of India, to the subcommittee of the Official Indian Pharmacopoeia.

He has authored numerous articles on herbal medicines, including the Official Indian Pharmacopoeia monographs, and is a member of the review committee of the Indian Herbal Pharmacopoeia.

Kishor Patwardhan is currently a professor in the Department of Kriya Sharir, Faculty of Ayurveda, Banaras Hindu University. His doctoral work was on identifying issues, concerns and challenges of Ayurveda education in India.

He is involved in developing tools for the assessment of Ayurveda parameters, such as Prakriti and Agnibala. He has lectured on various platforms in India and abroad on topics such as academic writing, research methodology, educational research, education policy and Ayurveda physiology. He has received the AYUSH-sponsored Vaidya-Scientist Fellowship from Transdisciplinary University (TDU), Bengaluru, and has recently been awarded the Dr. C. Dwarikanath Award from the Indian Association for Study of Traditional Asian Medicine (IASTAM) for newer interpretations of Ayurveda principles. He has authored important papers on education policies and research practices. His research interests include Ayurveda biology, Ayurveda education and policies on higher education. He has worked as a member of many scientific advisory committees, editorial boards and task forces.

R. C. Saxena, MBBS, MD, DIP CLIN PHARMOCOL (UK), MNASc, MNAMS, FIAMS, FIMSA, was Former Director and Head, Pharmacology, and Director Pharmacy, King George’s Medical University, Lucknow. He was the first Indian Clinical Pharmacologist qualified from the UK and trained at

viii Contributors

Hammersmit, Royal Postgraduate Medical School, University of London.

Dr. Saxena occupied first faculty position in Pharmacology, represented India at the First Clinical Pharmacology and Therapeutics (CPT) conference in London and was also the first Indian faculty member of the International Union of Basic and Clinical Pharmacology (IUPHAR) conference in Japan. His first work in the field of herbal medicine was related to clinical evaluation of Glycyrrhiza Glabra in Bockharts Impetigo, Pemphigus and other diseases on anti-inflammatory activity of a dual drug containing Withania ashwagandha and Cyperus rotundus. He is developing drugs for Alopecia and Vitiligo. He also published several books, in addition to a number of research papers in national and international journals.





Introduction

The thrust: why a new scientific path?

During the classical period, Ayurveda was a holistic medicine. First, the Dosha was identified; then, the first component of the herb, Rasa (taste), was selected.

Rasa was considered an important marker which indicated, initially, the right choice of the herb to treat not only symptoms but also the whole system by syn-chronizing Doshas, Vaata, Pitta and Kapha, collectively known as Tridoshas; Tridoshas represent the constitution of the patient. Thus, Ayurveda was a holistic, individually tailored medicine and was aimed at treating the whole person (body, mind, spirit and emotions). Ayurveda, as a Vedic medicine, was also employed by Hindu priests, preachers and yogis, while it is neither a holy medicine nor exclusively a Hindu medicine. Thus, Ayurveda remained the most employed medicinal system. The restructuring of Ayurveda, until now, was not possible because of stiff resistance from the exponents of holistic (holy) medicine.

With the introduction of the Linnaean system, Sanskrit names were converted to botanical names. That opened the gates of India for botanists and European plant collectors. The British passed the baton to scientists, pharmacognosists and pharmacologists. Holistic medicine was caught between two worlds. The only way out was to call Ayurveda a science – disease-specific, not Tridosha- specific.

Indian scientists started exploring the hidden potentials of Indian medicinal plants and tried to scan the validity of old knowledge.

To protect the holistic medicine from the scientific onslaught, in 1964, 54 classical and pro-classical books (actually 58) were given legal sanction in the Drugs and Cosmetic Act (Schedule I, section 3a) as “authoritative” books, giving them the status of a knowledge-base in Ayurveda. The whole exercise remained confined to the plants and formulations mentioned in classical and pro-classical texts.

As a result, only 499 medicinal plants were allowed into the Ayurvedic Pharmacopoeia of India. In monographs, classical attributes of each drug, according to the doctrine of Rasa, Guna, Virya, Vipaka and Karma, were retained. It was stated that “these were considered a reasonable basis and convenient reference point for clinical classification.” A few chemical constituents were also quoted to keep the flock together. Ultimately, it was admitted that such (holistic) parameters are not possible to measure by modern scientific methods and thus not mandatory.

For three centuries, Indian scientists had been trying to use the ancient wisdom and new scientific advancements for making Ayurveda an evidence-based,

2 Introduction

disease-specific medicinal system. But within the framework of a holistic system, which tries to treat the whole system, drug development for millions of people, whose prakriti (constitution) is not known, was not possible.

We were the first to divide Ayurvedic medicine into two periods, classical and modern. Our first book, The Modern Ayurveda: Milestones beyond the Classical Age, was published by CRC Press in 2012. This was followed by our review of six volumes of The Ayurvedic Pharmacopoeia of India in Ayurvedic Pharmacopoeial Plant Drugs: Expanded Therapeutics to highlight the inherent weakness of Ayurveda and establish the need of modern scientific tools for standardization, modern pharmacological tools for safety and efficacy evaluation, and application of biotechnology to elicit the mechanism of drug action. This book was also published by CRC Press.

In accordance with our understanding, a number of Ayurvedic scholars acknowledged the following: “No work can be ever said to be a complete work.

There always remains room for further improvement. The Ayurvedic Pharmacopoeia of India and Ayurvedic Formulary of India are no exception to this. The work of revision is being undertaken by the (Pharmacopoeial) committee in this respect. It is clear that even after revision there may remain a lot of room for improvement.” It was also acknowledged that “the method of conducting clinical trials of Ayurvedic drugs still remains a controversial issue.”

Holistic medicine (as Ayurvedic sciences) is still on the center stage. In this setup, scientists are facing a serious problem. We have no objection if a vaidya (Ayurvedic physician) is made secretary in the Ministry of AYUSH, and we have no objection if a vaidya is appointed as Director General of the Central Council for Research in Ayurvedic Sciences, provided research and development are accelerated and scientists get an opportunity to review various moves. There is a lot of difference between research in Ayurvedic sciences and research in Ayurveda. Those who guide the research, ask the team of scientists to prepare research findings, and produce an herbal drug, must believe in new research. The scientist who cannot climb all the steps of the ladder does half-hearted research with all possible shortcuts and gives half-baked results.

The biggest drawback is that Ayurvedic drug “research” is confined to only classical plant drugs, and the whole exercise more or less remain confined to centuries-old formulations. This problem is a serious one, so serious that it may adversely affect the future growth of a promising medicinal system. Already, most of the newly launched Ayurvedic drugs are facing veiled criticism from scientists.

Now, have a look at the scientific database provided by Indian scientists. The Reviews on Indian Medicinal Plants series of the Indian Council of Medical Research have already covered 4,951 medicinal plant species and cited 75,486

research papers (from A to P, May 2019) in 21 volumes. Earlier, in The Wealth of India series, 22 volumes were published by the Council of Scientific and Industrial Research.

No country can ignore this scientific surge. We are giving a number of suggestions for the transformation of Ayurveda into an evidence-based system. We hope that our efforts will be taken in the right perspective and that all three of our

Introduction 3

books will inspire young academicians and scientists to see that Ayurveda gets a much-needed launch pad.

While concluding, we would like to acknowledge the contribution of Dr. Vikram Andrew Naharwar, a third-generation phytochemist. He remained with me for more than three months and organized a lot of raw material for the project. Dr. C. K. Katiyar always sorted out knotty issues of Ayurveda.

– C. P. Khare

Khare.herbalsociety@gmail.com





Part I

The legacy and logical steps

for a new therapeutic regimen





1 The need for liberal

regulations for promoting

evidence-based Ayurveda

Why Ayurvedic Medicine and Herbal Medicine are treated as two rival systems with different legal regulations?

Why all Indian medicinal Plants are not Ayurvedic Plants?

Why the research of the last three centuries is not a part of Ayurveda?

The Drugs and Cosmetics Act, 1940

(Editor’s note: First, we will quote certain clauses of The Drugs and Cosmetics Act, 1940 (23 of 1940) (as amended up to the 31 December 2016) and The Drugs And Cosmetics Rules, 1945 (as amended up to the 31st December 2016), which need to be reviewed for an all-round growth of the 5,000-year-old traditional medicinal systems of India.)

The Drugs and Cosmetics Act Chapter, 3(a): Drug [Ayurvedic, Siddha or Unani] includes all medicines intended for internal or external use for or in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, and manufactured exclusively in accordance with the formulae described in the authoritative books (of Ayurvedic, Siddha and Unani Tibb systems of medicine) specified in the First Schedule.

3(h): patent or proprietary medicine means –

(i) in relation to Ayurvedic, Siddha or Unani Tibb systems of medicine all formulations containing only such ingredients mentioned in the formulae described in the authoritative books of Ayurveda, Siddha or Unani Tibb systems of medicine specified in the First Schedule, but does not include a medicine which is administered by parenteral route and also a formulation included in the authoritative books as specified in clause (a); (ii) in relation to any other systems of medicine, a drug which is a remedy or prescription presented in a form ready for internal or external administration of human beings or animals and which is not included in the edition of the Indian Pharmacopoeia for the time being or any other Pharmacopoeia authorized in this behalf by the Central Government after consultation with the Drugs Technical Advisory Board constituted under section 5.

8 Legacy and logical steps

THE FIRST SCHEDULE [ See section 3( a)]1

A. Ayurvedic Books:2 contain 54 (actually 59) authoritative books. ( For

analysis, see chapter 3.)

(1. Subs. by Act 13 of 1964, s. 31, for the Sch. The First Schedule came into force with effect from 1–2–1969.)

Drugs and Cosmetics Rules, 1945

PART X A: 122 DAC. Permission to conduct clinical trial: (1) The Licensing Authority as defined in clause (b) of Rule 21, on being satisfied that the data submitted along with the application in support of the proposed clinical trial is adequate in all respects, issue permission for conduct of clinical trial, subject to the following conditions, namely:

(a) Clinical trial shall be conducted in compliance with the approved protocols, requirements of Schedule Y annexed to these rules, Good Clinical Practice Guidelines for conduct of clinical trials in India and other applicable regulations;

(b) Approval of the Ethics Committee shall be obtained before initiation of the study;

(c) Clinical trial shall be registered at Clinical Trials Registry of India before enrolling the first patient for the study;

(d) Annual status report of each clinical trial, as to whether it is ongoing, completed or terminated, shall be submitted to the Licensing Authority and in case of termination of any clinical trial the detailed reasons for the same shall be communicated to the said Licensing Authority; (e) Any report of serious adverse event occurring during clinical trial to the subject, after due analysis, shall be forwarded within ten days of its occurrence as per Appendix XI and in compliance with the procedures prescribed in Schedule Y.

( Editor’s Note: See The Controversy on PART X A: 122 DAC

and ADVISORY from AYUSH on April 2, 2019, at the end of

salient features of Drugs and Cosmetics Rules, 1945, chapter 2.) Part XVI: 158(B) Guidelines for issue of license with respect to Ayurveda, Siddha or Unani drugs.

I (A) Ayurveda, Siddha Unani Medicines under section 3(a): Ayurveda, Siddha or Unani drugs includes all medicines intended for internal or external use for or in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, and manufactured

The need for liberal regulations 9

exclusively in accordance with the formulae described in the authoritative books of Ayurvedic, Siddha and Unani Tibb system of medicine, as specified in the First Schedule;



(B) Patent or Proprietary medicine under section 3(h):

(i) In relation to Ayurvedic, Siddha and Unani Tibb system of medicine of all formulations containing only such ingredients mentioned in the formulae described in the authoritative books of Ayurveda, Siddha or Unani Tibb system of medicines specified in the First Schedule, but does not include a medicine which is administered by parenteral route and also a formulation included in the authoritative books as specified in clause (a); (iv) Aushadh Ghana (Medicinal plant extracts – dry/wet) obtained from plant mentioned in books of First Schedule of the Act include Aqueous or hydroalcoholic extracts.

II (A) For issue of licence to the medicine with respect to Ayurvedic, Siddha and Unani, the conditions relating to safety study and the experience or evidence of effectiveness shall be such as specified.

Guidelines for issue of license with respect to Ayurveda, Siddha or Unani drugs (Drugs and Cosmetics Rules 1945. See CCRAS Guidelines): 1 Category: Ayurveda, Siddha and Unani drugs, given in 158. B as referred in 3(a).

2 Ingredients: As per texts. (54 Authoritative books) 3 Indication(s): As per texts. (54 Authoritative books) 4 Requirement of non-clinical Safety data: Not required 5 Published Literature: Required

6 Requirement of non-clinical Efficacy data: Not required 1 Category: Any change in dosage form of Ayurveda Siddha and Unani drugs as described in section 3(a) of the Drugs and Cosmetics Act, 1940.

2 Ingredients: As per text

3 Indication(s): As per texts

4 Requirement of non-clinical Safety data: Not required 5 Published Literature: Required

6 Requirement of non-clinical Efficacy data: Not required 1 Category: Ayurveda, Siddha and Unani drugs referred in 3(a) to be used for new indication.

2 Ingredients: As per text

3 Indication(s): New*.

4 Requirement of non-clinical Safety data: Not required

10 Legacy and logical steps

5 Published Literature: If required

6 Requirement of non-clinical Efficacy data: Required II (B) For issue of license with respect to Patent or Proprietary medicine. The condition relating to Safety studies and experience or evidence of effectiveness shall be specified as follows:

1 Category: Patent or Proprietary medicine containing crude drugs 2 Ingredients: As per text

3 Indication(s): Textual Rationale

4 Requirement of non-clinical safety data: Not required 5 Published Literature: Of ingredients

6 The requirement of non-clinical efficacy data: Pilot study as per relevant protocol for ASU drugs



For the issue of license with respect to medicine Aushadh Ghana, extract of medicinal plant (dry or wet):

Category: Crude drug/Aqueous extract(s)/hydro-alcoholic extracts/

dry/wet

Ingredient(s): As per text

Indication: Textual Rationale

Requirement of non-clinical Safety data: Not Required

Published Literature Not Required

Requirement of non-clinical Efficacy data: Not Required

Category: Aqueous extract dry/wet

Ingredient(s): As per text

Indication: New indications*

Requirement of non-clinical Safety data: Not Required

Published Literature: Not Required

Requirement of non-clinical Efficacy data: Required

Category: Hydro-Alcohol extract dry/wet

Ingredient(s): As specified

Indication: As per text

Requirement of non-clinical Safety data: Not Required

Published Literature If Required

Requirement of non-clinical Efficacy data: Not Required

Category: Hydro-Alcoholic extract dry/wet

Ingredient(s): As specified

Indication: New indications*

Requirement of non-clinical Safety data: Required

Published Literature: If Required

Requirement of non-clinical Efficacy data: Required

The need for liberal regulations 11

Category: Other than Hydro/Hydro-Alcoholic extracts containing other solvents

Ingredient(s): As specified

Indication: As specified/claimed

Requirement of non-clinical Safety data: Required for oral preparations. Single dose toxicity, Repeated systematic toxicity (long term toxicity studies in rats), Reproductive and Developmental toxicity, Genotoxicity, Carcinogenicity, metal/mineral toxicity (in cases of mineral/metal ingredients).

Published Literature: If Required

Requirement of non-clinical Efficacy data: Required

The standard protocol will also include the concept of Anupan, Prakriti and

Tridosha etc. published by Central Research Councils Ayurveda, Siddha, Unani and other Government/Research Bodies.

* New indication means which is other than mentioned in 1st schedule books of Drugs and Cosmetics Act 1940.

ADVISORY from AYUSH on April 2, 2019

Subject: Scientific Studies and publication of Research Papers on AYUSH

drugs and treatments by non-AYUSH researchers/scientists.

Whereas it is reported that research papers and scientific studies on AYUSH

(Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homoeopathy systems) drugs and treatments have been published by non-AYUSH scientists/researchers with unfounded statements & conclusions to damage the credibility and sanctity of the whole system and qualified AYUSH experts were not involved/consulted in these studies and research publications.

Whereas AYUSH systems are officially recognized an integral part of the country’s healthcare delivery network and are promoted and mainstreamed through various policies, strategies, and schemes of Government of India including the National Health Policy-2017, National Health Mission and National AYUSH Mission. Principles, concepts, and approaches of AYUSH

systems and their drug-based interventions are not at all comparable to the prevalent modern medical system. Whereas for scientific development of AYUSH systems, Central Government has inter alia established five Research Councils (viz. Central Council for Research in Ayurvedic Sciences; Central Council for Research in Unani Medicine; Central Council for Research in Sidhha; Central Council for Research in Homoeopathy; and Central Council for Research in Yoga & Naturopathy), published Good Clinical Practice GCP) guidelines for conduct of clinical trials in Ayurvedic, Sidhha and Unani medicine and implemented Extramural Research Scheme to support projects of scientific exploration of AYUSH, details are available in the Ministry’s

website www.ayush.gov.in;

12 Legacy and logical steps

Whereas potential and scope of AYUSH in public healthcare cannot be jeopardized and the people may not be distracted or dissuaded from resorting to AYUSH

from arbitrary statements and unfounded conclusions in the scientific studies and research publications related to AYUSH; Considering accordingly the need of protecting public image of AYUSH, all non-AYUSH researchers, scientists, institutions and editors of the medical/scientific journals are hereby advised to involve appropriate Expert/Institution/Research Council of AYUSH in conducting any scientific study/clinical trial/research intervention to explore AYUSH drug or treatment and for vetting of the publication of its outcomes and findings to prevent incorrect, arbitrary and ambiguous statements and conclusions about AYUSH.

All concerned are urged to take note of the advisory for compliance by the respective researchers/scientists/investigators. F. No. Z.2502310912018-DCC

(AYUSH)

For comments by Ayurvedic educationists and scientists, see “Each and every step of AYUSH will have far-reaching impact.”

General Guidelines for Clinical Evolution of Ayurvedic

Intervention (CCRAS):

In Drugs and Cosmetics Rules, 1945, Part XVI, legally there is no need of safety study or proof of effectiveness if an Ayurvedic drug is based on Text or Text ingredients and for treatment identified in the Texts. Water and Hydro-alcoholic extracts are also exempted. CCRAS has issued General Guidelines for Clinical Evolution of Ayurvedic Intervention (Volume III) should be referred to for Patent and Proprietary non-text based drugs or for drugs using other than water and hydro-alcoholic extracts.

For researchers, this document is worth going through.

Excerpts

The fundamental aspects of holistic systems need adequate positioning while designing clinical trials to examine the safety and efficacy of Ayurveda approaches. Furthermore, the other challenges and issues related to quality and safety viz. dosage forms/delivery system, diverse concepts and complex approaches in trial design, diagnosis and therapy, outcomes of clinical efficacy and drug interactions also pose certain limitations in research. A holistic approach may be adopted to validate the therapies and approaches with the integration of principles of Ayurveda and bio-medicine. Such an approach with well-designed research plans could possibly facilitate to generate tangi-ble evidence.

The following approach has been suggested by CCRAS:

The need for liberal regulations 13

Evidence Base in Ayurveda: Suggested Approach

Disease/Participant Classification

Diagnosis based on

Ayurvedic Principles Prakrti,

Modem Methods

Dosha, Dushya etc.

Therapeutic classification of Drugs

Conventional

Ayurvedic

Stage I: Controlled Clinical Observations

Combined Results

Analysis based on

Conventional

Ayurvedic principles

Stage II

Expanded Therapeutic Use

Mechanism of Action

(Traditional: Modern)

General Methodologies and Guidelines of Drug

Development (CCRAS):

Preparatory phase (1)

Prevalence survey and Formulation of drug/combination for Specific targeted indication and activity. (Appropriate basis of literary survey, previous clinical data of ingredients/any other data of claims, classical evidences, etc.)

Drug development phases (2)

Collection of raw drugs (2). (considering current good agricultural practices good field collection practices and classical textual methods.)

14 Legacy and logical steps

Botanical identification/Pharmacogonostic/Chemical studies of ingredients (3). (Based on available guidelines and classical methodology.) Formulation of SOPs and Standardization, stability studies, Quality assur-ance (4). (Considering the classical methods and current available physical/

chemical, Biological parameters, microbial loads,

Heavy metal estimation, pesticide residues, etc. for standardization and safety).

Preclinical safety studies (5)

(Acute/sub-acute-chronic studies as per intended therapeutic use with Institutional Animal Ethics Committee (IAEC) approval).

Animal Studies for biological activity and /or mechanism of action for clinical correlation (6) with IAEC approval. (preparation of preclinical dossier.) Design of study and formulation of Clinical protocols (7). (As per current guidelines and adopting Classical methodology.)

Execution of clinical trial (8)

Bulk preparation of quality assured Drug for clinical trial, packing labeling etc. as per requirement with approval of Independent Ethics Committee (IEC)/Independent Review Board (IRB) and Clinical Trial Registery-India (CTRI) registration for trial conduct and monitoring of Data analysis.

Note: Intellectual Property Rights (IPR) Protection and issues of filing of patent to be addressed at suitable stage.

Phases of clinical trial for ayurvedic drug/patent or

proprietary medicines

Aim and Objective: To discover or verify the clinical, pharmacological (including pharmacodynamics/pharmacokinetics), and/or adverse effects, safety and/or efficacy.

Human pharmacology (Phase I)

(i) The objective of studies in this Phase is the estimation of safety and tolerability with the initial administration of an Ayurvedic Drugs/Patent or Proprietary Medicines into human(s). Studies in the Phase of development usually have non-therapeutic objectives and may be conducted in healthy volunteers or certain types of participants. Ayurvedic drug/Patent or Proprietary toxicity e.g. Ayurvedic drug/Patent or Proprietary Medicines with Schedule E-I ingredients are to be studied in participants.

Phase I trials should preferably be carried out with access to the necessary facilities to closely observe and monitor the participants.

The need for liberal regulations 15

(ii) Studies conducted in Phase I, usually intended to involve one or both of the following objectives:

a Maximum tolerated dose: To determine the tolerability of the dose range expected to be needed for later clinical studies and to determine the nature of adverse reactions that can be expected. These studies include both single and multiple dose administration.

b Early measurement of Drug activity: Preliminary studies of activity or potential therapeutic benefit may be conducted in Phase I as a secondary objective. Such studies are generally performed in later Phases but may be appropriate when the drug activity is readily measurable with a short duration of drug exposure in participants at this early stage.

Therapeutic exploratory trials (Phase II):

(i)

The primary objective of Phase II trials is to evaluate the effectiveness of an Ayurvedic Patent or Proprietary Medicines for a particular indication or indications in participants with the condition under study and to determine the common short term side-effects and risks associated with the drug.

Studies in Phase II should be conducted in a group of participants who are selected by relatively narrow criteria leading to a relatively homogeneous population. These studies should be closely monitored. An important goal for this Phase is to determine the dose(s) and regimen for Phase III trials.

Doses used in Phase II are usually (but not always) less than the highest doses used in Phase I. These studies should be intended to provide an adequate basis for marketing approval for Ayurvedic drug/Patent or Proprietary Medicines.

(ii) Additional objectives of Phase II studies can include evaluation of potential study endpoints, therapeutic regimens (including concomitant medications) and target populations (e.g. mild versus severe disease) for further studies in Phase II or III.

(iii) These objectives may be served by exploratory analyses, examining subsets of data and by including multiple endpoints in trials.

Therapeutic confirmatory trials (Phase III)

(i)

Phase III studies have primary objective of demonstration or confirmation of therapeutic benefits(s). Studies in Phase III are designed to confirm the preliminary evidence accumulated in Phase II that a drug is safe and effective for use in the intended indication and recipient population. Studies in Phase III may also further explore the dose-response relationships (relationships among dose, and clinical response), use of the drug in wider populations in different stages of disease, or the safety and efficacy of the drug in combination with other drug(s).

16 Legacy and logical steps

(ii) For Ayurvedic drug/Patent or Proprietary Medicines intended to be administered for long periods, trials involving extended exposure to the drug are ordinarily conducted in Phase III, although they may be initiated in Phase II. These studies carried out in Phase III complete the information needed to support adequate instructions for use of the drug (prescribing information).

(iii) For Ayurvedic drug/Patent or Proprietary Medicines approved outside India, Phase III studies need to be carried out primarily to generate evidence of efficacy and safety of the Ayurvedic drug/Patent or Proprietary Medicines in Indian participants when used as recommended in the prescribing information. Prior to conduct of Phase III studies in Indian participants.

(iv) If the application is for the conduct of clinical trials as a part of multi-national clinical development of the drug, the number of sites and participants as well as the justification for undertaking such trials in India should be provided to the Licensing Authority along with the application.

Post marketing trials (Phase IV)

Post Marketing trials are studies (other than routine surveillance) performed after drug approval and related to the approved indication(s). These trials go beyond the prior demonstration of the drug’s safety, efficacy and dose definition. These trials may not be considered necessary at the time of new drug approval of Ayurvedic drug/Patent or Proprietary Medicines but may be required by the Licensing Authority for optimizing the drug’s use. They may be of any type but should have valid scientific objectives. Phase IV trials include additional drug-drug interaction(s), dose-response or safety studies and trials designed to support use under the approved indication(s), e.g. mortality/morbidity studies, epidemiologi-cal studies etc.

NOTE

• For classical Ayurvedic drugs with the same textual indications, directly phase III/IV trial may be conducted.

• For classical Ayurvedic drug with new indications/Patent or Proprietary Medicines, directly phase II trial may be conducted.

• Patent or Proprietary Medicines with Schedule E-I ingredients, Phase I trials may be conducted as appropriate.

There are mainly two types of clinical studies: Observational and Experimental.

Observational study

An observational study is one which tries to explore the cause-and-effect relationships. Like experimental study the investigators are not able to control the

The need for liberal regulations 17

participants by allocating in groups or assigning any particular treatment. The Investigators only observe the participants involved and their responses by asking questions, or taking some measurements, or looking at clinical records.

A sample survey is an example of an observational study. Followings are observational studies:

Case series studies: Case-series is a descriptive study design wherein a series of cases of any particular disease that one might observe in one’s clinical practice, hospital and so on is presented. There is no control group in this type of study. In terms of evidence, this is a weak study design but it can help provide leads in designing research studies.

Case reports: Documentation of reports on a single participant constitutes case reports. They do not use control groups and hence do not have high statistical validity or cannot provide conclusion about the causality but can provide leads to the formulation of a hypothesis for potentially high impact research studies.

Case control studies: When a correlation is drawn between factors or exposures as causal in participants who have a specific health condition. These studies are retrospective when the history and reports of the participant are analyzed and a correlation is drawn if they might have been causal. This is compared with the history and reports of participants who do not have the health condition. This level of evidence in such studies is low when compared to randomized controlled trials or cohort studies because just a statistical association do not necessarily conclude cause and effect relationship. For example, tobacco and cancer.

Cohort studies: A ‘cohort’ meaning is a population who are exposed to similar environmental conditions. This is a kind of observational study where one group of a cohort with exposure to a particular causative agent or a treatment is compared with a similar group who are not exposed. They are followed up prospectively. The level of evidence here is lower when compared to randomized controlled trials. For example, tobacco use among working and none working adolescents.

Cross sectional studies: A cross sectional study is an observational study that aims at determining the exposure and prevalence of disease at the same point in time in a given population for e.g., prevalence of post traumatic stress disorders in people after Tsunami. It can also be used in determining the sensitivity and specificity of new diagnostic tests.

Experimental study

In a clinical trial, participants receive specific interventions according to the research plan or protocol created by the Investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants’ behavior, such as diet. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or to no intervention. Some clinical trials compare interventions that

18 Legacy and logical steps

are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. The scientific integrity of the trial and the credibility of the data from the trial depend substantially on the trial design.

Single arm trials: Single arm trial is the simplest trial design. A sample of participants with a particular disease is administered an intervention and the effect is measured after a decided period of time to observe the response.

This design is adopted where placebo effect is minimal or there is no scope for incorporating or it is unethical to include a placebo arm. The level of evidence is low in this design usually. However, it is apt for validation o f Panchakarma procedures, application of leech, Agnikarma, Ksharasutra, etc.

Cross over trials: In a cross over design, the objective is to compare the effect of therapies. The trial participant is randomly allocated to one treatment protocol for a period of time and then later after a wash out period, the same participant is randomly allocated to another treatment protocol and the effects of treatments are compared.

Factorial Trials: Factorial designs are considered when the objective of the study is to compare effects of a minimum of two treatment protocols either alone or in combination. For example, if there are two interventions A and B

then group-1 is given intervention A, group-2 is given B, group-3 is administered both A and B and group-4 is given neither. Factorial designs are considered when the effects o f more than two interventions are to be evaluated.

Non inferiority trials (Active Controlled trials): This type of trial design consists of testing the effect of a particular treatment in comparison with an available standard treatment. Non inferiority trials are designed to effectively evaluate the effect of a particular intervention where incorporation of a placebo group is unethical.

Parallel design: Placebo controlled trials: A placebo is an agent that produces an effect on the disease through a psychological mechanism i.e., through a non specific effect which does not comply with a definable, physiological mechanism. Therefore, placebo effect needs to be nullified to prove that drug /therapy /formulation intended to produce an effect on the disease occurs genuinely through a definable bio – physiological mechanism. Placebo controlled design with randomization and blinding produces highest evidence. They require large sample sizes.

Three arms trial: Placebo and active control: This design involves inclusion of a placebo as well as an active control group and provides good internal evidence of sensitivity.

Add on Study: An add on study is a placebo-controlled trial wherein a new agent is concomitantly administered in participants in addition to receiving a standard treatment. These kind of studies are useful when the existing treatment is not fully effective and there is evidence that another treatment,

The need for liberal regulations 19

in addition, can bring about better outcomes and if there are no adverse drug reactions or interactions.

Three arms trial: Placebo and active control: This design involves inclusion of a placebo as well as an active control group and provides good internal evidence of sensitivity.

Add on Study: An add on study is a placebo-controlled trial wherein a new agent is concomitantly administered in participants in addition to receiving a standard treatment. These kind of studies are useful when the existing treatment is not fully effective and there is evidence that another treatment in addition can bring about better outcomes and if there are no adverse drug reactions or interactions.

Replacement study: In this design a new drug or placebo is randomly added to the conventional treatment and the conventional treatment is then slowly withdrawn usually by tapering. This design can effectively evaluate the ability of the participant to maintain the baseline status after withdrawal of the conventional treatment.

Early escape rescue treatment: If in a trial, administration of a treatment protocol is either ineffective or if it results in worsening of the disease and who otherwise would require a rescue treatment like in seizures or angina then the trial treatment is withdrawn. Here the need to change the treatment becomes the study end point. This design evaluates short term effectiveness of a treatment protocol.

Limited placebo period: In situations where it is not possible to continue the participants for long duration of placebo administration the placebo group is maintained for a short duration and then the trial would go on with an active control group without the placebo group. This design evaluates short term effectiveness of a treatment protocol.

Additional doses design: This design involves randomizing participants into parallel groups of different fixed doses of a certain treatment protocol. This design evaluates dose based response.

Randomized withdrawal: In this design participants getting a test treatment for a particular period of time are randomly assigned to continued test treatment and placebo. Difference between those receiving continued treatment and those on placebo reveals the effect of active treatment and evaluates the status of remission or aggravation of a particular disease and long term efficacy.

No-treatment concurrent control: No treatment concurrent control design involves randomization of participants into test treatment and no treatment. This design can be used when it is not possible to use double blinding.

External control (including historical control): This is a comparative trial where participants receiving an active treatment is compared with a control from another study at another setting at the same point of time (External control) or if it is taken from a study conducted at an earlier point of time (historical control) it is known as external control.

20 Legacy and logical steps

Designs amenable to test ayurvedic therapies

Black-box design

Generally, Ayurvedic treatments are not just isolated administration of a therapeutic molecule or a single drug but, are a combination of drugs/procedures that constitute a therapy for a particular health condition for a particular individual.

Therefore, a traditional treatment that may consist of a set of therapeutic procedures should be considered as one single module which is studied in comparison with either placebo or a standard treatment. This allows the Ayurvedic treatments to be determined within its theoretical framework and not compromising with the fundamental principles of traditional medicine.

Reverse Pharmacology (RP) design

In the realm of traditional medicines, many herb based medicinal formulations have known to have healing effects on many health conditions but such results have not been pursued rigorously through research studies to know the effect of such medications in various complex biological systems. Therefore the concept of Reverse Pharmacology (RP) helps in addressing the issue where the effect of the Ayurvedic formulation on a health condition is known but the mechanism of action is not known. In this approach, the drug candidate travels a reverse path from ‘clinics to laboratory’ rather than classical ‘laboratory to clinics. This concept has three phases as follows:

RP-Phase I: This involves an experiential phase where comprehensive documentation of clinical observations of the effect of standardized Ayurvedic drug on the biological systems is done.

RP-Phase II: The purpose of this phase is to evaluate the target activity of the Ayurvedic formulation/drug/Therapy under in-vitro and in-vivo models and exploratory studies for tolerability, drug-interactions and dose-range.

RP-Phase III: The purpose of this phase is to carry out basic and clinical studies at several levels of biological organization and to identify and correlates of drug safety and efficacy.

Studies in this phase should be able to decipher mechanisms of action at multiple biological systems and to optimize safety, efficacy and acceptability of the leads in natural products based on relevant science.

Placebo controlled trials

The use of a placebo generates evidence of better quality. Placebo controlled trials are intended to establish the medicinal value of many Ayurvedic single plant drugs which are preferred globally (added by the Author). It allows Investigators to distinguish specific from non-specific effects of treatment in order to determine

The need for liberal regulations 21

whether the additional cost, risk and effort of a specific treatment are worthwhile.

It is also important for understanding the mechanism of a treatment. This is true for the evaluation of all drugs. It is not only of academic interest, but is also practical value, especially for developing new treatments from traditional ones.

However, in some cases, where disease-based whole phytocomplex treatment is not preferred, placebo controlled trials may not be possible. The principles of Ayurveda follow the system biology approach where the response to a therapy is evaluated in terms of the body as a whole and not confined individual system.

Most of the drugs are also polyformulations consisting of ingredients from plant, mineral and animal origins and not an active molecule as in case of the modem system of medicine. It is very difficult to have the trial drug and placebo prepared in a way that they are similar in colour, taste, size, weight, same smell and same consistency.

Therapy in Ayurvedic system of medicine also involves procedural interventions like Panchakarma in Ayurveda and so on for which designing placebo becomes impossible. In such cases, appropriate control groups can be incorporated like active controls or no interventions etc.

Different controls can be used in clinical trials to answer different questions.

The use of a placebo, when possible, is desirable, because it generates evidence of better quality. Placebo controlled trials are intended to establish whether treatment is valuable over and above what might be achieved by a control treatment, and not whether treatment is valuable at all. Thus, it allows Investigators to distinguish specific from non-specific effects of treatment in order to determine whether the additional cost, risk and effort of a specific treatment are worthwhile. It is also important for understanding the mechanism of a treatment. This is true for the evaluation of all drugs. It is not only of academic interest, but is also of practical value, especially for developing new treatments from traditional ones. However, in some cases, placebo controlled trials may not be possible.

Data-based studies

Systematic reviews: These are studies based on already published studies. A certain review criteria is decided and with a sound methodology, the results of the published studies are scrutinized and summarized for e.g., Effect of herbal medicines with significant effect on Hamilton depression rating scale in participants suffering from depression.

Meta analysis

These studies are also based on already published studies. The study compiles and examines the results of number of valid studies on a particular topic and consolidated results are presented. For example Meta-analysis of RCTs on the anxiolytic effect of Ashwagandha.

Data based studies on Ayurvedic drugs can provide much needed evidence to recommend use of Ayurvedic interventions among scientific community.

22 Legacy and logical steps

Conventionally, the level of evidence is ranked in order of risk of bias and from top to bottom ranked as Meta-analyses, Systematic reviews, Interventional studies, Observational studies and experts’ opinions. (See Annexure III – Level of evidence.)

However, due to classical textual evidence, long history of use and vast clinical experience, this hierarchical ranking of level of evidence may not be completely apt for Ayurveda and its approaches.

Randomization

Randomization is used to develop comparable groups to assess therapeutic interventions. It is essential to control various known, and even unknown, biases. Nev-ertheless, there are many situations where randomization can be impossible or unethical. The best way to solve this problem is probably by the proper selection of control treatments.

Randomization method and procedure (wherever applicable)

Simple random samples: This is a procedure where each individual of a population has equal probability of being selected. A simple random sample is representative of a population and gives external validity. The results obtained have good generalize ability of results. Random number generators are available online. It can also be generated using excel sheet.

Random allocation: Random allocation is a procedure of randomly allocating an identified sample to different groups. Each participant has the same probability of being assigned to a particular group.

Block randomization: This randomization procedure helps in achieving same sample size in two or more groups. Block randomization is done by generating random permuted blocks (blocking). For e.g., in a block size of six consecutively enrolled participants three can be allocated to one treatment group and three to another. The ratio of allocation can also change.

This method helps in interim analysis.

Stratified randomization

To avoid imbalances among baseline characteristics, pre-randomization stratifica-tion is done based on requirement like age, gender, prognostic factors etc.

Methods of blinding

Blinding is a process of ensuring that the people involved in a research study (participants or investigators) do not know about what treatment they are receiving. This procedure is incorporated to minimize the biases that arise due to differences in treatment, management, investigator who is carrying out the study, rather who assesses the participants or one who interprets the results. These biases

The need for liberal regulations 23

arise because participants who know about the active treatment might report more favorable outcomes. The Raters or Investigators who know about the treatment may over enthusiastically rate the response to a treatment or they might under-mine the response to placebo or no treatment. Knowledge of treatment might influence the people to use favorable statistical tests.

Open: The participants, investigators, and data analyst know about what treatment they are receiving.

Single blind: Here either the participant or investigator does not know about the treatment.

Double blind: Here neither the participant nor the investigator knows about the treatment.

Triple blind: This is a blinding procedure in which the participant, the investigator and the data analyst does not know about the treatment.

Randomization codes and procedures for breaking the code

Breaking the codes/un-blinding in case of emergency

Randomization codes are computer generated. Requirement for unblinding arises out of an emergency. The Investigator gets the primary information about the emergency and therefore he should have a developed mechanism for breaking the codes. The investigator should access to sealed envelopes 24 hours a day. He can also delegate a suitable person to carry out the code break. The sponsor should be notified about the code break within 24 hours. In a non emergency situation the code-break cannot be done without the approval of the sponsor.

Breaking the codes/un-blinding at the end of the trial

Breaking the codes/un-blinding is done by a formal request to the Sponsor and head of the Institute but should not be done until the following events have been completed:

• Completion of last follow up of the participant

• All data has been entered and validated and there is no scope for further changes.

It is better that the statistician is also blinded until the analysis is complete.

Information on establishment of study code, where it will be kept and when, how, and by whom it can be broken in the event of an emergency.

Allocation concealment

Allocation concealment is a procedure that ensures that either participants or investigators do not know what is being received by the participant. Ideally, the

24 Legacy and logical steps

procedure is done as follows: The trial drug and placebo are prepared in a way that they are similar in colour, taste, size, weight and smell.

In double blind study a random sequence of codes is generated centrally and assigned to the prospective participants. Sequentially numbered sealed opaque coded envelopes with aluminium foils to prevent revealing against bright light are assigned to each trial participant with details of the treatment inside. After obtaining the consent, the random code is assigned to the participant. The envelopes are generally stored in the pharmacy and the pharmacist gives the containing drug or placebo to the participant.

In single blind studies where the investigator knows about what the participant is going to receive, the centrally generated random sequence of numbers is assigned to the prospective participants in terms of who is going to receive drug or placebo. The sequentially numbered sealed envelopes are coded for drug or placebo. The codes should not be in such a way that if the un-blinding is done for one participant in case of emergency then, it should not reveal the codes for all the participants. For example, if ‘0’ is used to code placebo and ‘1’ to drug, then if an emergency situation necessitates, un-blinding the information about all the participants is automatically revealed. The codes could be generated and kept by the sponsor/central funding agency and will be broken by them in case of emergency.

Blind assessment

Blind assessment is a critical component of conventional evaluation of therapeutic interventions.

However, in the evaluation of efficacy of procedure-based therapies (such as Panchakarma therapy, Ksharasutra, Agnikarma, Jalauka therapy, etc) and Multi-drug regime it may be difficult, impractical or impossible for the Investigator to be kept ignorant of what treatment the participants are receiving.

Treatment blinding in the evaluation of Ayurvedic medicines should adopt the approach of conventional medicines, e.g. using active and control formulations with similar appearance, taste and weight. However, if the Ayurvedic medicine cannot be administered in a predetermined standardized formulation, it will be impossible to keep the treatment blinded.

Summary

(Ayurvedic) Drug includes all medicines intended for internal or external use for or in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, and manufactured exclusively in accordance with the formulae described in, the authoritative (54) books specified in the First Schedule of The Drugs and Cosmetics Act, 1940.

Patent or proprietary Ayurvedic medicine means: (1) All formulations containing only such ingredients mentioned in the formulae described in the

The need for liberal regulations 25

authoritative books of Ayurveda (2) In relation to any other systems of medicine, a drug which is not included in the edition of the Indian Pharmacopoeia for the time being or any other Pharmacopoeia authorized in this behalf by the Central Government, after consultation with the Drugs Technical Advisory Board.

All non-AYUSH researchers, scientists, institutions and editors of the medical/scientific journals are advised to involve appropriate Expert/Institution/

Research Council of AYUSH in conducting any scientific study/clinical trial/

research intervention to explore AYUSH drug or treatment and for vetting of the publication of its outcomes and findings to prevent incorrect, arbitrary and ambiguous statements and conclusions about AYUSH. (ADVISORY

from AYUSH on April 2, 2019.)

Final report of the AYUSH task force (Submitted to Ministry

of AYUSH, Government of India, on 12 October 2015.)

Salient features

A few decades from now, single knowledge system based medical hospitals, clinics and even medical colleges, will become relics and even AYUSH systems will not be any exception. The best way ahead seems to be for AYUSH systems and modern medicine to collaborate on sound footing of the scientific evidence base, in the best interest of public health.

5.3 Recommendations

5.3.4 The definition of Drug of AYUSH origin is very strict and only classical formulation can be considered as drug in regulation. It should be amended in a way so that it can include new drugs and formulations of natural origin either from classics, ethnobotany origin or from the research outcomes.

5.3.5 The regulations should be upgraded to align with international standards wherever they exist like GMP and contaminants in a time bound fashion giving reasonable time to the industry to upgrade itself. Tax incentive for such upgraded industry should be offered.

5.3.10 The public lab infrastructure is in a dismal state and there is a need to think of Public-Private Partnership (PPP) model for their operation. Also rather than creating labs in government sector except for well managed referral labs, more and more labs in non-governmental and private sectors should be notified.

5.3.11 There is a need for up gradation of public labs by prescribing National Accreditation Board for Testing and Calibration Laboratories (NABL) accredita-tion as a requirement to upgrade our regulatory framework to international standards. Only accredited labs should be used under the D&C Act – this can be done right away.

26 Legacy and logical steps

5.3.15 The AYUSH industry needs high quality medical plants and therefore, the Medicinal plant certification scheme of National Medicinal Plants Board in collaboration with Quality Council of India (NMPB-QCI) needs to be promoted.

5.3.16 The cultivation of medicinal plants by AYUSH manufacturers based on Good Agricultural Practice (GAP) should be incentivized.

1.2 Goals underlying the recommendations

1 To establish safety and efficacy of AYUSH treatments for diseases of national and global importance using internationally accepted research methods and designs.

2 To promote collaborative clinical and basic research that has the potential to transform healthcare, involving reputed AYUSH and modern medical institutional partners in India and abroad.

3 To develop patents, novel products, services and biological concepts including tissue engineering and nano engineering medical products that have the potential to impact global health.

6 To support high quality publications as well as peer-reviewed, indexed, high impact journals.

1.3.1. Recognize selected existing reputed autonomous health science institutions from public or private sectors, engaged in basic/applied research, clinical practice and community outreach with a track record of minimum 15 years of innovative work and possess the legal status of universities or centers of excellence and upgrade them into institutes of national importance.

Such institutions whether in public or private sector should have autonomy to engage in innovative research and education. These institutes will also be expected to publish high quality publications as well as, peer-reviewed, indexed, high impact journals.

1.3.2. Support large scale multi-centric clinical research involving reputed AYUSH and modern medical colleges, universities, hospitals and research institutions both in the public or private sector. These studies should be undertaken mainly public or private sector conforming to globally accepted guidelines and suitable reporting standards, such as Consolidated Standards of Reporting Trials (CONSORT), Strengthening and Reporting of Observational Studies in Epidemiology (STROBE), Animal Research Reporting of in vivo Experiments (ARRIVE) etc. based on both International classification of diseases (ICD) and AYUSH classification system with novel and epistemologically sensitive methods and designs.

5.1.1 Industry

The AYUSH industry is currently regulated under the Drugs and Cosmetics Act that also regulates the modern medicine industry. It is observed that the regulator is focused more on modern medicine than on AYUSH regulation. Consequently,

The need for liberal regulations 27

the AYUSH industry regulation gets neglected with many states not even having suitably qualified manpower for AYUSH regulation and hence on the ground the consumer does not get access to quality products as intended under the regulation. Further, there is poor inflow of samples to AYUSH labs for testing quality and the labs set up by investing considerable funds by the Ministry of AYUSH, function poorly. While international standards for GMP have been prescribed by WHO for herbal medicines, the AYUSH regulation is still short of international standards like GMP as per Schedule T and therefore AYUSH products are not globally competitive.

5.3.2 Services

1. The regulations should be based on international standards, if available, and to this end, all existing regulations should be reviewed and upgraded to such standards in a time bound manner keeping in view the relevant industry’s preparedness.

Editor’s Note: The Holistic concept of Ayurveda was unique 5000 years back. It was based on Vata-Pitta- Kapha- prakriti-linked imbalance in the body.

Now, Ayurvedic medicines are to be produced for millions whose prakriti is not known. Holistic medicine is an individually-tailored medicine. That is the reason its formulations contain many herbs added on the basis of a number of Ganas and Vargas which may not be required in a disease-based herbal medicinal system. For further development of Ayurveda as a disease-based system, we will be suggesting a number of steps for which regulatory liber-alization will be needed.

In India, the national policy on traditional and alternative medicine was introduced in 1940 in the form of Drug and Cosmetic Act 1940 and Drug and Cosmetic Rule, which was updated in several instate. In 1959, Govt of India recognized traditional Indian System of Medicine (ISM) and updated Drug and Cosmetic Act. Several expert committees for different ISM were established from time to time and the earliest was established in 1962. In the year 1969, separate chapter related to Ayurveda, Siddha and Unani drugs was inserted by act 13 of 1964 in the Act, which partly similar to those for conventional pharmaceuticals.

Later the act was modified again with some substitutions in the year 1983, 1987, 1994

and 2002. In 2006 and 2008 guideline for evaluation and analysis of drugs under ISM

was given under Drug and Cosmetic Rule 1945. The Central Council of Indian Medicine (CCIM) is constituted in the year 1970, which involved in the framing and implementing different regulations including the curricula and syllabii in ISM (i.e., Ayurveda, Siddha and Unani). In 2012, Sowa Rigpa system of medicine is incorporated in the CCIM. Department of Indian Medicine and Homeopathy (ISM & H) was formed with the objective to develop the ISM. In 2003, this Department was renamed as Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), and in 2014 separate ministry on AYUSH was formed.

28 Legacy and logical steps

References

1 Government of India, Ministry of Health and Family Welfare (Department of Health), The Drugs and Cosmetics Act and Rules. The Drugs and Cosmetics Act, 1940 (23 of 1940) (As amended up to the 31st December, 2016) and The Drugs and Cosmetics Rules, 1945 (As amended up to the 31st December, 2016).

2 General Guidelines for Drug Development of Ayurvedic Formulations Volume 1. Published by Central Council for Research in Ayurvedic Sciences (CCRAS).

3 General Guidelines for Safety/Toxicity Evaluation of Ayurvedic Formulations, Volume II. Published by CCRAS.

4 General Guidelines for Clinical Evaluation of Ayurvedic Interventions Volume III. Published by CCRAS.

Some portions in the text have been highlighted by the Editor for emphasis.





2 Each and every step

of AYUSH will have

a far-reaching impact

Opinion of Ayurveda educationists

A recent advisory (F. No. Z.25023–10912018-DCC (AYUSH) dated 2 April 2019) issued by the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India, expresses concerns regarding the publication of research papers and scientific studies on AYUSH drugs and treatments “by non-AYUSH scientists/researchers with unfounded statements and conclusions to damage the credibility and sanctity of the whole system” because

“qualified AYUSH experts were not involved/consulted in these studies and research publications.” This advisory further states that

potential and scope of AYUSH in public healthcare cannot be jeopardized and the people may not be distracted or dissuaded from resorting to AYUSH

from arbitrary statements and unfounded conclusions in the scientific studies and research publications related to AYUSH.

The advisory therefore states that

all non-AYUSH researchers, scientists, institutions and editors of the medical/scientific journals are hereby advised to involve appropriate Expert/

Institution/Research Council of AYUSH in conducting any scientific study/

clinical trial/research intervention to explore AYUSH drug or treatment and for vetting of the publication of its outcomes and findings to prevent incorrect, arbitrary and ambiguous statements and conclusions about AYUSH.

Such steps would not only curb the much-needed unbiased research in these traditional medicine systems but also limit the freedom to think, both of which are fundamental requirements for improving our understanding in any discipline. We believe that actual disrepute to the traditional Indian healthcare systems, including Ayurveda, is caused by the mushrooming of low-quality journals that publish poor-quality research, often by AYUSH “experts” themselves. The low-quality research derives from the unsubstantiated data being included in postgraduate/

PhD theses in the numerous colleges and universities that have mushroomed. It

30 Legacy and logical steps

is also a known fact that many of these AYUSH colleges retain their recognition through “ghost” patients, teachers and even students. Obviously, the pseudo-research conducted at these institutions not only brings a bad name to AYUSH but also generates a workforce that can only do more damage to the system. The low-quality medicines being marketed by spurious pharmacies also bring disrepute to AYUSH. The ministry should be more concerned with these rather than placing a gag on studies and voices that report research findings that may not fully agree with the traditionally held views.

It is possible that there are non-AYUSH researchers who also generate and publish poor research output. However, just as there are good and quality-conscious AYUSH researchers, there are non-AYUSH researchers who have contributed and continue to do so positively and significantly to the understanding of the principles and mechanisms of actions of these treatment modalities. For example, the pioneering and extensive contributions of a few organic chemists to the chemistry of herbal products, widely used in Ayurveda, are well known. Likewise, many basic science studies on modes of actions of a large variety of herbal and Ayurvedic preparations unraveled their biological mechanisms and opened new and effective therapeutic applications. Many such studies have also unraveled positive and negative interactions between herbal and modern medicines. Several genomic and molecular biologists have produced significant medicines. Several genomic and molecular biologists have discovered significant concepts of Ayurveda in terms of contemporary biology. These are but a few examples of significant contributions by primarily non-AYUSH researchers that have truly enriched the field. An unopposed faith in ancient knowledge and practices on account of their being traditional, without revalidation in the contemporary context, is indeed ominous.

The AYUSH practices and formulations need to be substantiated by evidence-based understanding. Studies undertaken by AYUSH or non-AYUSH researchers that question a traditionally held belief and bring systematic evidences challenging its rationality, need to be taken seriously rather than being considered as a distraction or “insult” to the ancient wisdom. Intellect and social order move forward only with knowledge and understanding that go beyond what our predecessors knew.

Actually, we need to foster more unbiased multidisciplinary research rather than making it a close-door system consisting only of allies.

Asking the journal editors to ensure the inclusion of AYUSH experts as authors in a research paper is not only against the autonomy of a researcher but is also pejorative to the reputation of “science publishing.”

– S. C. Lakhotia

SERB Distinguished Fellow, Department of Zoology,

Banaras Hindu University; Kishor Patwardhan,

Professor in Kriya Sharir Banaras Hindu University

and Sanjeev Rastogi, Professor (Associate), State

Ayurvedic College, Lucknow. ( Current Science, May 2019.)

Far-reaching impact of AYUSH 31

Comments by eminent scientists

No democratic nation can regiment free research by academia. The image has to be built and not protected or projected! This advisory can have no legal validity. The quality of research has to be built with training, apprenticeship, expertise in R&D methods and proper peer review of research papers. But I do agree that AYUSH experts/researchers can be part of many investigations for drawing on their rich clinical experience and knowledge of AYUSH

systems.

Who decides the expertise/Institution/Research Council of AYUSH, with a proven track record and training in scientific exploration in AYUSH drug or treatment? How would the Ministry of AYUSH control drug research in other countries or pharmaceutical/nutraceutical R&D industry abroad or in India? Many of the medicinal plants used in Ayurveda are also indigenous to TCM, South Asian Medicine, African healers, etc. How can that be controlled?

As per the advisory, my teacher late Dr. Rustom Jal Vakil should not have worked on Sarpagandha, that led to a revolution in therapeutics.”

– Ashok D. B. Vaidya MD, PhD, FAIM

Former Regional Medical Director (South Asia)

Ciba-Geigy (Now Novartis); Research Director, Kasturba

Health Society-Medical Research Centre; Adjunct

Professor, Saurashtra University, Rajkot; Drexel University,

Philadelphia; Transdisciplinary University, Bengaluru

AYUSH should answer the following questions: I. Rationale for issuing such an Advisory? II. Is it evidence based? III. How to define qualified AYUSH

experts? IV. Will such advisory not restrict the research in Ayurveda in modern laboratories? V. Is the research data generated in AYUSH established laboratories compatible with global standards? VI. Has AYUSH published their own journal having impact factor or global standard in spite of large funding?

VII. Does AYUSH have a list of Ayurveda postgraduates/doctorate working in modern laboratories of our own country/abroad? VIII. Have AYUSH har-monized protocols/regulations?

It may not be out context to mention that even today, AYUSH do not have their own Indexed journal with impact factor till date. Why young Ayurveda graduates/postgraduates perform extraordinary well at National labs ICMR/

CSIR/DBT many public/private organizations except Ayush supported labs?

Most of these experienced students leave AYUSH and India, as AYUSH does not have a special scheme to absorb/tap this talent on suitable positions, nor efforts are being made in this direction. This may be analyzed critically.

We endorse the views of Dr. Ashok Vaidya that the “quality of research has to be built with training, apprenticeship, expertise in R&D methods, providing state-of-art infrastructure and proper peer review of research papers” to

32 Legacy and logical steps

popularise the pride of Ayurveda. It is vice versa and AYUSH-Advisory is detrimental for the department itself.

– Dr. B. Dinesh Kumar, FNAMS, FAPASc, FTASc, FIPS

Coordinator, Centre for Advanced Research for

Pre-clinical Toxicology (PCT); President, Indian

Pharmacological Society (IPS); Secretary,

Nutrition Society of India (NSI); National Institute

of Nutrition (NIN) Indian Council of Medical Research

It is explicitly calling for censorship, albeit (one that is) voluntary for now.

It is essentially an instruction to the public-sector funding agencies to ensure compliance. This is a classic ploy we have seen repeatedly used in the past few years.

– Satyajit Rath

Medical Immunologist and teacher

Indian Institute of Science Education and Research, Pune

Any attempt to discourage research in AYUSH by non-AYUSH streams would have disastrous consequences to the already struggling system facing allegations of lack of scientific evidence.

In my opinion, the advisory is hyper protective knee jerk reaction by the Ministry.

AYUSH had earlier signed agreements with scientific organizations like Department of Biotechnology and the Council of Scientific and Industrial Research to promote and conduct research. The same AYUSH issuing such advisories displays lack of vision and direction. – Dr. Chandra Kant Katiyar CEO (Technical) Healthcare, (Zandu) Emami Ltd, Kolkata

Opinions expressed in the media indicate that scientists are worried that the advisory is intended to suppress results that might be unfavorable to AYUSH. Several researchers had in the past highlighted that even agencies meant to frame regulations for AYUSH had promoted remedies without adequate scientific evidence.

Government laboratories too have released traditional remedies without adequate evidence of their health claims. Two laboratories under the Council of Scientific and Industrial Research (CSIR), about five years ago, had introduced two herbal medications for the treatment of diabetes. It was pointed out that there were no records of clinical trials on either of the two products.





3 To move with the times

Expand the knowledge base

of Ayurveda

Ayurveda’s future development should not be confined to the texts of 54 Authoritative books approved by AYUSH. This might preclude all new discoveries and research.

As a nation, we have a responsibility to further our traditional knowledge and improve and keep it updated and valid. By relying on 54 classical books which have historical references without any means of subjecting these writings to scrutiny, we have arrested the development of Ayurveda and consigned the science to history.

Current regulations of AYUSH are guided by 54 books that form the legal knowledge base of Ayurveda, on the basis of which formularies and pharmacopoeias of Ayurveda have been/are being developed. The list of authoritative books of Ayurveda is given in the first schedule of The Drugs and Cosmetics Act, 1940, amended on 1.2.1983, 31.8.1994 and 15.4.2010 (54 A, B, C, D).

Following is the legal knowledge base of Ayurveda:

1 Arogya Kalpadruma.

2 Arka Prakasha.

3 Arya Bhishak.

4 Ashtanga Haridaya.

5 Ashtanga Samgraha.

6 Ayurveda Kalpadruma.

7 Ayurveda Prakasha.

8 Ayurveda Samgraha.

9 Bhaishajya Ratnavali.

10 Bharat Bhaishajya Ratnakara.

11 Bhava Prakasha.

12 Brihat Nighantu Ratnakara.

13 Charaka Samhita.

14 Chakra Datta.

15 Gada Nigraha.

16 Kupi Pakva Rasayana.

17 Nighantu Ratnakara.

18 Rasa Chandanshu.

19 Rasa Raja Sundara.

34 Legacy and logical steps

20 Rasaratna Samuchaya.

21 2Rasatantra Sara Va Siddha Prayoga Samgraha, Part I; 21 (a)3 Rastantra Sar Va Siddha Prayog Samgraha, Part II (Edition 2006).

22 Rasa Tarangini.

23 Rasa Yoga Sagara.

24 Rasa Yoga Ratnakara.

25 Rasa Yoga Samgraha.

26 Rasendra Sara Samgraha.

27 Rasa Pradipika.

28 Sahasrayoga.

29 Sarvaroga Chikitsa Ratnam.

30 Sarvayoga Chikitsa Ratnam.

31 Sharangadhara Samhita.

32 Siddha Bhaishajya Manimala.

33 Siddha Yoga Samgraha.

34 Sushruta Samhita.

35 Vaidya Chintamani.

36 Vaidyaka Shabda Sindhu.

37 Vaidyaka Chikitsa Sara.

38 Vaidya Jiwan.

39 Basava Rajeeyam.

40 Yoga Ratnakara.

41 Yoga Tarangini.

42 Yoga Chintamani.

43 Kashyapa Samhita.

44 Bhela Samhita.

45 Vishwanathachikitsa.

46 Vrindachikitsa.

47 Ayurvedachintamani.

48 Abhinavachintamani.

49 Ayurveda-ratnakara.

50 Yogaratnasangraha.

51 Rasamrita.

52 Dravyaguna nighantu.

53 Rasamanjari.

54 Bangasena. 154A. 2 A yurvedic Formulary of India and its parts. 54B. Ayurveda Sara Samgraha. 354C. Ayurvedic Pharmacopoeia of India. 454D. Ayurvedic Pharmacopoeia of India and its Parts. (128–8–1987; 215–4–2010;

311–6–2002; 415–4–2010.)



212 31–8–1994. 213 15–4–2010.

212 31–8–1994. 213 15–4–2010.

1 Inserted by GSR 735 (E), dt 28–8–1987.

2 Substituted for “Ayurvedic Formulary of India” vide GSR 337(E), dt. 15–4–2010.

3 Inserted vide GSR 423(E), dt. 11–6–2002.

4 Inserted vide GSR 337(E), dt. 15–4–2010.

To move with the times 35

The period, name of author/editor/commentator and publisher are not mentioned.

Thus the list from 1 to 54 and 54B lacks transparency. It is difficult to identify the authentic text of almost all classical treatises due to commentators of different periods and editors of different schools of thoughts. Titles by contemporary vaidyas do not reflect their original contribution or research inputs, while the titles published by Ayurvedic drug manufacturers do not fall in the category of classical texts. Bharat Bhaishajya Ratnakara (number 11) was published by Unjha Pharmacy; Rasa tantra va siddha prayog sangraha (number 21) was published by Krishna Gopal Ayurveda Bhavan, Ajmer, Siddhayoga Sangraha (number 33) was published by Baidyanath Ayurveda Bhavan, Calcutta, and Ayurveda Sar Sangraha (number 54B, placed between Ayurvedic Formulary of India and Ayurvedic Pharmacopoeia of India) was published by Sri Baidyanath Bhavan Pvt. Ltd., Nagpur. ( Identity of publishers is disclosed by the Editor.) The original list has been drawn irrespective of the historical value of the content and is not arranged chronologically. Charaka Samhita is placed at 13th place and Sushruta Samhita at 34th, while Arogya Kalpadrum (Malayalam, by Kaikulangara Ramavarrier*) is at number 1; Arka Prakasha (Ravana) at number 2; Arya Bhishak (Gujarati, by Shankar Daji Pade*) at number 3; Ayurveda Sangraha (Bangla*) at number 8; Bharat Bhaishajya Ratnakara, published by Unjha Pharmacy, at number 11.

Only a few titles are available in Ayurvedic colleges and research libraries.

Out of 54 Ayurvedic books enlisted in the Drugs and Cosmetics Act of 1940, the Central Council for Research in Ayurvedic Sciences (CCRAS) has published/

processed the translations of 13 books:

Published books: Astanga Samgraha; Basavarajeeyam; Abhinava Chintamani; Rasa Pradeepika (Telugu); Sahasra Yoga; Rasa Chandansu (Marathi, in Press).

Books still being processed: Arya Bhishaka (Gujarati*); Vaidyak Chikitsa Sara (Gujarati); Ayurveda Sangraha (Bangla*); Arogya Kalpadruma (Malayalam*); Nighantu Ratnakara (Marathi); Sarva Roga Chikitsa Ratnam (Malayalam); Bhela Samhita.

* Identified by the Editor.

Though Sahasrayoga Sanskrit/Hindi text was published by CCRAS on Novem-ber 30, 1990, Ayurvedic Formulary of India, Part II, 2000, and Ayurvedic Formulary of India, Part I (revised edition), 2003, quoted Sanskrit text from Sahasrayoga, published by Sri Ramvilasam Press, Quilon in 1963. (There are variations in Sanskrit texts and interpretations of plant drugs in both publications.) Ayurvedic compound formulations of the following “additional texts,” in addition to 54 authorized books listed in the Drugs and Cosmetics Act, were included in the Ayurvedic Formulary of India, Part I (revised edition) and Part II:

1 Vaidya Yoga Ratnavali (published by Indian Medical Practitioners’ Cooperative Pharmacy, Chennai)

2 Dravya gun Vigyan (Vaidya Yadavaji Trikamji Acharya, the name of the publisher not given)

36 Legacy and logical steps

3 Ayurvedic Aushadhi Gunadharma Shastra (Acephali Private Ltd.) 4 Rasa yoga Sundara (anonymous)

5 Rasa Ratnakara (anonymous)

6 Rasoddhar tantra (Rasasala Aushadhasrama)

7 Brahad yoga tarangani

8 Pharmacopoeia of Hospital of Integrated Medicine, Madras (1956) A number of compound drugs, quoted from these “additional texts,” are neither time-tested nor validated by experimental or clinical trials.

For Ayush Elective Curriculum for MBBS students (for 2019), which will be changed after the first experiment, the following “Important Resources” (books and research material) have been approved:

1 Kutumbiah P, Ancient Indian Medicine, Orient Longman, Chennai, India, 1969 (reissued 1999).

2 Srikanthamurthy KR, Biographical History of Indian Medicine, Chaukhambha Orientalia, Jaikrishnadas Ayurveda series no. 137, Varanasi, India, 2005.

3 Narayanaswamy V, Origin and development of Ayurveda: A brief history, Ancient Science of Life, 1998, 1(1): 1–7.

4 Patwardhan K., The history of the discovery of blood circulation: Unrecognized contributions of ayurveda masters, Adv Physiol Educ, 2012, 36: 77–82.

5 Muthu CA, Short review of the history of ancient Hindu medicine, Proc R

Soc Med, 1931, 6: 177–190.

6 Patwardhan K, Human Physiology in Ayurveda, Chaukhambha Orientalia, Varanasi, India, 2008.

7 Conboy LA, I Edshteyn, H Garivaltis, Ayurveda and Panchakarma: Measuring the effects of a holistic health intervention, The Scientific World Journal, 2009, 9: 272–280, doi:10.1100/tsw.2009.35.

8 Loukas M et al, Anatomy in ancient India: A focus on the Susruta Samhita. J

Anat, 2010, 217: 646–650.

9 Savrikar S, B Ravishankar, Bhaishajya Kalpanaa-The ayurvedic pharmaceutics-an overview, African Journal of Traditional, Complementary and Alternative Medicines, 2010, 7(3): 174–184.

10 Chaudhary A, N Singh, Herbo mineral formulations (Rasaoushadhies) of Ayurveda: An amazing inheritance of ayurvedic pharmaceutics, Ancient Science of Life, 2010, 30(1): 18–26.

11 Kurande VH et al., Reliability studies of diagnostic methods in Indian traditional ayurveda medicine: An overview, J Ayurveda Integr Med, 2013, 4: 67–76.

12 Thakar VJ, Diagnostic methods in Ayurveda, Ancient Science of Life, 1982, 1(3): 139–145.

13 Singh RH, The psychosomatic disorders and their management in Ayurveda, Ancient Science of Life, 1981, (1): 41–48.

14 Rastogi S, Development and validation of a Prototype Prakriti Analysis Tool (PPAT): Inferences from a pilot study, Ayu, 2012, 33(2): 209–218, doi:10.4103/0974-8520.105240.

To move with the times 37

15 Juyal RC et al, Potential of Ayurgenomics approach in complex trait research: Leads from a pilot study on Rheumatoid Arthritis. Novelli G, ed. PLoS One, 2012, 7(9): e45752, doi:10.1371/journal.pone.0045752.

16 Mahalle NP et al, Association of the constitutional type of Ayurveda with cardiovascular risk factors, inflammatory markers and insulin resistance.

Journal of Ayurveda and Integrative Medicine, 2012, 3(3): 150–157, doi:10.4103/0975-9476.100186.

17 Dey S, Pahwa P, Prakriti and its associations with metabolism, chronic diseases, and genotypes: Possibilities of new born screening and a lifetime of personalized prevention, Journal of Ayurveda and Integrative Medicine, 2014, 5(1): 15–24, doi:10.4103/0975-9476.128848.

18 Ajanal M et al, Adverse drug reaction and concepts of drug safety in Ayurveda: An overview, Journal of Young Pharmacists, 2013, 5(4): 116–120, doi:10.1016/j.jyp.2013.10.001.

19 Wal P et al, Pharmacovigilance of herbal products in India, Journal of Young Pharmacists, 2013, 3: 256–258, doi:10.4103/0975-1483.83780.

20 Rastogi S, Why and how? Addressing the two most pertinent questions about pharmacovigilance in Ayurveda, International Journal of Ayurveda Research, 2011, 2(1): 48–52, doi:10.4103/0974-7788.83187.

21 Chaudhary A et al, Pharmacovigilance: Boon for the safety and efficacy of Ayurvedic formulations, Journal of Ayurveda and Integrative Medicine, 2010, 1(4): 251–256, doi:10.4103/0975-9476.74427.

22 Manohar PR et al, DHARA: Digital helpline for Ayurveda research articles, Journal of Ayurveda and Integrative Medicine, 2012, 3(2): 97–101, doi:10.4103/0975-9476.96530.

23 Rotti H et al, DNA methylation analysis of phenotype specific stratified Indian population, Journal of Translational Medicine, 2015, 13: 151, doi:10.1186/s12967-015-0506-0.

24 Govindaraj P et al, Genome-wide analysis correlates Ayurveda Prakriti, Scientific Reports, 2015, 5: 15786.doi:10.1038/srep15786.

25 Wujastyk D, Interpreting the image of the human body in premodern India, Int J Hindu Studies, 2009, 13: 189–228.

This list has no link with “authoritative” knowledge base because it is aimed at offering an olive branch to the students of modern medicine.

The big questions that students of modern medicine will raise include, why has research of the last three centuries been ignored arbitrarily? And why is it that all the plant drugs found in India are not treated as Ayurvedic drugs? Only those plants mentioned in 54 Books are Ayurvedic plants?

How can it be kept secret that the following Unani plant drugs are part of Ayurveda?

1 Ajwain-khurasani ( Hyoscyamus niger Linn.); Parseek Yavaani ( Bhavaprakasha) 2 Aqarqarha ( Anacyclus pyrethrum DC.); Aakaarkarbha ( Bhavaprakasha) 3 Banafshaa ( Viola pilosa Wall.) ( Ayurvedic Formulary of India, Part II)

4 Behman safed ( Centeurea behen Linn.) ( Ayurvedic Formulary of India, Part II)

38 Legacy and logical steps

5 Behman surkh ( Salvia haemetodes Linn.) ( Ayurvedic Formulary of India,

Part II)

6 Chobachini ( Smilax china Linn.); Dweepaantara Vachaa ( Bhavaprakasha) 7 Gheekuwaar ( Aloe barbadensis Mill.) Kanyaasaara ( Bhavaprakasha) 8 Gozabaan ( Onosma bracteaum Wall.); Gojihvaa ( Bhavaprakasha) 9 Juphaa ( Hyssopus officilanis Linn.) ( Ayurvedic Formulary of India, Part II)

10 Khatmi ( Althea officinalis Linn.) ( Ayurvedic Formulary of India, Part II)

11 Khoobakalaan ( Sysmbrium iro Blume) ( Ayurvedic Formulary of India, Part II)

12 Khoonkharaabaa ( Dasmonorps draco Blume); Rakta-niryaas ( Ayurvedic Formulary of India, Part II)

13 Papitaa Desi ( Carica papaya Linn.); Erandakarkati ( Ayurvedic Pharmacopoeia of India, Part I, Vol. VI.)

14 Pudinah ( Mentha viridis Linn.) (Ayurvedic Pharmacopoeia of India, Part I,

Vol. V.)

15 Revandachini ( Rheum emodi Wall.); used as a substitute for Amlvetus ( Sharangadhara Samhita)

16 Rumimustagi ( Pistacia lentiscus Linn.) ( Ayurvedic Formulary of India, Part II)

17 Unnaab ( Zizyphus jujube Mill. ( Ayurvedic Formulary of India, Part II)

18 Sapistaan ( Cordia dichotama Frot. F.) ( Ayurvedic Formulary of India, Part II)

(116 Ayurvedic Plant drugs were adopted by Unani Tibb. Few Ayurvedic scholars will know that an Unani hakim, Bahwa Khan, during the reign of Sikandar Shah Lodi more than 500 years ago, translated the works of Charaka, Sushhruta, Vagbhat, Sharangadhara and Chakradatta into Persian. The book “Madan-us-Shifa Shahi” was published by Navalkishore Press, Lucknow.)

That tomorrow is not far off when AYUSH will welcome new plant drugs.

Why? The Red List is getting longer every day. See “Threat to Plant Drugs of Ayurvedic Formulations.”





4 The classical age in countries

that are now leaders in

herbal medicine

China

The Yellow Emperor’s Internal Classic (around 300 bc) is one of the oldest and most comprehensive extant works in China. Its 18 volumes encompass basic Traditional Chinese Medicine (TCM) recorded theories of the viscera and bowels, meridians and yin and yang, information on hygiene, clinical symptoms, acupunc-ture and moxibustion, and prescriptions and drugs. The guiding principles behind classical TCM are four properties – cold, hot, warm and cool; five tastes – sour, bitter, sweet, acrid and salty; “Five Elements” – Fire, Earth, Metal, Water, and Wood; and Yin and Yang attributive channels or organs in the body on which a drug has a major effect. 1

The popular treatment known as Traditional Chinese Medicine is actually a modern modification of the +2000-year-old Chinese Medicine and was formed in the early to mid-twentieth century.

In the formation of TCM, important philosophical and practical doctrines from Classical Chinese Medicine (CCM) were left behind in order to simplify the medicine and to train new practitioners.

By simplifying the medicine, some of the theoretical tools were overlooked.

Here are some of the main differences between Classical Chinese Medicine and Traditional Chinese Medicine:

(1) Health is an active process of nourishing life in order to maximize one’s potential (CCM)

(1) Health defined as the absence of symptoms and ailments (TCM) (2) Individual diagnosis and treatment (CCM)

(2) Standardized diagnosis and treatment (TCM)

(3) Treating according to individual assessment in conjunction with universal factors of time and space (CCM)

(3) Treating according to patterns using formulas of points (TCM)

40 Legacy and logical steps

(4) Treating the whole person in a holistic approach (CCM)

(4) Treating separate symptoms and systems in the body (TCM)

(5) The mind is primary to the body (CCM)

(5) The body is primary to mind (TCM)

(6) Treating according to one’s personal qi and constitution (CCM) (6) People with similar patterns will be treated similarly (TCM) (7) Different treatment according to gender (CCM)

(7) No difference between genders (TCM)

(8) Different treatment according to season (CCM)

(8) No consideration to the season (TCM)

(9) Different techniques for treating existing conditions and preventing future ailments (CCM)

(9) Similar principles for treatment and prevention (TCM)2

The Institute for Medicinal Plant Development, Beijing, founded in 1983, employs more than 350 scientists in nine departments for carrying out research on Chinese medicinal plants. Researchers include botanists, agronomists, organic and analytical scientists, and pharmacologists. The focus is on new medicinal plant resources, new production techniques of herbal drugs, new processing and extraction methods, tissue culture experimentation, and chemical and pharmaco-

logical studies. 1

References

1 Herbal Emissaries by Steven Foster and Yue Chongxi, Healing Arts Press, Rochester, Vermont, 1992.)

2 www.sourcecentre.ca/classical-chinese-medicine-vs-traditional-chinese-medicine/

America

Sauer’s Herbal Cures1

America’s first book of herbal healing, Sauer’s Herbal Cures, was assembled by Pennsylvania apothecary and printer Christopher Sauer (1721–1784). Theodor Zwinger (1658–1724) was a Swiss physician whose herbal was first published in 1696. He was a conservative physician, for he adhered to the system of humor, signatures, numerologies and even lunar arrangements. His book was devoted to placing herbs in their temperament of hot and cold, dry or moist so that they might be paired with the right humor governing the human body. Their active

The classical age in herbal medicine 41

quantities were defined in terms of their inherent salts, a system of evaluation that was linked to Paracelsus (1493–1541). Proper pairing of these temperaments was thought to create a healthful balance, which was determined by the various states of blood.

Theodor Zwinger’s son, Friedrich, revised his father’s herbal in 1744. And this was the edition that was sold in America, from which Christopher Sauer II drew the material. Sauer decided to serialize his herbal by publishing it in install-ments. It took 16 years. By that time it became scientifically out of date. Only 266

medicinal herbs were listed. Ginger was the first herb that appeared in the first installment of 1762.

Ingwer (Ginger): Ginger was one of the first herbs to be included in Sauer’s Herbal, appearing as it did in the first instalment of 1762. Ginger is warm and dry to the third degree and possesses numerous spicy, oily, and volatile salts. Thus, it has the very same virtues as calamus, galingale, pepper, and other spices of similar warmth and dryness. For those with a sangui-nary nature, ginger should be used very little. It is good for those with a cold stomach. It promotes digestion, awakens the appetite, takes off watery vapors, and strengthens weak eyesight.

Basilien (Sweet Basil): A warming and drying herb. It strengthens the head, brain, and stomach; loosens internal obstructions; cures dizziness so long as the condition is not brought on by high blood pressure. Basil cleanses the matrix, strengthens it, and gently promotes the menses. But only leaves and seeds are used in simples. Water of sweet basil and borage mixed together and a spoonful taken now and then will give very good treatment in case of depression, enliven the heart. And ward off fainting. If its seeds are soaked until soft in water, they will discharge a white mucilage. It serves as a good treatment for scurvy of the gum, and for chapped and cracked lips, cracked nipples and chapped breasts and for rawness of the privates. Water of Sweet Basil and Borage water mixed together and a spoonful taken now and then will give very good treatment in cases of depression, enliven the heart, and ward off fits of fainting.

Burretsch (Borage): For medical purposes, borage is gathered when the sun moves into the sign of Gemini or into the sign of Cancer. The root. leaves, and little flowers are the parts used. They have property of warming gently, of defending the heart, of refreshing the spirit, and of opening obstructions of the spleen. Two parts of loaf sugar and one part flowers and grind in a marble or wooden mortar until reduced to fine powder. This conserve of borage is especially effective for cases of depression. A cordial can be prepared by infusing the flowers in brandy.

The distilled water of borage delights and enlivens the heart, guards against fainting spells, banishes melancholy, cleanses the blood. Sauer pointed out that cooking borage destroys its medical properties.

42 Legacy and logical steps

Reference

1 Sauer’s Herbal Cures: America’s First Book of Botanic Healing, translated and edited by William Woys Weaver, Routledge, New York. 2001.

Britain

The English Physitian1

In Britain, Nicholas Culpeper (1616–1654) is the household name for herbal medicine. He is famous for his herbal, The English Physitian, which first appeared in 1652 and since then has been reprinted in over 100 editions, not only in England but also in America, where it became the first medical book to be published (Boston 1708). He has undeservedly earned the reputation of a quacksalver since he was in conflict with the College of Physicians and believed in astrology, something Culpeper, however, shared with many of his contemporaries. In the seventeenth century astrology was still so deeply rooted in everybody’s mind that we can find traces of it in the writings of William Harvey and Francis Bacon.2

Culpeper followed the classical medical precepts of Hippocrates and Galen.

He also subscribed to the doctrine of signatures – that is, the belief that plants contain some physical sign of what they are meant to treat: for example, the belief that walnuts are good for your brain because they look like little brains.

These beliefs weren’t so uncommon for seventeenth-century academics and physicians, and some plants were identified as useful before being assigned their

“signature.”

A medical populist, Culpeper’s mission was to put medicine and natural healing back into the hands of the people. According to Culpeper, physicians, by and large, used Latin to keep their knowledge out of the hands of the public. To put medical knowledge and power back into the hands of the people, Culpeper wrote an unauthorized critical translation of The London Dispensatory in English (1651), with the result that many British physicians tried to brand him as a quack and charlatan. Culpeper also translated Galen’s Art of Physick from Latin into English. This work deals with the basic tastes, temperatures and energetics of medicinal substances and how these properties produce the whole range of therapeutic actions associated with them.

Culpeper’s best known work, A Complete Herbal ( The English Physician), gives the astrological indications of every herb in terms of planets and signs of the zodiac. According to Culpeper, plants were able to channel and embody the subtle life energies of the planets, which were then consumed as food and medicine.

Through an elaborate system of planetary sympathies and antipathies, he found the right herb or formula to treat the patient’s illness.

We are quoting just three examples from Culpeper’s Complete Herbal: Government and Virtues of Garlick: Mars owns this herb. This was anciently accounted the poor man’s treacle, it being a remedy for all diseases and hurts

The classical age in herbal medicine 43

(except those which itself breed). It provokes urine, and women’s courses, kills worms in children, cuts and voids tough phlegm, purges the head, helps the lethargy, is a good preservative against, and a remedy for any plague, sore, or foul ulcers; takes away spots and blemishes in the skin, eases pain in the ears, ripens and breaks imposthumes or other swellings. Many authors quote many diseases this is good for, but conceal its vices. Its heat is very vehement, and all vehement hot things send up by ill-flavored vapors to the brain. In choleric men it will add fuel to the fire. In men oppressed by melancholy, it will attenuate the humor, and send up strong fancies, and as many strange visions to the head; therefore let it be taken inwardly with great moderation.

Government and virtues of Agrimony: It is an herb under Jupiter, and the sign of cancer; and strengthens those parts under the planet and sign and removes diseases in them by sympathy, and those under Saturn, Mars and Mercury by antipathy, if they happen in any part of the body governed by Jupiter, or under the signs Cancer, Sagittarius or Pieces; therefore must needs be good for gout, either used outwardly in oil or ointment or inwardly in an electuary, or syrup, or concerted juice. It is of a cleansing and cutting faculty, without any manifest heat, moderately drying and binding. It opens and cleanses the liver, helps the jaundice, and is very beneficial to the bowels, healing all inward wounds, bruises, hurts, and other distempers. I cannot stand and give you reason in every herb why it cures such diseases, but you will find them true throughout the book.

Government and virtues of Fox-Glove: The plant is under the domination of Venus, being of a gentle cleansing nature, and withal very friendly to nature.

The herb is familiarly and frequently used by the Italians to heal any fresh or green wound, the leaves being but bruised and bound thereon; and the juice thereof is also used in old sores, to cleanse, dry, and heal them. The decoction thereof made of with some sugar or honey, is available to cleanse and purge the body both upwards and downwards, sometimes of tough phlegm and clammy humours, and to open obstructions of the liver and spleen. It has been found by experience to be available for the king’s evil, the herb bruised and applied, or an ointment made with the juice thereof, and so used. I am confident that an ointment of it is one of the best remedies for scabby head.

References

1 Culpeper’s Complete Herbal, Wordsworth Editions Ltd. 1995.

2 Journal of the Royal Society of Medicine, September 1994, 87: 552.

Gerard’s Herbal1

John Gerard (also John Gerarde, c. 1545–1612) was the renowned Elizabethan herbalist, with a large herbal garden in London. He was the author of a 1,484-page

44 Legacy and logical steps

illustrated Herball, or Generall Historie of Plantes, first published in 1597. It became the most prevalent botany book in English in the seventeenth century.

Except for additions of some plants from his own garden and from North America, Gerard’s Herbal is largely an unacknowledged English translation of Rembert Dodoens’s herbal, published in 1554, itself highly popular in Dutch, Latin, French and other English translations. Gerard’s Herball contains high-quality drawings of plants, largely derived from Continental European sources. Two decades after Gerard’s death, the book was corrected and expanded to about 1,700 pages. The botanical genus Gerardia is named in Gerard’s honor.

We will give Gerard’s version of Herbe Gerard and three examples of his text (in sixteenth-century English):

Herbe Gerard: John Gerard equated Herbe Gerarda with Herbe Gerard, Wilde Masterwort, Ashweed and German name Podagraria. (Herb-Gerard and Ashweed are common names of Aegopodium podagraria Linn. Masterwort is the common name of Angelica atropurpuria. The line drawing given with the text resembles both plants.) Herbe Gerard with his roots stamped, and laid upon members that are troubled or vexed with the gout, swageth the paine, and taketh away the selling and inflammations thereof, which occasioned the Germanes to give it the name Podagraria because of his virtues in curing the gout.

Clownes Wound-wort or All-heale: The leaves hereof stamped with Axungia or hog’s grease, and applied unto greene wounds in manner of a pultesse, heal them in short time, and in such absolute manner, that it is hard for any that have not had the experience thereof to beleeve: for being in Kent about a Patient, it chanced that a poore man in mowing of Person did cut his leg with a sithe, wherein hee made a wound to the bones, and withall very large and wide, and also with great effusion of bloud; the poore man crept unto this herbe, which he bruised with his hands, and tied a great quantitie of it unto the wound with a piece of his shirt, which presently stanched the bleeding, and ceased the paine, insomuch that the poore man presently went to his daies worke againe, and so did from day to day, without resting one day until he was perfectly whole; which was accomplished in a few daies, by this herbe stamped with a little hogs greese, and so laid upon it in manner of a pultesse, which did as it were glew or sodder the lips of the wound together, and heale it according to the first intention, as wee terme it, that is, without drawing or bringing the wound to suppuration or matter; which was fully performed in seven daies, that would have required forty daies with balsam itselfe. I saw the wound and offered to heale the same for char-ity; which he refused, saying that I could not heale it so well as himself; a clownish answer I confess, without any thankes for my good will; where-upon I named it (plant) Clownes Wound-wort. Since which time my selfe have cured many grievous wounds, and some mortall, with the same herb.

Onion: The onion do bite, attenuate or make thin, and cause dryness. Being boiled they do lose their sharpness, especially if the water be twice or thrice

The classical age in herbal medicine 45

changed, and yet for all they doe not lose their attenuating qualities. The juice of onion snuffed up into nose, purgeth the head, and draweth forth raw flegmaticke humors. Stamped with salt, rue, and honey, and so applied, they are good against the biting of a mad dog. Roasted in the embers and applied, they ripen and breaks cold Apostumues, Biles. And such alike. The juice taketh away the heat of scalding with water or oile, as also burning with fire and gunpowder. Onion sliced and dipped in the juice of Sorrell, and given unto the Sicke of a tertian Auge, to eat, takes away the fitin once or twice so taking them. The onion being eaten, yea though it is boiled, causeth headache, hurteth the eyes, and maketh the man dim sighted, dulleth the senses.

( Allium cepa).

African Marigold: The unpleasant smel, especially of that common sort with single floures doth shew that it is of a poisonsome and cooling qualitie; and also the same is manifested by divers experiments: for I remember, said Dodonaeus, that I did see a boy whose lipps and mouth when he began to chewthe floures did swell extremely; as it hath often happened unto them, that playing or piping with quils or kexes of Hemlockes, do hold them a while between their lipps: likewise he saith, we gave to a cat the floures with their cups, tempered with fresh cheese, shee fortwith mightily swelled, and a little while after died. All which things doe declare that this herbe is of venomous and poysonsome facultie; and that they are not to be heark-ened unto, that suppose this herb to be a harmlesse plant: so to conclude, these plants are most venomous and full of poison, and therefore not to be touched or smelled unto, much lesse is used in meat or medicine. (No line drawing with the text. African Marigold is a confusing name. The described plant shold be equated with Cineraria lyrata DC., Wild Parsley. Cineraria lyrata is a toxic plant.)

1 Gerard’s Herbal, John Gerard’s Historie of Plants, Edited by Marcus Wood-ward, Tiger Books International, Middlesex, UK, 1998.

Germany

Hildegard von Bingen’s Physica1

In Germany, the rise of Christianity brought the art and science of healing within the deeply spiritual bounds of the church more than 2,500 years back. During this period Hildegard von (of) Bingen (1098–1179) authored the nine books of Physica (Natural Science). Hildegard of Bingen was a German nun and polymath.

Hildegard’s writings were not only the first books on herbals and medicine written by a woman but were also instrumental in establishing founding principles of nutritional treatment, herbal healing and medieval medical treatments.

Natural medicine as a practice was quickly adopted and propagated by the monks. This monastic medicine aggregated expertise from ancient Greek, Roman and Arabic cultures. The monastic practice codified, documented, and

46 Legacy and logical steps

tested various practices and their outcomes. It remained the epicenter of natural

medicine for hundreds of years.1

Overview of the section about plants in Physica:

(a) Physica (“Plants”) contains 230 sections on medicinal uses of plants. Hildegard makes little attempt to describe the plant for purposes of identification, and she assumes, rather than spells out, the medical and physiological theories behind the uses of the plants. She used German colloquial names of the plants to be used as herbs. The names of herb herbs change from place to place. The identical name may not be the same herb that is used now.

(b) She was not always clear about the specific ailment; for example, she used gicht to cure gout, arthritis, rheumatism, lumbago and sciatica.

(c) She follows the traditional view that created things consist of mixture of four elements – hot, cold wet, dry – in which one or two qualities predominate.

Every herb is either warm or cold. The warmth of the herb signifies the soul and the cold of herbs signifies the body. Herbs flourish according to their type when they overflow either with warmth or cold. For if herbs are all warm, no coldness can do anything contrary to their usefulness. If, however, they are all cold and not warm in any way, they might be useless since warm things resist the cold and cold things resist the warm.

(d) Certain herbs have very strong aromas, others the harshness of the most pungent aromas. They can curb many evils since evil spirits do not like them.

(e) Certain herbs hold the foam of the elements. People who try to seek their own fortunes are deceived by these. The devil loves these herbs and mingles with them.

(f) Hildegard combines the elements with a theological notion ultimately derived from Genesis according to which everything on earth was put there for the use of humans.

(g) Since the balance of the elements and their corresponding humors determined good or bad health in people, it was important to know the elemental qualities of plants. People could then determine their effect according to whether they are in or out of humor, that is, in a balanced or unbalanced state.

Germany, now a world leader

With the introduction of cellular pathology in the late 1800s by the “Father of Modern Pathology,” German physician Rudolf Virchow, and the advent of modern medicine, the holistic concept of natural medicine nearly disappeared, leaving behind much of the ancient knowledge.

Currently in Germany, 600 to 700 plant-based medicines are available and are prescribed by some 70% of German physicians. A 1901 law, reaffirmed in 1961, allows for the sale of German herbal medicine as drugs, giving them special status as medicinal agents, a unique situation when compared with other countries.

Hopefully, this will not be the case for long. The herbs sold with the intent of

The classical age in herbal medicine 47

curing, alleviating or preventing disease or symptoms of illness have been allowed in the German market as drugs.

In 1976, Germany passed a law that required all medicines on the market (including conventional drugs) to be reviewed by scientific committees. In 1978,

a special committee on herbal remedies called Commission E3,4 was established.

With the global interest in herbal medicine rapidly expanding, the German Commission E monographs established by the German government’s counterpart to the US Food and Drug Administration – the German Federal Institute for Drugs and Medical Devices – are being used as the foundation for other regulatory and monograph systems emerging in Europe and around the world.

The European Scientific Cooperative on Phytotherapy (ESCOP)5 uses the monographs as the basis for review of scientifically accepted uses of herbal medicine throughout the European Union.

The World Health Organization draws on Commission E’s work to develop a new series of herbal monographs that help regulatory agencies worldwide develop

guidance for their own drug regulations.6

References

1 Hildegard’s Healing Plants, translated by Bruce W. Hozeski, Becon Press, Boston, 2001: xi–xv, 3.

2 https://healthyhildegard.com (a forum promoting holistic approach to the interconnec-tivity of spirit mind body.

3 The Complete German Commission E Monographs, edited by Blumenthal et al., American Botanical Council, Austin, TX, 1998.

4 Herbal Medicine: Expanded Commission E Monographs, American Botanical Council, Austin, TX, 2000.

5 ESCOP Monographs, Thieme, 2003 and 2009.

6 WHO Monographs on Selected Medicinal Plants, WHO, Geneva, Vol. 1–4, 2009.

Ancient Roman medicine

Pliny the Elder’s Natural History1

Roman medicine, during the first century, was described by Pliny the Elder (Gaius Plinius Secundus, ad 23–79) in Natural History, a massive work made up of 37

volumes that covered “Materia Medica” in Books XX through XXX.

A few excerpts from an authentic translation of the original text:1

Human blood for leprosy: I have said that leprosy did not occur in Italy before the time of Pompeius Magnus, and that though the plague usually begins on the face, a kind of freckle on the tip of the nose, yet presently the skin dries up over all the body, covered with spots of various colours, and uneven, in places thick, in others thin, in others hard as with rough itch-scab, finally however going black, and pressing the flesh on to the bones, while the toes and fingers swell up. This plague is native to Egypt. When kings

48 Legacy and logical steps

were attacked, it was a deadly thing for the inhabitants, because the tubs in the baths used to be prepared with warm human blood for its treatment. This disease indeed quickly died out in Italy.

(Book XXVI)

Human blood for quinsy: The blood let from any part of the patient himself makes, we are told by Orpheus and Archelaus, a very efficacious application for quinsy; efficacious too if applied to the mouth of those who have fainted in an epileptic fit, for they rise up immediately. Some say the big toes should be pricked and the drops of blood applied to the face, or that a virgin should touch it with her right thumb; hence their conclusion that epileptics should eat virgin meat. Aeschines the Athenian used the ash of excrements for quinsy, sore tonsils, sore uvula, and carcinomata.

(Book XXVIII)

Woman’s milk as medicine: As to the use of woman’s milk, it is agreed that it is the sweetest and most delicate of all, very useful in long fevers and coeliac disease, especially the milk of a woman who has already weaned her baby. It is found most efficacious if she has given birth to a boy, and much the most efficacious is hers, who has borne twin boys and herself abstains from wine and the more acrid foods. The milk of a woman however who has borne a girl is excellent, but only for curing spots on the face.

The saliva too of a fasting woman is judged to be powerful medicine for bloodshot eyes and fluxes, if the inflamed corners are occasionally moistened with it, the efficacy being greater if she has fasted from food and wine the day before.

(Book XXVIII)

Ass’s milk: It is thought that ass’s milk removes wrinkles from the face, making the skin white and soft, and it is well known that some women every day bathe their cheeks in it seven times, keeping carefully to that number. Pop-paea, wife of the Emperor Nero, began this custom, even preparing her bath-tubs with the milk, and for this purpose she was always attended by troops of she-asses.

(Book XXVIII)

Elephant’s blood as medicine: The blood of an elephant, particularly that of the male, checks all the fluxes that are called ivory shavings with Attic honey are said to remove dark spots on the face, and ivory dust whitlows. By the touch of the trunk headache is relieved, more successfully if the animal also sneezes. The right side of the trunk used as an amulet with the red earth of Lemnos is aphrodisiac. The blood too is good for consumption, and the liver for epilepsy.

(Book XXVIII)

The classical age in herbal medicine 49

Aphrodisiacs and antaphrodisiac: Aphrodisiacs: An application of wild-boar’s gall, pig’s marrow swallowed, or an application of ass’s suet mixed with a gander’s grease; also the fluid that Virgil too describes as coming from a mare after copulation, the testicles of a horse, dried so that they may be powdered into drink, the right testis of an ass taken in wine, or a portion of it worn as an amulet on a bracelet; or the foam of an ass after copulation, collected in a red cloth and enclosed, as Osthanes tells us, in silver. Salpe prescribes an ass’s genital organ to be plunged seven times into hot oil, and the relevant parts to be rubbed therewith, Dalion the ash from it to be taken in drink, or the urine of a bull after copulation to be drunk, or the mud itself made by it applied to the pubic parts.

Antaphrodisiac for men: An application of mouse’s dung. Intoxication is kept away by the roasted lung of a wild boar or pig, taken in food the same day on an empty stomach, or the lung used may be that of a kid.

(Book XXVIII)

Properties of (selected) medicinal plant drugs

Basil: Ocimuni (basil) too was severely condemned by Chrysippus as injurious to stomach, urine and eyesight, adding that it causes madness, lethargus and liver troubles, and that for this reason goats refuse to touch it, so that men also ought to avoid it. Certain authorities add that pounded ocimum, if covered by a stone, breeds a scorpion, and that ocimum chewed and left in the sun breeds worms; the Africans moreover hold that a man’s life is lost if he is stung by a scorpion on the same day as he has eaten ocimum. Moreover, some hold that if a handful of ocimum be pounded up with ten sea or river crabs, all the scorpions in the neighbour-hood are drawn to it. Diodorus in his Empirica says that the use of ocimum as a food breeds lice. The period that followed saw strong defenders of ocimum who said that goats do eat it, that no man’s mind has been affected by it, and that in wine and a little vinegar it cures the stings of land scorpions and the venom of those in the sea. Experience also proves, they say, that ocimum if smelt in vinegar is good for fainting; also for lethargus, and to cool inflammations; for headache, too, if used as a liniment with rose oil or with myrtle oil or with vinegar, and for eye fluxes if applied in wine. It is said too, to be beneficial to the stomach, to disperse flatulence by belching if taken in vinegar, to check looseness of the bowels if applied externally, to be diuretic, applied thus to be good for both jaundice and dropsy, and to check even the diarrhoea of cholera. Philistion therefore prescribed ocimum even for coeliac complaints and when boiled for dysentery; some against the advice of Plistonicus prescribe it in wine for tenesmus, spitting of blood and hardness of the hypochondria.

Applied to the breasts it checks the flow of milk.

(Book XX)

50 Legacy and logical steps

Linseed: Linseed is not only used in combination with other ingredients, but also by itself removes spots on women’s faces, and its juice benefits the eyesight. With frankincense and water or with myrrh and wine it relieves fluxes from the eyes, parotid abscesses with honey or grease or wax, fluxes from the stomach when sprinkled in water like pearl barley, and quinsies when boiled in water and oil and applied externally with anise. It is roasted to check looseness of the bowels. For coeliac trouble and dysentery it is applied in vinegar.

For pains of the liver it is eaten with raisins; for consumption electuaries are made from the seed with very useful results. Linseed meal, with soda or salt or ash added, softens indurations of the muscles, sinews, joints and nape of the neck, as well as the membranes of the brain. With a fig it also opens and brings to a head a parotid abscess; with the root moreover of wild cucumber it extracts bodies sticking into the flesh, including pieces of broken bone.

Boiled in wine it prevents a sore from spreading, and with honey checks erup-tions of phlegm. With an equal part of cress it cures scabrous nails, with resin and myrrh complaints of the testes and hernia, and in water gangrene. Stomach ache is cured by a decoction of one sextarius of linseed with an equal quantity of fenugreek in hydromel, and dangerous maladies of the intestines and lower trunk by an enema of linseed in oil or honey.

(Book XX)

Walnuts: Walnuts have received their name in Greek from the heaviness of the head which they being about; the trees themselves, in fact, and their leaves give out a poison that penetrates to the brain. The kernels if they are eaten have the same effect, though the pain is less severe. Freshly gathered, however, they are more agreeable. The dried nuts are more oily, and injurious to the stomach, difficult digestion, productive of headache and bad for a cough; they are good, however, for those who intend to vomit fasting, for tenesmus and for colic, as they bring away phlegm? Taken in time these nuts deaden the effects of poisons, neutralize onions and make their flavour milder. They are applied to inflammation of the ears, with rue and a little honey to the breasts and to sprains, with rue and oil to quinsy, and with onion, salt and honey to the bites of dogs and of humans.

(Book XXIII)

Cucumber: There is a variety of wild cucumber much smaller than the cultivated kind. The pale smooth variety is better than the grass-green and rough, and is slightly bitter. From it is made the drug called elaterium by pressing the juice out of the seed. Unless, to prepare it, the cucumber be cut open before it is ripe, the seed spurts out, even endangering the eyes. After being gathered, the cucumber is kept for one night and then cut open on the next day with a reed. The seed too is kept in ash to prevent the juice from running away.

This when pressed out is received in rain water, where it falls to the bottom.

Then it is thickened in the sun, and made into lozenges for the great benefit

The classical age in herbal medicine 51

of mankind, being good for dim vision, eye diseases and sores of the eyelids.

It is said that if the roots of vines are touched by this juice the grapes are not attacked by birds. The root too when boiled in vinegar is used as ointment in cases of gout, and its juice cures toothache. Dried and mixed with resin it heals impetigo, itch, what are called psoriasis and lichen, parotid swellings and superficial abscesses; it restores the natural colour to scars, while the juice of the leaves mixed with vinegar and poured by drops into the ears is a remedy for deafness.

Many authorities assign all these qualities to the cultivated cucumbers, which even apart from them is of great importance. For instance, the seed too, a three-finger pinch of it, when pounded with cummin and taken in wine, is beneficial for coughs, for phrenitis when drunk in woman’s milk, a dose of an acetabulum for dysentery, and with an equal weight of cummin for expectora-tion of pus. Taken in hydromel it is good for diseases of the liver. With sweet wine it is diuretic, while for kidney pain it is used with cumrnin as an enema.

Another kind of wild gourd is called colocynthis. The fruit is smaller than the cultivated, and full of seed. The pale variety is more useful than the grass-green. Taken by itself when dried it is a drastic purge. Used also as an enema an injection is a remedy for all complaints of the bowels, of the kidneys, and of the loins, as well as for paralysis. After the seed has been picked out, hydromel is added and boiled down to one half, which gives a very safe strength for an injection of four oboli. The stomach is benefited also by taking pills made of the dry powder mixed with boiled honey. In jaundice seven seeds of it are taken, to be followed immediately by hydromel. The pulp added to wormwood and salt cures toothache, while its juice warmed with vinegar makes loose teeth firm. Rubbed on with oil it likewise relieves pains of spine, loins and hips. Moreover, wonderful to relate, an equal a number of its seeds, fastened to the body in a cloth, is said to reduce those fevers which the Greeks call periodic. The warmed juice, also, of the shredded cultivated colocynthis cures earache, and its inner pulp without the seed corns on the feet, as well as the suppurations called by the Greeks άποστήματα. The juice obtained by boiling down the whole pulp along with the seeds makes loose teeth firm and stops toothache, and a boiled mixture of it with wine stops inflammation of the eyes. An application of the pounded leaves with fresh cypress leaves, or of the fruit alone, roasted in a clay pot, reduced to powder and added to goose grease, is a cure for wounds. Moreover, when fresh, with shreds of its bark it cools gout and inflammations of the head, especially of babies, and erysipelas by the application to the part affected of the same shreds, or of the seeds. The juice from scrapings, mixed with rose-oil and vinegar, makes a liniment which cools the heat of fevers. The dust of the dried fruit applied to burns is wonderfully healing. Chrysippus the physician disapproved of gourds as food, but there is a general agreement that they are very beneficial to the stomach, and also for ulceration of the intestines and bladder.

(Book XX)

52 Legacy and logical steps

Radish: Cultivated radishes moreover, besides what has been said about them, purge the stomach, loosen phlegm, promote urine and bring away bile.

In addition, a decoction of the skin in wine, drunk in the morning up to three cyathi, breaks up and eliminates gall-stones. A decoction of the same in vinegar and water is used as liniment for the bites of serpents. The radish too is good for a cough if taken with honey in the morning on an empty stomach; its seed too when roasted and chewed by itself. To use a radish as an amulet and to drink either a decoction of its leaves in water or its juice neat in doses of two cyathi is good for phthiriasis. Good for inflammation is a liniment of radishes crushed by themselves, and for a fresh bruise a liniment made from the skin with honey. Lethargic persons are benefited by eating them at their hottest, asthmatics by the seed, first roasted and then beaten up with honey. Radishes are also useful for poisons, counteracting the sting of the cerastes and of the scorpion. With hands rubbed with radish or its seed you may handle these creatures without fear, and a radish placed on scorpions kills them. Radishes too counteract the poisons of fungi and of henbane, and moreover, as Nicander tells us, the effects of drinking bull’s blood. Both the physicians with the name of Apollodorus prescribe radishes to be given for mistletoe poisoning; but Apollodorus of Citium recommends the pounded seed in water, he of Tarentum the juice. Radishes also reduce the size of the spleen, and are good for the liver and pains in the loins; taken also with vinegar or mustard they are beneficial in cases of dropsy, lethargus, epilepsy and melancholia. Praxagoras would administer it to patients with iliac, and Plistonicus to those with coeliae disease. If eaten with honey they also cure ulcers of the intestines and suppurations of the chest. Some for these purposes prefer to cook them in mud; [Mayhoff’s reading: “to smear them over with mud before cooking.”] if so taken they promote, according to them, the menstrual discharge. Taken with vinegar or honey they bring away intestinal worms; a decoction of them boiled down to one third, drunk with wine, is good for intestinal hernia; so taken they draw off superfluous blood.

For these purposes and for spitting of blood Medius prescribes that they should be given cooked, as well as to women lying-in to increase the supply of milk; Hippocrates that radishes should be rubbed on the head of women when the hair falls off, and that they should be placed on the navel for pains in the womb. They also bring scars back to the original colour of the skin. An application also of the seed soaked in water arrests ulcers called phagedaenae. Democritus thinks that as a food radishes are aphrodisiac; for this reason, perhaps, some have maintained that they are injurious to the voice. The leaves, but only those of the long radish, are said to improve the eyesight; should however too strong a dose of radish be applied as a remedy, they prescribe the immediate use of hyssop, for it is antipathetic. For deafness the juice of the radish is dropped into the ear. But, for those who would vomit, it is very useful to eat radishes after a meal.

(Book XX)

The classical age in herbal medicine 53

Stray parsnip: A kind is staphylinus, is called stray parsnip. Its seed, crushed and taken in wine, soothes a swollen belly, and the hysterical chokings and pains of women, to such an extent that it restores the womb to normal, benefits their abdomen, moreover, if applied in raisin wine, benefiting men also when pounded with an equal part of bread and drunk in wine as a cure for bellyache. It is diuretic also, and if applied fresh with honey, or after being sprinkled dry on flour it stays phagedaenic ulcers. Its root, taken in hydromel, Dieuches prescribes against affections of the liver, spleen, loins and kidneys; Cleophantus in cases also of chronic dysentery. Philistion boils it in milk; for strangury he prescribes four ounces of the root, giving it in water for dropsy, likewise for those stricken by pitonitetanus, pleurisy and epilepsy. It is said that those who carry it are not bitten by serpents, and that those who have eaten of it, if bitten, receive no hurt; for bites it is applied with axlegrease, and its leaves are chewed as a remedy for indigestion. Orpheus said that there is in staphylinus a love-philtre, perhaps because it is a proved fact that when eaten it is an aphrodisiac; for which reason some have declared that by it conception is aided. For all other purposes the cultivated kind too is powerful, but the wild plant is more efficacious, especially that growing on rocky soils. The seed of the cultivated kind too is a cure for the sting of scorpions when taken in wine or vinegar and water. Its root used as a dentifrice is a cure for toothache. Another kind is staphylinus, which they call stray parsnip. Its seed, crushed and taken in wine, soothes a swollen belly, and the hysterical chokings and pains of women, to such an extent that it restores the womb to normal, benefits their abdomen, moreover, if applied in raisin wine, benefiting men also when pounded with an equal part of bread and drunk in wine as a cure for bellyache. It is diuretic also, and if applied fresh with honey, or after being sprinkled dry on flour it stays phagedaenic ulcers. Its root, taken in hydromel, Dieuches prescribes against affections of the liver, spleen, loins and kidneys; Cleophantus in cases also of chronic dysentery. Philistion boils it in milk; for strangury he prescribes four ounces of the root, giving it in water for dropsy, likewise for those stricken by pitonitetanus, pleurisy and epilepsy. It is said that those who carry it are not bitten by serpents, and that those who have eaten of it, if bitten, receive no hurt; for bites it is applied with axlegrease, and its leaves are chewed as a remedy for indigestion. Orpheus said that there is in staphylinus a love-philtre, perhaps because it is a proved fact that when eaten it is an aphrodisiac; for which reason some have declared that by it conception is aided. For all other purposes the cultivated kind too is powerful, but the wild plant is more efficacious, especially that growing on rocky soils. The seed of the cultivated kind too is a cure for the sting of scorpions when taken in wine or vinegar and water. Its root used as a dentifrice is a cure for toothache. Another kind is staphylinus, which they call stray parsnip. Its seed, crushed and taken in wine, soothes a swollen belly, and the hysterical chokings and pains of women, to such an extent that it restores the womb to normal, benefits their abdomen, moreover, if applied in raisin wine,

54 Legacy and logical steps

benefiting men also when pounded with an equal part of bread and drunk in wine as a cure for bellyache. It is diuretic also, and if applied fresh with honey, or after being sprinkled dry on flour it stays phagedaenic ulcers. Its root, taken in hydromel, Dieuches prescribes against affections of the liver, spleen, loins and kidneys; Cleophantus in cases also of chronic dysentery.

Philistion boils it in milk; for strangury he prescribes four ounces of the root, giving it in water for dropsy, likewise for those stricken by pitonitetanus, pleurisy and epilepsy. It is said that those who carry it are not bitten by serpents, and that those who have eaten of it, if bitten, receive no hurt; for bites it is applied with axlegrease, and its leaves are chewed as a remedy for indigestion. Orpheus said that there is in staphylinus a love-philtre, perhaps because it is a proved fact that when eaten it is an aphrodisiac; for which reason some have declared that by it conception is aided. For all other purposes the cultivated kind too is powerful, but the wild plant is more efficacious, especially that growing on rocky soils. The seed of the cultivated kind too is a cure for the sting of scorpions when taken in wine or vinegar and water. Its root used as a dentifrice is a cure for toothache.

(Book XX)

Cabbage: The earliest Greeks divided cabbage into three varieties; (a) the curly, which they called selinas from the resemblance of its leaves to those of parsley, useful for the stomach and moderately laxative; (b) the helia, with broad leaves growing out of the stem, from which some have called it cau-lodes, of no importance in medicine; (c) the third, crambe properly so-called, with thinner leaves of plain shape and very close together, is more bitter but very beneficial. Cato thinks most highly of the curly variety, next after it approving the smooth cabbage with large leaves and big stem. He considers it good for headache, dimness of the eyes and sparks in them, for the spleen, the stomach and the hypochondria, when taken raw in the morning with oxymel, coriander, rue, mint and root of silphium, in doses of two acetabula, saying that their power is so great that he who pounds the ingredients together feels himself growing stronger. He therefore recommends that it should either be pounded with these herbs when taken in a draught, or at least be in sauce made from them; while for gout and rheumatic joints a liniment should be made with a dash of rue, coriander and salt, along with barley flour; he adds that its water, boiled down, is wonderfully beneficial for sinews and joints, if they are fomented with it. Wounds, whether fresh or old, and even cancerous sores, which can be healed by no other treatment, should, so he prescribes, first be fomented with hot water and then have pounded cabbage applied to them twice daily. Similar treatment he prescribes for fistulas also and sprains; for tumours too, both such as must be brought to a head and those that need to be dispersed.

As cabbage is the enemy of the vine, they say that it opposes wine; that if taken in food beforehand it prevents drunkenness, taken after drinking it dispels its unpleasant effects.

(Book XX)

The classical age in herbal medicine 55

Large Juniper: The big Cedrus (the large Juniper), which Greek botanists call cedrelate, yields a pitch which is called cedria. It (oil) preserves dead bodies uncorrupted by time, but causes living ones to decaya strange inconsistency, to rob the living of their life and to give a quasi-life to the dead! It also makes clothes decay and kills animal life. For this reason I should not think it ought to be used as a remedy for quinsy, or for indigestion, as some have recommended, taken by the mouth. I should also be afraid to rinse the teeth with it in vinegar, when they ache, or to drop it into the ears for hardness of hearing or worms. Gossip records a miracle: that to rub it all over the male part before coition prevents conception.

(Book XXIV)

Reference

1 Natural History (Rackham, Jones, & Eichholz)/Book 20 to 28, https://en.wikisource.org/

wiki/Natural_History_(Rackham,_Jones,_%26_Eichholz)/Bo., accessed March 21–22, 2019. (I = Pliny The Elder.)

These examples are enough to prove that by investing all our energy and

resources in reviving and revalidating the tenets of the classical period of India,

we are fighting a losing battle against an herbal renaissance.





5 Avoiding scientific inquiry

is not possible now

Col. Sir Ram Nath Chopra (MRCS, England 1907; B. Ch, Cambridge, UK, 1908;

MD, 1912; Sc D, Cantab; FRCS, London) wrote in 19331:

• Attempts at the revival of Ayurvedic and Unani systems in their present form (based on classical doctrines) are bound not to succeed.

• When it is remembered that the Ayurvedic system of medicine has been practically stationary for about 1,500 years and that no attempt has been made to advance the knowledge in conjunction with the progress of the world, one would find it very difficult to reconcile to the old theories of 2,000 years ago, however much one may stretch their significance, with the recent advance of the world of science. After imparting instruction to the Ayurvedic students in modern physiology, bacteriology, pathology, etc., to ask them to apply the doctrine in Vayu, Pitta and Kapha etc. (4 humours in case of Unani medicine –

Khoon, Balgham, Safra and Sauda, i.e., blood, phlegm, yellow bile and black bile), to explain the causation of disease, might not be convincing to them and might bring nothing but chaos and discord to their minds. The students trained under such a system might neither be good at one nor the other.

• History shows that many of our important pharmacopoeial drugs were known and were also used in some form or other possibly long before they were introduced into the Western medicine and before their actions were investigated on scientific lines. On the other hand, there are sure to be others of little therapeutic value that are given merely because they were mentioned in some old manuscripts, and no one has taken the trouble to confirm the truth of these statements. Attempts must be made to separate the good ones from the useless ones, and for this, a systematic investigation of these drugs must be undertaken. Medicine is a progressive science; in every department, an attempt is being made to replace empiricism by rationalism and nowhere is this more evident than in the science of pharmacology and therapeutics.

• When it is said that a drug like Sarca indica is useful in menorrhagia or Cephalandra indica in diabetes or Boerhavia diffusa in dropsy, the (medical) profession will not accept these assertions, as these are symptoms and not

58 Legacy and logical steps

diseases; what we (scientists) want to know is their particular value in these various conditions and how they help to restore the tissue to their normal condition.

• The active principles, responsible for their therapeutic action, have to be isolated and worked out. The way in which the effect is brought about and the manner in which the important organs of the body are affected has to be determined by animal experiments.

• The question of making suitable preparations and their preservation so as to make their potency independent of climatic and seasonal variations next assumes prominence.

• The standardization of (herbal) drugs and preparations by chemical and biological methods of the assay is an important factor to secure therapeutic uniformity so that the amount of active principle in each dose is not subjected to irregular variations.

• The active and useful drugs should be separated from those which are inactive and worthless.

• Until drugs are investigated on rational lines, their use by the profession in India must be restricted.

• Much more could be done in furthering the cause of indigenous medicine by a thorough study of indigenous drugs than by wholesale revival of the old system under vastly changed circumstances.

• The scientific mind is not satisfied by mere statements, no matter from what source they originate, unless corroborated by clinical and experimental evidence.

The first prime minister of India, Pandit Jawahar Lal Nehru, observed:2

There can be no doubt that these ancient systems (Ayurveda and Unani) of India have an honorable history and that they had a great reputation. Most people know that even now they have some very effective remedies. It is necessary, however, that every approach to the problem should be made on the basis of scientific method and persons who are Ayurvedic, Unani physicians should have also full knowledge of modern methods. This means that there should be basic training in scientific methods for all including those who wish to practice Ayurveda or Unani systems.

In 1989, Dr. Nitya Anand, the then Director, Central Drug Research Institute, Lucknow, wrote: “Knowledge is greatly advanced since these (traditional, Ayurvedic) systems were developed. It is necessary to examine them in the light of

modern development to rationalize their basic tenets.”3

Dr. BN Dhavan, the then Director, Central Drug Research Institute, Lucknow, also advocated scientific evaluation of herbs and observed: “The disease pattern and health care needs of the country have changed significantly in recent years; the priorities were different when the texts of traditional systems of medicine

were created.”3

Avoiding scientific inquiry impossible now 59

In 1994, VV Sivarajan and Indira Balachandran wrote4:

Reflecting on the decline of Ayurveda after a Brahmanic period (800 bc–ad 10005), one would find that there are three broad, all-pervading reasons for it:

• A complacent attitude among men of Ayurveda that everything is written in the ancient texts and there is little scope for further studies. The faith has, over the centuries, brought in a certain amount of lethargy among them and has taken away the spirit of questioning and experimentation.

• A self-righteous feeling that their practice reflects ancient wisdom.

• Reluctance on their part to seek and get collaboration from people working in other allied fields.

According to these authors, pharmacognosy is the most neglected area of medicinal plant research in Ayurveda. The state of affairs is extremely chaotic. A number of studies are available on prepared drugs, forgetting the fact that without standards in the herbal sources of raw drugs there cannot be any standard in prepared drugs. One has to go by materials and not by literature. The plant taxonomy can provide unambiguous, universally accepted identification of plants, yet there is a subtle but firm resistance from men of Ayurveda against this unsolicited offer of assistance. “They are paranoid about ancient Ayurvedic texts and myopic in their approach to collaboration with other allied scientific disciplines.” (VV Sivarajan is Professor of Botany at University of Calicut, Kerala; Indira Balachandran is Research Officer at Herbal Garden, Arya Vaidya Sala, Kottakkal, Kerala.) In 2014, Dr. Bhushan Patwardhan wrote5:

The easiest path to promote the classical period of Ayurveda is based on emotions and past glory uncritically. Already there are demands for new Universities, new research institutes, new industries, new clinical establishments exclusively for AYUSH. One can take the emotional stand that AYUSH is indigenous, divine and time-tested. Raising any questions about the evidence of efficacy, theory or practice may not be tolerated. Embracing modern methods, scientific investigation and innovations to explore and enhance ancient wisdom may be seen as an insult to its prestige and exalted status. Such an uncritical approach is not likely to lead to the desired revitalization of AYUSH

in the long-term, nor to meaningful change in the health sector. Such an easy route of resisting contemporary medical trends would lead to stagnancy, and would be detrimental to the long-term sustenance and growth of AYUSH.

The editors of the Reviews on Indian Medicinal Plants series of the Indian Council of Medical Research wrote:

The clinical reports have been objectively included in the Monographs without comments on their validity. It is needless to mention that there are

60 Legacy and logical steps

innumerable ethical, technical, logistic hindrances and bias involved in the conduct of clinical trials. A number of the reported clinical trials are scientifically unacceptable primary because of lack of adequate training in the conduct of scientific clinical trials, and lack of commitment to the scientific drill.

In most of the cases, a biostatistician has not been involved at any stage of the trial.

Dr. Ranjit Roy Chaudhury wrote in a WHO publication (SEARO No. 20): It has been said that those plants still being used today, which stood the test of time. . . . Natural selection needs to be examined carefully. . . . A plant which was therapeutically effective may have undergone mutation and become therapeutically ineffective due to ecological or environmental factors.

Setting aside all these observations, The Ayurvedic Pharmacopoeia of India, remained firm to the traditional line.

References

1 Chopra Col. Sir RN et al, Indigenous Drugs of India, second edn, Academic Publishers, Kolkata.

2 Cited in “An Overview of Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homoeopathy in India,” AYUSH, 2004.

3 Research and Development of Indigenous Drugs, 1989, Institute of History of Medicine and Medical Research, Hamdard Nagar, New Delhi-110 062.

4 Sivarajan VV, Indira Balachandran, Ayurvedic Drugs and Their Plant Sources (ADPS), 1994, Oxford and IBH Publishing Co. Pvt Ltd., New Delhi: 10–11. Kottakkal, Kerala.

5 Patwardhan B, Journal of Ayurveda & Integrative Medicine, April–June 2014, 5, www.

jaim.in Editorial.





6 Ayurvedic pharmacognosy

and pharmacology

In modern perspective

In The Ayurvedic Pharmacopoeia of India the “properties and actions” of a herb have been assessed on the basis of Rasa (taste), Guna (physical property), Veerya (potency), Vipaaka (again, taste indicating herb’s action after ingestion) and Karma ( Prabhaava or therapeutic effect of the herb). Except for Rasa, which is perceivable, other parameters are not perceivable, inferable; these are linked to physiological manifestations.

Sweet ( Madhura), sour ( Amla), salty ( Lavana), pungent ( Katu), bitter ( Tikta) and astringent ( Kasaaya) are six Rasas ( tastes).

Physical properties ( Guna) of herbs have been divided into 20 categories: light, heavy, cold, hot, unctuous, dry, dull, immobile, mobile, soft, hard, clear, slim, smooth, rough, minute, bulk, solid and fluid.

The potency of the herb ( Veerya) has been divided into Sheeta (cold) and Ushna (hot) segments.

The herb is selected for medicinal use after assessing the imbalance or dis-harmony due to Doshas (morbidities) – Vaata ( Vaayu), Pitta and Kapha, known as Tridoshas when grouped together. The entire treatment regimen of Ayurvedic treatment revolves around the theory of Tridosha.

Once the Dosha (morbidity) has been identified, the first component of the herb, Rasa (taste), is selected. Rasa is considered an important marker which indicates, initially, the right choice of the herb.

Sweet taste pacifies Vaata and Pitta but aggravates Kapha.

Sour taste pacifies Vaata but aggravates Pitta and Kapha.

Salty taste pacifies Vaata but aggravates Pitta and Kapha.

Pungent taste pacifies Kapha but aggravates Vaata and Pitta.

Bitter taste pacifies Pitta and Kapha but aggravates Vaata.

Astringent taste pacifies Pitta and Kapha but aggravates Vaata.1

In The Ayurvedic Pharmacopoeia of India, Karma of the drug is defined by its impact on Dosha, followed by an explanatory note:

Since the effort is to compile pharmacopoeial monographs of Ayurvedic drugs, the accent on classical attributes of respective drugs according to the

62 Legacy and logical steps

doctrine of Rasa, Guna, Veerya, Vipaaka and Karma has not been lost sight of, though some of them appear to be abstract and subjective in the absence

of an established experimental method to qualify them (emphasis added).

This statement was modified in the preface of The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI, 2008: “Rasa, Guna, Virya, Vipaka, and Karma are considered a reasonable basis and convenient reference point for clinical classification.

Such parameters are not possible to measures by modern scientific methods

thus not mandatory (emphasis added). ”

A large number of drugs have got no specific odour. The “odour” is examined by directly smelling 25 g of the powdered drug contained in a package or freshly powdered. If the odour is discernible, the sample is rapidly transferred to an open container and re-examined after 15 minutes. If the odour persists to be discernible, it is described as having odour. . . . The “taste” of a drug is examined by taking a small quantity of 85 mesh powder by a tip of the moist glass rod and applying on the tongue previously rinsed with water. This may not be done in case of poisonous drugs indicated in the monographs.

Vaata, Pitta and Kapha were also not easy to define. Vaata was equated with breath, Pitta with fire and Kapha with mucus.2 To counteract this type of “mis-translation,” an effort was made to “reinterpret” the theory of Rasa, Guna Veerya, Vipaaka, Karma and Tridosha by some scholars of Ayurvedic medicine.

Arvind Chopra and Vijai V. Doiphode opined that, to a certain degree, modern analytical chemistry has been used to assign properties of each of the tastes ( Rasas). The sour, sweet, pungent and astringent tastes are determined by acids, starches and sugars, aromatics and tannins. The bitter taste is due to chemicals such as berberine. Salty taste, uncommon in plants, is found in minerals. All the three Doshas ( Vaata, Pitta and Kapha) should be treated as primary dynamic

physiologic forces.3

The Ayurvedic philosophy describes a unifying hypothesis linking the universe with all living and nonliving matter. Human and plant in the hierarchy of cosmic evolution consist of the same basic matter – Panchbhuutas (earth, water, air, fire and ether). Vaata (material = air + ether), the most powerful force, governs motion and controls cell division, arrangement and differentiation, impulse transmission (including cardiorespiratory and all the higher functions in the brain); movement of body fluids and excreta, parturition and, above all, the mind; it is most relevant to the nervous and musculoskeletal system. Pitta (material = fire) governs metabolism and formation of tissues and waste products; it is most relevant to the digestive and endocrine system. Kapha (material = earth + water) increases cell mass, promotes bonding of tissues, prevents the destruction of tissues, maintains strength and immunity, and determines body growth. The six tastes ( Rasas) transmit the properties of Panchbhuutas; each taste has a dosha-related attribute, and drugs in Ayurveda have been classified according to their effect on Dosha. Doshic Prakriti (functional constitution) of the patient is diagnosed and treated by an Ayurvedic physician.

Each Dosha has its own characteristic, physiologic and psychologic expres-sions. Vaata is dry, cold, light and clear. Pitta is hot, light, fluid and clear. Kapha

Ayurvedic pharmacognosy and pharmacology 63

is cold, wet, heavy, cloudy and static. Although Vaata, Pitta and Kapha often

colonize in the intestines, stomach and chest, they are ubiquitous.3

Bhagwan Dash, Mahadihassan, Udupa, Asima Chatterjee and Satyesh Chandra Pakrashi also tried to validate the Tridosha hypothesis.

According to Bhagwan Dash, Vaayu is responsible for all movements and sensations, including motor actions inside the body. Pitta is responsible for all physio-chemical activities of the body in the form of metabolism, production of heat and energy, and Kapha is the substance which maintains compactness or

cohesiveness in the body by providing the fluid matrix to it.4

According to Mahadihassan S. and Udupa K. N., the three morbidities ( Doshas) can be easily estimated by biochemical studies. These authors have equated Vaata with acetylcholine liberated by the cerebral cortex and peripheral and parasym-pathetic nerve endings, Pitta with catecholamines liberated by the hypothala-mus, sympathetic nerve endings and adrenal medulla and Kapha with histamine secreted by the brain stem. The drugs, when administered, act by promoting or

destroying the respective neurohumors or their precursors.5

These “modified interpretations” indicate that a concerted effort is made to establish the significance of the theory of Tridosha and Rasa, Guna, Veerya, Vipaaka, Prabhaava/Karma in Holistic Ayurveda, which was known to treat the whole system of the individual. But now, all other classical medicines have changed their course, from Holistic and individually tailored treatment to disease-based treatment. If a drug is not produced for millions of people whose Doshic Prakriti (functional constitution) is impossible to identify, the whole edifice may just remain a glorified museum.

We must realize that the situation has changed drastically. After imparting instruction to the Ayurvedic students in modern physiology, bacteriology, pathology (and radiology), to ask them to apply the doctrine of Vaata, Pitta and Kapha to explain the causation of disease, might not be convincing to them and might bring nothing but chaos and discord to their mind.

We will give only a few examples of pharmacognosy of Ayurvedic herbs to demonstrate the difficulty in understanding the proper profile of a plant drug.

(a) Brahmi ( Bacopa monnieri): Rasa: Tikta; Guna: Laghu; Veerya: Ushna;

Vipaaka: Katu; Prabhaava: Medhya. Pacifies Kapha-Vaata.

(b) Manduukaparni ( Centella asiatica): Rasa: Tikta, Anu-rasa: Kashaya; Guna: Laghu; Veerya: Sheeta; Vipaaka: Madhura; Prabhaava: Medhya.

Pacifies Kapha-Pitta. ( Dravya Guna Vijnana, Vol. II, 1978, by P. V. Sharma.) The Rasa, Guna, Veerya, Vipaaka complex of a number of Ayurvedic herbs, which differ in therapeutic actions, is the same!

(a) Haridra ( Curcuma longa): Rasa: Tikta, Katu; Guna: Ruksha; Laghu; Veerya: Ushna; Vipaaka: Katu.

(b) Tulasi ( Ocimum sanctum): Rasa: Katu, Tikta; Guna: Laghu, Ruksha; Veerya: Ushna; Vipaaka: Katu.

64 Legacy and logical steps

Even herbs with different therapeutic actions were shown to have the same activity on Vaata, Pitta, and Kapha: (a) Paarsika Yavaani ( Hyoscyamus niger): Rasa: Tikta, Katu; Guna: Ruksha; Veerya: Ushna; Vipaaka: Katu. Pacifies Kapha-Vaata.

(b) Nirgundi ( Vitex negundo): Rasa: Katu, Tikta; Guna: Ruksha, Laghu; Veerya: Ushna; Vipaaka: Katu. Pacifies Kapha-Vaata.

(c) Bhringaraaja ( Eclipta alba): Rasa: Katu, Tikta; Guna: Laghu, Ruksha; Veerya: Ushna; Vipaaka: Katu. Pacifies Kapha-Vaata.

(d) Baakuchi ( Psoralia corylifolia): Rasa: Katu, Tikta; Guna: Laghu, Ruksha; Veerya: Ushna; Vipaaka: Katu. Pacifies Kapha-Vaata.

( Dravya Guna Vijnana, Vol. II, 1978, by P. V. Sharma)

There is a caution even for cow’s milk, if these parameters are followed.

India has 37 pure cattle breeds. Five of these, Sahiwal, Gir, Red Sindhi, Thar-parkar and Rathi, are known for their milking prowess. A few other breeds, Kank-rej, Ongole and Hariana, belong to dual breeds.

Following properties have been attributed to cow’s milk in Ayurveda ( Yogarat-nakara, Varnabheda):

Black cow’s milk: Vaatahara (pacifies Vaata).

Yellow cow’s milk: Vaata-Pittahara (pacifies Vaata and Pitta).

White cow’s milk: Kaphavardhaka (aggravates Kapha).

Milk of a cow whose calf is very young: Tridoshakaaraka (aggravates all the three doshas).

An example of data fudging

No reference of Carica papaya could be traced in classical texts. Ayurvedic Pharmacopoeia of India included it among Ayurvedic plant drugs as Erandakarkati (synonyms: Madhukarkati, Gopaalakarkati) and supported its constituents by quoting a Sanskrit verse ( shloka), in classical style, composed by a contemporary Vaidya, P. V. Sharma. (API, Part I, Vol. VI: 358.) Vaidya P. V. Sharma also defined its Rasa: Katu, Tikta; Guna: Laghu, Ruksha, Tikshna; Veerya: Ushna; Vipaaka: Katu; Karma: Kaphahara, Muutral.

Prabhava or Karma was obviously based on ethnomedicine or the doctrine of signatures.

The relevance of signatures of plants and animal’s intuition-based selection or rejection of plants was not confined to medieval Europe or traditional Chinese medicine. Charaka also used to get feedback from shepherds who used to take animals to the jungle for grazing.

Brahmi pacifies Kapha-Vaata, Manduukaparni Kapha-Pitta. This may indicate that their universal Medhya activity is not linked to Rasa, Guna, Veerya and Vipaaka or Vaata, Pitta and Kapha prakriti of the subject but to their chemical constituents that have now been characterized.

Ayurvedic pharmacognosy and pharmacology 65

Ayurvedic Pharmacopoeia of India still continues to quote Rasa, Guna, Veerya, Vipaaka and Prabhaava, even after admitting that these parameters are not possible to measures by modern scientific methods thus not mandatory (thus are redundant for the Pharmacopoeia). After the sixteenth century, Ayurvedic authors have hardly provided Rasa, Guna, Veerya, Vipaaka and Prabhaava with any new herb adopted by Ayurveda. How can both parameters – Rasa, Guna, Veerya, Vipaaka and Prabhaava and standard test procedures for identity, purity and strength of the herb go side by side?

We are now concerned with the standardization of crude herbs, extracts, quality of finished products with the modern analytical tools like high-performance liquid chromatography (HPLC), high-performance thin-layer liquid chromatography (HPTLC) and gas chromatography (GC), and estimation of functional groups, marker compounds, and estimation of biologically active compounds.

References

1 Chatterjee A, Satyesh Chandra Pakrashi, Basic concepts of ayurveda, Treatise on Indian Medicinal Plants, I, 1999.

2 Balch PA, Prescription for Herbal Healing, 2002.

3 Chopra A and Vijay V. Doiphode, Ayurvedic medicine, core concept, therapeutic principles and current relevance, Medical Clinics of North America, January 2002, 86(1).

4 Dash B, Lilitesh Kashyap, Materia Medica of Ayurveda, Concept Publishing Company, New Delhi-110 015, 1980.

5 Mahadihassan S, A comparative study of early system of Indian cosmology and Tridosha doctrine, Ind J Hist Sci, 1980; A scientific interpretation of Tridosha doctrine of humorology, Anc Sci Life, 1986, 6(1); The Tridosha doctrine traced to breath as soul, Anc Sci Life, 1989, 9(1). Udupa K.N, Ayurveda for the service of common man, Anc Sci Life, 1983, 2(3). Cited in Ayurvedic Drugs and their Plant Sources, Sivarajan and Balachandran.





7 How classical procedures

lost ground

In Ayurveda, Bhaishaja-Kalpana (Pharmaceutical preparation procedures) is the next step after the herb is identified and collected. Mostly fresh herbs were used until the sixteenth century. Now, we find many important plants, stored after collection, lose their medicinal properties within one year (six months to one year).

They hardly reach the consumer before the expiry period.1

Hemidesmus indicus (Saarivaa), Tinospra cordifolia (Guduchi), Adhatoda visica (Aduusaa), Abroma augusta (Ulatkambal), Sphaeranthus indicus (Mundi), Ruta graveolens (Sudaab), Lavandula stoechas (Ustukhuddus) retain their potency up to 6 months. Gymnema sylvestra (Gurmaar), Solanum indicum (Kantkari varieties), Nardostachys jatamansi (Jatamansi), Valeriana jatamansi (Tagar), Eugenia jambolana (Jaamun seeds), Clerodendron serratum (Bhaarangi), Convolvulus pluricaulis (Shankhpushpi), Ashwagandha, Emblica officinalis (Aamalaki), Curculigo orchioides (Black Musali), Asparagus adscendens (White Musali), Pueraria tuberosa (Vidarikand), Argyreia speciosa (Bidhaaraa), Asparagus racemosus (Shataavari), Blepharis edulis (Utangan), Abutilon indicum (Atibalaa), Sida cordifolia (Balaa), Boerhaavia diffusa (Punarnavaa), Chicorium intybus (Kasni), Holarrhena antidysenterica (Kutaja), Saussurea lappa (Kushtha), Swertia chirata (Chirayitaa), Acorus calamus (Vacha), Centella asiatica (Manduukaparni), Bacopa monnieri (Braahmi) and Tribulus terrestris (Gokhru) are some such herbs that start deteriorating before they are delivered to herbal pharmacies.

Collection of herbs is also not being done scientifically. For example, annual plants should be collected before the ripening of seeds, biennials during spring and perennials during autumn. Twigs must be of the first year’s growth and roots, leaves and bark should be collected in the cold, hot and rainy seasons, respectively. Emblica officinalis (Aamalaki) should be collected when the fruits are fully ripe, while tons and tons of raw Aamalaki are being used in Chyavanpraasha. The consumer is not aware of all these aspects. Commercial firms and professional herb collectors never follow these instructions. After collection herbs are dumped in bundles or in gunny bags, exposing them to sun, rain, and dust, which adversely affect their therapeutic effectiveness and their active principles get deteriorated.

Thus herbal medicines are prepared in total disregard of standard methods.

This affected the shelf-life of Ayurvedic drugs. Ayurvedic Churna (powders) should be used within two months.2 If kept in tight containers, they can retain

68 Legacy and logical steps

potency for one year.3 Kwaaath churna retains potency only for two months.

Gutika vati, pills of herbal composition, retain their potency for 12 months.

Avaleha, Ghrita and Taila retain their potency for 16 months. Aasavas and Arish-

tas can be kept for any length of time in well-closed bottles or jars.4

Now we go back to 2000 bc and try to find out how herbal medicines were processed and how they were impregnated for the preservation of their medicinal properties.

Charaka in Charaka Samhita, Vimansthan 7, 22, advised the use of sukshma churna (micro-pulverized powder). The process of impregnating the herb with its own juice or decoction has also been described (7, 16). Jarjarikaran (trituration) of the micro-pulverized powder is included in Chikitsasthan, 26, 244.

According to Sushruta, the churna (powder) of essential parts of the plant belonging to a group, is saturated for 7 days with the equal quantity of decoction of plants belonging to a separate group but having same properties, then only the final product is to be accepted as the churna with required medicinal properties.

(Sushruta Samhita, Chikitsasthan, 10, 3; 12, 10).

At this point, we would like to remember the seer who gave the Ayurvedic dictum: mardanam gunavardhanam (trituration accentuates and hidden medicinal properties of the herb). And we would like to highlight the (conveniently forgot-ten) formulation of Chatusshashti Prahari Pippali ( Ayurveda Sarsangriha, Kasa Chikitsa Adhikar), wherein it has been advised that Piper longum should be triturated (in its own decoction) for 64 prahars (192 hours); (for 72 hours if the triturating machine is run by an electric motor).

Thus, impregnating and triturating the herb was of utmost importance in the mind of the physician. It was important to ensure that the herb, as soon as administered, is absorbed quickly at the cell level and enters the body as a dynamic agent.

According to Sushruta, subtlety is the quality by virtue of which a drug can penetrate into the smallest capillary and channels of the biological system (Sushruta Samhita, Sutrasthan 46, 158). This theory has also been propounded in Bhavaprakash (ad 1600). Hemaadri elaborated it in his commentary on the ad 700 text of Ashtanghridaya of Vagbhata.

In Ayurveda, impregnating the herb and its trituration were supposed to go together. The process of impregnating the herb was called bhavana. Out of 100g micropulverized powder, 20 g powder was boiled in 4 parts of water till 3 parts of the water evaporate. This decoction was mixed well with the remaining powder and after drying it at 50°c, put in a porcelain mortar and trituration is done for 6

to 8 hours. This process was repeated six times. After seven bhavanas the herb is transformed into a rasayana (tonic or a potent medicinal agent).

It is a matter of great concern that we slept over all these basic principles and the Ayurvedic system of medicine remained totally neglected for about three centuries. The herbal trade remained dominated by unscrupulous businessmen, semi-literate religious preachers, and priests. The unorganized sector had a heyday. The market remained flooded with substandard medicines.

How classical procedures lost ground 69

The second phase of jarjarikaran came in 1918, when J & J DeChane of Hyderabad introduced micro-herbal medicines and incorporated the theory of rasayana in the manufacturing process, reviving the process enunciated in samhitas. DeChane produced herbal medicines by micro-pulverizing and “atomizing”

the herbs so that the medicine gets absorbed from the mucous membrane into the system. The dosage of “atomized” medicines was surprisingly low when compared to that of traditional compounds which ranges from 4 g to 15 g. In an experiment, DeChane herbo-mineral medicines were further triturated homeopathically.

It was found that Albosang (a tonic for general debility, containing Ashwagandha) was more effective in 3× potency than in an approximate dose of 160 mg.

During the 1950s, Sundarrao Bhaskarji Vaidya, a medical practitioner from Mumbai, coined the term “Sukshma Ayurvediya Aushadhi.” He converted the medicine into sukhma medicine by diluting it in water and reduced the dose substantially. Vaidya Panchanan Gangadhar Shastri Gune, Ahmadnagar (1950), and Ayurvedacharya A. V. Astikar, Nasik (1966), prepared sukshma suvarna bhasma by triturating suvarna bhasma and milk-sugar taken in 1:10 ratio. 0.01 sukshma suvarna bhasma was as effective as 1 gm of suvarna bhasma. Similarly, sukshma Chandrakala, sukshma Ashtamurti, sukshma Vasantkusumakar, and sukshma Samirapannaga were prepared and tested. Sukshma Samirapannaga was devoid of side-effects which are usually produced by the drug.

In Calcutta, Dr. Ghosh S. C. made a combination of medicinal herbs with the alcohol-water mixture, medicated the sugar globules with the combination and treated various ailments. When used singly, a dose of 10–15 ml Ocimum sanctum (Tulasi) juice is required, but when the same was used in combination with the alcohol-water mixture, 2–3 drops were sufficient to produce the same result.

During recent years Kulkarni P. H., Institute of Indian Medicine, Pune, and Ranjana Y Abhang, Jnana Prabodhini Institute of Research in Ayurvedic Medicine, Pune, tried to establish the theory of Herbal Microcosm through various clinical trials.

In a clinical trial by Swarge J. M. and Kulkarni P. H., juice of Aloe indica and Adhatoda vasica was mixed in a ratio of 3:2 in an equal amount of alcohol. The tincture was added to three times its weight of sugar globules. Out of 100 patients treated with this drug, 90 were relieved completely of their complaints of cough

and cold.5

Kulkarni P. H. prescribed Bhuu-nimbaadi tablets (1 tablet of 250 mg three times a day) for 21 days to 50 patients suffering from amlapitta (acid dyspeptic affections). Excellent response was observed in 25 cases, while a good and fair response was seen in 22 and 3 cases, respectively. There were no side-effects. The drug was prepared by boiling equal quantities of Swertia chirata, Azadirachta indica, Terminalia chebula, T.belerica, Phyllanthus emblica, Trichosanthes dioica, Adhatoda vasica, Tinospora cordifolia, Fumaria parviflora and Eclipta alba in water.6

Ashokarishta and Lodhrasava mixture in subtle ( sukshma) form (4 globules three times a day) was given to patients suffering from gynecological diseases.

92% of the patients showed excellent results. The drugs were found free of side-effects.7

70 Legacy and logical steps

Vasosin, consisting of ingredients like Adhatoda vasica ( Vasaka), Solanum xanthocarpum (Kantakari), Punica granatum (Daadim twak), Piper longum (Pippli) and Cinnamomum cassia (Daalchini oil), was tried in subtle form (V-3x globules) on 50 patients suffering from cough and breathlessness. V-3x globules were given three times a day for 7 days. The result was excellent in 80% of cases.7

Subtle ( sukshma) Triphala guggul (TG-3x), consisting of Terminalia belerica (Baheraa), T. chebula (Haritaki), Emblica officinalis (Aamalaki) and Commiphora mukul gum-resin (Guggulu), was tried on 28 patients of obesity. Four globules, three times a day were orally administered to all patients for a period of 3 months.

A significant weight loss was observed without any side-effect.7

A subtle form of a mixture of Khadirarishta, Mahamanjishthadi kwath and Sarivadyasava (four 3× globules three times a day) was given to patients suffering from various skin disorders like eczema, pruritus, acne, and vitiligo. 26% of

patients got relief in 30 days and 56% needed 90 days for relief.7

Ranjana Y. Abhang’s first document on “Ayurveda and Sukshma Medicine”

appeared in 1985,8 1987, and another document “The Pharmacy of Sukshma Medicines” in 1987.9

In 1992 and 1993 Ranjana carried out double-blind controlled studies to evaluate the effect of Centella asiatica (Manduukaparni) in 3× potency (1 disket of sugar and 1 drop of tincture of 3× Centella asiatica made one dose, and four doses were given every day). She also tried Bacopa monierri (Braahmi) on children having 55–90 and 100 IQ, respectively. There was a significant improvement in intelligence and performance due to the administration of the sukshma medicine.10

Jnana Prabodhni Institute of Research in Ayurvedic Medicines, Pune, prepared sukshma medicines by combining the herb with alcohol and by triturating it in milk-sugar.

Piper nigrum (Maricha), Azadirachta indica (Nimba), Embelia ribes (Vidanga), Tribulus terrestris (Gokhru), Solanum xanthocarpum (Kantakaari), Iris germanica (Pushkarmuula), Hemidesmus indicus (Saarivaa), Ricinus communis (Eranda), Carum copticum (Ajmoda), Saraca indica (Ashoka), Herpestis mon-niera (Braahmi) and Phyllanthus emblica (Aamalaki) were prescribed, combined with alcohol, following Charaka Samhita.

Sukshma suvarna bhasma, sukshma abhraka bhasma, sukshma praval pishti, sukshma mahalakshmivilas rasa, sukshma shwaschintamani rasa and sukshma vatachintamani rasa were prepared by trituration in milk-sugar in a 1:100 ratio.

Only the form of the medicine is changed, but the action remains unaltered and could be used according to the basic principles of Ayurveda.

These sukshma medicines were put on clinical trials in the Jnana Prabodhini Institute’s Comprehensive Health Care Scheme in 137 villages of the Shivaganga and Gunjavani river valley, about 25 km away from Pune. The sukshma medicines were found effective and devoid of side-effects and reactions, suitable for a delicate constitution. (Ranjana Y Ahhang, Journal Res Edu Indian Med, 1985, Vol IV, 59–66.)

The method of triturating and tableting the herbal compounds was the same, as is being followed by homoeopathic pharmacies. Here a problem arose. Absolute

How classical procedures lost ground 71

conversion of herbal contents to a homeopathic medicine was rejected by the consumers. Thus, sukshm Ayurveda collapsed.

Ayurveda, as usual, maintained its eternal and holy image, while most of the old, essential procedures, laid down by great visionaries, were mutilated by none other than the protagonists of Ayurveda. In the next chapter, we will discuss the strategy scientists are adopting to make Ayurveda a progressive disease-based system.

References

1 Singh R, Vanaushadhi Nidarshika, 1983.

2 Pharmacopoeial Standards of Ayurvedic Formulations, CCRAS, 1987.

3 Ayurvedic Formulary of India, second revised edn, 2003.

4 Pharmacological Standards for Ayurvedic Formulations, Central Council for Research in Ayurveda and Siddha, New Delhi, 1987: 445, 450, 457.

5 Deerghayu international, 1990, 6(3): 5.

6 Deerghayu international, 1995, 11–01(41): 24–26.

7 Kulkarni PH, ed, Ayurved Research Papers, II, 1995.

8 Journal of Res Edu Indian Med, IV: 59–66.

9 Deerghayu international, 1987, III–2, 18–22.

10 Journal of Research in Ayurveda and Siddha, 1992, 13(1–2): 35–47; ibid, 1993, 14(1–2): 10–24.





8 Identification of proper herbs

A new scientific route

• In the Ayurvedic Formulary of India, herbal components have been reproduced from classical texts by Sanskrit names

• A number of Sanskrit names of the plants, over the course of time, have been linked to different plants in different parts of India. The Sanskrit name remains the same, the name of the classical drug also remains the same, while a different herb, equated with a different botanical name, having different chemical constituents, is used.

• Thus the classical name of the herb, equated with different botanical names, will exhibit different biological activities.

• Extinct herbs have been retained in compound formulations; substitute herbs have been permitted without comparing their chemical constituents and biological activity.

• Only revalidated herbs by clinical or experimental trials are to be retained.

Traditional uses should not be taken as the final word. Those found redundant should be discarded.

• Properties of compound formulations are to be revised in the present context (as the drug is to be used today, not 3,000 years back). Instead of Indication Pluralism, the specific curative property is to be retained.

• A number of synonyms of botanical names have been Sanskritized. For example, Monochoria vaginalis has been Sanskritized as Bhaga-patra (Bhaga = vagina); Abroma Augusta as Pishaacha-kaarpaasa (= Devil’s Cotton); Equisetum arvense as Aswapuchh (= Horse tail); Dictamnus albus as Agni-jwaalaa (= Gas Plant).

• Nonclassical Sanskritized names have been assigned to a number of plants. For example, Vrakkaphala, Kaajutaka for Anacardium occidentale (Kaaju); Ganagaatra for Annona squamosal (custard apple); Raktagunjana for Beta vulgaris (beet root); Erandakarkati for Carica papaya (papaya); Rakta-vrantaaka for Lycopersicon esculentum (tomato); Granjana for Daucus carota (carrot).

• Sanskrit verses ( shlokas) have been composed by contemporary vaidyas and quoted in the Ayurvedic Pharmacopoeia of India for giving a classical touch to a number of new botanical drugs as if it is religious conversion.

Sanskrit shloka on Erandakarkati ( Carica papaya) was composed by Prof.

74 Legacy and logical steps

P. V. Sharma (API, Vol. VI); Erandakarkati is itself a nonclassical Sanskritized name of common Indian name Papitaa or papaya. Shlokas on Naahi ( Enicostemma axillare, Indian Gentiana); Parnya yavani leaf ( Coleus amboinicus, Pattharchuur); Patrasnuhi ( Euphorbia nivulia); Takkola ( Illicium verum, star anise); Vajrranna ( Pennisetum typhoides, pearl millet), composed by contemporary scholars, are also quoted in API, Vol. VI. Such shlokas as a part of a Pharmacopoeia carry a pseudosanctity and are proving a more unethical trend than other adulterants.

Now, we give 85 examples of the complexity of botanical drugs of Ayurvedic Pharmacopoeia of India. This will prove that effective and universally acceptable herbal drugs are possible only when validated botanicals, instead of more than ambiguous classical Ayurvedic text names, are used. The age of the Sanskrit medium was over more than three centuries back. Following list in by Botanical names, alphabetically: Taalisha

Taalisha still remains a drug of disputed source. Abies webbiana and Taxus wallichiana both are known as Taalisha patra. Two samples of needles and twigs from two different locations of central Nepal gave alpha-pinene 3.0, 10.3; fascile 3.5, 9.3; beta-pinene 5.1, 3.3; limonene 6.1, 2.3; bornyl acetate 4.2, 15.5; and carvone 5.8, 0.75%, respectively. Leaves obtained from Sikkim-Himalayan region gave a biofla-vonoid, abiesin; two glycosides, methylbetuloside, and betuloside; n-triacontanol and beta-sitosterol. A new alkaloid, 1-(4’ methoxyphenyl)-aziridine was isolated.

Svarna-taali (yellow-flowered sp. of rhododendron?) was used as a substitute for Taalisha patra during the sixteenth century. Leaves of Rhododendron anthopogon D.Don., R. campanulatum D.Don. And R. lepidotum Wall. are also passed on as Taalisha patra. A sample of Rhododendron anthopogon leaves from Pindari (at 4500m altitude) contained quercetin, myricetin, taxifolin, kaempferol, kaempferol-4’ methyl ether, kaempferol-3-O-beta-D-glucopyranoside, and quercetin 3-O-alpha-L-rhamnopyranoside.

National Formulary of Unani Medicine equated Zarnab (Taalisapattar) with Flacourtia cataphracta, also with Cinnamomum tamala Nees. Flacourtia cataphracta leaf extracts gave beta-amyrin, alpha-amyrin, a mixture of beta-sitosterol and stigmasterol (from both leaves and stem bark); beta-sitosterol-3–0-beta-D-glucoside, 5–0-caffeoylquinic acid (from leaves). Leaves yield an essential oil (0.2–0.6%).

Cinnamomum tamala Nees leaf oil resembles C. zeylanicum leaf oil which contains d-alpha-phellandrene and 78% eugenol. A sample of oil from Assam (yield 2.0%) has been found to contain as high as 80–85% eugenol (13.3 and 1.0% from Kumaun hills and Joginder Nagar, respectively. (Clove contains 60–90% eugenol.

Cinnamomum tamala leaves belong to two chemotypes: eugenol type and cinnamic aldehyde type. Eugenol type trees are found in Kashmir, Tehri Garhwal, other tropical and subtropical Himalayan areas. Khasi and Jaintia hills and West Bengal. Eugenol type trees occur more widely than cinnamic aldehyde type.

Identification of proper herbs 75

Ativishaa, Atis

Daughter tubers of Aconitum heterophyllum Wall. ex Royle constitutes the main drug, Atis root. Mother tubers are considered inferior. The root yielded 0.79%

of total alkaloids; atisine, heterotisine, hestisine, heterophyllisine, heterophylline, heterophyllidine, atidine, hetidine, benzoylheterotisine, F-dihydroatisine, and hetisinone; atisinol closely related to atisine (Atisine yield 0.4%).

Commercial Atis (Patis) of the market is not the root of A. heterophyllum. The market drug is adulterated with the roots of Chaerophyllum villosum Wall. and Aconitum kashmiricum Stapf ex Coventry.

Vacha

Acorus calamus Linn. is the official drug. Roots of Alpinia galanga Willd, known as Sugandh Vachaa, are sometimes supplied as Vach. Commercial material of North-east regions is adulterated with Costus speciosus (Koen) Sims. There is a second variety of Vachaa called Shveta Vachaa or Haimavati Vachaa. This is provisionally equated with Acorus gramineus Soland or Iris germanica Linn.

and Paris polyphylla Sm. Baal Vach ( Paris polyphylla); Malaya Vachaa ( Alpinia galanga); Dweepaantara Vachaa ( Smilax china Linn.) Four chemo-types of calamus are used in herbal medicine:

Type I: Acorus calamus L. var. americanus, a diploid American variety; Type II: var. vulgaris L. (var. calamus), a European triploid; Type III and IV: var. augustatus Bess. And var. versus L., subtropical tetraploids.

Beta-asarone in different chemo-types: In type I, beta-asarone and other phenylpropanoids are absent. It is superior in spasmolytic activity to other types.

In type II, III and IV, the major constituent is usually beta-asarone (isoasarone) up to 96%. Indian calamus oil contains up to 82% asarone and its beta-isomer.

(Beta-asarone is carcinogenic in animal studies.)

The American variety is isoasarone free. European form contains less than 10%

isoasarone; others contain up to 96% beta-isoasarone in the volatile oil.

Vaasaa

Vaasaa is equated with Adhatoda vasica Nees (Syns. A. zeylanica Medic., Justicia adhatoda Linn.). A. beddomei C. B. Clarke, used in Kerala, also contains vasicine and vasicinone. It is considered to be more active than A. zeylanica.

Hamspaadi

Hamspaadi is equated with Adiantum lunulatum Burm., Adiantum philippenese Linn. syn. A. lunulatum Burm. Fonds gave hopane-type, isohopane-type, neo-hopane-type, norhopane-type and fernane-type triterpenoids. The market drug

76 Legacy and logical steps

consists commonly of Adiantum venustum Don. And/or A. capillus-veneris Linn.

The genuine material is scarce.

In Kerala, Desmodium triflorum (L.) DC. Is used as Hamsapadi. Vitis pedata Vahl is also known as Hamsapadi. In Tamil Nadu, Coldenia procumbens Linn. is the source of Hamsapadi.

Ayurvedic Pharmacopoeia of India (Part I, Vol. VI) equated A. capillus-veneris Linn. with Bijapatra, which could not be found in any classical text. A. capillus-veneris Linn. is known as Hamsraaj in folk medicine. The market drug is adulterated with Adiantum venustum Don.

Paashaanabheda

Bergenia ciliata (Haw.) Sternb. Syn. Bergenia ligulata (Wall.) Engl. (Saxifragaceae) is the Indian pharmacopoeial name of Paashanabheda,

Aerva lanata (Linn.) Juss. (Fam. Amaranthaceae) is used in Tamil Nadu, Rotula aquatica Lour. (Boraginaceae) and Homonoia riparia Lour. Syn. Adelia neriifolia Roth. (Euphorbiaceae) are used in Kerala. In Kerala, Aerva lanata is used as Bhadra.

Sthuula-Aila

Sthuula-aila is the pharmacopoeial name equated with Amomum subulatum Roxb.

In Kerala, fruits of Pucedanum grande C. B. Clarke are used as Sthuula-aila.

Dhava

Dhava is the pharmacopoeial name equated with Anogeissus latifolia Wall. The Indian Medical Practitioners’ Cooperative Stores Ltd. (IMPCOPS), Chennai, is using Syzygium hemisphericum (Walp.) Alston, syn. Eugenia hemispherical Wight, fam. Myrtaceae, as Dhava since 1968. IMPCOPS drug sources were reviewed by the botanist, S. Usman Ali of The Captain Srinivas Murti Research Institute, Chennai. Syzygium hemisphericum (Walp.) Alston is found in South India, Western Ghats South, Maharashtra Sahyadri, Sri Lanka, up to 1,400m, also in East Indies, Malaya, Pacific Islands, Philippines (related species of Eugenia jambos). In Tamil Nadu, White Rose Apple Wood, Syzygium hemisphericum, known as Vennavalmaram, is used as Dhava, while A. latifolia is in abundance in Madurai, Tirunelveli and Tamil Nadu, also in Andhra Pradesh, Karnataka, and Kerala.

Heartwoods of both ( A. latifolia and S. hemisphericum), were used for preparing cart wheels, which was the identification source of Dhava.

According to Ayurvedic Pharmacopoeia of India (Part I, Vol. VI), two varieties are mentioned in classical texts: Dhava of Charak: Madhura-tvaka, Madhurav-alkala, Vaka-vriksha (Crane Tree). Dhava of Dhanvantari Nighantu and Raaja Nighantu (twelfth to fourteenth century): tikta (bitter) (API, VI).

Identification of proper herbs 77

Chandaa

Chandaa is the pharmacopoeial name equated with Angelica archangelica Linn.

In Kerala, Costus specious (Koenig) Smith is used for Chandaa and Choraka (the white and yellow varieties), while Choraka is the pharmacopoeial name equated with Angelica glauca Edgew.

Agaru

Agaru is the pharmacopoeial name equated with Aquillaria agallocha Roxb.

Syn. A. malaccensis Lam. In South India, Vepris bilocularis Engl. And Anaphalis neelgeeriana DC. Are used as Krishnaaguru and Dysoxylum labaricum Bedd. Ex Hiern as Sveta Aguru.

Agarwood or Eaglewood of commerce is derived from the fungus-infected tree through wounds caused by species of Aspergillus, Fusarium, and Penicillium, also by some of Fungi linperfecti.

Vriddhadaaru

Vriddhadaaru is the pharmacopoeial name equated with Argyreia nervosa (Burm.

f.) Boj., syn. A. speciosa Sweet. Roots of Ipomoea pes-caprae (L.) Sw., syn. I.

biloba Chois. And I.

petaloidea Chois. are common substitutes in South and North-west India, respectively.

Naakuli

In Ayurvedic Formulary of India, Part 1, page 320, Naakuli is equated with Aristolochia indica Linn. Ishvari is the pharmacopoeial name equated with Aristolochia indica Linn. Sarpagandhaa (syn. Naakuli) is also the pharmacopoeial name equated with Rauvolfia serpentina. In Ayurvedic Pharmacopoeia of India.

Part I, Vo. III, Aristolochia indica Linn. is equated with Gandganaakuli.

In India, Rauvolfia tetraphyla Linn. is used as a substitute when Rauvolfia serpentina is not available. Roots of R. densifolia Benth. and R. micrantha Hook. f.

are sometimes found mixed in Kerala and Western India.

Dvipaantara Damanaka

Dvipaantara Damanaka is the pharmacopoeial name equated with Artemisia absinthium Linn. The original name is Afsanteen of Unani medicine and Wormwood of Western herbal. Damanaka was an aromatic shrub. It was a constituent of Mahasugandhi Taila of Bhavaprakasha. Aeq-e-Afsanteen of Unani medicine is used in hepatitis, while Damanaka was used as a massage oil ingredient for reducing obesity and skin diseases.

78 Legacy and logical steps

Shataavari

Shataavari is the pharmacopoeial name equated with Asparagus recemosus Willd.

Mahaashataavari, mentioned in classical texts, is equated with A. sarmentosus Linn. Roots of A. sarmentosus are more commonly used as a substitute for Shataavari in South India.

The trade procures three varieties as Shataavari: var. racemosus, common in plains and upper ghats in Hassan (Karnataka); var. gavanika Miq., distributed in Deccan peninsula, Karnataka, Gujarat, and Madhya Pradesh; var. subacerosa Baker distributed in Sikkim at altitudes of 300–1200m.

Braahmi

Braahmi is the pharmacopoeial name equated with Bacopa monnieri (Linn.) Wettst., syn. Herpestis monnieria (Linn.) H. B. and K. Centella asiatica (L.) Urban, syn. Hydrocotyle asiatica Linn. and its two other species, H. rotundifolia Roxb. And H. javanica Thumb is being used as Braahmi in some parts of India.

These have been identified as Manduukaparni.

Danti

Danti is the pharmacopoeial name equated with Baliospermum montanum Muell.-

Arg. Croton tiglium Linn. is used as a substitute in Tamil Nadu. Dantimuula is sold as Danti, Hastidanti, and Dravanti. Hastidanti is equated with Croton oblongifolius Roxb. And Dravanti with Jatropha curcas Linn. Roots of Ricinus communis Linn. is a common adulterant.

Sahachara

Sahachara is the pharmacopoeial name equated with Barleria prionitis Linn.

In Kerala, other Acanthaceae spp. are used as Sahachara: Nilgirianthus ciliatus (Nees) Bremek., Ecbolium viride (Forsk.) Alston and J usticia betonica Linn.

Daaruharidra

Daaruharidra is the pharmacopoeial name equated with Berberis aristata DC.

B. aristata Hook. f. & Thomson (non DC.), B. asiatica Roxb., B. chitria Lindl.

Are also used as Daaruharidra.

The stem bark of Coscinium fenestratum Colebr. is used as a substitute in Kerala and Tamil Nadu, and is considered better thorn Berberis. It is Known as Ceylon Calamba or False Calamba. Coscinum fenestratum contains berberine up to 3.5%; while Berberis aristata DC. contains 2.76% berberine. Root and root bark of B. lycium Royle is the usual adulterant.

Identification of proper herbs 79

Rakta Punarnavaa

Rakta Punarnavaa is the pharmacopoeial name equated with Boerhaavia diffusa Linn.

Trianthema portulacastrum Linn. is used as a substitute in the South, and sold as Sveta punarnavaa. Trianthema portulacastrum is also equated with Kathilla (a synonym of Punarnavaa). The white variety of Punarnavaa is svetamuulaa (having white roots), Rakta punarnavaa is raktapushpaa ( h aving red flowers). Species with red and white flowers exist in both, Boerhavia and Trianthema spp.

Shallaki

Shallaki is the pharmacopoeial name equated with Boswellia serrata Roxb. Indian material is found adulterated with the gum of Garuga pennata Roxb. Substantial quantities of the oleo-gum-resin are imported from Gulf countries and North Africa, obtained from B. carteri Birdw. And B. frereana Birdw.

Karanja

Karanja is the pharmacopoeial name equated with Pongamia pinnata Pierre.

Three plant species are being used as Karanja because their flowers impart color to the water. Pongamia pinnata Pierre, a tree, is equated with Karanja, Karan-jaka, Naktamaala (AFI synonyms) and Udakirya. Holoptelea integrifolia (Roxb.) Planch., also a tree, is equated with Chirbilva, Putika, Putikaranja (AFI synonyms) and Prakiryaa; Caesalpinia bonduc (L.) Roxb. Dandy & Exell., a shrub, has been identified as Lataakaranja (AFI synonym), Kantaki karanja and Karanji.

Priyangu

Priyangu is the pharmacopoeial name equated with Callicarpa macrophylla Vahl. Aromatic buds of C. macrophylla are accepted by many scholars as Phool Priyangu and while aromatic kernels of Prunus mahaleb Linn. fruits as Gandha Priyangu. Fruits of Aglaia roxburghiana Miq. are also sold in North India as Priyangu. In Kerala, dried male flowers of Myristica fragrans Houtt. are sold as Priyangu; flower buds of M. malabarica Lam. and Orchrocarpus longifolius Benth. & Hook. are sold in Chennai (Tamil Nadu) and fruits of Zanthoxylum budrunga Wall. in Kerala.

Paathaa

Paathaa is the pharmacopoeial name equated with Cissampelos pareira Linn.

The root is sometimes found adulterated with the roots of Stephania glabra Hk. f.

Bigger var. (Raaja-paathaa is equated with Stephania hernandifolia Walp. and Cyclea peltata (Lamk.) Hook. f. & Thoms. True Pareira Brava is derived either

80 Legacy and logical steps

from Chondrodendron tomentosum Ruiz & Pav. (a native of Peru and Brazil) or from C. platyphyllum Miers. In South India, roots of Cyclea peltata Diel are considered to be the true source of Paathaa.

Bhaarangi

Bhaarangi is the pharmacopoeial name equated with Clerodendrum serratum (Linn.) Moon. None of the Clerodendrum spp. are the sources of what is available as Bhaarangi in the market. It has been found that stem bark of Elaeodendron glaucum Pers. and Gardenia turgida Roxb. or Picrasma quassioides Benn. are being used as Bhaarangi since long. Particularly in eastern India, the bark of Picrasma quassiodes is sold as Bhaarangi.

( Clerodendrum serratum and Elaeodendron glaucum: distributed throughout India, common in southern and eastern India. Gardenia turgida: Bihar, Maharashtra, Karnataka, Tamil Nadu. Picrasma quassioides: North-eastern India.) Aparaajitaa

Aparaajitaa is the pharmacopoeial name equated with Clitoria ternatea Linn.

The market samples of Shankhapushpi from South India, consisted largely of C. ternatea, while from other regions contained dried herb of Canscora decussata Roem. & Schult., Convolvulus microphyllus Sieb. ex Spreng. (syn. C. pluricaulis Choisy), Evolvulus alsinoides L. and Lavendula bipinnata Kuntze (syn. L. bur-manii Benth.).

Kerala physicians do not discriminate between Aparaajitaa and Shankhapushpi and use Clitoria ternatea in place of both. (Visnnukraantaa, a blue-flowered variety of Shankhapushpi, is treated as a synonym of Aparaajitaa in Bhavaprakasha, sixteenth century.)

Gandira

Gandira is the pharmacopoeial name equated with Coleus forskohlii Briq. syn. C, barbatus Benth., Plectranthus barbatus Andr. There is great confusion regarding the identity of Gandira. Gandira may be cited as an example where the wrong use of synonyms clouds the correct identity of a drug plant. Gandira is mentioned in Sushrut Samhita (56, 46, 247). According to Sushrut, it supresses stool and urine, Ayurvedic Pharmacopoeia also listed muutrabandh and malabandh among its properties, Indian National Academy equated Gandira with Cucumus utilatis-simus Linn. In Kerala, Cayratia carnosa Gaggnep. is reported as being used as Gandira. Two varieties of Gandira have been suggested by Ayurvedic scholars, sthalaja (nonaqautic) and jalaja (aquatic). Nonaquatic variety has been suggested as Coleus ambroinicus Lour. or C. barbatus Benth. (as mint species) and aquatic variety as Achyranthes acquatica Br. But none of the property of C. forskohlii matches with the Ayurvedic sources so far suggested.

C. forskohlii is the source of forskolin (0.1% on dry weight basis). In none of the other Coleus spp. ( C. amboinicus, C. scutellarioides, C. coninus, C. malabaricus,

Identification of proper herbs 81

and C. rotundifollius) forskolin could be detected at levels down to 1 x 10−4% on dry wt. of plant material.

Shankhapushpi

Shankhpushpi is the pharmacopoeial name equated with Convolvulus pluricaulis Convolvulus pluricaulis is used as Shankhapushpi in North India; Clitoria ternatea Linn. and Canscora decussata Schult. in South India. Canscora decussata and Lavendula bipinnata O. Ktze. are used as Shankhapushpi in Bengal. Evolvulus alsinoides is treated as Vishnukraantaa, Vishnukraandi, Vishnugandhi of Siddha medicine.

Kaaliyaka

Kaaliyaka is the pharmacopoeial name equated with Coscinium fenestratum (Gaertn.) Colebr. while Pita Chandan is the official name in Ayurvedic Formulary of India.

Stem bark of C. fenestratum is used as a substitute of Daaruharidra ( Berberis aristata) DC. in Tamil Nadu and Kerala.

Kebuka

Kebuka is the pharmacopoeial name equated with Costus speciosus (Koerning ex Retz.) Smith. Not to be confused with Saussurea lappa C. B. Clarke.

In the market, dried pieces of Kebuka root tuber are sold as Kalihaari ( Gloriosa superba Linn.). Laangli is the pharmacopoeial name equated with Gloriosa superba Linn.

Kumkuma

Kumkuma is the pharmacopoeial name equated with Crocus sativus Linn.

During the classical period, the drug sources were Mimusops elengi Linn. or Mesua ferrea Linn. The heartwood of both is dark red or deep reddish brown (color of rudhir). Flower buds of Mesua ferrea contain a yellow coloring matter, flowers yield a reddish brown volatile oil.

Kashmiraj was mentioned for the first time by Vagbhata (sixth–seventh century).

Chakrapaani (eleventh century) interpreted Rudhira of Charaka as Kumkuma.

Kesara and Keshara are difficult to define in Ayurvedic literature.

Kesharaahva, in most cases, has been treated as a synonym of Naagakesara (stamens of Mesua ferrea) and where preceded by the Padma or its synonyms, as only Padmakesara or as Padma and kesara both. Kesara has also been interpreted as Bakul ( Mimusops elengi). It appears (after analysis of classical references) that Kesara was never been used in the texts as a synonym of Kashmiraja kesara).

In Ayurvedic Formulary of India, Part I, Second Edn. (page 317), Keshara and Kesara are synonyms of Naagakeshara equated with Mesua ferrea, while Kumkuma (page 318) is equated with Crocus sativus, and there is no entry in

82 Legacy and logical steps

the column for the official name. In Ayurvedic Formulary of India, Part II, First Revised Edn., Kumkuma, and Keshara are the synonym, equated with Crocus sativus Linn. (page 330); while Naagakeshara, Naagakesara, and Kesara are synonyms, equated with Mesua ferrea (page 334).

Krishna Saarivaa, Shveta Saariva

Krishna Saariva is the pharmacopoeial name equated with Cryptolepsis buchanani Roem. & Schult.

Black stem pieces of C. buchanani are used and sold in Uttar Pradesh market as Anantamuula. Ichnocarpus frutescens R. Br. is used as Krishna Saarivaa and Decalepis hamiltonii Wight & Arn. As Saariva in South India. Ichnocarpus frutescens is also used as the black variety of Saarivaa in Bengal.

Two varieties of Saarivaa are mentioned in Ayurvedic texts: Shveta (white) and Krishna (black). Shveta Saariva is the pharmacopoeial name equated with Hemi-sdesmus indicus (L.) R. Br. Tylophora fassciculata Ham. Ex Wight and Decalepis hemiltonii have been suggested by Ayurvedic scholars as to the black and white varieties.

Taalmuuli

Taalmuuli is the pharmacopoeial name equated with Curculigo orchioides Gaertn.

In Kerala, in practice, C. orchioides is used for both, the black and white variety of Mushali (known as Nilappana in Malayalam).

A black variety of Mushali is used since long as Taalamuuli. The white variety of Mushali is equated with Chlorophytum arundinaceum Baker (Nepal, Bhutan, and Bihar) and C. borivilianum (cultivated in Jalgaon, Maharashtra). The commercial drug of the white variety contains the tubers of Chlorophytum arundinaceum, C. tuberosum Baker and C. attenuatum Baker (found on the hills in Kerala, Karnataka, Tamil Nadu and on the hills near Udaipur in Rajasthan).

Aamra Haridra

Aamra Haridra is the pharmacopoeial name equated with Curcuma amada Roxb.

The genuine material is available in West Bengal, Kerala, and Tamil Nadu.

At the majority of trade centers, C. aromatica Salisb., wild turmeric, is sold as Aambaahaldi.

Haridra

Haridra is the pharmacopoeial name equated with Curcuma longa Linn.

Rajani, Nishaa, Nishi, Raatri, Nilakanth are wrong synonyms of Haridra. These should be equated with C. caesia Roxb. (cultivated mainly in West Bengal).

Source of Radix curcumae in China: Curcuma wenyujin Y. H. Lee et C. Ling, C. kwangsiensis S. Lee et al., C. F. Lang, C. phaeocaulis Val.

Identification of proper herbs 83

Karchura

Karchura is the pharmacopoeial name equated with Curcuma zedoaria Rosc.

Rhizomes of Curcuma caesia Roxb. are sold as a substitute, especially in West Bengal.

The source of Karchura in Kerala, in recent times, has been Kaempfera galanga Linn.

Shimshapaa

Simshapaa is the pharmacopoeial name equated with Dalbergia sissoo Roxb.

Two varieties of Shimshapaa are mentioned in Ayurveda (Dhanvantari Nighantu, prior to thirteenth century). The second variety is equated with D.

latifolia Roxb.

In Kerala, the heartwood of Xylia xylocarpa Roxb. Taub. is used as Shimshapaa.

Dhattuura

Dhatuura is the pharmacopoeial name equated with Datura metel Linn.

Indian Dhatura species contain alkaloids hyoscyamine and hyoscine, but D.

metel Linn., additionally, contains meteloidine, as a specific characteristic (Indian Council of Medical Researh).

Shaalparni

Shaalparni is the pharmacopoeial name equated with Desmodium gangeticum DC.

The drug is sometimes adulterated or even substituted with the roots of Desmodium pulchellum Benth. ex Baker. (especially in material coming from Garhwal hills.) Roots of Flemingia chappar Ham. and F. semialata Roxb. are also used as substitutes.

Kerala physicians, by and large, accepted Psuedarthria viscida (L.) W. & A. as the source plant of Shaalparni.

Bhringaraaja

Bhringaraaja is the pharmacopoeial name equated with Eclipta alba Hassk.

Three varieties are mentioned in Ayurvedic texts, shvetapushpi (white-flowered), nilapushpi (blue-flowered) and pitapushpi (yellow-flowered). In practice, no distinction is made between white and blue flowered varieties which are equated with E. alba. The yellow-flowered variety is considered a different drug and is equated with Wedelia chinensis (Osbeck) Merr. syn. W. calendulacea (Linn.) Less non Rich.

Haliotropium brevifolium Wall. is equated wrongly with a white variety of Bhringaraaja. The adulterants include Ageratum conyzoides Linn., Caesulia axillaris, and Alternanthera sesselis.

84 Legacy and logical steps

Vidang

Vidang is the pharmacopoeial name equated with Embelia ribes Brum. f.

Embelia tsjeriam-cottam A. DC. syn. E. rabusta C. B. Cl. is a commonly employed substitute for Vidanga. Fruit of Myrsine africana Linn. is the main adulterant.

Hingu

Hingu is the pharmacopoeial name equated with Ferula foetida Regel. Ferula narthex Boiss. is an inappropriate equation of Ferula asafoetida Linn. since its volatile oil is reported to be sulfur-free.

Charaka used dried fruits of Hingu (Hinguka) in a gruel as a blood purifier and purgative ( Charaka Samhita, Su. 2, 29)27, Hingu and Hingupatri in medicinal ghee for insanity.

Hingupatri is the pharmacopoeial name equated with Ferula jaeschkeana Vatke. Two more botanical sources have been suggested: Ferula narthex Boiss or Gardenia gummifera Linn. f. (Naadihingu). Hinguparni (Ci 9, 63), Hingu-patrikaa (Ci 9, 72), Hinguvaatikaa (Ci 15, 108) of Charaka Samhita still renain unidentified.

Parpata

Parpata is the pharmacopoeial name equated with Fumaria parviflora Lam.

In Kerala, Hedyotis brachypoda DC., H. corymbosa (L.) Lam. and H. diffusa Willd. are generally accepted as Parpata. IMPCOPS, Chennai, is using Mollugo cerviana Ser. as Parpataka.

Naadihingu

Naadihingu is the pharmacopoeial name equated with Gardenia gummifera L. f.

Leaf buds and young shoots of G. gummifera, as also of G. lucida Roxb. Syn.

G. resinifera Roth. yield a resinous exudation, known as Cumbi Gum.

The gum is not related to Ferula spp., nor is a substitute for any Ferula product.

A flavonoid (gardenin A, its methyl ether and acetate) has been isolated from the plant gum (3.76%); six cycloartane triterpenes dikamaliartanes A-F, along with the flavonoid gardenin E, were also isolated.

Laangali

Laangali is the pharmacopoeial name equated with Gloriosa superba Linn.

Sliced rhizomes of Costus spiciosus (Koem.) Sims. (Kabuka) are often adulterated with the drug Laangali. Their action on uterus has been found to be nearly similar to that of Laangali.

Identification of proper herbs 85

Yashti

Yashti is the pharmacopoeial name equated with Glycyrrhiza glabra Linn.

A number of botanical drugs were used as a substitute for Madhuyashti during the classical period.

The root of Abrus precatorius is still known as Indian liquorice as it contains glycyrrhizin.

Taverniera cuneifolia Arn. syn. T. nummularia Baker (found in plains of Punjab, Gujarat and the Deccan), was known as Jetimad in Mumbai. (Common names of Yashtimadhu are Jethi Madh in Gujarat, Jeshta Madha in Maharashtra, jashti-madhu in Bengal.)

Shathi

Shathi is the pharmacopoeial name equated with Hedychium spicatum Ham. ex Smith

The rhizome of Hedychium coronarium Koening is the most common adulterant.

H. spicatum (a Himalayan plant) is not available in South India. Curcuma zedoaria Roscoe is used as Shathi. Kaempfera galanga Linn. is used as a substitute.

Wall.

Riddhi

Riddhi is the pharmacopoeial name equated with Habernaria intermedia D.Don.

Habernaria spp. (H. intermedia, H. acuminata Thw., H. goodyeroides D.Don.) are collected in the Dehradun region and sold as Riddhi-Vriddhi. (Riddhi-Vriddhi pair is a constituent of Ashta Varga of Classical Ayurveda.) Habernaria edgeworthii Hook. f. ex Collete. and H. intermedia are used in Kerala as Riddhi-Vriddhi.

Substitute drug of Riddhi is Dioscoria bulbifera Linn. ( Ayurvedic Fomulary of India).

Kutaja

Kutaja is the pharmacopoeial name equated with Holarrhena antidysenterica (Roth) A. DC. and Indrayava is the pharmacopoeial name equated with Holarrhena antidysenterica Wall.

Wrightia antidyserterica (L.) R. Br is the currently valid name of Kutaja (Indian Council of Medical Research, Medicinal Plants Unit). The stem bark of Wrightia tomentosa R. & S. and W. tinctoria R. Br. are often substituted for the genuine drug.

Two varieties of Kutaja have been mentioned in Ayurvedic texts, male and female. Holarrheana antidysenterica is supposed to be the male, Wrightia tinctoria the female. The male variety of fruits are bigger than the female variety.

86 Legacy and logical steps

Bitter Indrayava is the fruit of H. antidysenterica; sweet Indrayava is the fruit of Wrightia tinctoria R.Br.

Chirbilva

Chirbilva is the pharmacopoeial name equated with Holoptelea integrifolia Planch.

Two species of Karanja trees have been mentioned in texts: Puutika (Chira-bilva, Prakirya) and Naktamaala (Udakirya); equated with Holoptelea integrifolia and Pongamia pinnata Lierra., respectively. The third Karanja is a shrub, Kantaki Karanja or Lata Karanja, equated with Caesalpinia bonduc (L.) Roxb. It is a later addition. (In Ayurvrdic Pharmacopoeia of India, Part I, Vol. III, therapeutic uses quoted from Bhavaprakasha in Sanskrit are about Shriphala (Bilva). (Quoted wrongly for Chirbilva.)

Paarsika Yavaani

Paarsika Yavaani is the pharmacopoeial name equated with Hyoscyamus niger Linn.

Seeds of H. niger and H. muticus Linn. are the official source of Paarasika yavaani. ( H. muticus is Egyptian Henbane.)

Commercial samples of the drug sold in Gujarat were found to be seeds of Cleome viscosa Linn.

Pushkara

Pushkara is the pharmacopoeial name equated with Inula racemosa Hook. f.

Roots of Saussurea lappa C. B. Clarke is commonly found mixed with commercial samples of Pushkaramèla. The plant is restricted to Western Himalayas.

Even in Bhavaprakasha (sixteenth century), Kushtha (Saussurea lappa) was a substitute for Pushkaramuula. The accepted source of the drug in Kerala was Coffea travancorensis Wt. & Arn. ( Psilanthus travancorensis), which is scarce.

Hapushaa

Hapushaa is the pharmacopoeial name equated with Juniperus communis Linn.

In South India, Sphaeranthus indicus Linn. is used as the drug source. Kerala physicians consider Hapushaa and Mundi as synonymous.

Madayanti

Madayanti is the pharmacopoeial name equated with Lawsonia inermis Linn.

Nil Madayantika could not be traced in classical texts. Madayanti/Madayanti-kaa is mentioned in Bhavaprakasha (sixteenth century), but it was equated with Mallikaa, a Jasmine species. Medini and Madyantikaa were its synonyms.

Identification of proper herbs 87

Henna (Mehendi) was originally an Unani plant drug. Classical Ayurvedic drug as Mendi, Mendikaa, Madyantikaa (Charaka, Sushruta, 1000 bc; Vagabhatta, sixth–seventh century). It was included in Mahaanila Ghrit of Sushruit which was specific for leprosy. Madayanti Kvatha (Sahasrayoga, a non-Samhita Kerala Materia Medica, CCRAS text) is a single herb preparation for bleeding disorders.

Jivanti

Jivanti is the pharmacopoeial name equated with Leptadenia reticulata W. & A.

The market drug, in most parts of the country, is the whole herb of Ephemeran-tha macraei (Lindl.) Hunt & Summerh syn. Dendrobium macraei Lindl., known as Swarna Jivanti.

Roots of Holostemma ada-kodien Schult are used as Jivanti in South India, especially in Kerala. Majority of Ayurvedic practitioners has probably been using different orchid species having a similar appearance and belonging to Pholidota spp. or Desmotrichum fimbriatum Bl. syn. Dendrobium macraei Lindl.

Kaakoli

Kaakoli is the pharmacopoeial name equated with Lilium polyphyllum D.Don.

Tuberous roots of Roscoea procera Wall. are also used as Kaakoli.

Withania somnifera Dunal. roots are used as a substitute for Kaakoli and Kshirakaakoli (in double quantities).

Kshirakaakoli

Kshirakaakoli is the pharmacopoeial name equated with Fritillaria roylei Hook.

In addition to Fritillaria roylei, orchids being sold in the market include Roscoea procera Wall., Nomocharis oxypetala Royle and Lilium polyphyllum D.Don., as well as Mimuscops kauki Linn.

Jivaka and Rshbhaka

Jivaka and Rshbhaka is the pharmacopoeial name equated with Malaxis acuminata D.Don.

Malaxis mucifera (Lindley) Kuntz. syn. Microstylis musifera Ridly is also used as Jivaka. Malax acuminata is used as Rshbhaka. Pueraria tuberosa DC. is used as a substitute of Jivaka and Rshbhaka.

Muurvaa

Muurvaa is the pharmacopoeial name equated with Marsdenia tenacissima Wight. & Arn.

M. tenacissima is wrongly supplied in the Northern markets under the name of Trivrit.

88 Legacy and logical steps

Jingini was used as a substitute for Muurvaa during the sixteenth century.

(Jingini is equated with Lannea coromandelica Merill.) In Kerala, Chonemorpha fragrans (Moon) Alston is the accepted source of Muurvaa. Sansevieria roxburghiana Schult. is used in Tamil Nadu.

Kaaka-Naasikaa

Kaaka-Naasikaa is the pharmacopoeial name equated with Martynia annua Linn.

Seeds of Anamirta paniculata W. & A. are used as Kaaka-Naasikaa in Tamil Nadu.

Naagakeshara

Naagakeshara is the pharmacopoeial name equated with Mesua ferrea Linn.

In Ayurvedic Formulary of India, Part I, Second Edn. (page 317), Keshara and Kesara are synonyms of Naagakeshara equated with Mesua ferrea, while Kumkuma (page 318) is equated with Crocus sativus, and there is no entry in the column for the official name. In Ayurvedic Formulary of India, Part II, First Revised Edn., Kumkuma and Keshara are the synonyms, equated with Crocus sativus Linn. (page 330); while Naagakeshara, Naagakesara, and Kesara are synonyms, equated with Mesua ferrea (page 334).

Flower buds of Mammea suriga (Ham.) Kesterm (Fam. Cluciaceae) are known as Rakta-Naagakesara; immature fruits of Cinnamomum tamala Nees. & Eberm as Krishna-Naagakesara; and immature fruits of Dillenia pentagyna Roxb. as Malabar-kesara. In Tamil Nadu and adjacent states, tender fruits of Cinnamomum wightii or fruits of Dillenia pentagyna are used as Naagakeshara.

Jaatiphala

Jaatiphala is the pharmacopoeial name equated with Myristica fragrans Houtt.

East Indian nutmeg is available in three grades: (i) Banda nutmeg, considered to be the finest, contains up to 8% essential oil; (ii) Siaruw nutmeg, as good as Banda, contains c. 6.5% essential oil; and (iii) Penang nutmeg, usually wormy and moldy, derived from M. argentea Warb., suitable only for distillation purposes.

Bombay nutmeg, an adulterant of true nutmeg, is obtained from M. malabarica Lam., known as False Nutmeg.

Jataamaansi

Jataamaansi is the pharmacopoeial name equated with Nardostachys jatamansi DC.

Rhizomes of Selinum vaginatum C. B. Cl. and S. tenuifolium Wall. (known as Muraa) are sold as a cheap substitute for Jataamaansi.

Identification of proper herbs 89

Gojihvaa

Gojihvaa is the pharmacopoeial name equated with Onosma bracteatum Wall.

Elephantopus scaber Linn. is the source of Gojihvaa in Kerala Not to be confused with Gaozabaan. Unani drug Gaozabaan is not derived from O. bracteatum in India. The market drug is dried leaves and nutlets of Anchusa strigosa Labill, and flowers of Echium amoenum (Gul-e-Gaozabaan). Kashmiri Gaozabaan is derived from Macrotomia benthami (Wall.) A. DC.

Borago officinalis Linn. is equated with Gaozabaan in the National Formulary of Unani medicine. In Siddhayogasangraha (Vaidya Yadavji Trikamji) coined a new entity, Go-Javaana-Gojihvaa and equated it with Onosma bracteatum Wall.

( Ayurvedic Formulary of India, Part II, First English Edition. Page 69. On page 332, Go-Javana, as a synonym of Gojihvaa, is spelled as Gavajavaana.) Papata

Papata is the pharmacopoeial name equated with Pavetta indica var. tomentosa Hook. ( Ayurvedic Formulary of India, Part I, Second Revised Edition, equated Parpata, Parpataka, and Parpati with Fumaria parviflora Lam., page 321–322.

Parpata is not to be confused with Papata which is known as Kath-champaa.) According to some authors, P. indica is confined only to South India. Plants of other regions are P. carassiculas Bremek and P. indica sensu Hook. f.

A market survey reveals that Morinda pubscens Smith and Stylocoryne lucens Gamble (both Rubiaceae) are also accepted as the drug source.

Jalapippali

Jalapippali is the pharmacopoeial name equated with Phyla nodiflora Greene syn.

Lippia nodiflora Rich. Ayurvedic Formulary of India, Part I, page 314, equated Lippia nodiflora with Jalakarna, which is not a synonym of Jalapippali in any text. Phyla nodiflora is a pot herb, the leaves are reported to be eaten in Sri Lanka, while Jalapippali of classical texts was bitter and astringent.

National Academy of Ayurveda ( Rashtriya Ayurveda Vidyapeeth) equated Phyla nodiflora with Siddha drug Poduthalai. The Wealth of India, Indian Council of Medical Research, Medicinal Plant Unit, and Central Institute of Medical and Aromatic Plants did not equate P. nodiflora with any classical Ayurvedic drug.

Scientists of Indian National Science Academy equated Jalapippali with Ranunculus aculeata Pers. (Poison buttercup). This created doubt about the proper identification of a classical drug. The Wealth of India equated Jalapippali with Commelina salicifolia Roxb.

Taamalaki

Taamalaki is the pharmacopoeial name equated with Phyllanthus fraternus Webst.

90 Legacy and logical steps

Ayurvedic Formulary of India, Part I, wrongly equated Taamalaki with Phyllanthus niruri Linn. (page 327). Indian species is identified by Prof. Webster of California University. Phyllanthus niruri Linn. is an American species.

P. amarus Schum & Thonn. and P. airy-shawii Brunal & Roux, syn. P. debilis Klein ex Willd. are very common in Kerala and are used as a source of Taamalaki.

P. urinaria Linn. may also be used.

Kankol

Kankol is the pharmacopoeial name equated with Piper cubeba Linn. f.

Adulterants include Piper crassipes Korth., P. cannum Blume, P. baccatum Blume, Litsea cubeba Pers. Also P. clusii DC. and P. guineanse DC. (African spp.).

Maricha

Maricha is the pharmacopoeial name equated with Piper nigrum Linn.

Whole black pepper is often adulterated with fruits of Lantana camara Linn., Vitex altissima, seeds of Carica papaya Linn., dried and roasted berries of Schinus molle Linn.

In Bhavaprakasha (sixteenth century) seeds of Shigru ( Moringa oleifera Lam.) are described as Shveta maricha.

Raasanaa

Raasanaa is the pharmacopoeial name equated with Pluchea lanceolata Oliver & Hiern.

Pluchea lanceolata is the official Raasnaa, the substitute plant drug is Alpinia galanga Willd., which is used in South India. ( Ayurvedic Formulary of India, Part

I, page 323.)

Polygonum grabrum Willd. are sold since decades in Varanasi market as Raasanaa. Vanda roxburghii R. Br. is used in Bengal; Dodonaea viscosa Linn.

in Andhra Pradesh. Heliotropium strigosum Willd. is sold as Raasanaa in Bihar.

Rakta Chitraka

Rakta Chitraka is the pharmacopoeial name equated with Plumbago indica Linn.

Three varieties of Chitraka are mentioned in classical texts based on the color of the flower, red, white and black (blue). Vaagabhatta (sixth–seventh century) mentions a yellow-flowered variety instead of the red one.

White flowered variety ( Plumbago zeylanica L.) is used in North India. The red-flowered variety ( P. indica) is used in South India and Bengal. Black (blue)-

flowered variety is possibly P. auriculata Lam. (= P. capensis Thumb.), not used as a source of Chitraka.

In South India, Rakta chiraka is considered to be therapeutically more active.

The roots, as well as the root bark of P. indica, form an important indigenous drug, but less commonly used than those of P. zeylanica.

Identification of proper herbs 91

Medaa and Mahaa Medaa

Medaa and Mahaa Medaa are the pharmacopoeial names equated with Polygonatum cirrhifolium Royle

Polygonatum verticillatum (L.) Alloini also has been identified as Medaa, Asparagus racemosus Willd. is the substitute of Medaa and Mahaa medaa.

Lonikaa

Kozuppaa is the pharmacopoeial name equated with Portulaca oleracea Linn.

Kozuppaa is confined to Kerala and Tamil Nadu, while Lonikaa or Loni are classical Ayurvedic plant names of Charaka Samhita, Sushruta Samhita, and Ashtangahridaya,

In Kerala, at least three different plants are currently used as the source of Lonika (Malyalam Kozuppa) in different parts of Kerala: Alternanthera sessilis Linn., Glinus oppositifolius, and Portulaca oleracea.

Alternanthera sessilis (Matysakshi) has been the source of Kozuppaa since long in Kerala.

Asana

Asana is the pharmacopoeial name equated with Pterocarpus marsupium Roxb.

Asana is a synonym of Terminalia tomentosa W. & A. and Bridelia montana Willd. in Maharashtra. The heartwood of Terminalia tomentosa and Bridelia montana is sometimes found as adulterants.

Rakta-Chandana

Rakta-Chandana is the pharmacopoeial name equated with Pterocarpus santalinus Linn.

The heartwood of Adenanthera pavonia Willd. is often passed on as a substitute. The heartwood of Caesalpinia sappan Linn. is sometimes mistakenly used.

Raktachandana may be used as a substitute in place of Chandan-shveta (Santalum album Linn.) and Karpura (camphor). (Rakta-chandana has no aroma.) Sarpagandhaa

Arpagandhaa is the pharmacopoeial name equated with Rauwolfia serpentina (Linn.) Benth. ex Kurz.

Roots of Rauvolfia tetraphylla Linn., cultivated in various parts of India, are employed as a substitute when R. serpentina root is not available. Among major adulterants are thin roots of Tabernaemontana divaricata (L.) R. Br. Roots of Rauvolfia densiflora Benth. and R. micrantha Hook. f. are sometimes found mixed in Kerala and Western India.

Sarpagandhaa of Ayurvedic texts was not Rauvolfia serpentina of modern medicine, which was identified by the German scientist Rauwolf. In Ayurvedic texts,

92 Legacy and logical steps

Naakuli and Gandha Naakui were the drugs that were included in compound formulations for mental diseases. Sarpasugandhaa was a synonym of Naakuli. Dalhan’s Sarpachhatrikaa and Varshaasu chhatrakaaraa indicate that Sarpagandhaa of Ayurvedic texts was a Kavaka (mushroom) that was toxic.

Kushtha

Kushtha is the pharmacopoeial name equated with Saussurea lappa C. B. Clarke.

Kuth, commonly known as costus in trade, has no connection with the botanical genus Costus. Kustha is used as a substitute for Pushkar-mula ( Inula racemosa Hook. f.) and Tagara ( Valeriana wallichii DC.).

In Unani medicine, Qust-e-Arabi (Sweet var. is equated with Iris germanica Linn.) and Qust-e-Hindi, bitter var. with S. lappa.

Gajapippli

Gajapippli is the pharmacopoeial name equated with Scindapsus officinalis Schoott.

In Kerala, sliced and dried inflorescence of Balanophora indica Wall. and pieces of the stem (not fruits) of Scindapus officinalis are sold as Gajapippali.

Gajapippali was used as a substitute of Piper longum Linn. root.

Bhootakeshi

Bhootakeshi is the pharmacopoeial name equated with Selinum vaginatum C. B.

Clarke.

Bhootakeshi roots are covered by hair-like fibers. Several species, Nardostachys, Selinium, and Corydalis have a similar appearance and are likely to be called Bhootakeshi, Putankeshi, and Jatilaa.

Roots of S. vaginatum are frequently mixed with those of Seseli sibricum Benth. ex C. B. Clarke and sold in Jammu as a cheap substitute of Nardostachys jatamansi DC. rhizome.

Mahaa Balaa

Mahaa Balaa is the pharmacopoeial name equated with Sida rhombifolia Linn.

(Yellow-flowered var.) syn. S. rhomboidea Roxb. ex Fleming. (White-flowered variety.)

While Sida cordifolia is a widely used source of Balaa in northern parts of India, Kerala physicians have adopted Sida rhombifolia ssp. retusa for Balaa. Sida acuta is also widely used as an adulterant in Kerala.

Kaakamaachi

Kakamaachi is the pharmacopoeial name equated with Solanum nigrum Linn.

Identification of proper herbs 93

Diploid. Each form differs from the other. Tetraploids closely resemble S.

luteum Mill.

Hexaploid: mostly occurs in temperate parts, rarely in warmer regions.

Solanum americanum Linn. syn. S. incertum Dunal; S. rubrum Mill., is also treated as S. nigrum. Solanum nigrum auct. non. Linn. syn. S. americanum Mill. is equated with Kaakamaachi in South India. Geophilla repens (Linn.) I.

M. Johnson, syn. G. reniformis D.Don (Fam. Rubiaceae) is used as Karintakaali (Kaakamaachi) in Kerala.

Leaves of S. nigrum sometimes occur as an adulterant of Indian belladonna.

Mundi

Munditikaa is the pharmacopoeial name equated with Sphaeranthus indicus Linn.

S. africanus Linn. is used as Mahaamundi.

In Kerala, Sphaeranthus indicus is equated with Hapushaa (Juniperus communis Linn.); red and white varieties of Hapushaa with S. indicus and S. africanus Linn., respectively. This is not acceptable to other schools of Ayurveda.

(In The Wealth of India, Vol X, page 4, Hapushaa and Shveta Hapushaa are included among synonyms of S. indicus and S. africans, respectively.) Vishamushthi

Vishmushthi is the pharmacopoeial name equated with Strychnos nux-vomica Linn.

Nux-vomica seeds are often adulterated with the seeds of S. potatorum Linn. f.

and S. nux-blanda A. W. Hill.

Nux-vomica is a tree, while S. colubrina Linn. is a climber of the Deccan peninsula, from Konkan to Cochin. Its roots, seeds bark and wood contain strychnine and brucine. Also used as Nux-vomica.

Kiraatikta

Kiratikta is the pharmacopoeial name equated with Swertia chirata Buch. Ham.

Substitution of (Himalayan) Kiraatatikta by other species of Swertia ( S. angustifolia Buch.-ham. and S. alata Royle) and Andrographis paniculata Nees is done to such an extent that they are passed on in the drug market as original Chirayataa.

Andrographis paniculata is even known as chirayata variety.

Lodhra

Lodhra is the pharmacopoeial name equated with Symplocos racemosa Roxb. In Bhavaprakasha, two varieties are mentioned: Shaavara and Pattikaa (thick bark).

Shaavara Lodhra is equated with S. racemosa and Pattikaa Lodhra with S. crataegoides Buch-Ham. In Kerala, S. cochinchinensis (Lour.) S. Moore (= Symplocos spicata Roxb.) is used as Lodhra.

94 Legacy and logical steps

Sthauneya

Sthauneya is the pharmacopoeial name equated with Taxus baccata Linn.

Taxus baccata Linn. is European Yew. Himalayan Yew is T. wallichiana Zucc. syn.

T. baccata Linn. subsp. wallichiana (Zucc.) Pilgoe; T. baccata Hook. f. non Linn.

In Ayurvedic Formulary of India (Part I, page 327), Abies webbiana Lindl.

is equated with Taalisa. A. pindrow Spach. and Taxus baccata Linn. have been recognized as its substitutes. In South Indian compounds, T. baccata is used as Taalispatra.

All these examples will prove that due to a fundamental weakness in the identification of the proper herbs and assumptions about the final outcome, formulations of the classical periods were overloaded with many herbs and indication pluralism that could have been otherwise avoided.

In “Ayurvedic Pharmacopoeial Plant Drugs” we had pointed out a number of discrepancies in the selection of herbs and clinically unreliable applications of classical drugs; Panchgavya Ghrita for treating epilepsy, Ashwagandha for phthisis, Khadirarishta for heart diseases, Sarasvatarishta for the disorder of semen and Chyanprasha for gout and heart diseases.

The way out to solve the problem

When we can accommodate botanical names of Ayurvedic plants, phytochemical markers and chemical constituents, why can’t we accept pharmaceutical names in Ayurvedic Prarmacopoeia of India, Ayurvedic Formulary of India and on the label of all plant drugs, to avoid wrong identification of material and adulteration? Even WHO changed its approach in monographs on botanical drugs in 1999.

In all classical compounds of Ayurvedic Formulary of India, Sanskrit names with updated pharmaceutical names in brackets should be used. Sanskritized nonclassical names should be replaced with validated common vernacular or English names to avoid the impression that they were used during the classical period, while they are new entities. For proper plant parts (leaf, fruit, seed, root), international pharmaceutical names should be adopted.

Himalaya Drug Company, the manufacturers of research-oriented herbal/Ayurvedic drugs, recently upgraded their label drugs’ presentation. Though they have not yet used international pharmaceutical names, both Ayurvedic and botanical names with plant parts are now mentioned. With extract, herb to extract ratio should have been mentioned.

We will give some examples of pharmaceutical names of Ayurvedic plant drugs from WHO Monographs on Selected Medicinal Plants:

Achillea millefolium Linn. herb

(Herba Millefolii),

Aesculus hippocastanum Linn. seed

(Semen Hippocastani),

Alliun cepa Linn. bulb

(Bulbus Allii Cepae),

Allium sativum Linn. bulb

(Bulbus Allii Sativi),

Identification of proper herbs 95

Althaea officinalis Linn. root

(Radix Althaceae),

Ammi majus Linn. fruit

(Fructus Ammi Majoris),

Andrographis paniculata (Burm.f.) Nees herb (Herba Andrographidis), Berberis vulgeris Linn. bark

(Cortex Berberidis),

Boswellia serrata Rox. ex Colebr. Gum

(Gummi Boswellii).

Pharmaceutical names have been in use since 1992

German Commission E Monographs, The Scientific Foundation for Herbal Medicinal Products (ESCOP), The British Herbal Compendium, WHO and the Pharmacopoeia of People’s Republic of China have been using pharmaceutical names since 1992.

We will provide an exhaustive list of pharmaceutical names in the next pages.

Pharmacopoeia of People’s

Republic of China

Pharmaceutical names

While we are still trying to promote Sanskrit names as Pharmaceutical Names, Chinese have already adopted both Botanical and Pharmaceutical Names, used by German Commission E, European Scientific Cooperative on Phytotherapy (ESCOP), and WHO.

AYUSH should have a look at the pharmaceutical names of Pharmacopoeia of the People’s Republic of China, which will be referred to by the researchers worldwide.

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Abrus cantoniensis

Herba Abri

Jigucao

Abutilon theophrastii

Semen Abutili

Qingmazi

Acacia catechu

Catechu

Ercha

Acanthopanax gracilistylus

Cortex Acanthopanacis

Wujiapi

Achyrantes bidentata

Radix Achyranthis Bidentatae

Niuxi

Aconitum carmichaeli

Radix Aconiti

Chuanwu

Aconitum kusnezoffii

Folium Aconiti Kusnezoffii

Caowuye

Aconitum kusnezoffii

Radix Aconiti Kusnezoffii

Caowu

Acorus calamus

Rhizoma Acori Calami

Zangchangpu

Acorus tatarinowii

Rhizoma Acori Tatarinowii

Shichangpu

Adenophora stricta

Radix Adenophorae

Nanshashen

Adenophora tetraphylla

Radix Adenophorae

Nanshashen

Aesculus chinensis

Semen Aesculi

Suoluozi

Aesculus chinensis

var. chekiangensis

Semen Aesculi

Suoluozi

Agrimonia pilosa

Herba Agrimoniae

Xianhecao

Ailanthus altissima

Cortex Ailanthi

Chunpi

Akebia quinata

Fructus Akebiae

Yuzhizi

Akebia trifoliata

Fructus Akebiae

Yuzhizi

Akebia trifoliata var.

Fructus Akebiae

Yuzhizi

australis

Albizia julibrissin

Flos Albiziae

Hehuanhua

Albizia julibrissin

Cortex Albiziae

Hehuanpi

Alisma orientalis

Rhizoma Alismatis

Zexie

Allium chinensis

Bulbus Alii Macrostemonis

Xiebai

Allium macrostemon

Bulbus Alii Macrostemonis

Xiebai

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Allium tuberosum

Semen Allii Tuberosi

Jiucaizi

Aloe barbadensis et spp.

Aloe

Luhui

Aloe ferox et spp.

Aloe

Luhui

Alpinia galanga

Fructus Galangae

Hongdoukou

Alpinia katsumadai

Semen Alpiniae Katsumadai

Caodoukou

Alpinia officinarum

Rhizoma Alpiniae Officinarum

Gaoliangjiang

Alpinia oxyphylla

Fructus Alpiniae Oxyphyllae

Yizhi

Amomum compactum

Fructus Amomi Rotundus

Doukou

Amomum kravanh

Fructus Amomi Rotundus

Doukou

Amomum longiligulare

Fructus Amomi

Sharen

Amomum tsaoko

Fructus Tsaoko

Caoguo

Amomum villosum

Fructus Amomi

Sharen

Amomum villosum var.

Fructus Amomi

Sharen

xanthioides

Ampelopsis japonica

Radix Ampelopsis

Bailian

Andrographis paniculata

Herba Andrographis

Chuanxinlian

Anemarrhena asphodeloides Rhizoma Anemarrhenae

Zhimu

Anemone raddeana

Rhizoma Anemones Raddeanae

Liangtoujian

Angelica dahurica

Radix Angelicae Dahuricae

Baizhi

Angelica pubescens

Radix Angelicae Pubescentis

Duhuo

Angelica sinensis

Radix Angelicae Sinensis

Danggui

Apocynum venetum

Folium Apocyni Veneti

Luobumaye

Aquilaria sinensis

Lignum Aquilariae Resinatum

Chenxiang

Arctium lappa

Fructus Arctii

Niubangzi

Areca catechu

Pericarpium Arecae

Dafupi

Areca catechu

Semen Arecae

Binglang

Arisaema amurense

Rhizoma Arisaematis

Tiannanxing

Arisaema erubescens

Rhizoma Arisaematis

Tiannanxing

Arisaema heterophyllum

Rhizoma Arisaematis

Tiannanxing

Aristolochia contorta

Fructus Aristolochiae

Madouling

Aristolochia contorta

Herba Aristolochiae

Tianxianteng

Aristolochia debilis

Fructus Aristolochiae

Madouling

Aristolochia debilis

Herba Aristolochiae

Tianxianteng

Aristolochia debilis

Radix Aristolochiae

Qingmuxiang

Aristolochia fangchi

Radix Aristolochiae Fangchi

Guangfangji

Aristolochia manshuriensis

Caulis Aristolochiae

Manshuriensis

Guanmutong

Arnebia euchroma

Radix Arnebiae

Zicao

Arnebia guttata

Radix Arnebiae

Zicao

Artemisia annua

Herba Artemisiae Annuae

Qinghao

Artemisia argyi

Folium Artemisiae Argyi

Aiye

Artemisia capillaris

Herba Artemisiae Scopariae

Yinchen

Artemisia scoparia

Herba Artemisiae Scopariae

Yinchen

Asarum heterotropoides var. Herba Asari

Xixin

mandshuricum

Asarum sieboldii, A.

Herba Asari

Xixin

sieboldii var. seoulense

Asparagus cochinchinensis

Radix Asparagi

Tiandong

Aster tataricus

Radix Asteris

Ziwan

Astragalus complanatus

Semen Astragali Complanati

Shayuanzi

( Continued)

(Continued)

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Astragalus membranaceus

var. mongholicus

Radix Astragali

Huangqi

Atractylodes chinensis

Rhizoma Atractylodis

Cangzhu

Atractylodes lancea

Rhizoma Atractylodis

Cangzhu

Atractylodes macrocephala

Rhizoma Atractylodis

Baizhu

Macrocephalae

Atropa belladonna

Herba Belladonnae

Dianqiecao

Aucklandia lappa

Radix Aucklandiae

Muxiang

Bambusa textilis

Concretio Silicea Bambusae

Tianzhuhuang

Bambusa tuldoides

Caulis Bambusae in Taeniam

Zhuru

Baphicacanthus cusia

Indigo Naturalis

Qingdai

Baphicacanthus cusia

Rhizoma et Radix

Nanbanlangen

Baphicacanthis Cusiae

Belamcanda chinensis

Rhizoma Belamcandae

Shegan

Benincasa hispida

Exocarpium Benincasae

Dongguapi

Bletilla striata

Rhizoma Bletillae

Baiji

Bolbostemma paniculatum

Rhizoma Bolbostematis

Tubeimu

Brassica juncea

Semen Sinapsis

Jiezi

Brassica juncea

Semen Brassicae Junceae

Jiezi

Broussonetia papyrifera

Fructus Broussonetiae

Chushizi

Brucea javanica

Fructus Bruceae

Yadanzi

Buddleja officinalis

Flos Buddlejae

Mimenghua

Bupleurum chinense, B.

Radix Bupleuri

Chaihu

scorzonerifolium

Buxus mierophyila var.

Cyclovirobuxinum D

Huanweihuangyangx ing D

sinica et spp.

Caesalpinia sappan

Lignum Sappan

Sumu

Calvatia gigantea

Lasiosphaera seu Calvatia

Mabo

Calvatia lilacina

Lasiosphaera seu Calvatia

Mabo

Camellia meiocarpa

Oleum Camelliae

Chayou

Camellia oleifera

Oleum Camelliae

Chayou

Campsis grandiflora

Flos Campsis

Lingxiaohua

Campsis radicans

Flos Campsis

Lingxiaohua

Canarium album

Fructus Canarii

Qingguo

Canavalia gladiata

Semen Canavaliae

Daodou

Cannabis sativa

Fructus Cannabis

Huomaren

Carpesium abrotanoides

Fructus Carpesii

Heshi

Carthamus tinctorius

Flos Carthami

Honghua

Cassia acutifolia

Folium Sennae

Fanxieye

Cassia angustifolia

Folium Sennae

Fanxieye

Cassia obtusifolia

Semen Cassiae

Juemingzi

Cassia tora

Semen Cassiae

Juemingzi

Celosia argentea

Semen Celosiae

Qingxiangzi

Celosia cristata

Flos Celosiae Cristatae

Jiguanhua

Centella asiatica

Herba Centellae

Jixuecao

Centipeda minima

Herba Centipedae

Ebushicao

Chaenomeles speciosa

Fructus Chaenomelis

Mugua

Changium smyrnioides

Radix Changii

Mingdangshen

Choerospondias axillaris

Fructus Choerospondiatis

Guangzao

Chrysanthemum indicum

Flos Chrysanthemi Indici

Yejuhua

Chrysanthemum morifolium Flos Chrysanthemi

Juhua

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Cibotium barometz

Rhizoma Cibotii

Gouji

Cichorium glandulosum

Herba Cichorii

Juju

Cichorium intybus

Herba Cichorii

Juju

Cimicifuga dahurica

Rhizoma Cimicifugae

Shengma

Cimicifuga foetida

Rhizoma Cimicifugae

Shengma

Cimicifuga heracleifolia

Rhizoma Cimicifugae

Shengma

Cinnamomum camphora

Oleum Eucalypti

Anyou

et spp.

Cinnamomum cassia

Cortex Cinnamomi

Rougui

Cinnamomum cassia

Oleum Cinnamomi

Rouguiyou

Cinnamomum cassia

Ramulus Cinnamomi

Guizhi

Cirsium japonicum

Herba Cirsii Japonici, Radix

Daji

Cirsii Japonici

Cirsium setosum

Herba Cirsii

Xiaoji

Cissampelos pareira var.

Herba Cissampelotis

Yahunu

hirsuta

Cistanche deserticola

Herba Cistanches

Roucongrong

Citrus aurantium

Fructus Aurantii Immaturus

Zhishi

Citrus aurantium

Fructus Aurantii

Zhiqiao

Citrus grandis

Exocarpium Citri Grandis

Huajuhong

Citrus grandis “Tomentosa” Exocarpium Citri Grandis

Huajuhong

Citrus medica

Fructus Citri

Xiangyuan

Citrus medica var.

Fructus Citri Sarcodactylis

Foshou

sarcodactylis

Citrus reticulata and its

Pericarpium Citri Reticulatae

Chenpi

cultivars

Citrus reticulata and its

Pericarpium Citri Reticulatae

Qingpi

cultivars

Viride

Citrus reticulata and its

Exocarpium Citri Rubrum

Juhong

cultivars

Citrus reticulata and its

Semen Citri Reticulatae

Juhe

cultivars

Citrus sinensis

Fructus Aurantii Immaturus

Zhishi

Citrus wilsonii

Fructus Citri

Xiangyuan

Clematis armandii

Caulis Clematidis Armandii

Chuanmutong

Clematis chinensis

Radix Clematidis

Weilingxian

Clematis hexapetala

Radix Clematidis

Weilingxian

Clematis manshurica

Radix Clematidis

Weilingxian

Clematis montana

Caulis Clematidis Armandii

Chuanmutong

Clinopodium chinensis

Herba Clinopodii

Duanxueliu

Clinopodium polycephalum Herba Clinopodii

Duanxueliu

Cnidium monnieri

Fructus Cnidii

Shechuangzi

Codonopsis pilosula,

C. pilosula var. modesta

Radix Codonopsis

Dangshen

Codonopsis tangshen

Radix Codonopsis

Dangshen

Coix lacrymajobi var.

Semen Coicis

Yiyiren

ma-yuen

Commelina communis

Herba Commelinae

Yazhicao

Coptis chinensis

Rhizoma Coptidis

Huanglian

Coptis deltoidea

Rhizoma Coptidis

Huanglian

Coptis teeta

Rhizoma Coptidis

Huanglian

( Continued)

(Continued)

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Cordyceps sinensis

Cordyceps

Dongchongxiacao

Cornus officinalis

Fructus Corni

Shanzhuyu

Corydalis decumbens

Rhizoma Corydalis

Xiatianwu

Decumbentis

Corydalis yanhusuo

Rhizoma Corydalis

Yanhusuo

Crataegus pinnatifida

Fructus Crataegi

Shanzha

Crataegus pinnatifida var.

Fructus Crataegi

Shanzha

major

Cremastra appendiculata

Pseudobulbus

Cremastrae seu Pleiones

Shancigu

Crocus sativus

Stigma Croci

Xihonghua

Croton tiglium

Fructus Crotonis

Badou

Curculigo orchioides

Rhizoma Curculiginis

Xianmao

Curcuma kwangsiensis

Radix Curcumae

Yujin

Curcuma kwangsiensis

Rhizoma Curcumae

Ezhu

Curcuma longa

Rhizoma Curcumae Longae

Jianghuang

Curcuma longa

Radix Curcumae

Yujin

Curcuma phaeocaulis

Radix Curcumae

Yujin

Curcuma phaeocaulis

Rhizoma Curcumae

Ezhu

Curcuma wenyujin

Radix Curcumae

Yujin

Curcuma wenyujin

Rhizoma Wenyujin Concisum

Pianjianghuang

Curcuma wenyujin

Rhizoma Curcumae

Ezhu

Cuscuta chinensis

Semen Cuscutae

Tusizi

Cyathula officinalis

Radix Cyathulae

Chuanniuxi

Cynanchum atratum

Radix Cynanchi Atrati

Baiwei

Cynanchum glaucescens

Rhizoma Cynanchi Stauntonii

Baiqian

Cynanchum paniculatum

Radix Cynanchi Paniculati

Xuchangqing

Cynanchum stauntonii

Rhizoma Cynanchi Stauntonii

Baiqian

Cynanchum versicolor

Radix Cynanchi Atrati

Baiwei

Cynanchum versicolor

Radix Cynanchi Atrati

Baiwei

Cynomorium songaricum

Herba Cynomorii

Suoyang

Cyperus rotundus

Rhizoma Cyperi

Xiangfu

Daemonorops draco

Sanguis Draxonis

Xuejie

Dalbergia odorifera

Lignum Dalbergiae Odoriferae

Jiangxiang

Daphne genkwa

Flos Genkwa

Yuanhua

Datura metel

Flos Daturae

Yangjinhua

Daucus carota

Fructus Carotae

Nanheshi

Dendrobium candidum

Herba Dendrobii

Shihu

Dendrobium chrysanthum

Herba Dendrobii

Shihu

Dendrobium fimbriatum

var. oculatum

Herba Dendrobii

Shihu

Dendrobium loddigesii

Herba Dendrobii

Shihu

Dendrobium nobile

Herba Dendrobii

Shihu

Descurainia sophia

Semen Descurainiae

Tinglizi

Desmodium styracifolium

Herba Desmodii Styracifolii

Guangjinqiancao

Dianthus chinensis

Herba Dianthi

Qumai

Dianthus superbus

Herba Dianthi

Qumai

Dichroa febrifuga

Radix Dichroae

Changshan

Dictamnus dasycarpus

Cortex Dictamni

Baixianpi

Dimocarpus longan

Arillus Longan

Longyanrou

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Dioscorea futschauensis

Rhizoma

Dioscoreae Septemlobae

Mianbixie

Dioscorea hypoglauca

Rhizoma

Dioscoreae Hypoglaucae

Fenbixie

Dioscorea opposita

Rhizoma Dioscoreae

Shanyao

Dioscorea septemloba

Rhizoma Dioscoreae

Septemlobae

Mianbixie

Diospyros kaki

Calyx Kaki

Shidi

Dipsacus asperoides

Radix Dipsaci

Xuduan

Dolichos lablab

Semen Lablab Album

Baibiandou

Drynaria fortunei

Rhizoma Drynariae

Gusuibu

Dryopteris crassirhizoma

Rhizoma Dryopteris

Crassirhizomatis

Mianmaguanzhong

Echinops grijisii

Radix Echinopsis

Yuzhou loulu

Echinops latifolius

Radix Echinopsis

Yuzhou loulu

Ecklonia kurome

Thallus Eckloniae

Kunbu

Eclipta prostrata

Herba Ecliptae

Mohanlian

Ephedra equisetina

Herba Ephedrae

Mahuang

Ephedra intermedia

Herba Ephedrae

Mahuang

Ephedra intermedia

Radix Ephedrae

Mahuanggen

Ephedra sinica

Herba Ephedrae

Mahuang

Ephedra sinica

Radix Ephedrae

Mahuanggen

Epimedium brevicornum

Herba Epimedii

Yinyanghuo

Epimedium koreanum

Herba Epimedii

Yinyanghuo

Epimedium pubescens

Herba Epimedii

Yinyanghuo

Epimedium sagittatum

Herba Epimedii

Yinyanghuo

Epimedium wushanense

Herba Epimedii

Yinyanghuo

Equisetum hiemale

Herba Equiseti Hiemalis

Muzei

Eriobotrya japonica

Folium Eriobotryae

Pipaye

Eriocaulon buergerianum

Flos Eriocauli

Gujingcao

Erodium stephanianum

Herba Erodii

Laoguancao

Erycibe obtusfolia

Caulis Erycibes

Dinggongteng

Erycibe schmidtii

Caulis Erycibes

Dinggongteng

Eucalyptus globulus et spp.

Oleum Eucalypti

Anyou

Eucommia ulmoides

Cortex Eucommiae

Duzhong

Eugenia caryophyllata

Flos Caryophylli

Dingxiang

Eupatorium fortunei

Herba Eupatorii

Peilan

Euphorbia humifusa

Herba Euphorbiae Humifusae

Dijincao

Euphorbia kansui

Radix Kansui

Gansui

Euphorbia lathyris

Semen Euphorbiae

Qianjinzi

Euphorbia maculata

Herba Euphorbiae Humifusae

Dijincao

Euphorbia pekinensis

Radix Euphorbiae Pekinensis

Jingdaji

Euryale ferox

Semen Euryales

Qianshi

Evodia rutaecarpa

Fructus Evodiae

Wuzhuyu

Evodia rutaecarpa var.

Fructus Evodiae

Wuzhuyu

bodinieri

Evodia rutaecarpa var.

Fructus Evodiae

Wuzhuyu

officinalis

Fagopyrum dibotrys

Rhizoma Fagopyri Dibotryis

Jinqiaomai

Ferula fukanensis

Resina Ferulae

Awei

Ferula sinkiangensis

Resina Ferulae

Awei

( Continued)

(Continued)

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Foeniculum vulgare

Fructus Foeniculi

Xiaohuixiang

Forsythia suspensa

Fructus Forsythiae

Lianqiao

Fraxinus chinensis

Cortex Fraxini

Qinpi

Fraxinus rhynchophylla

Cortex Fraxini

Qinpi

Fraxinus stylosa

Cortex Fraxini

Qinpi

Fraxinus szaboana

Cortex Fraxini

Qinpi

Fritillaria cirrhosa

Bulbus Fritillariae Cirrhosae

Chuanbeimu

Fritillaria delavayi

Bulbus Fritillariae Cirrhosae

Chuanbeimu

Fritillaria hupehensis

Bulbus Fritillariae Hupehensis

Hubeibeimu

Fritillaria pallidiflora

Bulbus Fritillariae Pallidiflorae Yibeimu

Fritillaria przewalskii

Bulbus Fritillariae Cirrhosae

Chuanbeimu

Fritillaria thunbergii

Bulbus Fritillariae Thunbergii

Zhebeimu

Fritillaria unibracteata

Bulbus Fritillariae Cirrhosae

Chuanbeimu

Fritillaria ussuriensis

Bulbus Fritillariae Ussuriensis

Pingbeimu

Fritillaria walujewii

Bulbus Fritillariae Pallidiflorae

Yibeimu

Ganoderma lucidum

Ganoderma

Lingzhi

Ganoderma sinensis

Ganoderma

Lingzhi

Gardenia jasminoides

Fructus Gardeniae

Zhizi

Gastrodia elata

Rhizoma Gastrodiae

Tianma

Gentiana crassicaulis

Radix Gentianae Macrophyllae Qinjiao

Gentiana dahurica

Radix Gentianae Macrophyllae Qinjiao

Gentiana macrophylla

Radix Gentianae Macrophyllae Qinjiao

Gentiana manshurica

Radix Gentianae

Longdan

Gentiana ringescens

Radix Gentianae

Longdan

Gentiana scabra

Radix Gentianae

Longdan

Gentiana straminea

Radix Gentianae Macrophyllae Qinjiao

Gentiana triflora

Radix Gentianae

Longdan

Geranium carolinianum

Herba Geranii

Laoguancao

Geranium wilfordii

Herba Geranii

Laoguancao

Ginkgo biloba

Folium Ginkgo

Yinxingye

Ginkgo biloba

Semen Ginkgo

Baiguo

Glechoma longituba

Herba Glecomae

Lianqiancao

Gleditsia sinensis

Fructus Gleditsiae Abnormalis

Zhuyazao

Gleditsia sinensis

Spina Gleditsiae

Zaojiaoci

Glehnia littoralis

Radix Glehniae

Beishashen

Glycine max

Semen Sojae Preparatum

Dandouchi

Glycyrrhiza glabra

Radix Glycyrrhizae

Gancao

Glycyrrhiza inflata

Radix Glycyrrhizae

Gancao

Glycyrrhiza uralensis

Radix Glycyrrhizae

Gancao

Hedysarum polybotrys

Radix Hedysari

Hongqi

Helwingia japonica

Medulla Helwingiae

Xiaotongcao

Hippophae rhamnoides

Fructus Hippophae

Shaji

Homalomena occulta

Rhizoma Homalomenae

Qiannianjian

Hordeum vulgare

Fructus Hordei Germinatus

Maiya

Houttuynia cordata

Herba Houttuyniae

Yuxingcao

Hyoscyamus niger

Semen Hyoscyami

Tianxianzi

Ilex cornuta

Folium Ilicis Cornutae

Gouguye

Illicium defengpi

Cortex Illicii

Difengpi

Illicium verum

Oleum Anisi Stellati

Bajiao Huixiangyou

Impatiens balsamina

Semen Impatientis

Jixingzi

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Imperata cylindrica var.

Rhizoma Imperatae

Baimaogen

major

Inula britannica

Flos Inulae

Xuanfuhua

Inula helenium

Radix Inulae

Tumuxiang

Inula japonica

Flos Inulae

Xuanfuhua

Inula japonica

Herba Inulae

Jinfeicao

Inula linariifolia

Herba Inulae

Jinfeicao

Inula racemosa

Radix Inulae

Tumuxiang

Isatis indigotica

Folium Isatidis

Daqingye

Isatis indigotica

Radix Isatidis

Banlangen

Isatis indigotica

Indigo Naturalis

Qingdai

Juglans regia

Semen Juglandis

Hetaoren

Juncus effusus

Medulla Junci

Dengxincao

Kaempferia galanga

Rhizoma Kaempferiae

Shannai

Knoxia valerianoides

Radix Knoxiae

Hongdaji

Kochia scoparia

Fructus Kochiae

Difuzi

Laminaria japonica

Thallus Laminariae

Kunbu

Lasiosphaera fenzlii

Lasiosphaera seu Calvatia

Mabo

Leonurus japonicas

Fructus Leonuri

Chongweizi

Leonurus japonicus

Herba Leonuri

Yimucao

Lepidium apetalum

Semen Lepidii

Tinglizi

Ligusticum chuanxiong

Rhizoma Chuanxiong

Chuanxiong

Ligusticum jeholense

Rhizoma Ligustici

Gaoben

Ligusticum sinense

Rhizoma Ligustici

Gaoben

Ligustrum lucidum

Fructus Ligustri Lucidi

Nüzhenzi

Lilium brownii var.

Bulbus Lilii

Baihe

viridulum

Lilium lancifolium

Bulbus Lilii

Baihe

Lilium pumilum

Bulbus Lilii

Baihe

Lindera aggregata

Radix Linderae

Wuyao

Lindera communis

Oleum Linderae

Xiangguozhi

Linum usitatissimum

Semen Lini

Yamazi

Liquidambar formosana

Fructus Liquidambaris

Lulutong

Liquidambar formosana

Resina Liquidambaris

Fengxianzhi

Liquidambar orientalis

Styrax

Suhexiang

Liriope muscari

Radix Liriopes

Shanmaidong

Liriope spicata var. prolifera Radix Liriopes

Shanmaidong

Litchi chinensis

Semen Litchi

Lizhihe

Lithospermum erythrorhizon Radix Lithospermi

Zicao

Litsea cubeba

Fructus Litseae

Bichengqie

Lonicera confusa

Flos Lonicerae

Jinyinhua

Lonicera dasystyla

Flos Lonicerae

Jinyinhua

Lonicera hypoglauca

Flos Lonicerae

Jinyinhua

Lonicera japonica

Flos Lonicerae

Jinyinhua

Lonicera japonica

Caulis Lonicerae

Rendongteng

Lophatherum gracile

Herba Lophatheri

Danzhuye

Luffa cylindrica

Retinervus Luffae Fructus

Sigualuo

Lycium barbarum

Cortex Lycii

Digupi

Lycium barbarum

Fructus Lycii

Gouqizi

Lycium chinense

Cortex Lycii

Digupi

Lycopodium japonicum

Herba Lycopodii

Shenjincao

( Continued)

(Continued)

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Lycopus lucidus var. hirtus

Herba Lycopi

Zelan

Lygodium japonicum

Spora Lygodii

Haijinsha

Lysimachia christinae

Herba Lysimachiae

Jinqiancao

Magnolia biondii

Flos Magnoliae

Xinyi

Magnolia denudata

Flos Magnoliae

Xinyi

Magnolia officinalis

Cortex Magnoliae Officinalis

Houpo

Magnolia officinalis

Flos Magnoliae Officinalis

Houpohua

Magnolia officinalis var.

Cortex Magnoliae Officinalis

Houpo

biloba

Magnolia officinalis var.

Flos Magnoliae Officinalis

Houpohua

biloba

Magnolia sprengeri

Flos Magnoliae

Xinyi

Mahonia bealei

Caulis Mahoniae

Gonglaomu

Mahonia fortunei

Caulis Mahoniae

Gonglaomu

Malva verticillata

Fructus Malvae

Dongkuiguo

Melia azedarach

Cortex Meliae

Kulianpi

Melia toosendan

Cortex Meliae

Kulianpi

Melia toosendan

Fructus Toosendan

Chuanlianzi

Menispermum dauricum

Rhizoma Menispermi

Beidougen

Mentha haplocalyx

Herba Menthae

Bohe

Mentha haplocalyx

Oleum Menthae

Bohesuyou

Dementholatum

Momordica cochinchinensis Semen Momordicae

Mubiezi

Momordica grosvenori

Fructus Momordicae

Luohanguo

Morinda officinalis

Radix Morindae Officinalis

Bajitian

Morus alba

Fructus Mori

Sangshen

Morus alba

Folium Mori

Sangye

Morus alba

Ramulus Mori

Sangzhi

Morus alba

Cortex Mori

Sangbaipi

Mosla chinensis

Herba Moslae

Xiangru

Murraya exotica

Folium et Cacumen Murrayae

Jiulixiang

Murraya paniculata

Folium et Cacumen Murrayae

Jiulixiang

Myristica fragrans

Semen Myristicae

Roudoukou

Nardostachys chinensis

Radix seu Rhizoma

Nardostachyos

Gansong

Nardostachys jatamansi

Radix seu Rhizoma

Nardostachyos

Gansong

Nelumbo nucifera

Folium Nelumbinis

Heye

Nelumbo nucifera

Plumula Nelumbinis

Lianzixin

Nelumbo nucifera

Receptaculum Nelumbinis

Lianfang

Nelumbo nucifera

Nodus Nelumbinis Rhizomatis Oujie

Nelumbo nucifera

Semen Nelumbinis

Lianzi

Nelumbo nucifera

Stamen Nelumbinis

Lianxu

Nigella glandulifera

Semen Nigellae

Heizhongcaozi

Notopterygium forbesii

Rhizoma et Radix Notopterygii Qianghuo

Notopterygium incisum

Rhizoma et Radix Notopterygii Qianghuo

Ocimum gratissimum

Oleum Ocimi Gratissimi

Dingxiang Luoleyou

Omphalia lapidescens

Omphalia

Leiwan

Ophiopogon japonicus

Radix Ophiopogonis

Maidong

Oroxylum indicum

Semen Oroxyli

Muhudie

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Oryza sativa

Fructus Oryzae Germinatus

Daoya

Paeonia lactiflora

Radix Paeoniae Rubra

Chishao

Paeonia suffruticosa

Cortex Moutan

Mudanpi

Paeonia veitchii

Radix Paeoniae Rubra

Chishao

Panax ginseng

Radix Ginseng

Renshen

Panax ginseng

Folium Ginseng

Renshenye

Panax japonicus

Rhizoma Panacis Japonici

Zhujieshen

Panax japonicus var.

Rhizoma Panacis Majoris

Zhuzishen

bipinnatifidus

Panax japonicus var. major

Rhizoma Panacis Majoris

Zhuzishen

Panax notoginseng

Radix Notoginseng

Sanqi

Panax quinquefolium

Radix Panacis Quinquefolii

Xiyangshen

Papaver somniferum

Pericarpium Papaveris

Yingsuqiao

Paris polyphylla var.

Rhizoma Paridis

Chonglou

chinensis

Paris polyphylla var.

Rhizoma Paridis

Chonglou

yunnanensis

Perilla frutescens

Fructus Perillae

Zisuzi

Perilla frutescens

Folium Perillae

Zisuye

Perilla frutescens

Caulis Perillae

Zisugeng

Periploca sepium

Cortex Periplocae

Xiangjiapi

Peucedanum decursivum

Radix Peucedani

Qianhu

Peucedanum praeruptorum

Radix Peucedani

Qianhu

Pharbitis nil

Semen Pharbitidis

Qianniuzi

Pharbitis pupurea

Semen Pharbitidis

Qianniuzi

Phaseolus angularis

Semen Phaseoli

Chixiaodou

Phaseolus calcaratus

Semen Phaseoli

Chixiaodou

Phellodendron amurense

Cortex Phellodendri

Huangbo

Phellodendron chinensis

Cortex Phellodendri

Huangbo

Phragmitis communis

Rhizoma Phragmitis

Lugen

Phyllanthus emblica

Fructus Phyllanthi

Yuganzi

Phyllostachys nigra var.

Caulis Bambusae in Taeniam

Zhuru

henonis

Physalis alkekengi var.

Calyx seu Fructus Physalis

Jindenglong

franchetii

Physochlaina infundibularis Radix Physochlainae

Huashanshen

Phytolacca acinosa

Radix Phytolaccae

Shanglu

Phytolacca americana

Radix Phytolaccae

Shanglu

Picrasma quassioides

Ramulus et Folium Picrasmae

Kumu

Picrorhiza scrophulariiflora Rhizoma Pircrorhizae

Huhuanglian

Pinellia ternata

Rhizoma Pinelliae

Banxia

Pinus massoniana et spp.

Pollen Pini

Songhuafen

Pinus spp.

Oleum Terebinthinae

Songjieyou

Pinus tabulaeformis et spp.

Pollen Pini

Songhuafen

Piper kadsura

Caulis Piperis Kadsurae

Haifengteng

Piper longum

Fructus Piperis Longi

Bibo

Piper nigrum

Fructus Piperis

Hujiao

Plantago asiatica

Herba Plantaginis

Cheqiancao

Plantago asiatica

Semen Plantaginis

Cheqianzi

Plantago depressa

Herba Plantaginis

Cheqiancao

Plantago depressa

Semen Plantaginis

Cheqianzi

( Continued)

(Continued)

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Platycladus orientalis

Semen Platycladi

Baiziren

Platycladus orientalis

Cacumen Platycladi

Cebaiye

Platycodon grandiflorum

Radix Platycodonis

Jiegeng

Pleione bulbocodioides

Pseudobulbus

Cremastrae seu Pleiones

Shancigu

Pleione yunnanensis

Pseudobulbus

Cremastrae seu Pleiones

Shancigu

Pogostemon cablin

Herba Pogostemonis

Guanghuoxiang

Polygala sibirica

Radix Polygalae

Yuanzhi

Polygala tenuifolia

Radix Polygalae

Yuanzhi

Polygonatum cyrtonema

Rhizoma Polygonati

Huangjing

Polygonatum kingianum

Rhizoma Polygonati

Huangjing

Polygonatum odoratum

Rhizoma Polygonati Odorati

Yuzhu

Polygonatum sibiricum

Rhizoma Polygonati

Huangjing

Polygonum aviculare

Herba Polygoni Avicularis

Bianxu

Polygonum bistorta

Rhizoma Polygoni Bistortae

Quanshen

Polygonum cuspidatum

Rhizoma Polygoni Cuspidati

Huzhang

Polygonum multiflorum

Radix Polygoni Multiflori

Heshouwu

Polygonum multiflorum

Caulis Polygoni Multiflori

Shouwuteng

Polygonum orientale

Fructus Polygoni Orientalis

Shuihonghuazi

Polygonum tinctorium

Folium Polygoni Tinctorii

Liaodaqingye

Polygonum tinctorium

Indigo Naturalis

Qingdai

Polyporus umbellatus

Polyporus

Zhuling

Poria cocos

Poria

Fuling

Portulaca oleracea

Herba Portulacae

Machixian

Potentilla chinensis

Herba Potentillae Chinensis

Weilingcai

Prinsepia uniflora

Nux Prinsepiae

Ruiren

Prunella vulgaris

Spica Prunellae

Xiakucao

Prunus armeniaca

Semen Armeniacae Amarum

Kuxingren

Prunus armeniaca

Semen Armeniacae Amarum

Kuxingren

mandshurica

Prunus armeniaca sibirica

Semen Armeniacae Amarum

Kuxingren

Prunus armeniaca var. ansu Semen Armeniacae Amarum

Kuxingren

Prunus davidiana

Semen Persicae

Taoren

Prunus humilis

Semen Pruni

Yuliren

Prunus japonica

Semen Pruni

Yuliren

Prunus mume

Flos Mume

Meihua

Prunus mume

Fructus Mume

Wumei

Prunus pedunculata

Semen Pruni

Yuliren

Prunus persica

Semen Persicae

Taoren

Pseudolarix kaempferi

Cortex Pseudolaricis

Tujingpi

Pseudostellaria heterophylla Radix Pseudostellariae

Taizishen

Psoralea corylifolia

Fructus Psoraleae

Buguzhi

Pueraria lobata

Radix Puerariae

Gegen

Pueraria thomsonii

Radix Puerariae

Gegen

Pulsatilla chinensis

Radix Pulsatillae

Baitouweng

Punica granatum

Pericarpium Granati

Shiliupi

Pyrola calliantha

Herba Pyrolae

Luxiancao

Pyrola decorata

Herba Pyrolae

Luxiancao

Pyrrosia lingua

Folium Pyrrosiae

Shiwei

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Pyrrosia petiolosa

Folium Pyrrosiae

Shiwei

Pyrrosia sheareri

Folium Pyrrosiae

Shiwei

Quisqualis indica

Fructus Quisqualis

Shijunzi

Ranunculus ternatus

Radix Ranunculi Ternati

Maozhaocao

Raphanus sativus

Semen Raphani

Laifuzi

Rehmannia glutinosa

Radix Rehmanniae

Dihuang

Rhaponticum uniflorum

Radix Rhapontici

Loulu

Rheum officinale

Radix et Rhizoma Rhei

Dahuang

Rheum palmatum

Radix et Rhizoma Rhei

Dahuang

Rheum tanguticum

Radix et Rhizoma Rhei

Dahuang

Rhododendron dauricum

Folium Rhododendri Daurici

Manshanhong

Rhododendron dauricum

Oleum Rhododendri Daurici

Manshanhongyou

Rhododendron molle

Flos Rhododendri Mollis

Naoyanghua

Rhus chinensis

Galla Chinensis

Wubeizi

Rhus potaninii

Galla Chinensis

Wubeizi

Rhus punjabensis var. sinica Galla Chinensis

Wubeizi

Ricinus communis

Oleum Ricini

Bimayou

Ricinus communis

Semen Ricini

Bimazi

Rosa chinensis

Flos Rosae Chinensis

Yuejihua

Rosa laevigata

Fructus Rosae Laevigatae

Jinyingzi

Rosa rugosa

Flos Rosae Rugosae

Meiguihua

Rubia cordifolia

Radix Rubiae

Qiancao

Rubus chingii

Fructus Rubi

Fupenzi

Salvia miltiorrhiza

Radix Salviae Miltiorrhizae

Danshen

Sanguisorba officinalis, S.

Radix Sanguisorbae

Diyu

officinalis var. longifolia

Santalum album

Lignum Santali Albi

Tanxiang

Saposhnikovia divaricata

Radix Saposhnikoviae

Fangfeng

Sarcandra glabra

Herba Sarcandrae

Zhongjiefeng

Sargassum fusiforme

Sargassum

Haizao

Sargassum pallidum

Sargassum

Haizao

Sargentodoxa cuneata

Caulis Sargentodoxae

Daxueteng

Saururus chinensis

Herba seu Rhizoma Saururi

Sanbaicao

Schisandra chinensis

Fructus Schisandrae Chinensis Wuweizi

Schisandra sphenanthera

Fructus

Schisandrae Sphenantherae

Nanwuweizi

Schizonepeta tenuifolia

Herba Schizonepetae

Jingjie

Schizostachyum chinense

Concretio Silicea Bambusae

Tianzhuhuang

Scrophularia ningpoensis

Radix Scrophulariae

Xuanshen

Scutellaria baicalensis

Radix Scutellariae

Huangqin

Scutellaria barbata

Herba Scutellariae Barbatae

Banzhilian

Sedum sarmentosum

Herba Sedi

Chuipencao

Selaginella pulvinata

Herba Selaginellaceae

Juanbai

Selaginella tamariscina

Herba Selaginellaceae

Juanbai

Semiaquilegia adoxoides

Radix Semiaquilegiae

Tiankuizi

Sesamum indicum

Semen Sesami Nigrum

Heizhima

Sesamum indicum

Oleum Sesami

Mayou

Setaria italica

Fructus Setariae Germinatus

Guya

Siegesbeckia glabrescens

Herba Siegesbeckiae

Xixiancao

Siegesbeckia orientalis

Herba Siegesbeckiae

Xixiancao

Siegesbeckia pubescens

Herba Siegesbeckiae

Xixiancao

( Continued)

(Continued)

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Sinapsis alba

Semen Sinapsis (Albae)

Jiezi

Sinocalamus beecheyanus

var. pubescens

Caulis Bambusae in Taeniam

Zhuru

Sinomenium acutum

Caulis Sinomenii

Qingfengteng

Sinomenium acutum var.

Caulis Sinomenii

Qingfengteng

cinereum

Sinopodophyllum emodi

Fructus Sinopodophylli

Xiaoyelian

Smilax glabra

Rhizoma Smilacis Glabrae

Tufuling

Sophora flavescens

Radix Sophorae Flavescentis

Kushen

Sophora japonica

Fructus Sophorae

Huaijiao

Sophora japonica

Flos Sophorae

Huaihua

Sophora tonkinensis

Radix Sophorae Tonkinensis

Shandougen

Sparganium stoloniferum

Rhizoma Sparganii

Sanleng

Spatholobus suberectus

Caulis Spatholobi

Jixueteng

Spirodela polyrrhiza

Herba Spirodelae

Fuping

Stachyurus chinensis

Medulla Stachyuri

Xiaotongcao

Stachyurus himalaicus

Medulla Stachyuri

Xiaotongcao

Stellaria dichotoma var.

Radix Stellariae

Yinchaihu

lanceolata

Stemona japonica

Radix Stemonae

Baibu

Stemona sessilifolia

Radix Stemonae

Baibu

Stemona tuberosa

Radix Stemonae

Baibu

Stephania tetranda

Radix Stephaniae Tetrandae

Fangji

Sterculia lychnophora

Semen Sterculiae Lychnophorae Pangdahai

Strychnos nux-vomica

Semen Strychni

Maqianzi

Styrax tonkinensis

Benzoinum

Anxixiang

Swertia mileensis

Herba Swertiae Mileensis

Qingyedan

Tamarix chinensis

Cacumen Tamaricis

Xiheliu

Taraxacum mongolicum et

Herba Taraxaci

Pugongying

spp.

Taraxacum sinicum et spp.

Herba Taraxaci

Pugongying

Taxillus chinensis

Herba Taxilli

Sangjisheng

Terminalia bellerica

Fructus Terminaliae Billericae

Maohezi

Terminalia chebula

Fructus Chebulae

Hezi

Terminalia chebula var.

Fructus Chebulae

Hezi

tomentella

Tetrapanax papyriferus

Medulla Tetrapanacis

Tongcao

Tinospora capillipes

Radix Tinosporae

Jinguolan

Tinospora sagittata

Radix Tinosporae

Jinguolan

Torreya grandis

Semen Torreyae

Feizi

Toxicodendron vernicifluum Resina Toxicodendri

Ganqi

Trachelospermum

Caulis Trachelospermi

Luoshiteng

jasminoides

Trachycarpus fortunei

Petiolus Trachycarpi

Zonglu

Tribulus terrestris

Fructus Tribuli

Jili

Trichosanthes kirilowii

Fructus Trichosanthis

Gualou

Trichosanthes kirilowii

Pericarpium Trichosanthis

Gualoupi

Trichosanthes kirilowii

Radix Trichosanthis

Tianhuafen

Trichosanthes kirilowii

Semen Trichosanthis

Gualouzi

Trichosanthes rosthornii

Fructus Trichosanthis

Gualou

Botanical Name

Pharmaceutical Drug Name

Chinese Name Roman

Trichosanthes rosthornii

Pericarpium Trichosanthis

Gualoupi

Trichosanthes rosthornii

Radix Trichosanthis

Tianhuafen

Trichosanthes rosthornii

Semen Trichosanthis

Gualouzi

Trigonella foenum-graecum Semen Trigonellae

Huluba

Tussilago farfara

Flos Farfarae

Kuandonghua

Typha angustifolia et spp.

Pollen Typhae

Puhuang

Typha orientalis et spp.

Pollen Typhae

Puhuang

Typhonium giganteum

Rhizoma Typhonii

Baifuzi

Uncaria hirsuta

Ramulus Uncariae cum Uncis

Gouteng

Uncaria macrophylla

Ramulus Uncariae cum Uncis

Gouteng

Uncaria rhynchophylla

Ramulus Uncariae cum Uncis

Gouteng

Uncaria sessilifructus

Ramulus Uncariae cum Uncis

Gouteng

Uncaria sinensis

Ramulus Uncariae cum Uncis

Gouteng

Vaccaria segetalis

Semen Vaccariae

Wangbuliuxing

Verbena officinalis

Herba Verbenae

Mabiancao

Viola yedoensis

Herba Violae

Zihuadiding

Viscum coloratum

Herba Visci

Hujisheng

Vitex negundo var.

Folium Viticis Negundo

Mujingye

cannabifolia

Vitex negundo var.

Oleum Viticis Negundo

Mujingyou

cannabifolia

Vitex trifolia

Fructus Viticis

Manjingzi

Vitex trifolia var.

Fructus Viticis

Manjingzi

simplicifolia

Vladimiria souliei

Radix Vladimiriae

Chuanmuxiang

Vladimiria souliei var.

Radix Vladimiriae

Chuanmuxiang

cinerea

Xanthium sibiricum

Fructus Xanthii

Cang’erzi

Zanthoxylum bungeanum

Pericarpium Zanthoxyli

Huajiao

Zanthoxylum nitidum

Radix Zanthoxyli

Liangmianzhen

Zanthoxylum schinifolium

Pericarpium Zanthoxyli

Huajiao

Zingiber officinale

Rhizoma Zingiberis Recens

Shengjiang

Zingiber officinale

Rhizoma Zingiberis

Ganjiang

Ziziphus jujuba

Fructus Jujubae

Dazao

Ziziphus jujuba var. spinosa Semen Ziziphi Spinosae

Suanzaoren

Source: Southern Cross University, Australia.

International pharmaceutical

names

Pharmaceutical Name

Botanical Name

Common English Name(s)

Absinthii herba

Artemisia absinthium

Wormwood

Aconiti herba

Aconitum napellus

Aconite herb, Monkshood

herb

Aconiti tuber

Aconitum napellus

Aconite tuber, Monkshood

tuber

Adonidis herba

Adonis vernalis

Pheasant’s Eye herb

Agni casti fructus

Vitex agnus castus

Chaste Tree fruit

Agrimoniae herba

Agrimonia eupatoria

Agrimony

Agrimoniae herba

Agrimonia procera

Cocklebur

Alchemillae alpinae herba

Alchemilla alpine

Alpine Lady’s Mantle herb

Alchemillae herba

Alchemilla vulgaris

Lady’s Mantle

Allii cepae bulbus

Allium cepa

Onion

Allii cepae bulbus

Allium esculentum

Onion

Allii cepae bulbus

Allium porrum

Onion

Allii sativi bulbus

Allium sativum

Garlic

Allii satwi bulbus

Porvium sativum

Garlic

Aloe barbadensis

Aloe barbadensis

Aloe

Aloe barbadensis

Aloe barbadensis

Curacao aloe

Aloe barbadensis

Aloe vera

Aloe

Aloe capensis

Aloe ferox

Cape aloe

Aloe gel

Aloe vera

Aloe vera gel

Althaeae folium

Althaea officinalis

Marshmallow leaf

Althaeae radix

Althaea officinalis

Marshmallow root

Ammeos visnagae fructus

Ammi daucoides

Bishop’s Weed fruit

Ammeos visnagae fructus

Ammi visnaga

Bishop’s Weed fruit

Ammi majoris fructus

Ammi majus

Bishop’s Weed fruit

Andrographidis herba

Andrographidis paniculata

Chiretta herb

Anethi fructus

Anethum graveolens

Dill seed

Anethi herba

Anethum graveolens

Dill herb

Angeliaceae sinensis radix

Angelica sinensis

Chinese Angelica root

Angelicae fructus

Angelica archangelica

Angelica seed

Angelicae herba

Angelica archangelica

Angelica herb

Angelicae radix

Angelica archangelica

Angelica root

Anisi aetheroleum

Pimpinella anisum

Aniseed essential oil

Anisi fructus

Pimpinella anisum

Anise/Aniseed

Anisi stellati

Illicium return

Star Anise

Pharmaceutical Name

Botanical Name

Common English Name(s)

Antennariae dioicae flos

Antennaria dioica

Cat’s Ear flower, Cat’s Foot

flower

Apii fructus

Apium graveolens

Celery seed

Apii herba

Apium graveolens

Celery herb

Apii radix

Apium graveolens

Celery root

Apium graveolens

Apium graveolens

Celery

Armeniacae semen

Prunus armeniaca

Apricot seed

Armoraciae rusticanae

Armoracia rusticana

Horseradish

radix

Armoraciae rusticanae

Cochlearia armoracia

Horseradish

radix

Arnicae flos

Arnica chamissonis

Arnica flower

Arnicae flos

Arnica montana

Arnica flower

Artemisiae vulgaris herba

Artemisia vulgaris

Mugwort herb

Artemisiae vulgaris radix

Artemisia vulgaris

Mugwort root

Asparagi herba

Asparagus officinalis

Asparagus herb

Asparagi rhizoma

Asparagus officinalis

Asparagus root

Astragali radix

Astragalus membranaceus

Astragalus root

Astragali radix

Astragalus mongholicus

Astragalus root

Aurantii flos

Citrus aurantium

Bitter Orange flower

Aurantii flos aetheroleum

Citrus aurantium

Bitter Orange flower oil

Aurantii pericarpium

Citrus aurantium

Bitter Orange peel

Avenae fructus

Avena sativa

Oats

Avenae herba

Avena sativa

Oat herb

Avenae stramentum

Avena sativa

Oat straw

Azadirachti folium

Azadirachta indica

Neem tree leaf

Balsamum peruvianum

Myroxylon balsamum

Peruvian Balsam

Balsamum tolutanum

Myroxylon balsamum

Tolu Balsam

Bardanae radix

Arctium lappa

Burdock root

Bardanae radix

Arctium minus

Burdock root

Bardanae radix

Arctium tomentosum

Burdock root

Barosmae folium

Agathosma betulina

Buchu leaf

Barosmae folium

Barosma betulina

Buchu leaf

Basilici aetheroleum

Ocimum basilicum

Basil oil

Basilici herba

Ocimum basilicum

Basil herb

Belladonnae folium

Atropa belladonna

Belladonna leaf, Deadly

Nightshade leaf

Belladonnae radix

Atropa belladonna

Belladonna root, Deadly

Nightshade root

Berberidis cortex

Berberis vulgaris

Barberry bark

Berberidis fructus

Berberis vulgaris

Barberry

Berberidis radicis cortex

Berberis vulgaris

Barberry root bark

Berberidis radix

Berberis vulgaris

Barberry root

Betulae folium

Betula pendula

Birch leaf

Betulae folium

Betula pubescens

Birch leaf

Boldo folium

Peumus boldus

Boldo leaf

Boraginis flos

Borago officinalis

Borage flower

Boraginis herba

Borago officinalis

Borage herb

Bromelainum

Ananas comosus

Bromelain

Bruceae fructus

Brucea javanica

Brucea fruit

Bryoniae radix

Bryonia alba

Bryonia root

( Continued)

(Continued)

Pharmaceutical Name

Botanical Name

Common English Name(s)

Bryoniae radix

Bryonia cretica

Bryonia root

Bupleuri radix

Bupleurum chinense

Chinese thorowax root

Bupleuri radix

Bupleurum falcatum

Bupleurum root

Bursae pastoris herba

Capsella bursa pastoris

Shepherd’s Purse

Cacao semen

Theobroma cacao

Cocoa seed

Cacao testes

Theobroma cacao

Cocoa

Cajuputi aetheroleum

Melaleuca leucodendra

Cajeput oil

Calendulae flos

Calendula officinalis

Calendula flower

Calendulae herba

Calendula officinalis

Calendula herb

Callunae vulgaris flos

Calluna vulgaris

Heather flower

Callunae vulgaris herba

Calluna vulgaris

Heather herb

Camphora

Cinnamomum camphora

Camphor

Capsicum

Capsicum frutescens

Cayenne (Paprika)

Cardamomi fructus

Elettaria cardamomum

Cardamom

Cardui mariae fructus

Silybum marianum

Milk Thistle fruit

Cardui mariae herba

Silybum marianum

Milk Thistle herb

Caricae fructus

Ficus carica

Figs

Caricae papayae folium

Carica papaya

Papaya leaf

Caricis rhizoma

Carex arenaria

Sarsaparilla root, German

Carthami flos

Carthamus tinetorius

Safflower flower

Carvi aetheroleum

Carum carvi

Caraway oil

Carvi fructus

Carum carvi

Caraway seed

Caryophylli flos

Eugenia caryopfryllata

Cloves

Caryophylli flos

Jambosa caryoplvyllus

Cloves

Caryophylli flos

Syzigium aromaticum

Cloves

Castaneae folium

Castanea sativa

Chestnut leaf

Castaneae folium

Castanea vesca

Chestnut leaf

Castaneae folium

Castanea vulgaris

Chestnut leaf

Centarii herba

Centaurium erythraea

Centaury herb

Centarii herba

Centaurium minus

Centaury herb

Centaurii herba

Centaurium umbellatum

Centaury herb

Centaurii herba

Erythraea centaurium

Centaury herb

Centellae herba

Centella asiatica

Asiatic pennywort herb

Centellae herba

Trisanthus cochinchineusis

Asiatic pennywort herb

Chamomillae flos

Chamomilla rucutita

Chamomille, German

Chamomillae romanae flos

Anthemis nobilis

Chamomile, Roman

Chamomillae romanae flos

Chamaemelum nobile

Chamomile, Roman

Chelidonii herba

Chelidonium majus

Celandine herb

Chrysanthemi vulgaris flos

Chrysanthemum vulgare

Tansy flower

Chrysanthemi vulgaris flos

Tanacetum vulgare

Tansy flower

Chrysanthemi vulgaris

Chrysanthemum vulgare

Tansy herb

herba

Chrysanthemi vulgaris

Tanacetum vulgare

Tansy herb

herba

Cichorium intybus

Cichorium infybus

Chicory

Cimicifugae racemosae

Cimicifuga racemosa

Black Cohosh root

rhizoma

Cinchonae cortex

Cinchona pubescens

Cinchona bark

Cinchonae cortex

Cinchona succirubra

Cinchona bark

Cinnamomi cassiae cortex

Cinnamomum aromaticum

Cinnamon bark, Chinese

Pharmaceutical Name

Botanical Name

Common English Name(s)

Cinnamomi cassiae cortex

Cinnamomum cassia

Cinnamon bark, Chinese

Cinnamomi ceylanici

Cinnamomum verum

Cinnamon bark

cortex

Cinnamomi ceylanici

Cinnamomum zeylanicum

Cinnamon bark

cortex

Cinnamomi cortex

Cinnamomum cassia

Cinnamon bark

Cinnamomi flos

Cinnamomum aromaticum

Cinnamon flower

Cinnamomi flos

Cinnamomum cassia

Cinnamon flower

Citri sinensis pericarpium

Citrus sinensis

Orange peel

Cnici benedicti herba

Cnicus benedictus

Blessed Thistle herb

Coffeae carbo

Coffea Arabica

Coffee charcoal

Coffeae carbo

Coffea canephora

Coffee charcoal

Coffeae carbo

Coffea liberica

Coffee charcoal

Coffeae carbo

Coffea spp.

Coffee charcoal

Colae semen

Cola nitida

Cola nut

Colchicum, Colchicum

Colchicum autumnale

Autumn Crocus

autumnale

Colocynthidis fructus

Citruiius colocynthis

Colocynth

Condurango cortex

Marsdenia condurango

Condurango bark

Convallariae herba

Convallaria majalis

Lily-of-the-valley herb

Coptidis rhizoma

Coptis chinensis

Chinese goldthread rhizome

Coriandri fructus

Coriandrum sativum

Coriander

Crataegi flos

Crataegus laevigata

Hawthorn flower

Crataegi flos

Crataegus monogyna

Hawthorn flower

Crataegi folium

Crataegus laevigata

Hawthorn leaf

Crataegi folium

Crataegus monogyna

Hawthorn leaf

Crataegi folium cum flore

Crataegus azardus

Hawthorn leaf and flower

Crataegi folium cum flore

Crataegus laevigata

Hawthorn leaf and flower

Crataegi folium cum flore

Crataegus monogyna

Hawthorn leaf and flower

Crataegi folium cum flore

Crataegus oxycanthoides

Hawthorn leaf and flower

Crataegi folium cum flore

Crataegus pentagyna

Hawthorn leaf and flower

Crataegi fructus

Crataegus laevigata

Hawthorn berry

Crataegi fructus

Crataegus monogyna

Hawthorn berry

Croci stigma

Crocus sativa

Saffron

Cucurbitae peponis semen

Cucurbita pepo

Pumpkin seed

Curcumae longae rhizoma

Curcuma aromatica

Turmeric root

Curcumae longae rhizoma

Curcuma domestica

Turmeric root

Curcumae longae rhizoma

Curcuma longa

Turmeric root

Curcumae xanthorrhizae

Curcuma xanthorrhiza

Turmeric, Javanese

rhizoma

Cyani flos

Centaurea cyanus

Cornflower

Cymbopoginis citrati

Cymbopogon citratus

West Indian lemongrass oil

aetheroleum

Cymbopoginis citrati herba Cymbopogon citratus

West Indian lemongrass

Cymbopoginis nardi herba

Cymbopogon nardus

Ceylon citronella grass

Cymbopoginis winteriani

Cymbopogon winterianus

Java citronella oil

aetheroleum

Cynarae folium

Cynara scolymus

Artichoke leaf

Cynoglossi herba

Cynoglossum clandestinum

Hound’s Tongue herb

Cynoglossi herba

Cynoglossum officinale

Hound’s Tongue herb

Cytisi scoparii flos

Cytisus scoparius

Scotch Broom flower

( Continued)

(Continued)

Pharmaceutical Name

Botanical Name

Common English Name(s)

Cytisi scoparii flos

Sarothamnus scoparius

Scotch Broom flower

Cytisi scoparii herba

Cytisus scoparius

Scotch Broom herb

Cytisi scoparius flos

Cytisus scoparius

Broom flower, Scotch

Cytisi scoparius flos

Sarothamnus scoparius

Broom flower, Scotch

Cytisi scoparius herba

Cytisus scoparius

Broom herb, Scotch

Cytisi scoparius herba

Sarothamnus scoparius

Broom herb, Scotch

Delphinii flos

Delphinium consolida

Delphinium flower

Droserae herba

Drosera intermedia

Sundew herb

Droserae herba

Drosera longifolia

Sundew herb

Droserae herba

Drosera ramentacea

Sundew herb

Droserae herba

Drosera rotundifolia

Sundew herb

Dulcamarae stipites

Solanum dulcamara

Woody Nightshade

Echinaceae angustifoliae

Echinacea angustifolia

Echinacea Angustifolia herb

herba

Echinaceae angustifoliae

Echinacea angustifolia

Echinacea Angustifolia root

radix

Echinaceae pallidae herba

Echinacea pallida

Echinacea Pallida herb

Echinaceae pallidae radix

Echinacea pallida

Echinacea Pallida root

Echinaceae purpureae

Echinacea purpurea

Echinacea Purpurea herb,

herba

Purple Coneflower herb

Echinaceae purpureae radix Echinacea purpurea

Echinacea Purpurea root

Eleutherococci radix

Acanthopanax senticosus

Siberian Ginseng root

Ephedrae herba

Ephedra shennungiana

Ephedra

Ephedrae herba

Ephedra sinica

Ephedra

Equiseti herba

Equisetum arvense

Horsetail herb

Eschscholziae

Eschscholzia californica

California Poppy

Eucalypti aetheroleum

Eucalyptus fructicetorum

Eucalyptus oil

Eucalypti aetheroleum

Eucalyptus globulus

Eucalyptus oil

Eucalypti aetheroleum

Eucalyptus polybractea

Eucalyptus oil

Eucalypti aetheroleum

Eucalyptus smithii

Eucalyptus oil

Eucalypti folium

Eucalyptus globulus

Eucalyptus leaf

Euphrasiae herba

Euphrasia officinalis

Eyebright herb

Faex medicinalis

Candida utilis

Yeast, Brewer’s

Faex medicinalis

Saccaromyces cerevisiae

Yeast, Brewer’s

Farfarae flos

Tussilago farfara

Coltsfoot flower

Farfarae folium

Tussilago farfara

Coltsfoot leaf

Farfarae herba

Tussilago farfara

Coltsfoot herb

Farfarae radix

Twssilago farfara

Coltsfoot root

Filicis maris folium

Dryopteris filix-mas

Male fern leaf

Filicis maris herba

Dryopteris filix-mas

Male fern herb

Filicis maris rhizoma

Dryopteris filix-mas

Male fern rhizome

Filipendula ulmaria

Spiraea ulmaria

Meadowsweet

Filipendulae ulmariae

Filipendula ulmaria

Meadowsweet flowering

herba

tops

Foeniculi aetheroleum

Foeniculum vulgare

Fennel oil

Foeniculi fructus

Foeniculum vulgare

Fennel seed

Foenugraeci semen

Trigonella foenum-graecum Fenugreek seed

Fragariae folium

Fragaria vesca

Strawberry leaf

Fragariae folium

Fragaria viridis

Strawberry leaf

Frangulae cortex

Frangula alnus

Buckthorn bark

Pharmaceutical Name

Botanical Name

Common English Name(s)

Frangulae cortex

Rhamnus frangula

Buckthorn bark

Fraxini cortex

Fraxinus excelsior

Ash bark

Fraxini folium

Fraxinus excelsior

Ash leaf

Fucus

Ascophyllum nodosum

Bladderwrack

Fucus

Fucus vesiculosus

Bladderwrack

Fumariae herba

Fumaria officinalis

Fumitory

Galangae rhizoma

Alpinia officinarum

Galangal

Galegae officinalis herba

Galega officinalis

Goat’s Rue herb

Galeopsidis herba

Galeopsis ochroleuca

Hempnettle herb

Galeopsidis herba

Gakopsis segetum

Hempnettle herb

Galii odorati herba

Galium odoratum

Sweet Woodruff herb

Gelsemii rhizoma

Gelsemiums sempervirens

Yellow Jessamine rhizome

Gentianae radix

Gentiana lutea

Gentian root

Ginkgo folium

Ginkgo biloba

Ginkgo Biloba leaf/leaf

extract

Ginseng radix

Panax ginseng

Ginseng root

Glycyrrhizae radix

Glycyrrhiza uralensis

Licorice root

Graminis flos

Poa spp.

Hay flower

Graminis rhizoma

Agropyron repens

Couch grass rhizome

Grindeliae herba

Grindelia robusta

Gumweed herb

Grindeliae herba

Grindelia squarrosa

Gumweed herb

Guaiaci lignum

Guaiacum officinale

Guaiac wood

Guaiaci lignum

Guaiacum sanctum

Guaiac wood

Gugguli gummi

Commiphora mukul

Indian boledlium oleo-gum

resin

Gypsophilae radix

Gypsophila paniculata

Soapwort root, White

Hamamelidis cortex

Hamamelis virginiana

Witch Hazel bark

Hamamelidis folium

Hamamelis virginiana

Witch Hazel leaf

Harpagophyti radix

Harpagophytum

Devil’s Claw root

procumbens

Harunganae

Harungana

Haronga bark and leaf

madagascariensis cortex

madagascariensis

et folium

Hederae helicis folium

Hedera helix

Ivy leaf

Helenii radix

Inula helenium

Elecampane root

Helichrysi flos

Helichrysum arenarium

Sandy Everlasting flower

Hepatici nobilis herba

Hepatica nobiiis

Liverwort herb

Herniariae

Herniaria glabra

Rupturewort

Herniariae

Herniaria hirsute

Rupturewort

Hibisci flos

Hibiscus sabdariffa

Hibiscus flower

Hippocastani cortex

Aesculus hippocastanum

Horse Chestnut bark

Hippocastani flos

Aesculus hippocastanum

Horse Chestnut flower

Hippocastani folium

Aesculus hippocastanum

Horse Chestnut leaf

Hippocastani semen

Aesculus hippocastanum

Horse Chestnut seed

Hydrastis rhizoma

Hydrastis canadensis

Goldenseal rhizomes, roots

Hyoscyami folium

Hyoscyamus niger

Henbane leaf

Hyperici herba

Hypericum perforatum

St. John’s Wort flowering

tops

Hyssopi aetheroleum

Hyssopus officinalis

Hyssop oil

Hyssopi herba

Hyssopus officinalis

Hyssop herb

Ipecacuanhae radix

Cephaelis ipecacuanha

Ipecac root

( Continued)

(Continued)

Pharmaceutical Name

Botanical Name

Common English Name(s)

Iridis rhizoma

Iris florentina [Iris

Orris root

germanica var. florentina]

Iridis rhizoma

Iris germanica

Orris root

Iridis rhizoma

Iris pallida

Orris root

Juglandis folium

Juglans regia

Walnut leaf

Juglandis fructus cortex

Juglans regia

Walnut hull

Juniperi fructus pseudo-

Juniperus communis

Juniper berry

fructus

Lamii albi flos

Lamium album

White Dead Nettle flower

Lamii albi herba

Lamium album

White Dead Nettle herb

Laminariae stipites

Laminaria cloustonii

Kelp

Laminariae stipites

Laminaria hyuperborea

Kelp

Lavandulae aetheroleum

Lavandula angustifolia

Lavender essential oil

Lavandulae flos

Lavandula angustifolia

Lavender flower

Lecithin ex soja

Glycine max

Soy Lecithin

Ledi palustris herba

Ledum palustre

March Tea

Leonuri cardiacae herba

Leonurus cardiac

Motherwort herb

Levistici radix

Levisticum officinale

Lovage root

Lichen islandicus

Cetraria islandica

Iceland Moss

Lini semen

Linum usitatissimum

Flaxseed/Linseed

Liquiritiae radix

Glycyrrhiza glabra

Licorice root

Lupuli strobulus

Humulus lupulus

Hops strobili

Lycopi herba

Lycopus europaeus

Bugleweed

Lycopi herba

Lycopus virginicus

Bugleweed

Majoranae aetheroleum

Majorana hortensis

Marjoram oil

Majoranae aetheroleum

Origanum majorana

Marjoram oil

Majoranae herba

Majorana hortensis

Marjoram herb

Majoranae herba

Origanum majorana

Marjoram herb

Malvae arboreae flos

Alcea rosea

Hollyhock flower

Malvae arboreae flos

Althaea rosea

Hollyhock flower

Malvae flos

Malva sylvestris

Mallow flower

Malvae folium

Malva sylvestris

Mallow leaf

Manna

Fraxinus ornus

Manna

Marrubii herba

Marrubium vulgare

Horehound herb

Mate folium

Ilex paraguariensis

Maté

Matricariae flos

Chamomilla rucutita

Chamomille flower, German

Matricariae flos

Matricaria recutita

Chamomile flower, German

Melalencae alternifolia

Meraleuca alternifolia

Australian tea tree oil

aetheroleum

Meliloti herba

Melilotus altissimus

Sweet clover herb

Meliloti herba

Melilotus officinalis

Sweet clover/Melilot herb

Melissae folium

Melissa officinalis

Lemon balm leaf

Menthae arvensis

Mentha arvensis

Mint oil

aetheroleum

Menthae piperitae

Mentha x piperita

Peppermint oil

aetheroleum

Menthae piperitae folium

Mentha x piperita

Peppermint leaf

Mentzeliae cordifoliae

Mentzelia cordifolia

Mentzelia

Menyanthis folium

Menyanthes trifoliate

Bogbean leaf

Millefolii flos

Achillea millefolium

Yarrow flower

Pharmaceutical Name

Botanical Name

Common English Name(s)

Millefolii herba

Achillea millefolium

Yarrow herb

Myristica aril

Myristica fragrans

Mace

Myristica fragrans

Myristica fragrans

Nutmeg

Myrrha gummi

Commiphora molmol

Myrrh oleo-gum resin

Myrtilli folium

Vaccinium myrtillus

Bilberry leaf

Myrtilli fructus

Vaccinium myrtillus

Bilberry fruit, Blueberry

fruit

Nasturtii herba

Nasturtium officinale

Watercress herb

Niauli atheroleum

Melaleuca viridiflora

Niauli oil

Ocimi Sancti folium

Ocimum sanctum

Holy Basil leaf

Oenotherae oleum

Oenothera biennis

Evening primrose oil

Oleae folium/oleum

Olea europaea

Olive leaf/oil

Oleandri folium

Nerium oleander

Oleander leaf

Ononidis radix

Ononis spinose

Restharrow root

Origani vulgaris herba

Origanum vulgare

Oregano herb

Orthosiphonis folium

Orthosiphon spicatus

Java tea/dried leaves and

tops

Orthosiphonis folium

Orthosiphon stamineus

Java tea/dried leaves and

tops

Paeoniae flos

Paeonia mascula

Peony flower

Paeoniae flos

Paeonia officinalis

Peony flower

Paeoniae radix

Paeonia lactifolia

Peony root

Paeoniae radix

Paeonia mascula

Peony root

Paeoniae radix

Paeonia officinalis

Peony root

Papainum crudum

Carica papaya

Papain

Passiflorae herba

Passiflora incarnata

Passionflower herb

Petasitidis folium

Petasites spp.

Petasites leaf

Petasitidis rhizoma

Petasites hybridus

Petasites root

Petroselini fructus

Petroselinum crispum

Parsley seed

Petroselini herba/radix

Petroselinum crispum

Parsley herb/root

Phaseoli fructus sine

Phaseolus vulgaris

Kidney bean pods (without

semine

seeds)

Phospholipide ex soja

Glycine max

Soy Phospholipid

Piceae aetheroleum

Abies alba

White Spruce oil

Piceae aetheroleum

Abies sachalinensis

Fir Needle oil

Piceae aetheroleum

Abies sibirica

Fir Needle oil

Piceae aetheroleum

Picea abies

Fir Needle oil

Piceae aetheroleum

Picea excels

Fir Needle oil

Piceae turiones recentes

Abies alba

Fir shoots, fresh

Pimpinellae herba

Pimpinella major

Pimpinella herb

Pimpinellae herba

Pimpinella saxifraga

Pimpinella herb

Pimpinellae radix

Pimpinella major

Pimpinella root

Pimpinellae radix

Pimpinella saxifraga

Pimpinella root

Pini aetheroleum

Pinus mugo

Pine Needle oil

Pini aetheroleum

Pinus nigra

Pine Needle oil

Pini aetheroleum

Pinus pinaster

Pine Needle oil

Pini aetheroleum

Firms sylvestris

Pine Needle oil

Pini turiones

Pinus sylvestris

Pine sprouts

Piperis methystici rhizoma

Piper methysticum

Kava Kava rhizome

Plantaginis lanceolatae

Plantago lanceolata

Ribwort Plantain leaf/herb

folium/herba

( Continued)

(Continued)

Pharmaceutical Name

Botanical Name

Common English Name(s)

Plantaginis ovatae semen

Plantago isphagula

Psyllium seed, Blonde

Plantaginis ovatae semen

Plantago ovata

Psyllium seed, Blonde

Plantaginis ovatae testa

Plantago isphagula

Psyllium seed husk, Blonde

Platycodi radix

Platycodon grandiforum

Chinese-Japanese bell-

flower root

Podophylli peltati resina

Podophyllum peltatum

Mayapple resin

Podophylli peltati rhizoma

Podophyllum peltatum

Mayapple root

Polygalae radix

Polygala senega

Senega Snakeroot

Polygalae radix

Polygala tenuifolia

Polygala root

Polygoni avicularis herba

Polygonum aviculare

Knotweed herb

Populi cortex

Populus spp.

Aspen bark

Populi folium

Populus spp.

Aspen leaf

Populi gemma

Populus spp.

Poplar bud

Potentillae anserinae herba

Potentilla anserina

Potentilla herb

Primulae flos

Primula elatior

Primrose flower

Primulae flos

Primula veris

Primrose flower

Primulae radix

Primula elatior

Primrose root

Primulae radix

Primula veris

Primrose root

Pruni africanae cortex

Prunus Africana

Pygeium bark

Pruni africanae cortex

Pygeum africanum

Pygeum bark

Pruni spinosae fructus

Prunus spinose

Blackthorn berry

Pruni spinosae flos

Prunus spinose

Blackthorn flower

Psyllii semen

Plantago afra

Psyllium seed, Black

Psyllii semen

Plantago arenaria

Psyllium seed, Black

Psyllii semen

Plantago indica

Psyllium seed, Black

Psyllii semen

Plantago psyllium

Psyllium seed, Black

Ptychopetali lignum

Ptychopetalum olacoides

Muira Puama

Ptychopetali lignum

Ptychopetalum unicatum

Muira Puama

Pulmonariae herba

Pulmonaria officinalis

Lungwort herb

Pulsatillae herba

Pulsatilla pratensis

Pasque flower

Pulsatillae herba

Pulsatilla vulgaris

Pasque flower

Quercus cortex

Quercus petraea

Oak bark

Quercus cortex

Quercus robur

Oak bark

Raphani sativi radix

Raphanus sativus

Radish

Ratanhiae radix

Krameria triandra

Rhatany root

Rauwolfiae radix

Rauvolfia serpentina

Indian Snakeroot

Rehmanniae radix

Rehmannia glutinosa

Figwort root

Rhamni cathartici fructus

Rhamnus catharticus

Buckthorn berry

Rhamni purshianae cortex

Frangula purshiana

Cascara Sagrada bark

Rhei radix

Rheum officinale

Rhubarb root

Rhei radix

Rheum palmatum

Rhubarb root

Rhododendri ferruginei

Rhododendron fermgineum

Rhododendron, Rusty-

folium

leaved

Rhoeados flos

Papaver rhoeas

Corn Poppy

Ribis nigri folium

Ribes nigrum

Blackcurrant leaf

Rosae flos

Rasa centifolia

Rose flower

Rosae flos

Rosa gallica

Rose flower

Rosae fructus

Rosa spp.

Rose hip seed

Rosae pseudofructus

Rosa spp.

Rose hip

Rosae pseudofructus cum

Rosa spp.

Rose hip and seed

fructibus

Pharmaceutical Name

Botanical Name

Common English Name(s)

Rosmarini folium

Rosmarinus officinalis

Rosemary leaf

Rubi fruticosi folium

Rubus fruticosus

Blackberry leaf

Rubi fruticosi radix

Rubus fruticosus

Blackberry root

Rubi idaei folium

Rubus idaeus

Raspberry leaf

Rubiae tinctorum radix

Rubia tinctorum

Madder root

Rusci aculeati rhizoma

Ruscus aculeatus

Butcher’s Broom rhizome

Rutae folium

Ruta graveolens

Rue leaf

Rutae herba

Ruta graveolens

Rue herb

Sabal fructus

Sabal serrulata

Saw Palmetto berry

Sabal fructus/Serenoea

Serenoa repens

Saw Palmetto berry

repentis fructus

Saccharomyces cerevisiae

Saccaromyces cerevisiae

Brewer’s yeast

Salicis cortex

Salix alba

White Willow bark

Salicis cortex

Salix daphnoides

Willow bark

Salicis cortex

Salix fragilis

White Willow bark

Salicis cortex

Salix purpurea

White Willow bark

Salviae folium

Salvia officinalis

Sage leaf

Sambuci flos

Sambucus nigra

Elder flower

Saniculae herba

Sanicula europaea

Sanicle herb

Santali albi lignum

Santalum album

White Sandalwood

Santali lignum rubrum

Pterocarpus santalinus

Sandalwood, Red

Saponariae rubrae herba

Saponaria officinalis

Soapwort herb, Red

Saponariae rubrae radix

Saponaria officinalis

Soapwort root, Red

Sarsaparillae radix

Smilax aristolochiaefolii

Sarsaparilla root

Sarsaparillae radix

Smilax febrifuga

Sarsaparilla root

Sarsaparillae radix

Smilax regelii

Sarsaparilla root

Scillae bulbus

Urginea maritima

Squill bulb

Scopolia rhizoma

Scopolia carniolica

Scopolia root

Scutellariae radix

Scutallaria baicalensis

Baical Skullcap root

Secale cornutum

Claviceps purpurea

Ergot

Selenicerei grandiflori flos

Selenicereus grandiflorus

Night-blooming Cereus

flower

Selenicerei grandiflori

Selenicereus grandiflorus

Night-blooming Cereus

herba

herb

Senecionis herba

Senecio nemorensis

Senecio herb

Sennae folium

Cassia acutifolia

Senna leaf

Sennae folium

Cassia angustifolia

Senna leaf

Sennae folium

Cassia senna

Senna leaf

Sennae folium

Senna alexandrina

Senna leaf

Sennae fructus

Cassia acutifolia

Senna pod

Sennae fructus

Cassia angustifolia

Senna pod

Sennae fructus

Cassia senna

Senna pod

Sennae fructus

Senna alexandrina

Senna pod

Serpylli herba

Thymus serphyllum

Wild Thyme herb

Sinapis albae semen

Sinapis alba

White Mustard seed

Solidago virgaureae herba

Solidago virgaurea

European Goldenrod herb

Sorbi aucupariae fructus

Sorbus aucuparia

Mountain Ash berry

Spinaciae folium

Spinacia oleracea

Spinach leaf Spiny

Stramonii folium

Datura stramonium

Jimsonweed leaf

Stramonii semen

Datura stramonium

Jimsonweed seed

Strychni semen

Strychnos nuxvomica

Nux Vomica seed

Symphyti folium

Symphytum officinale

Comfrey leaf

( Continued)

(Continued)

Pharmaceutical Name

Botanical Name

Common English Name(s)

Symphyti herba

Symphytum officinale

Comfrey herb

Symphyti radix

Symphytum officinale

Comfrey root

Syzygii cumini cortex

Syzygium cumini

Jambolan bark

Syzygii cumini cortex

Syzygium jambolona

Jambolan bark

Syzygii cumini semen

Syzygium cumini

Jambolan seed

Syzygii cumini semen

Syzygium jambolona

Jambolan seed

Tanceti parthenii herba

Tanacetum parthenium

Feverfew herb

Taraxaci herba

Taraxacum officinale

Dandelion herb

Taraxaci radix cum herba

Taraxacum officinale

Dandelion root with herb

Terebinthina laricina

Larix decidua

Larch Turpentine

Terebinthina veneta

Larix decidua

Venetian Turpentine

Terebinthinae aetheroleum Pinus spp.

Turpentine oil, Purified

rectificatum

Thymi herba

Thymus vulgaris

Thyme herb

Thymi herba

Thymus zygis

Thyme herb

Tiliae carbo

Tilia cordata

Linden charcoal

Tiliae flos

Tilia cordata

Linden flower

Tiliae flos

Tilia platyphyllos

Linden flower

Tiliae folium

Tilia cordata

Linden leaf

Tiliae folium

Tilia platyphyllos

Linden leaf

Tiliae lignum

Tilia cordata

Linden wood

Tiliae lignum

Tilia platyphyllos

Linden wood

Tiliae tomentosae flos

Tilia argentea

Silver Linden flower

Tiliae tomentosae flos

Tilia tomentosa

Silver Linden flower

Tormentillae rhizoma

Potentilla erecta

Tormentil root

Tormentillae rhizoma

Potentilla tormentilla

Tormentil root

Tropaeolum majus

Tropaeolum majus

Nasturtium

Turnerae diffusae folium

Turnera diffusa

Damiana leaf

Turnerae diffusae herba

Turnera diffusa

Damiana herb

Uncariae cortex

Uncaria tomentosa

Cat’s claw bark

Urticae folium

Urtica spp.

Nettle leaf

Urticae herba

Urtica spp.

Nettle herb

Urticae radix

Urtica spp.

Nettle root

Usnea

Usnea spp.

Usnea

Uvae ursi folium

Arctostaphylos uva-ursi

Uva Ursi leaf

Valerianae radix

Valeriana officinalis

Valerian root

Verbasci flos

Verbascum densiflorum

Mullein flower

Verbasci flos

Verbascum thapsus

Mullein flower

Verbenae herba

Verbena officinalis

Verbena herb

Veronicae herba

Veronica officinalis

Veronica herb

Vincae minoris herba

Vinca minor

Periwinkle

Violae odoratae rhizoma

Viola odorata

Sweet Violet root and herb

and herba

Violae tricoloris herba

Viola tricolor

Heart’s Ease herb

Visci albi fructus

Viscum album

Mistletoe berry

Visci albi herba

Viscum album

Mistletoe herb

Visci albi stipitis

Viscum album

Mistletoe stem

Yohimbehe cortex

Pausinystalia yohimbe

Yohimbe bark

Zedoariae rhizoma

Curcuma zedoaria

Zedoary rhizome

Zingiberis rhizoma

Zingiber officinale

Ginger root

Zizyphi fractus

Zizyphus jujuba Mill.

Chinese jujube fruit

Source: The complete German Commission E Monographs, Blumenthal et al, American Botanical council, Austin, Texas; ESCOP Monographs, Second revised edn, Thieme, Stuttgard, Germany; British Herbal Medicine Association; Selected Medicinal Plants (Vol. 1, 2, 3), WHO, Geneva.





9 Pruning of

classical formulations

Suggested process

A widespread perception that prevails among Ayurvedic scholars is that there is no need for carrying out any research in Ayurveda because whatever has been written in ancient classical texts is the ultimate truth and has been written only after sound research. However, they fail to recognize that in classical texts, too, it has been clearly stated that accepting any theory without repeatedly examining it is not a sign of a rationally minded physician. Further, the descriptions that were documented hundreds of years ago need not necessarily match with the present-day situation. There might have also been a loss of information during its transfer from one version of the text to the next. Therefore, there is a need for inculcating the habit of questioning among Ayurveda teachers and students, and only then will good research questions emerge.

Col. Ram Nath Chopra wrote against this trend and raised the issue in 1933

when he suggested that attempts must be made to separate the good herbs from the useless ones and for this, a systematic investigation of these drugs must be

undertaken.1

Prof. (Dr.) A. J. Baxi (Gujarat Ayurved University, Jamnagar) wrote in 1986: Dashamuula Kwaath Churna and Dashamuulaarishta contain powders of the roots of ten different plants. These plants belong to different families and some of them contain chemical compounds which under favorable conditions may interact or undergo enzymatic reactions causing oxidation of the hydroxyl group or reduction of keto group or breaking up of double bounds, etc., forming altogether different compounds in the final product. To study this possibility it is necessary to plan an elaborate scheme. We may take each plant separately one by one and process it under similar experimental conditions and study the changes in chemical constituents at every stage. Then, permutations and combinations will have to be carried out by mixing plant 1 and 2; 1 and 3; 1 and 4; 2 and 3; 2 and 4; 2 and 5; 1, 2 and 3; 1, 2, 3 and 4; and like that as many combinations as possible will be required to be studied. Such an elaborate study would indicate as to what were the intermediate products and what is the final constitution. An instrumental study at every stage will be more helpful and would give us the information about the genu-

ineness and quality of each drug.2

122 Legacy and logical steps

Redundant herbs can be easily removed from the compound.

The same process has been advised recently by A. Subramoniam: “In the development of a polyherbal formulation, using active extract/fraction/compound from 3 herbs (Herb 1, 2 and 3) first pharmacological evaluation of each plant has to be carried out, using 3 or 4 reasonable doses; if active the optimum dose may be fixed in each case. Then, combinations of 2 plants (1 + 2, 2 + 3 and 1 + 3) in different ratios (generally optimum dose in each case and lower than that) have to be evaluated. Finally, the combinations with the 3 plants (1 + 2 + 3) in different rations are to be done. The safety study (toxicological evaluation) for the most promising combinations should be carried out. When the number of plant ingredients in the combination increases, the work to be carried out increases tremendously when various permutations are considered. Numerous plants with widely varying degrees of the same therapeutic action are occurring. For example, in India, more than 100 plants are reported to have antidiabetes and/or hypoglycemic property. In such cases, potential plants have to be compared for efficacy and safety and the most promising plants are to be used for further studies aimed at drug development.”2a

Ayurvedic Formulary of India (AFI), Part I, first edn, 1978, included the roots of all the ten plants: Aegle marmelos, Oroxylum indicum, Gmelina arborea, Stere-osperumum suaveolens, Premna integerifolia (Mahat panchmuula), and Desmodium gangeticum, Uraria picta, Solanum indicum, Solanum xanthocarpum, and Tribulus terrestris (Kshudra panchamuula) in the compound, while in its second revised edition, 2003, an option has been provided to use either the root or the stem-bark of the first five plants (Mahat panchmuula), and aboveground parts of the remaining five plants (Kshudra panchamuula). The Dashamuula complex is based on Sushruta’s classification of plant drugs (Gana). Kshudra panchamuula and Mahat panchmuula taken together constitute Dashamuula (Sushruta, Sutra 38: 66–70). The Dashmuula group alleviates all the three doshas. It cures kaasa (bronchitis), sannipaata (high fever due to vitiation of all the three doshas), shirorti (headache), shvaasa (asthma) and hikkaa (hiccup). Apatantraka (convul-sion) was added in the sixteenth century.

In classical Ayurvedic medicine, plant parts like root, bark, flower, seed, fruit and leaves are used for their specific therapeutic activities.3 If an old medicinal

plant, described in the ancient texts, is sought to be prepared in a different manner from that described in the literature, then, even if this difference consists of a few different chemical steps or a new ingredient, or has one ingredient less, this medicine will be treated as any new drug.4 Thus, Dashamuulaarishta and all Dashmuula products are now new drugs and all of them are to be rechristened and removed from the status of classical drugs so that consumers are not misled.

Keeping the therapeutic target in mind, only those herbs which can play an active role can be retained and others can easily be discarded.

Pruning classical formulations 123

Like many other drugs of the classical period, the profile of Dashamuulaarishta also changed with the passage of time. Label herbs remained the same, but expensive or extinct herbs were modified as per individual’s discretion. Ayurvedic Formulary of India recommended Dashamuulaarishta for following therapeutic uses in 1978: emesis, malabsorption syndrome, abdominal lump, cough, asthma, tissue wasting, neurological affections, and piles. This was expanded in its second edition, 2003: fistula-in-ano, anemia, jaundice, diseases of the skin, excessive flow of urine, digestive impairment, diseases of the abdomen, gravel in urine, calculus, dysuria, infertility, emaciation, deficiency of semen and debility. (This expansion is obviously arbitrary.)

Dabur recommends Dashamuulaarishta as a general tonic and restorative for women; Baidyanath Ayurved Bhavan for nervous diseases, anemia, cough, piles and as an alterative and bitter tonic; Emami (Zandu) for cough, piles, anorexia, alcoholism, asthma, vomiting, as a stimulant, alterative and bitter tonic; Indian Medical Practitioner’s Cooperative Pharmacy (IMPCOPS), Chennai, as a restorative, digestive, cardiac and nervine tonic.

Now, let us see the biological activities of Classical Dashamuula Kwaath. Its extract produced CNS depressant effect in albino mice; reduced the spontaneous motor activity, potentiated the pentobarbitone hypnosis and antagonized the amphet-amine-induced hyperactivity. It also exhibited a tranquilo-sedative activity like a major tranquilizer and blocked the condition avoidance response in rats.5 Another

study indicated that Dashamuula Kwaath extract effectively produced an aspirin-like analgesic, antipyretic and anti-inflammatory effect in mice.6 Dey et al. (1968) reported that Solanum indicum induced drowsiness, motor activity alertness in mice and significantly potentiated barbiturate hypnosis in locomotor-decreased mice.7

Dhawan et al. (1977) reported that the entire plant extract of Uraria picta exhibited CNS depressant activity.8 Marmin, a coumarin, isolated from the root of Aegle marmelos, showed an anti-inflammatory effect against carrageenan-induced inflammation in rats. The methanolic extract of the rootbark inhibited the beating rate of cultured mouse myocardial cells. Among the isolated constituents, aurapten is found to be the most potent inhibitor comparable with verapamil.9 The

root of Desmodium gangeticum gave gangetin, one of the pterocarpans isolated from the hexane extract of the root. It showed significant anti-inflammatory activ-

ity in rats.10 Alcoholic extract of the stem bark of Gmelina arborea showed anti-

inflammatory activity comparable to phenylbutazone.”11

Thus, if we scan the published literature, on the basis of leads already available, the number of herbs can be reduced from so-called Dashmuulaarishta, Dashmuula Kwaath, and other Dashmuula products that contain many additional herbs.

A Srilankan compound formulation, Karvi Panchakadasha Kashaaya, consisted of 50 herbs, was shortened to five herbs, Carum carvi, Inula racemosa, Ricinus communis, Bacopa monnieri, and Boerhavia diffusa, and was prescribed in the form of decoction (made by boiling 50 g crude drugs in 400 ml water, reducing to one-eighth) to 80 randomly selected patients of essential hypertension, as

124 Legacy and logical steps

an adjuvant with modern hypertensive drugs, also as an independent drug). At the end of 28 days, both the groups showed significant symptomatic improvement

and reduction in systolic and diastolic blood pressure.12

Shunthi Guggulu, a CCRAS drug for rheumatoid arthritis, can be quoted as another example. It contains only two herbs: Zingiber officinale Rhizome and Commiphora wightii gum resin. A multicenter observational study revealed the satisfactory improvement of symptoms, namely reduction in pain, morning stiffness, swelling in joints besides reduction in ESR levels. Out of 497 patients, about 67% of patients, under a course of 6 weeks treatment, showed general functional capability and improvement in general condition.

The clinical study was conducted at the then CRI, Bhubaneswar, on 63 patients of rheumatoid arthritis recruited into two groups, namely Group-A (Shunthi Guggulu) and Group-B ( Yogaraja guggulu, Amavata-Rasa/Vatagajankusha-rasa and Maharasanadi-kwatha).

The result indicated a better effect of Shunthi guggulu (Group A) as compared to the other set of medicines (Group B). (Group B drugs belong to Ayurvedic classics and contain 28, 8, 15, and 32 herbo-mineral drugs, respectively.) The observations in another clinical trial of Shunthi-Guggulu on 50 patients of rheumatoid arthritis showed a significant effect as about 80% of the patients who completed the full course of treatment showed either marked or complete relief (complete relief 13, marked relief 19).

A clinical trial with four single drugs – Commiphora mukul oleoresin, Acorus calamus. Inula racemosa and Terminalia arjuna (against placebo) may provide sufficient leads for pruning complicated cardioprotective formulations.13 All the four drug-treated groups showed mild to moderate improvement in symptoms of chest pain and dyspnea. Commiphora mukul oleoresin and Inula racemosa groups showed a significant reduction in body weight as well as correction of lipid profile. However, restoration of HDL was significant only in Terminalia arjuna group. Favourable ECG changes of mild to a moderate degree were noted in all the four groups. Total Lipid Atherogenicity Index was significant in Inula racemosa group: Commiphora mukul oleoresin +, Acorus calamus −, Inula racemosa ++, Terminalia arjuna +.

In an earlier clinical trial, dried and powdered roots of Inula racemosa and purified oleoresin of Commiphora mukul in 1:1 (w/w) proportion were prescribed (6–8 g/day in divided doses) for six months, and gave encouraging results in

hyperlipidemia.14

Now that a good number of single herbs are exhibiting CNS-CVS active, antihypertensive, hypolipidemic and cardioprotective potential in experimental and clinical trials, a concerted effort should be made to review and restructure complicated compound formulations of classical medicine. Only scientifically validated and therapeutically substantiated herbs should be retained. It is no more possible to accept the herb selection procedure of the sixteenth century in the twenty-first century.

Pruning classical formulations 125

In the chapter, “Basic Steps for Restructuring Ayurvedic Formulations,” we will discuss the classification of herbs (the group of herbs) by Charaka, Sushruta, and Vagbhata, which were used for formulating classical polyherbal drugs. Each classification is to be screened as suggested by Dr. A. J. Baxi and A. Subramoniam for its therapeutic strength. We suggest this as a basis of restructuring classical formulary.

References

1 Chopra Col. Sir RN, Indigenous Drugs of India, 1933, first edn, 1958, second reprint 1994, Academic Publishers, Kolkata-700 009: page 6.

2 CCRAS, Perspectives in Pharmaceutical Aspects of Indian Medicinal Plants, Scientific Seminar on Medicinal Plants Research, Pune, 1986.2a, Subramoniam A, Annals of Phytomedicine, 2014, 3(1): 31–36.

3 Shah DC, SN Sannd, Regional Research Centre, CCRAS, Rehari Chowk, Jammu, Scope of Research and Development on Ayurvedic Medicinal Plants with Reference to Their Useful Parts.

4 Chaudhury Dr Ranjit Roy, Herbal Medicine for Human Health, WHO, Regional Publication, SEARCO. No. 20: 59.

5 Gupta RA et al, Pharmacological Studies on Dashammula Kwaath, JRAS, 1983, IV: 73–84.

6 Ibid 1984, JRAS, V(1–4): 38, 50.

7 Neuropharmacological properties of several Indian medicinal plants, Jour Res Ind Med, 3(1): 9–18.

8 Screening of Indian plants for biological activity, Part IV, Ind Jour Exp Biol, 15: 208–219.

9 Kakiuchi et al, Planta Med, 1991, 57: 43; Handa et al, Fitoterapia, 1992, 63: 3.

10 Handa et al, Fitoterapia, 1992, 63: 12.

11 Agrawal et al, Ind J Nat Prod, 1994, 19(1): 14.

12 Ariyawansa HAS, RH Singh, supervisor, 1999. Ph. D. thesis, Dept of Kayachikitsa, Banaras Hindu University, Varanasi.

13 Singh RH, Institute of medical sciences, Banaras Hindu university, Varanasi, Ayu International, Gujarat Ayurved University, Jamnagar, January–March 2001, 1(1).

14 Ramji Singh et al, JRAS, 1991, XIII: 1–18.





10 The pragmatic nature

of Ayurveda

No restrictions on revising

old formulations

Ayurvedic Drug Formulations, which were based on Ganas or Vargas devised by Charaka and Sushruta, were revised from time to time during the classical period, why we can not revise them for after assessing them on drug parameters of twenty-first century. We would like to give a few examples to prove our point: 1 During the period of Sushruta (first century bc.), Triphala was composed of one part of Haritaki ( Terminalia chebula), two parts of Vibhitaki ( Terminalia bellerica), and four parts of Aamalaki ( Emblica officinalis) (Sushruta, sutra 38: 56, 57). During the period of Bhavamisra (sixteenth century) all the three components were used in equal parts (Bhavaprakasha, Haritakyaadi Varga, 41). Therapeutic properties remained the same.

2 Pancha Gavya Ghrita (Charaka Samhita, Chi. 10: 16) was composed of cow’s urine, dung filtrate, milk, sour curd and ghee (purified butter), in equal quantities. It was used for Apasmaara (epilepsy), Kaamalaa (jaundice) and Jvara (fever).

If these ingredients were collected from aja (goat), the drug was called Panchaaja; if collected from mahishaa (buffalo), the drug was called Panch Mahisha. After adding Kaashisha (mineral, green vitriol), Katu rohini ( Picrorhiza kurroa), roots of Jati ( Jasminum officinale) and Haridra ( Curcuma longa), either Panch Gavya or Panchaaja or Panch Mahisha was used for cleansing ulcers.

Maha Panch Gavya Ghrita (Ashtangahridaya) contained 42 extra herbs ( Ayurvedic Formulary of India, Part I, Second Revised Edition: 95, 96.).

This can be prescribed for Apasmaara (epilepsy), Kaamalaa (jaundice), Jvara (fever), and also for Udara roga (diseases of abdomen), Bhagandara (fistula-in-ano), Visham jvara (intermittent fever), Shopha (edema), Arsha (piles), Paandu (anemia), Gulma (abdominal lump), Kaasa (cough), Graharoga (diseases due to ill effects of planets, psychotic syndrome).

This formulation can be easily revalidated as it contains Dashamuula, Triphala, Haridraadi Gana, Tryuushana Gana and other components of Dashemaani.

Pancha Gavya Ghrita of Sahasrayoga (Non-Samhita, Kerala Materia Medica) contains only basic five components (to be used for Apasmaara (epilepsy), Kaamalaa (jaundice) and Jvara (fever).

128 Legacy and logical steps

Second variation of Sahasrayoga, does not contain Dashamuula,

but contains Triphala, and 14 additional plant drugs, a totally different formulation, to be used as a rejuvenating tonic with fertility promoting properties ( Putradaa), and for retarding ageing, protecting from the onslaught of planets ( Mahaagraha-pidaa-naashaka) and fear from ghosts ( Bhuuta-bhaya-naashana). (Sahasrayoga, CCRAS text, page 316.) 3 Elaadi Churna:

Elaadi Churna (Gadanigraha, twelfth century) contained eight components: cardamoms 1 part, cinnamon bark 2 parts, cinnamon leaves 3 parts, naagakesara stamens 4 parts, black pepper 5 parts, long pepper 6 parts, dry ginger 7 parts, and sugar 28 parts.

In Bhaishajya ratnavali (seventeenth century), only three components were retained (cardamoms, naagakesara stamens and long pepper), clove, jujuba pulp, priyangu ( Callicarpa macrophylla flowers), shaali ( Oryza sativa), Cyperus rotundus rhizome and chandana ( Santalum album) were added.

4 Draksharishta:

Gadanigraha (twelfth century) formulation was revised in Sharangadhara Samhita (thirteenth century). Nutmeg, cloves, cubebs, date fruits and chandana were dropped.

5 Kumaryaasava:

Sharangadhara Samhita (thirteenth century) text contains 44 ingredients, while the formulation of Yoga-rtnakara (sixteenth century) contained only 16

ingredients. Both have been incorporated in Ayurvedic Formulary of India,

Part I, as A & B.

6 Navaayasa Churna:

In Ashtangahridaya (seventh century), the formulation contains Loha bhasma (clax of iron) 27 parts, while in Bhaishajya ratnavali (seventeenth century), the content of Loha bhasma was reduced to 9 parts.

These examples show that there was no bar to add or drop ingrediants from formulations during the classical period (which was regulated by shashtras); all the time, while we are afraid of our shastras, actually we are afraid of results if our formulations are x-rayed. For the sake of better therapeutic results, we will have to add some and drop some ingredients.

Logistics of Ayurvedic formulations

Ayurvedic formulations were a part of holistic healing. The imbalances of the whole system of the patient were treated along with the symptoms of the disease.

Charaka, Sushruta, and Vagbhat worked out different classifications ( Ganas or Vargas) containing identified herbs, three, ten or more, in each). One formulation may contain either one Gana or Varga or even two or three G anas, depending upon nature of the ailment. These were meant for kuti or in-house treatment, based on the constitution of a particular patient.

The pragmatic nature of Ayurveda 129

Now, Ayurvedic drugs have emerged as OTC drugs and millions of people are buying them directly from chemists without consulting a qualified vaidya. Millions of people are showing interest in Ayurvedic medicines and their constitution is also not known. It has become imperative to modify Classical formulations based on main herbs and supporting herbs for bioavailability and subject them to an experimental or clinical trial. Thus Classical formulations will emerge as a standardized disease-based Ayurvedic medicine.

All Ganas and Vargas are first to be screened as the base-strength of classical formulations are to be checked by the architects of evidence-based Ayurveda.

After that, each herb can be screened on the basis of the last 200 hundred years’

research. which overweighs the foundation material we had in the sixteenth century.

We have at our disposal 22 volumes of T he Wealth of India series, published by NISCAIR, CSIR (Council of Scientific and Industrial Research). The original series was in 11 volumes which covered 5,000 plant species belonging to about 1,730 genera under 233 families. The last volume was published in 1976. After that revised and enlarged editions were published as 1A, 1B, and 2i. After 1992, the First Supplement series was published in five volumes (during 2000–2004).

The Second Supplement series was published during 2006–2009. The Supplement series covered 2,000 plant species belonging to over 1,000 genera. The main emphasis was on chemical constituents in the Supplementary series.

After the closure of The Wealth of India series, the Indian council of Medical Research (ICMR) brought out the first volume of “Reviews on Indian Medicinal Plants” in 2004. This on-going series is covering details of botanical, pharmacognostic, chemical, pharmacological/biological, clinical and toxicological aspects of Indian medicinal plants. Through May 2019, 21 volumes (A to P) covered 4,951

species. The text is based on 75,486 research papers (reference material is preserved in ICMR, Medicinal Plant Unit). Such a monumental work is not available in any Asian region.

This scientific progress will prove a boon to Ayurveda, and all old data can be revalidated for further growth of an evidence-based medicinal system.

In the next chapter, we will be giving basic details of Ganas and Vargas of the classical period.





11 Basic steps

For restructuring Ayurvedic

formulations

Understanding the criteria of drug formulation during the

classical period

Sushruta’s Classification of Ayurvedic Drugs is the pharmacological classification which will help drug researches in weeding out superfluous herbs from the classical formulations which are having multiple herbal components of different families of different geographical regions

The classification of Charaka is known as Dashemaani, 50 classifications having 10 herbs in each. His classification will not prove of much help in revalidating Ayurvedic formulations. We will try to correlate Charaka’s Varga with Sushruta and Vagbhata classifications in our text.

Sushruta Samhita (second century bc), and later on Vagabhata (ad sixth century) classified the group of drugs based on their multiple therapeutic indications and for their synergistic or holistic action – for example, Madhuka ( Glycyrrhiza glabra) is included in Haridraadi Gana, Brhatyaadi Gana, Kaakolyaadi Gana, Saarivaadi Gana, Anjanaadi Gana, Ambaashthaadi Gana, Nyagrodhaadi Gana and Utpalaadi Gana (in nine places); Chitraka ( Plumbago zeylanica) in Aaragvadhaadi Gana, Varunaadi Gana, Mushkakaadi Gana, Krishnaadi Gana, Aamalakyaadi Gana (in five places); Vacha ( Acorus calamus) in Vachaadi Gana, Vatsakaadi Gana, Mustaadi Gana, Vamanaoushadha Gana, and Niroohana Dravya, used for Niroohavasti Gana (in five places); Guduchi ( Tinospora cordifolia) in Guduchyaadi Gana, Aaragvadhaadi Gana, Salsaaraadi Gana, Shyaamaadi Gana, Patolaadi Gana, and Vallija panchamuula Gana (in six places); Paathaa ( Cissampelos pareira) in Aaragvadhaadi Gana, Krishnaadi Gana, Brhatyaadi Gana, Patolaadi Gana, Mustaadi Gana (in five places).

Now that scientifically validated clinical profile of all plant drugs are available, and main herbs, synergistic herbs, and herbs which promote bioavailability can be identified, it will be much easier to review Ayurvedic formulations which are based on multiple classifications covering multiple indications. Researchers can understand and interpret varied names of herbs and their disease-based applications and restructure a disease-based Ayurvedic formulary.

Sushruta’s vision was broad-based. He emphasized that components of a Gana can be used jointly or separately. He gave liberty to add drugs of other Ganas

132 Legacy and logical steps

or Vargas if so required. (Sushruta: Sutra 38: 82.) This was misconstrued, and, mainly due to lack of confidence, a number of other Vargas entered into Ayurvedic formulations to achieve Holistic effect of Ayurvedic drug. The inclusion of Dashmuula in a number of formulations is an example of this approach. Such formulations can be easily identified and restructured.

We find that Sushruta’s text has also been modified at many places by commentators. In the sixth century ad, Vagbhata revised the constituents and added one new Gana, Vatsakaadi, and changed the names of Kaakolyaadi and Saalasaaraadi Gana as Padmakaadi and Asanaadi, respectively.

In the main text, we have added the plant drugs of Ganas of Vagbhat for point-ing out certain variations. In the sixteenth century, in Bhavaprakasha Nighantu, eight Vargas of the text comprise near about 480 drugs. Possible adverse effects of 196 drugs of herbal origin were included so that while preparing formulations, herb to herb interaction is taken care of. We will be giving details at the end of the main text. While concluding, we have also given some suggestions, based on our study of classical texts.

We have taken the main text from Ayurveda Saukhyam text1 (sixteenth century) and Dravya Guna Vijnana (1993).2

In the main text, we have identified a number of obscure herbs of the Classical period and equated them with botanical names, though it was very tedious and time-consuming work.

Sushrut’s Ganas (Pharmacological Classifications) with

Charaka’s Vargas (Dashemaani)

1 Vidaarigandhaadi Gana:

Vidaari ( Pueraria tuberosa), Vidaarigandhaa ( Desmodium gangeticum), Vishvadevaa ( Abutilon indicum), Sahadevaa ( Sida rhombifolia), Shvadamshtra ( Tribulus terrestris), Prthakparni ( Uraria picta, also Marsdenia tenacissima), Shrgaala vinnaa (? Shrgaalikaa = Vidaari kanda, Ipomoea digitata), Shataavari ( Asparagus racemosus), Saariva ( Hemidesmus indicus), Jivaka, Rshabhaka (extinct), Mahaa sahaa ( Teramnus labialis), Kshudra sahaa ( Phaseolus trilobus), Brhati ( Solanum indicum), Kantakaari ( Solanum xanthocarpum), Punaranavaa ( Boerhaavia diffusa), Eranda ( Ricinus communis), Hamsapadi ( Adiantum lunulatum), Vrischikaali ( Tragia involucrata) and Rshabhi ( Mucuna pruriens).

The Vidaarigadhaadi Gana ameliorate Vaayu and Pitta, cure sosha (wasting diseases), gulma (tumor), angamarda (bodily soreness), urdhwa-swaasa (dyspnea), and kaasa (cough, bronchitis).

Charaka’s Varga: Brahaniya (nourishing), Hikkaanigraha (curative of hiccup), kaasahara (curative of cough), angamarda prashman (relieves bodily soreness), prajaasthaapana (curative of sterility), vayahasthaapana (prevents ageing).

Basic steps for restructuring 133

Vagbhat’s Vidaaryaadi Gana:

Vidaari, Eranda, Vrischikaali, Vrischeeva ( Boerhaavia verticillata), Devaah-vaya ( Cedrus deodra), Mudgaparni ( Phaseolus trilobus), and Maasaparni ( Teramnus labialis), Kanduukari ( Mucuna prurita) Jeevana Panchamuula (Mahaa shataavari, Kaakoli, Jivanti, Jivaka and Rshabhaka), Hraswa (Laghu) panchamuula, Gopasutaa (Saarivaa) and Tripaadi (Hamsapadi).

2 Aaragvadhaadi

Gana:

Aaragvadha ( Cassia fistula), Madana ( Randia dumetorum), Gopa ( Hemidesmus indicus) Ghontaa ( Ziziphus jujuba). Kantaki ( Solanum indicum), Kutaja ( Holarrhena antidysenterica), Paathaa ( Cissampelos pareira), Paatalaa ( Stereospermum suaveolens), Muuvaa ( Marsdenia tenacissima), Indrayava ( Wrightia tinctoria), Saptaparnaa ( Alstonia scholaris), Nimba ( Azadirachta indica), Kurantaka ( Barleria prionitis), Guduchi ( Tinospora cordifolia), Chitraka ( Plumbago zeylanica), Shaarngeshthaa ( Physalis minima or Cardiospermum halicacabum), Paruushaka ( Grewia asiatica), Karanjadwai (Karanja: Pongamia pinnata), Lataa Karanja: Caesalpinia bonduc), Patola ( Trichosanthes dioica), Kiraata-tikta ( Andrographis paniculata), and Sushavi ( Calycoptris floribunda).

Drugs of Aaragwadhaadi Gana alleviate Kapha and visha (poisoning, toxemia), and cures meha (urinary disorders), kushta (obstinate skin diseases including leprosy) jvara (fever), vami (vomiting) and kanduu (pruritus, itching), purifies dushta vrana (nonhealing ulcers)

Charaka’s Varga: Kushthaghna (curative of obstinate skin diseases), kanduughna (curative of pruritus), vishaghna (the antidote to poisoning).

Vagbhat’s Aaragwadhaadi Gana:

Aaragvadha, Indrayava ( Wrightia tinctoria seed), Paatali (Mushkaka = Schrebera swieteniodes), Kaakatiktaa, Nimba, Amritaa (Guduchi), Madhurasaa (Muurvaa = ( Marsdenia tenacissima), Sruva-vrksha (Vikankata = Flacourtia indica), Paathaa ( Cissampelos pareira), Bhuunimba ( Andrographis paniculata), Sairyaka (Sahachara = Barleria prionitis), Patola ( Trichosanthes dioica), Karanja-yugma (Karanja ( Pongamia pinnata), Lataa Karanja ( Caesalpinia bonduc), Saptachhada (Saptaparna), Agni (Chitraka), Sushavi (Kaaravi), Phala (Madana phala = ( Randia dumetorum), Baana (Sahachara) and Ghontaa.

3 Saalsaaraadi Gana:

Saalasaara ( Shorea robusta), Ajakarna ( Dipterocarpus turbinatus), Khadira ( Acacia catechu), Kaala skandha ( Diospyros embryopteris), Kramuka ( Areca catechu), Bhuurja ( Betula utilis), Meshashrngi ( Gymnema sylvestre), Tinisha ( Ougeinia dalbergioides), Chandana ( Santalum album), Kuchandana ( Pterocarpus santalinus), Shimshipaa ( Dalbergia sissoo), Shirisha ( Albizzia lebbeck), Asana ( Pterocarpus marsupium), Dhava ( Anogeissus latifolia), Arjuna ( Terminalia arjuna), Naktamaala ( Pongamia

134 Legacy and logical steps

pinnata), Ashvakarna ( Dipterocarpus alatus), Shaaka ( Tectona grandis), Guduchi ( Tinospora cordifolia), and Kaaliyaka ( Coscinium fenestratum).

Drugs of Saalsaaraadi Gana cure kushtha (obstinate skin diseases including leprosy), meha (urinary disorders, excessive urination), and paandu (anemia). They also cleanse Kapha and medas (adiposity).

Charaka’s Varga: Kushthagna (curative of obstinate skin diseases), muutra sangrahaniya (corrective of excessive urination), udardaprashaman (curative of urticaria).

Vagbhat’s Asanaadi Gana (Sushruta’s Saalasaaraadi Gana): Asana, Tinisa, Bhuurja, Swetavaaha (Arjuna), Prakeerya (Puutikaranja = Caesalpinia bonduc), Khadira, Kadara ( Acacia suma), Bhandi ( Albizzia lebbeck), Sinsapaa, Meshasringee, Trihima (Chandana, Raktachandana and Daaruharidraa), Tala (Taala), Palaasa, Jongaka (Agaru), Saaka ( Tectona grandis), Saala, Kramuka (Puuga), Dhava, Kulinga (Kaaliyaka?), Chaa-gakarna ( Vateria indica) and Ashvakarna.

4 Varunaadi Gana:

Varuna ( Crataeva nurvala), Aartgala ( Xanthium strumarium), Shigru ( Moringa pterygosperma, white variety), Madhu shigru (Red variety), Tarkaari ( Clerodendrum phlomidis), Meshashrngi (Gymnema sylvestre), Puteeka ( Holoptelea intgrifolia), Naktamaala ( Pongamia pinnata), Morata ( Maerua arenaria), Agnimantha ( Premna integrifolia), Saireyaka dwai ( Barleria prionitis and B. cristata), Bimbi ( Coccinia indica), Vasuka ( Osmanthus fragrans), Vasira (not identified), Chitraka ( Plumbago zeylanica), Shataavari ( Asparagus racemosu s), Bilva ( Aegle marmelos), Ajashrngi ( Pistacia integerrima), Darbha ( Imperata cylindrica), Brhati dwai ( Solanum indicum and Solanum melongena).

Drugs of Varunaadi Gana alleviate Kapha and reduce medas (adiposity).

They cure shirahshuula (headache), gulma (tumor) and aabhyantara vid-radhi (internal abscess).

5 Viratarvaadi

Gana:

Virataru ( Terminalia arjuna or Viravriksha = Dichrostachys cinerea), Sahachara dwai ( Barleria cristata and B. prionitis), Darbha ( Imperata cylindrical), Vrkshaadani ( Loranthus longiflorus), Gundra ( Typha angustata), Nala ( Phragmites karka or Arundo donax), Kusha ( Desmostachya bipinnata), Kaasha ( Saccharum spontaneum), Ashmabhedaka ( Bergenia ligulata), Agnimantha ( Premna obtusifolia), Morataa ( Maerua arenaria), Vasuka ( Osmanthus fragrans), Vasira ( Achyranthes aspera), Bhalluka ( Dioscorea species or Prunus species; fruit (red) juicy, cooling, sweet and sour, as described in text), Kurantika ( Celosia argentea), Indivara ( Nelumbo nucifera), Kapota vankaa ( Bacopa monnieri), Shvadamshtra ( Tribulus terrestris).

Basic steps for restructuring 135

The drugs of Viratarvaadi Gana cure diseases caused by Vaayu, ashmari (stone in urinary tract), sharkaraa (sediments in the urine), mutra krchhra (dysuria), and muutraghaata (anuria).

Charaka’s Varga: Muutravirechaniya (diuretic).

Vagbhat’s Viratarvaadi Gana:

Vellaantara (Virataru or Dirgha patra = Diospyros melanoxylon), Aranika (Agnimantha), Booka (?), Vrisha (Vaasaa), Asmabheda (Paashaanabheda), Gokantaka (Gokshura), Itkataa, Saaachara, Baana ( Barleria prionitis), Kaasa, Vrikshaadani, Nala, Kusadwai (Sthuula Darbha and Suukshma Darbha), Gunthaa ( Typha australis), Gundraa ( Typha angustata), Bhallu-uka (Syonaaka), Moraa, Kuranta (Sitivaaraka), Karambha (Uttamaarani), Paarthaa ( Terminalia arjuna).

6 Rodhraadi

Gana:

Rodhra = Lodhra, Saavar rodhra ( Symplocos racemosa and S. crataegoides), Palaasha ( Butea monosperma), Kutannta (Shyonaaka: Oroxylum indicum), Ashoka ( Saraca asoca), Phanji (Bhaargi: Clerodendrum serratum), Katphala ( Myrica nagi), Elavaaluka ( Prunus avium), Shallaki ( Boswellia serrata), Jingini ( Odina wodie, Jingi: Rubia cordifolia), Kadamba ( Anthocephalus cadamba), Shaala ( Shorea robusta) and Kadali ( Musa paradisiaca).

The drugs of Rodhraadi Gana reduce medas (adiposity), and Kapha. They cure yon i dosha (ailments of female genital tract), promote stambhana (retention power), improve complexion, and cure visha (poisoning, internal toxemia).

Charaka’s Varga: Vedanaathaapana (anodyne), vishaghna (the antidote to poisoning), purishasangrahaniya (renders fecal matter consistent).

Vagbhat’s Rodhraadi Gana:

Rodhra, Saavaraka Rodhra, Palaasa, Jingini, Sarala (Devadaaru), Katphala, Kutsitaamba (Kadamba), Kadali, Gatasoka (Asoka), Elavaalu, Paripelava (Kutannata = Oroxylum indicum) and Mocha ( Salmalia malabarica exudate).

7 Arkaadi Gana:

Arka ( Calotropis gigantea), Alarka ( Calotropis procera), Karanjadwai (Udkirya: Pongamia pinnata, Prkirya: Caesalpinia crista), Naagadanti ( Croton oblongifolius. Baliospermum montanum is used for both Danti and Naagadanti), Mayuuraka (Apaamaarga: Achyranthes aspera), Shvetaa ( Clitoria ternatea), Mahaa Shvetaa (Kshira Vidaari: Ipomoea digitata), Vrshchhikaali ( Heliotropium indicum), Alavanaa ( Celastrus paniculatus), and Taapasa vrksha ( Balanites aegyptica).

Drugs of Arkaadi Gana reduce Kapha and medas (adiposity). They cure visha (poisoning, toxemia), krmi (a parasitic infection) and kushtha (obstinate skin diseases including leprosy). They especially help in cleansing ulcers.

Charaka’s Varga: Vishaghna (the antidote to poisoning), kushthagnna (cures obstinate skin diseases including leprosy).

136 Legacy and logical steps

Vagbhat’s Arkaadi Gana:

Arka, Alarka, Naagadanti, Vishalyaa (Langali = Gloriosa superba), Bhaargi ( Clerodendrum serratum), Raasnaa ( Pluchea lanceolata), Vrshchhikaali ( Heliotropium indicum), Prakiryaa, Pratyakpushpi ( Achyranthes aspera), Peeta-taila ( Celastrus paniculatus), Udakirya (Karanja), Swetaa Yugm (Shvetaa and Mahaa Shvetaa), and Taapasa vrksha.

8 Surasaadi Gana

Surasaa ( Ocimum sanctum), Shveta surasaa (White-flowered Ocimum basilicum, common English name; ‘Magic White’), Phanijjaka ( Origanum majorana), Arjaka ( Ocimum canum), Bhuustrna ( Cymbopogon martini), Sugandhaka ( Nigella sativa or Suvarchalaa: Malva rotundifolia), Sumukha (Wild Ocimum pilosum), Kaalamaala ( Ocimun gratissimum black variety), Kaasmarda ( Cassia occidentalis), Kshavaka ( Centipeda orbicularis), Kharapushpa (A variety of Centipera minuta), Vidanga ( Embelia ribes), Katphala ( Myrica esculenta), Surabhi (Punnaaga: Calophyllum inophyllum), Nirgundi ( Vitex negundo), Kulaahala ( Celsia coromandelina), Unduru karnikaa ( Ipomoea reniformis), Phanji (Bhaargi: Clerodendrum serratum), Praachibala ( Peristrophe bicallyculata), Kaakamaachi ( Solanum nigrum), and Vishamushti ( Strychnos nux-vomica).

Drugs of Sursaadi Group alleviate Kapha and cure krmi (Parasitic infection), pratishyaaya (rhinitis), aruchi (anorexia), shvaasa (asthma), and kaasa (cough, bronchitis). They help in cleansing ulcers.

Charak’s Varga: Krmighna (curative of worms), shvaasahara (curative of labored breathing), shitaprashamana (curative of the sensation of cold).

Vagbhat’s Surasaadi Gana:

Surasayugma (Krishna Tulasi and Sweta Tulasi), Phanijja, Kaalamaalaa, Vidanga, Kharabusa (Kharapushpa = Origanum majorana), Vrishakarni (Muushikakarni = Ipomoea reniformis), Katphala ( Myrica nagi), Kaasa-marda, Kshavaka, Sarasi (?), Bhaargi, Kaamukaa ( Hiptage benghalensis), Kaakamaachi, Kaalahala, Vishamushti, Bhuustrina ( Cynbopogeon species), and Bhuutakeshi ( Selinum tenuifolium).

9 Mushkakaadi Gana:

Mushkaka (Moha Tree: Schrebera swietenioides), Palaasha ( Butea monosperma), Dhava ( Anogeissus latifolia), Chitraka ( Plumbago zeylanica), Madana ( Randia dumetorum), Vrikshaka (Vrikshavalli = Vid-aarikanda: Ipomoea digitata), Shimshapaa ( Dalbergia sissoo), Vajra vrksha (Vajra = Euphorbia neriifolia) and Triphala ( Terminalia chebula, Terminalia bellirica, Emblica officinalis fruits) Drugs of Mushkakaadi Gana reduce medas (adiposity) and correct the vitiation of shukra (semen). They cure meha (excessive flow of urine), arsha (piles), paandu (anemia), and sharkara (sediment in the urine).

Charaka’s Varga: Arshaghna (curative of piles and haemorrhoids).

Basic steps for restructuring 137

Vagbhat’s Mushkakaadi Gana:

Mushkaka (Mokshaka), Snuk ( Euphorbia neriifolia), Varaa (Triphalaa) Dweepi (Karanji = Caesalpinia crista), Palaasha, Dhava and Simsapaa.

10 Krishnaadi Gana:

Krishnaa ( Piper longam mature fruits), Granthika (Piper longum root), Chavya ( Piper chava), Chitraka ( Plumbago zeylanica), Vishaa (Ativishaa: Aconitum heterophyllum), Vishvaushadha ( Zingiber officinale dried rhizome), Ajaaji ( Cuminum cyminum), Paathaa ( Cissampelos pareira), Ramattha ( Ferula foetida), Renukaa ( Piper aurantiacum), Madhurasaa (Muurva: Marsdenia tenacissima), Siddhaartha ( Brassica alba), Tiktaa (Picrorhiza kurroa), Ushna (any one drug of Trikatu Group), Drekkaa ( Melia azedarach), Shakra yava ( Wrightia tinctoria), Ajmoda ( Trachyspermum roxburghianum), Truti ( Elettaria cardamomum), Bhaargi ( Clerodendrum serratum), and Vidanga ( Embelia ribes).

Drugs of Krishnaadi Gana stimulate the power of digestion. They cure gulma (tympanitis, abdominal lump, chlorosis), and shula (colic pain). They help in paachana of aama (impaired digestion), alleviate Kapha, stimulate appetite and cure jvara (fever).

Charaka’s Varga: Dipaniya (promoter of digestion), shuulaprashamana (cures colic pain), shitaprashamana (curative of the sensation of cold), svaasahara (curative of labored breathing).

11 Elaadi Gana:

Elaa ( Elettaria cardamomum), Tagara ( Valeriana wallichii), Kushtha ( Saussurea lappa), Maansi ( Nardostachys jatamansi), Dhyaamaka ( Andropogan lamgier species), tvak ( Cinnamomum zeylanicum thin bark), Patra ( Cinnamomum tamala), Naaga pushpa ( Mesua ferrea), Priyangu ( Callicarpa macrophylla or Prunus mahaleb), Harenukaa ( Vitex agnus-castus), Vyaaghra nakha ( Capparis horrida), Shukti ( Tamarindus indica sour fruit), Chandaa ( Angelica archangelica), Sthauneyaka ( Taxus baccata), Shriveshtaka ( Pinus roxburghii exudate), Chocha (Reddish powder of thick bark of Cinnamomum zeylanicum), Choraka ( Angelica glauca), Vaaluka (AFI: Cinnamomun cecidodephne), Guggulu ( Commiphora wightii gum-resin), Sarja rasaa ( Vateria indica resin), Turushka ( Liquidambar orientalis balsam), Kunduruka ( Boswellia serrata), Aguru ( Aquilaria agallocha), Sprkkaa ( Anisomeles malabarica), Ushira ( Vetiveria zizaniodes), Bhadra daaru ( Cedrus deodara), Kumkuma ( Crocus sativus stigma of flowers), and Punnaga keshara ( Mesua ferrea stamens).

Drugs of Elaadi Gana alleviate Vaayu and Kapha, cure visha (toxemia) and promote complexion ( varnaprasaadana). They also cure Kanduu (pruritus, itching), pidaka (pimples) and kotha (urticarial rashes).

Charak’s Varga: Varnya (improves complexion), kanduughna (curative of pruritus).

138 Legacy and logical steps

Vagbhat’s Elaadi Gana:

Elayugma (Suukshma Elaa and Sthuula Elaa), Turushka, Kushtha, Pha-lini ( Prunus mahaleb), Maamsi ( Nardostachys jatamansi), Jala (Hri-vera = Coleus vettiveroides), Dhyaamaka ( Andropogan lamgier species), Sprkkaa, Choraka, Chocha, Patra ( Cinnamomum tamala), Tagara ( Valeriana wallichii), Sthoneya ( Taxus baccata), Jaati rasa (Bola = Commiphora myrrha), Sukti ( Tamarindus indica sour fruit or Zizyphus jujube fruit), Vyaagra nakha, Amaraahwa (Devadaaru), Aguru, Shriveshtaka, Kunkuma, Chandana, Guggulu, Devadhuupa (Sarjarasa = Vateria indica resin), Khapura (Kunduruka = Boswellia serrata), Punnaaga ( Calophyllum inophyllum), and Naagaahwaya (Naagakesara).

12 Vachaadi Gana:

Vacha ( Acorus calamus), Ativisha ( Aconitum heterophyllum), Jimuuta ( Luffa pentandra), Japaa ( Hibiscus rosa-sinensis), Daaru ( Berberis aristata) and Shunthi ( Zingiber officinale dried rhizome).

Charaka’s Varga: Stanyashodhana (purifier of breast milk).

Vagbhat’s Vachaadi Gana:

Vacha, Jalada ( Cyperus rotundus), Devaahwa ( Cedrus deodara), Naagara (Sunthi), Ativishaa ( Aconitum heterophyllum), and Abhayaa ( Terminalia chebula).

13 Haridraadi Gana:

Haridraa ( Curcuma longa), Daaru haridraa ( Berberis aristata), Kalshi (Prshniparni: Uraria Picta), Yashti ( Glycyrrhiza glabra), and Kutaja seeds (Indrayava = Wrightia tinctoria, Kutaja: Holarrhena antidysenterica).

Drugs belonging to Vachaadi Gana and Haridraadi Gana (12, 13) help in the purification of breast milk ( stanavishodhana) and alleviate aama as well as atisaara (diarrhea), and aamaatisaara (diarrhea due to malabsorption).

They especially help in paachana (toning up the whole digestive system).

Charaka’s Varga: Stanyashodhana (purifier of breast milk).

Vagbhat’s Haridraadi Gana:

Haridraa, Daaruharidraa, Yastyaahwa (Yashti), Kalasi (Prisniparni), and Kutajodbhava (Indrayava = Wrightia tinctoria seeds).

14 Shyaamaadi Gana:

Trivrit ( Operculina turpethum), Bidhaara ( Ipomoea petaloidea), Danti ( Baliospermum montanum), Shankhni ( Ipomoea nil), Tilvaka ( Viburnum prunifo-lium), Kampillaka ( Mallotus phillipinensis), Mahaanimba ( Melia azedarach), Kramuka ( Areca catechu), Dravanti ( Croton tiglium), Indraayana ( Citrullus colocynthis), Aaragvadha ( Cassia fistula), Karanja ( Pongamia pinnata), Lataa Karanja ( Caesalpinia bonduc shrub), Guduchi (Tinospora cordifolia), Saptalaa ( Euphorbia pilosa), Vrddhadaaru bheda ( Argyreia speciosa), Snuhi ( Euphorbia neriifolia), Svarnakshiri ( Euphorbia thomsoniana).

Basic steps for restructuring 139

Drugs of Shyaamaadi Gana are purgative ( bhedana) in cases of obstinate constipation ( anaaha) and distention of the abdomen ( udaavarta). They cure gulma (abdominal lump) and visha (poisoning, toxemia).

Charaka’s Varga: Bhedaniya (purgative).

Vagbhat’s Syaamnadi Gana:

Syaamaa (Syaama = trivrit), Danti, Dravanti, Kramuka ( Areca catechu nut or Symplocos crataegoides), Kutarani ( Ipomoea turpethum), Sankhini, Char-masaahwaa ( Euphorbia pilosa), Swarnakshiri, Gavaakshi ( Trichosanthus palmata), Sikhari ( Achyranthes aspera), Rajanaka, Karanja (Karanja and Lataa Karanja: Pongamia pinnata, and Caesalpinia bonduc), Bastaantri (Argyreia speciosa), Vyaadhighata ( Cassia fistula), Bahurasa (Ikshu = Saccharum officinarum) and Teekshna-vriksha-phala (Pilu = Teekshna-vriksha, Salvadora persica fruit).

15 Brhatyaadi Gana:

Brhati ( Solanum indicum), Kantakaarikaa ( Solanum xanthocarpum), Kutaja phala ( Holarrhena antidysenterica fruits), Paathaa ( Cissampelos pareira), and Madhuka ( Glycyrrhiza glabra).

Drugs of Brhatyaadi Gana are paachaneeya (carminative). They alleviate Pitta, Vaayu, and Kapha. They cure arochaka feeling (anorexia), hrdroga (heart disease) and muutrakrchha (dysuria).

Charaka’s Varga: Hikkaanigraha (curative of hiccup).

16 Patolaadi Gana:

Patola ( Trichosanthes dioica), Chandana ( Santalum album), Kuchandana ( Pterocarpus santalinus), Muuvaa ( Marsdenia tenacissima), Guduchi ( Tinospora cordifolia), Paathaa ( Cissampelos pareira), and Katu rohini ( Picrorhiza kurroa).

Patolaadi drugs cure aruchi (anorexia), jvara (fever), chardi (vomiting), kandu (pruritus, itching), and visha (poisoning, toxemia).

Charaka’s Varga: Triptighna (cures anorexia).

Vagbhat’s Patolaadi Gana:

Patola, Katurohini, Chandana, Madhusravaa (Muuvaa), Guduchi and Paathaa.

17 Kaakolyaadi Gana:

Kaakoli (extinct), Kshira Kaakoli (extinct), Jivaka (extinct), Rshabhaka (extinct), Medaa (exitnct), Mahaa Medaa (extinct), Rddhi (extinct), Vrd-dhi (extinct) (see chapter “Threat to Classical Reputation” for detailed discussion on Ashta Varga), Mudgaparni ( Phaseolus trilobus), Maashaparni ( Teramnus labialis), Chinnaruhaa ( Tinospora cordifolia) Karakata-shrngi ( Pistacia integerrima), Tugaakshiri (Vanshalochana: Bamboo-manna), Padmaka ( Prunus cerasoides), Prapaundarika ( Nelumbium speciosum, white variety, roots), mrdvikaa (Vitis vinifera raisins), Jivanti ( Leptadenia reticulata), and Madhuka ( Glycyrrhiza glabra).

140 Legacy and logical steps

Drugs of Kaakolyaadi Gana alleviate Pitta and anil-shonita (gout). They are vitalizing, nourishing and aphrodisiac, galactagogue and produce Kapha.

Charaka’s Varga: Jivaniya (promoter of longevity). stanyajanana (promoter of lactation), shukrajanana (promoter of semen generation), prajaasthaapana (curative of sterility), vayahsthaapana (prevents aging).

Vagbhat’s Padmakaadi Gana (= Sushruta’s Kaakolyaadi Gana): Padmaka, Pundra ( Nelumbo nucifera) Vriddhi (extinct), Tugaa (Bamboo-mannaa), Riddhi (extinct), Sringi (Karkata-sringi), Amritaa (Guduchi) and the drugs constituting Jivantyaadi Gana.

Vagbhat’s Jivantyaadi Gana:

Jivanti ( Leptadenia reticulata), Kaakoli (extinct), Kshira kaakoli (extinct), Medaa (extinct), Mahaa Medaa (extinct), Mudgaparni ( Phaseolus trilobus), Maashaparni ( Teramnus labialis), Rshabhaka (extinct), Jivaka (extinct) and Madhuka (Yashtimadhu).

18 Uushakaadi Gana:

Uushaka (a variety of alkaline soil which could not be identified or Dorema ammoniacum exudate), Saindhava (rock salt), Shilaajatu (Asphalt, Rock’s mineral exudate), Guggulu ( Commiphora wightii exudate), Kaasisa (green vitreol), Hingu ( Ferula foetida), Tutthaka (blue vitreol).

Drugs of Uushakaadi Gana alleviate Kapha and help in the depletion of fat ( medovishoshana). They cure ashmari (stone in the urinary tract), sharkaraa (sediments in the urine), muutrakrchhra (dysuria), shuula (colic pain), and gulma (abdominal lump).

Vagbhat’s Uushakaadi Gana:

Uushaka, Tuththaka, Hingu, Kaasisadwai (Pushpakaasisa and Paansu-kaasisa), Saindhava, Shilaajatu.

19 Saarivaadi Gana:

Saariva ( Hemidesmus indicus), Madhuka ( Glycyrrhiza glabra), Chandana ( Santalum album), kuchandana ( Pterocarpus santalinus), Padmaka ( Prunus cerasoides), Kaashmarya phala ( Gmelina arborea fruits), Madhuuka pushpa ( Madhuca indica flowers), and Ushira ( Vetiveria zizaniodes). Drugs of Saarivaadi Gana cure pipaasaa (morbid thirst), rakta-pitta (bleeding disorders), and Pitta jvara (fever due to Pitta). They especially cure daaha (burning syndrome).

Charak’s Varga: Trshnaanigrahana (curative of morbid thirst), jvarahara (curative of fever), daahaprashaman (curative of burning sensation).

Vagbhat’s Saarivaadi Gana:

Saarivaa, Usheera, Kaashmarya, Madhuuka, Sisiradwai (Chandana and Raktachandana), Yashti (Yeshtimadhu) and Paruushaka ( Grewia asiatica).

20 Anjanaadi Gana:

Anjana (one of the five variants of collyriums, uparasa group of eight minerals, or could be the ash or Memecylon umbellatum or Hardwickia binata),

Basic steps for restructuring 141

Rasaanjana (dry extract of Berberis aristata heartwood), Naaga pushpa ( Minsops elangi flowers or stamen), Priyangu ( Callicarpa macrophylla or Prunus mahaleb), Nilotpala ( Nymphaea stellata), Nalada ( Vetiveria zizaniodes), Nalina ( Nelumbo nucifera), Kesara ( Mesua ferrea), and Madhuka ( Glycyrrhiza glabra).

Drugs of Anjanaadi Gana cure rakta-pitta (bleeding disorders, haemoptysis).

They cure visha (poisoning, toxemia) and an acute form of burning sensation inside the body ( aabhyantara daaha).

Charaka’s Varga: Shonitasthaapana (haemostatic), daahaprashamana (curative of burning sensation), vishagna (the antidote to poisoning).

Vagbhat’s Anjanaadi Gana:

Anjana, Priyangu, Maamsi, Padma ( Nelumbo nucifera), Utpala ( Nymphaea stellata), Rasaanjana, Elaa ( Elettaria cardamomum), Madhuka, Naagakesara ( Mesua ferrea).

21 Paruushakaadi Gana:

Paruushaka ( Grewia asiatica), Draakshaa (Vitis vinifera bigger raisins), Katphala ( Myrica nagi), Daadima ( Punica granatum), Raajaadana ( Mimusops indica fruits), Kataka ( Strychnos potatorium fruits), Shaaka phala ( Tectona grandis fruits), and Triphala ( Terminalia chebula, Terminalia bellirica, Emblica officinalis fruits).

The drugs of Paruushakaadi Gana alleviate Vayu and cure muutra dosha (urinary disorders). They are hrdya (cardiac tonic). They cure pipaasaa (morbid thirst) and ruchiprada (stimulate appetite).

Charaka’s Varga: Virechanopaga (purgative, due to Triphala), shrmahara (curative of fatigue), hrdya (cordial), trshnaanigrahana (curative of morbid thirst) Vagbhat’s Paruushakaadi Gana:

Paruushaka, Varaa (Triphala), Draakshaa, Katphala, Raajaahva (Aaragvadha = Casia fistula), Daadima, Shaaka ( Tectona grandis).

22 Priyangvaadi Gana:

Priyangu ( Callicarpa mavrophylla flower-buds or Prinus mahaleb kernel of fruits), Samangaa ( Mimosa pudica), Dhaataki ( Woodfordia fruticosa), Punnaga ( Calophyllum inophyllum), Naagakeshara ( Mesua ferrea), Chandana ( Santalum album), Rakta chandana ( Pterocarpus santalinus), Mocharasa (exudate of Bombax ciba tree), Rassanjana (extract of Daaru haridraa, Berberis aristata), Kumbheeka ( Pistia stratiotes), Srotonjana (one of the five variants of collyriums, uparasa group of eight minerals or could be ash of Memecylon umbellatum or Hardwickia binata), Padma keshara ( Nelumbo nucifera filament), Manjishthaa ( Rubia cordifolia) Dhanvayaasa ( Fagonia cretica).

Charaka’s Varga: Purisha-sangrahaniya (renders fecal matters consistent), sandhaaniya (promote the union of fractured parts, promote cell generation), shonitasthaapana (heamostatic), sangyaasthaapana (resuscitative).

142 Legacy and logical steps

Vagbhat’s Priyangvaadi Gana:

Priyangu, Pushpaanjana (Pushpaanjana is a variety of Anjana (Collyrium), white in color, used for eye diseases, and fever), Anjanayugmam (Srotonjana and Souveeranjana), Padmaa ( Nelumbo nucifera), Padmaadrajah (Padma stamen), Yojanavalli (Manjishtaa = Rubia cordifolia), Anantaa (Yavaasaa = Alhagi pseudalhagi), Maanadruma (Saalmali = Salmalia malabarica), Mocharasa (Saalmali gum-resin), Samangaa, Punnaaga, Sitha (Chandana = Santalum album), Madaniyahetu (Dhaataki = Woodfordia fruticosa).

23 Ambaashthaadi Gana:

Ambashthaa ( Cissampelos pariera), Dhaataki pushpa ( Woodfordia fruticosa flowers), Samangaa ( Mimosa pudica), Katvanga ( Allanthus excelsa), Madhuka ( Glycyrrhiza glabra), Bilva ( Aegle marmelos), Saavar Rodhra ( Symplocos crataegoides), Palaasha ( Butea monosperma), Nandivraksha ( Ficus arnottiana’; in a text, it was interpreted as Gambhaari, Gmelina arborea), and Padma keshara ( Nelumbo nucifera filament).

Charaka’s Varga: Sandhaaniya (promote the union of fractured parts, promote cell generation),

purisha-sangrahaniya (renders fecal matters consistent).

Vagbhat’s Ambashtaadi Gana:

Ambaashtaa, Madhuka ( Glycyrrhiza glabra), Namaskari (Samangaa), Nan-divriksha (Prarohi), Palaasha, Kachchura ( Fagonia cretica), Rodhra ( Symplocos racemosa), Dhaataki, Bilvapesika ( Aegle marmelos fruit pulp), Katvanga, and Kamalodbhava rajah ( Nelumbo nucifera filament).

Drugs of Priyangvaadi Gana and Ambaashthaadi Gana possess the same properties. They alleviate Pitta, promote stambhana (retention power), and are sandhaaniya (promote the union of fractured parts, promote cell generation), also heal the ulcer. They are beneficial in pakvaatisaara (chronic diarrhea).

24 Nyagrodhaadi Gana:

Nyagrodha ( Ficus benghalensis), Udunbara ( Ficus racemosa), Ashvattha ( Ficus religiosa), Plaksha ( Ficus lacor), Madhuuka ( Madhuca indica), Aamraataka (Spondias pinnata), Aamra ( Mangifera indica), Koshaamra (Laakshaa vrksha = Schleichera oleosa), Arjuna (Terminalia arjuna), Jambudwai (Syzygium cuminii, Syzygium jambos), Priyaala ( Buchanania lanzan), Madhuka ( Glycyrrhiza glabra), Katphala ( Myrica nagi), Vetasa ( Salix caprea), Kadamba ( Anthocephalus cadamba), Badari ( Zizyphus jujuba), Tinduka ( Diospyros peregrina), Shallaki ( Boswellia serrata), Rodhra (Lodhra, Saavar rodhra: Symplocos crataegoides and S. racemosa), Bhallaataka ( Semecarpus anacardium), Palaasha ( Butea monosperma), and Paarshva pippala ( Ficus arnottiana).

Drugs of Nyagrodhaadi Gana are graahi (astringent), sandhaaniya (promote the union ofractured parts, promote cell generation), vrnya (heal ulcer), raktipitta shamana (styptic), daaha prashamana (alleviate burning

Basic steps for restructuring 143

sensation). Used for treating ulcers or wounds, fractures, rakta-pitta (bleeding disordrs), daaha (burning sensation), prameha (urinary disorders), and yoni vikaara (disorders of female genital tract).

Vagbhat’s Nyagrodhaadi Gana:

Nyagrodha, Ashvattha, Udumbara, Rodhrayugma (Rodhara and Saavara Rodhra), Jambudwai, Arjuna, Kapitana ( Albizia lebbeck), Somavalka ( Acacia suma), Plaksha, Aamra, Vanjula ( Salix caprea), Piyaala ( Buchanania lanzen), Palaasa, Nandi ( Cidrus toona), Kolaa ( Zizyphus jujuba), Kadamba, Viralaa ( Diospyros tomentosa), Madhuka and Madhuuka.

Charaka’s Varga: Chhardinigraha (nausea preventing), purisha-sangrahaniya (renders fecal matters consistent), muutra sangrahaniya (corrective of excessive urination).

25 Guduchyaadi Gana:

Guduchi ( Tinospora cordifolia), Nimba ( Azadirachta indica), Dhaanyaka ( Coriandrum sativum), Padmaka ( Prunus cerasoides), and Rakta chandana ( Pterocarpus santalinus).

The drugs of Guduchyaadi Gana cure trshnaa (morbid thirst), daaha (burning syndrome), aruchi (anorexia), chardi (vomiting), and jvara (fever).

They have dipana property (stimulate the power of digestion).

Charaka’s Varga: Trshnaanigrahana (curative of morbid thirst).

Vagbhat’s Guduchyaadi Gana:

Guduchi, Padmaka, Arista ( Azadirachta indica), Dhaanyaka and Raktachandana.

26 Utpalaadi Gana:

Utpala ( Nymphaea alba), Kumuda ( Nymphaea stellata), Padma ( Nelumbo nucifera), Kalhaara ( Nymphaea rubra), and Madhuka ( Glycyrrhiza glabra).

Drugs of Utpalaadi Gana alleviate rakta-pitta (bleeding disorders), and cure visha (poisoning, toxemia), and chardi (vomiting).

Charaka’s Varga: Daahaprashamana (curative of burning sensation), Trshnaanigrahana (curative of morbid thirst), Muutravirajaniya (curative of coloured urine).

27 Mustaadi Gana

Musta ( Cyperus rotundus), Paathaa ( Cissampelos pareira), Nishaadwai ( Curcuma longa, Berberis aristata), Tikta ( Picrorhiza kurroa), Vacha ( Acorus calamus), Elaa ( Elettaria cardamomum), Ruk (Kushtha: Saussurea lappa), Vishaa (Ativishaa: Aconitum heterophyllum), Chaara (Priyaala: Buchanania lanzan fruit), Elaa (bigger variety: Amomum subulatum), and Shaarngishtha ( Physalis minima or Cardiospermum halicacabum).

Drugs of Mustaadi Gana contain shodhana (internal cleansing) components; paachana (carminative) and stanya (galactogogue) properties. They cure stana roga (diseases of the breast), and jvara (fever).

144 Legacy and logical steps

Charaka’s Varga: Lekhaniya (reducing obesity and scarifying), stanyashod-hana (purifier of breast milk).

Vagbhat’s Mustaadi Gana:

Mustaa, Vacha, Agni (Chitraka = Plumbago zeylanica), Dwinisaa (Haridraa and Daaruharidraa), Dwitiktaa (Katurohini and Kaakatikta = Picrorhiza kurroa and Cardiospermum helicacabum), Bhallaataka ( Semecarpus anacardium), Paathaa, Triphala, Vishaakhyaa ( Aconitum heterophyllum), Kushtha, Truti ( Elettaria cardamomum), Haimavati (Sweta vacha = Iris germanica)

28 Triphlaa:

Triphala or Phala trika: fruits of Haritaki ( Terminalia chebula, one part), Vibhitaki ( Terminalia bellirica, two parts), and Aamalaki ( Emblica officinalis, four parts).

Triphalaa complex alleviates Kapha as well as Pitta and cures meha (urinary diseases), as well as kushtha (obstinate skin diseases including leprosy). It is laxative, chaakshushya (promoter of eye sight) and digestive stimulant.

It cures visham jvara (irregular fever).

Charaka has described another variety of Triphala/ Phala trika. It contains Draakshaa ( Vitis vinifera raisins), Kaashmarya ( Gmelina arborea fruit), and Parushaka ( Grewia asiatica fruit). This was used for rakta-pitta (bleeding disorders). (Charaka Samhita, Sutrasthan 26: 28, 64, 86.).

29 Tryuushana Gana:

Pippali ( Piper longum), Maricha ( Piper nigrum) and Shunthi ( Zingiber officinale dried rhizome), as a group, is also known as Trikatu (Three Pungents).

It reduces Kapha and medas (adiposity), cures meha (urinary diseases), kushtha (obstinate skin diseases including leprosy) and tvagaamya (der-matitis). It is a digestive stimulant. Also cures gulma (abdominal lump), pinasa (chronic rhinitis) and mandaagni (dyspepsia).

30 Aamalakyaadi Gana:

Aamlaki ( Emblica officinalis), Abhayaa ( Terminalia chebula), Krshnaa ( Piper longam), Chitraka ( Plumbago zeylanica).

Drugs of Aamalakyaadi Gana cure jvara (fever). They are Chaakshushya (promote eye sight), vrshya (aphrodisiac, age-sustaining), bhedi (purgative), and agni prdipaka (a digestive stimulant).

Charaka’s Varga: Jvarahara (curative of fever).

31 Trapvaadi Gana (calcined minerals):

The group consists of calcined trapu (tin), sisa (lead), taamra (copper), rajata (silver), krshna lauha (old iron), suvarna (gold) and lauha mala (sludge iron).

Mineral drugs of Trapvaadi Gana are rakta-krmi-hara (cure blood and parasitic infection), alleviate pipaasaa (morbid thirst), visha (poisoning,

Basic steps for restructuring 145

toxemia), cure hrdroga (heart diseases), paandu (anemia), meha (urinary disorders).

32 Lakshaadi Gana:

Lakshaa ( lac: twigs of plants covered with the resinous bodies of the lac insect, Laccifer lacca), Aarevata (Aaragavadha: Cassia fistula), Kutaja ( Holarrhena antidysenterica), Ashvamaara (Karavira: Nerium indicum), Katphala (Myrica nagi fruit), Haridradwai ( Curcuma longa and Berberis aristata), Nimba ( Azadirachta indica), Saptachhada ( Alstonia scholaris), Maalati ( Jasminum officinale var. grandiflorum) and Traayamaanaa ( Gentiana kurroo).

The drugs of Lakshaadi Gana are kashaaya-tikta-madhura (astringent, bitter and sweet). They alleviate the vitiation of Kapha and Pitta. They cure kushtha (obstinate skin diseases including leprosy), and krmi (a parasitic infection). They help in cleansing of dushta vrana (nonhealing ulcer).

Charaka’s Varga: Krmighna (curative of worms), kushthaghna (curative of obstinate skin diseases).

33 Kshudra panchamuula (Laghu panchamuula):

Prshniparni ( Uraria picta), Shaaliparni ( Desmodium gangeticum), Brha-tidwai ( Solanum indicum and Solanum xanthocarpum), and Gokshura ( Tribulus terrestris) roots.

All these five roots taken together are brhana (nourishing), alleviate Vaayu and Pitta. The group is kashaaya (astringent), tikta (bitter) and madhura (sweet).

It cures diseases caused by vitiation of all the three doshas, and sannipaata (high fever due to vitiation of all the three doshas) and shirorti (headache).

34 Mahat panchmuula:

Bilva ( Aegle marmelos), Agnimantha ( Premna integrifolia), Shyonaaka ( Oroxylum indicum), Kaashmari ( Gmelina arborea) and Paatala ( Stereospermum suaveolens) roots.

All the five roots taken together are deepana (stimulate digestion) Kapha-Vaataghna (alleviates Kapha as well as Vaayu).

Dashamuula:

Both Kshudra panchamuula and Mahat panchmuula, taken together constitute Dashamuula (Sushruta, Sutra 38: 66–70). Dashmuula group alleviate all the three doshas. It cures kaasa (bronchitis), sannipaata (high fever due to vitiation of all the three doshas), shirorti (headache), shvaasa (asthma) and hikkaa (hiccup).

Charaka’s Dashmuula Varga: Shothahara (anti-inflammatory).

(See Editor’s Note.)

35 Vallija panchamuula:

Roots of Vidaari (Vidaari ( Pueraria tuberosa), Saariva ( Hemidesmus indicus), Chhagashrngi (Ajashrngi: Pistacia integerrima), Vatsaadani

146 Legacy and logical steps

(=Guduchi: Tinospora cordifolia), and Nishaa ( Curcuma longa or Curcuma caesia).

All the roots taken together are vrshya (aphrodisiac) and alleviate pittaanil ( Pitta as well as Vaayu).

Charaka’s Varga: Shukra shodhana (purifier of semen).

36 Panchakantaka:

Karamardaka ( Carissa carandas), Saireya ( Barleria prionitis), Trikantaka ( Tribulus terrestris), Shataavari ( Asparagus racemosus) and Grdhanakhi ( Capparis sepiaria).

All the five drugs, taken together, cure rakta-pitta (bleeding disorders), shopha (edema), shukra meha (spermaturia) and shukra dosha (vitiation of semen).

Charaka’s Varga: Shukra shodhana (purifier of semen).

37 Trna panchamuula:

Kusha ( Desmostachya bipinnata), Kaasha ( Saccharum spontaneum), Nala ( Arundo donax or Phragmites karka), Kaandekshu (Ikshu: Saccharum officinarum).

(Charaka: Shaali ( Oryza sativa), Kaasha ( Saccharum spontaneum), Shara ( Saccharum munja), Darbha ( Imperata cylindrica), and Ikshu ( Saccharum officinarum).

“The roots of five-grasses,” when taken together, alleviate daaha (burning syndrome), vitiation of pitta, treat disorders of the urinary bladder by vasti-shodhana and remove visha (toxemia).

Charaka’s Varga: Muutravirechaniya (diuretic).

Additional groups mentioned in Sushruta texts

1 Vatsakaadi Gana:

Vatsaka ( Holarrhena antidysenterica), Ativishaa ( Aconitum heterophyllum), Muurva ( Marsdenia tenacissima), Bhaargi ( Clerodendrum serratum), Elaa ( Elettaria cardamomum), Katuka ( Picrorhiza kurroa), Ushna ( Zingiber officinale dried rhizome or Piper longum or Piper nigrum, any one of Trikatu Group), Vacha ( Acorus calamus), Shyonaaka ( Oroxylum indicum), Ugraa (Mahaabhari Vacha: Alpinia galanga), Panch kolaa (see after Tri karshita Gana), Ajamoda ( Apium graveolens), Vella (= Vdanga: Embelia ribes), Ajagandhaa ( Gynandropsis gynandra), Siddhaartha ( Brassica alba), Jirakadwai ( Cuminum cyminum and Carum carvi, white and black, respectively), and Hingu ( Ferula foetida).

Drugs of Vatsakaadi Gana alleviate Vaayu and Kapha, and cure gulma (abdominal lump), arsha (piles), jvara (fever), and shuula (colic pain).

Basic steps for restructuring 147

2 Kadambaadi Gana:

Kadamba ( Anthocephalus cadamba), Vaaji karna (Ashwa karna: Vatica robusta), Karanja ( Pongamia pinnata), Kshavaka (Chhikkini: Centipeda orbicularis), and Gudaa (Drakshaa: Vitis vinifera raisins).

Drugs of (Kadambaadi Gana cure vitiated Kapha, paandu (anemia), tvaka roga (skin diseases), kushtha (obstinate skin diseases including leprosy), meha (urinary disorders), and visha (toxemia).

3 Karanjaadi Gana:

Karanja ( Pongamia pinnata), Vatsa (Kutaja: Holarrhena antidysenterica), Sairiya ( Barleria prionitis), Sushavi ( Calycoptris floribunda), and Saptaparna ( Alstonia scholaris).

Drugs of Karanjaadi Gana cure meha (urinary disorders), kushtha (obstinate diseases including leprosy), jvara (fever), chardi (vomiting), visha (toxemia), and vitiation of Kapha.

4 Tri karshita:

Naagara ( Zingiber officinale dried rhizome), Ativishaa ( Aconitum heterophyllum), and Musta ( Cyperus rotundus) taken together are called Tri karshita.

Drugs of Tri karshita alleviates Kapha, Pitta, and Vaayu, and cures jvara (fever). It is graahi (astringent) and possesses dipan (digestive stimulant) property.

5 Panch Kola:

Pippali ( Piper longam), Pippali muula ( Piper longam root), Chavya ( Piper chaba), Chitraka ( Plumbago zeylanica) and Naagara ( Zingiber officinale dried rhizome). Drugs of Pancha kola are deepniya (stimulate the power of digestion), and cure diseases caused by Kapha and Vaayu.

Vagbhata (sixth century ad) added some Panchakarma-

specific and Vaata, Pitta, Kapha alleviative drugs among its 31 Ganas.

1 Vamanaoushadha Gana (Emetics):

Madana ( Randia dumetorum), Madhuka ( Glycyrrhiza glabra), Tumbi ( Lagenaria siceraria), Nimba ( Azadirachta indica), Bimbi ( Coccinia indica), Visaalaa (= Indravaruni: Citrullus colocynthis), Trapusa ( Cucumis sativus), Kutaja ( Holarrhena antidysenterica), Muurvaa ( Marsdenia tenacissima), Devadaali ( Luffa echinata), Krimighna (Vidanga = Embelia ribes), Vidula ( Salix alba), Dahana ( Plumbago zeylanica), Chitraa ( Ricinus communis), Ghantaalikaa ( Crotalaria juncea), Karanja ( Pongamia pinnata), Kanaa ( Piper longam), Lavana (Rock-salt), Vacha ( Acorus calamus), Elaa ( Elettaria cardamomum), and Sarshapa ( Brassica campestris) are used as emetics.

148 Legacy and logical steps

2 Virechanaoushdha

Gana (Purgatives):

Nikumbha (Danti = Baliospermum montanum), Kumbha (Trivrit = ( Operculina turpethum), Triphalaa, Gavaakshi ( Trichosanthes palmata), Snuk ( Euphorbia neriifolia), Sankhini ( Euphorbia dracunculoides), Nilini ( Indigofera tinctoria), Tilwaka ( Symplocos racemosa), Samyaaka ( Cassia fistula), Kampillaka ( Mallotus philippinensis), Hemadugdhaa (Svarnakshiri = AFI: Euphorbia thomsoniana or Argemone maxicana), Dugdha (milk), Muutra (urine of cow) are used as purgatives.

3 Niroohana Dravya Gana (used for Niroohavasti):

Madana phala ( Randia dumetorum), Kutaja ( Holarrhena antidysenterica bark), Kushtha ( Saussurea lappa), Devadaali ( Luffa echinata), Madhuka ( Glycyrrhiza glabra), Vacha ( Acorus calamus), Dasamuula (see Susruta’s classification of drugs), Daaru (Devadaaru = Cidrus deodara), Raasnaa ( Pluchea lanceolata), Yava (Hordeum vulgare), Misi (Satapush-paa = Anethum sowa), Kritavedhana ( Luffa acutangula), Kulattha ( Dolichos biflorus), Madhu (honey), Lavana (Rock-salt) and Trivrit ( Operculina turpethum).

4 Shirsha virechaniya Gana (Sodhana Nasya):

Vella (Vidanga = Embelia ribes), Apaamaarga ( Achyranthes aspera), Tryuushana Gana, Daarvi ( Berberis aristata), Suraalaa ( Vateria indica resin), Shirisha beeja ( Albizzia lebbeck seeds), Baarhata beeja (Brhati beeja = Solanum indicum seeds), Saigrava beeja (Sigru beeja = Moringa oleifera seeds), Madhuuka Saara ( Madhuca indica flower extract), Saindhava (Rock-salt), Taarkshya shaila ( Rasaanjana Ayurvedic collyrium), Trutyou ( Elettaria cardamomum and Amomum subulatum), and Prithvikaa ( Carum carvi or Hingupatri = Ferula jaeschkeana or Gardenia gummifera).

5 Vaatahara

Gana:

Bhadradaaru ( Cedrus deodara), Nata (Tagara = ( Valeriana wallichii),) Kushtha ( Saussurea lappa), Dasamuula, Balaa ( Sida cordifolia) and Atibala ( Abutilon indicum) constitute Bhadradaarvaadi Gana.

Bhadradaarvaadi Gana, Viratarvaadi Gana and Vidaaryadi Gana were used Vaatahara Gana.

6 Pittahara Gana:

Duurvaa ( Cynodon dactylon), Anantaa (Yavaasaa = Alhagi pseudalhagi), Nimba ( Azadirachta indica), Vaasaa (Adhatoda vasica), Aat-maguptaa ( Mucuna prurita), Gundraa ( Typha angustata), Abhiru (Shataavari = Asparagus racemosus), Shitapaaki ( Sida cordifolia fruit), and Priyangu dhaanya ( Setaria italica).

Duurvaadi Gana checks Pitta.

Basic steps for restructuring 149

7 Kaphahara Gana:

Aargvadhaadi Gana, Arkaadi Gana, Mushkakaadi Gana, Asanaadi Gana, Surasaadi Gana, Mustaadi Gana and Vatsakaadi Gana.

8 Vatsakaadi Gana:

Vatsaka (Kutaja: Holarrhena antidysenterica), Vanatiktaka (Wild Picrorhiza kurroa), Muurvaa ( Marsdenia tenacissima), Bhaargi ( Clerodendrum serratum), Katukaa ( Picrorhiza kurroa), Maricha ( Piper nigrum), Ghunapriyaa ( Aconitum heterophyllum), Gandira ( Euphorbia neriifolia), Elaa ( Elettaria cardamomum), Paathaa ( Cissampelos pareira), Ajaaji ( Cuminum cyminum), Katvanga phala (Araluka = Ailanthus excels fruit), Ajamoda ( Apium graveolens), Siddhaartha ( Brassica alba), Vacha ( Acorus calamus), Jiraka ( Cuminum cyminum), Hingu ( Ferula foetida), Vidanga ( Embelia ribes), Pashugandhaa (Ajagandhaa = Gynandropsis gynandra), and Pancha kolaa (Pippali, Pippalimuula, Chavya, Chitraka and Sunthi).

Vatsakaadi Gana checks Vaata, Kapha and medas (adiposity), peenasa (chronic cold, sinusitis, rhinitis), Gulma (tumour), jvara (fever), shuula (colic pain) and durnaaman (piles).

The Eight Vargas of Bhavprakasha Nighantu8

1 Haritakyaadi Varga:

In this Varga, out of 94 plants, possible adverse effect of 26 drugs have been reported including four drugs belonging to Lavana (salt) and Kshaara (alkali) category. Bibhitaka ( Terminaliia bellirica), Paarsikayavaani ( Hyosymus niger), Bhanga ( Cannabis sativa) and Khaskhasa ( Papaver somniferum seeds) were reported with Madakrut (intoxicating) action.

Contraindications for therapeutic uses of Haritaki ( Terminalia chebula) and Aardraka ( Zingiber officinale), and probable adverse effects of the specific parts viz. Bibhitaka Majja (fruit pulp of Terminalia bellarica) and avasthaa (status of the drug) viz. dry Maricha ( Piper nigrum) and Pippali ( Piper longum). Fourteen drugs have been mentioned for their Pitta Dosha elevating property. Parsikayavani ( Hyosymus niger) and Jiraka ( Cuminum cyminum) are reported with grahini action (therapeutic absorptive measure) effective in the treatment of atisaara (diarrhea), grahini (irritable bowel syndrome) but drugs with this action should be avoided in constipation. Yavaani ( Trachyspermum ammi), Dhanyaka ( Coriandrum sativum), Shatapushpa ( Foeniculum vulgare), and Khasakhasa ( Papaver somniferum seeds) are mentioned for their adverse effect on shukradhaatu (male reproductive system). ( Coriandrum sativum), Shatapushpa ( Foeniculum vulgare), and Khasakhasa ( Papaver somniferum seeds) are mentioned for their adverse effect on shukradhatu (male reproductive system).

150 Legacy and logical steps

2 Karpuraadi Varga:

Drugs of this group consist of 58 aromatic drugs like Karpura ( Cinnamomum camphora), Chanadana ( Santalum album). Among these, some drugs are to be administered with care because of their properties and action. Three drugs, Aguru ( Aquailaria agallocha), Guggulu ( Commiphora wightii), Tvakapatra ( Cinnamomum cassia) vitiate Pitta and one drug, Padmaka ( Prunus cerasoides) vitiate Vaata Dosha. Priyangu ( Prunus mahaleb fruits or Callicarpa macrophylla flowers) leads to constipation and Renuka ( Vitex negundo) is reported with Garbhapatini (abortive) action.

3 Guduchyaadi Varga:

In this Varga, details of 124 drugs were mentioned. Out of these, 44 drugs are to be administered with care because of their properties and action. Sixteen drugs are Vaataprakopaka (vitiate Vaata Dosha), 14 Pittaprakopaka (vitiate Pitta Dosha) and 3 are Kaphadosha prakopaka (vitiate Kapha Dosha). Kalihari ( Gloriosa superba) is reported as Garbhapatini (abortifacient) and Karaveera ( Nerium odorum) as Vishavat (poisonous). Dhatuura ( Dhatura metel), Shyma Trivrut ( Operculina turpenthum) are reported with Madakrut (narcotics) action, Shigru ( Moringa pterygosperma) seeds and Bhutruna ( Cymbopogon citrates) are stated as Avrushya (decrease sexual interest). Eranda ( Ricinus communis) leaves are Rakapitta-prakopaka (vitiate Rakta and Pitta Dosha), fruit pulp as purgative.

4 Pushpa Varga:

In this group, out of 33 drugs, 11 are reported for side effect on Dosha, Dhaatu (seven tissues) and Mala (excreta). Tulasi ( Ocimum sanctum) and its variety Barbari ( Ocimum basilicum) are reported as Pittakrut (vitiate Pittadosha). Vishtambhi (heavy to digest) action has been shown for Pad-mini ( Nelumbium speciosum),

Kalhar ( Nymphaea alba) and Kadamba Pushpa ( Anthocephalus cadumba).

5 Vataadi

Varga:

Eight, out of 40 big trees, described under this group, are mentioned with their possible side effects. Among them, Shinshapa ( Dalbergia sissoo) and Arishtaka ( Sapindus mukorossi) were reported for their Garbhapatini (abortificant) and Katabhi ( Careya arborea) and Moksha ( Schrebera swietenioides) for their Shukrahat (antispermatogenic) properties.

6 Phalaadi Varga:

This group describes edible fruits which are otherwise considered healthy but still pose problems when consumed recklessly. Out of 56 fruits, 39

fruits are reported for their possible side effects. Mango, in unripe condition, leads to vitiation of Tridosha and Rakta Dhatu. Mango may hamper

Basic steps for restructuring 151

the digestive system and eyes if more is consumed. Among all fruits, five may hamper Agni (digestive system), two may hamper eye, while three may act on CNS, reported with moha (confusion), madakrut action (intoxication), if used irrationally. Panasa ( Artocarpus integrifolia) is contraindicated in gulma (abdominal disorders) and mandagni (decrease digestivepower). Kharbuuja (Dashaangula = Cucumis melo), turned into amla (sour), Madhura Rasa (sweet taste) and Kshaara (alkaline) are reported as Rakta-pittakara (causing blood disorder) and muutrakrach-hakara (causing dysuria). Ripe fruit of Trapusa ( Cucumis sativus) vitiate Pitta Dosha.

7 Dhaanya Varga:

This group consists of 33 plants of different varieties of Dhaanya (Grains), Shaali (cereals), Shashtika (a type of rice), Shuka (awned grains), Shimbi (pulses) and Kshudra Dhanya (grains of lower grade). All the members of this Dhaanya Varga are reported for their badhaalpavarchasa (constipative) properties and the Shimbi as Adhmankaraka (causes distention of abdomen) except Mudga ( Phaseolus radiatus) and Masura ( Lens esculentus). Among the drugs of Dhanya Varga, 23 are reported with side effects. Nishpava ( Dolichos lablab), Kulattha ( Dolichos biflorus) and Atasi ( Linum usitatissimum) are Shukraghna (antispermatogenic), while Yava-naala ( Sorghum vulgare) is Avrushya (decreases sexual interest).

Dry and roasted Chanaka ( Cicer arietinum) is Kushtha-prakopaka (causes skin diseases), while Triputa ( Lathyrus sativus) is Khanjatwa-pangutva-kari (hampers mobility). Atasi ( Linum usitatissimum) has been reported for its possible harmful effect on eye/eyesight.

8 Shaaka Varga:

Some vegetables were considered harmful to eyesight. They also reduce sexual potency, mental power, and strength. Among 66 different Shaaka (vegetables); 28 are reported with side effects. Shimbi shaaka (not to be confused with Mudgaparni = Phaseolus radiatus), and Sarshapa ( Brassica campestris) is reported as Tridoshkrut (vitiating Vaata, Pitta and Kapha) and are especially mentioned as Nindita (condemn for lowest quality) among all vegetables. It has been advised to avoid Surana ( Amorphophallus campanulatus) in Rakatapitta (bleeding disorders), Dadru and Kushtha (skin disorders).

Editor’s note: a number of classifications need

total restructuring. A few examples:

1 All Dashmuula and Panchmuula formulations are to be rechristened and should be considered as new drugs, traditional or textual names are misleading and deceptive due to changes in plant parts. Ayurvedic Formulary of India

152 Legacy and logical steps

provided stem bark and whole plant as substitutes for roots of Dashmuula.

We suggest that the classical formulation should be replaced with the following components:

Aegle marmelos leaves possess highly significant acute and subacute anti-inflammatory activity which may be due to the presence of lupeol and skimmianine in the leaves. In a study, the alcoholic extract of the leaves antagonized the histamine induced contractions and demonstrated positive relaxant effect in isolated guinea pig ileum and tracheal chain, suggesting inhibition of H1 receptor activity this extract may underlie these effects.9

Crude ethyl acetate, methanolic and water extracts of leaves of Oroxylum indicum showed significant antioxidant activity with IC50 values of 49.0, 55.0, respectively, at 100 µg/ml concentration.10

Crude extracts of Gmelina arborea plant are reported to possess wound-healing properties, antidiarrheal activity, antioxidant activity, antidiabetic activity, and antiulcer act.

Stereospermum suaveolens flowers are used with honey to stop cough.

Phytoconstituents such as 6-O-glucosyls-cutellarein7 dinatin, dinatin-7-glucuroniside, dinatin-7-glucuronide, quinones, stereochenols A and B, naphthoquinones, sterekunthal B, sterequinone C and stereolensin have been reported from the leaves of this plant.

The juice of Clerodendron phlomoides leaves is used as an alternative and bitter tonic. The plant is reported to be useful in inflammation, glycosuria, pox, coryza, scrotal enlargement, and postnatal complaints.11

The five roots ( Laghu Panchamuula) have already been replaced with their plant parts. From additional plant drugs of Dashmuula formulations, only the following can be retained, if found necessary, Lodhra, Guduchi, Manjishtha, and Pippali.

2 All Ashvagangha (Withania) formulations are to be subjected to experimental and clinical studies, due to change in its chemo-type. It has now been identified as Withania Ashvagandha sp. novo.

3 All formulations containing Mesua ferrea and Crocus sativa are to be reex-amined for their therapeutic properties, as Kesara and Keshara are synonyms, equated with Naagakesara ( Mesua ferrea) in Ayurvedic Formulary of India,

Part I, Second Revised Edition, 2003, page 317, and Keshara is not a synonym of Kumkuma, Crocus sativa, page 318) while Keshara is equated with Croccus sativa (Kumkuma) in Ayurvedic Formulary of India, Part II, 2000, page 330, which was published earlier to the revised edition of Vol. II. The equation changed after 3 years. In the monograph of Crocus sativa, Ayurveda Pharmacopoeia of India, Part I, Vol. IV did not include Chyavanprasha among important formulations. In Samhitas, Mesua ferrea was used as Kesara. Kaashmiraj, Vahleeka, Rudhir and Sankoch were synonyms of Kumkuma ( Crocus sativa).

Basic steps for restructuring 153

4 All formulations of Bhaargi (Bhaarangi) are to be checked for their botanical components, as Clerodendrum serratum or none of the Clerodendrum spp.

are the sources of what is available in the market. Pygmaeopremna herbacea is also known as Bharangi Tree (Qian jie cao, Chinese). During the sixteenth century, Bhaargi was scarce and in Bhavaprakasha the root of Kantakaari ( Solnum xathocarpum) was used as a substitute in Sudarshan Churna. Powdered barks of Clerodendrum serratum, Gardenia turgid, and Gardenia latifolia (used as “Bhaarangi”) together with Kantakaari ( Solnum xathocarpum), and Rhus succedanea (Karkatashringi) formed a common anti-asthmatic drug during the classical period.

5 All Nishaa (till now equated with Curcuma longa) formulations are to be reviewed. Synonyms of Curcuma longa are Haridra, Priyaka, Haridruma, Kaanchni, Hatta-vilaasini. Yoshitapriya, Vara-varnini. Other synonyms, Nisha, Rajani, Raatri, Nilakanth and Varna-vinaasini have no link to the synonyms of Curcuma longa. There are 32 formulations in Bhavaprakasha that contain Nishaa as a component. Nishaa was equated with Daaru nishaa, which was very yellow in color. Curcuma caesia in known as Kaali Haldi in West Bengal.

All Nishaa formulations should be revalidated by using Curcuma caesia.

Nishaamalaki Churna (Ashtangahridya) was prescribed for diabetes. The powdered drug contained Nishaa and Aamalaki (Emblic myrobalan) in equal quantity. The methanol extract of Curcuma caesia rhizome showed antidiabetic activity by lowering blood glucose in in vivo studies and controlled intestinal absorption of monosaccharides by inhibiting alpha amyl-ase and alpha glucosidase. It also enhanced the glucose uptake in yeast cells, proving proper glucose utilization.

Rajnayaadi Churna (Ashtangahridaya) contains Rajani rhizome. Used in Ayurveda for diarrhea, dysentery, and jaundice. Curcuma caesia powder is utilized by several tribals of the district Nadia of West Bengal, India, to treat fevers, stomach problems, diarrhea, heartburn, wind, bloating, colic, flatulence, and jaundice and other liver ailments.

6 Madhuka and Madhuuka are synonyms of Glycyrrhiza glabra and Madhuca indica, respectively. In Ayurvedic Formulary of India, Part I, page 319, Madhuuka is equated with Glycyrrhiza glabra and Madhuka with Madhuca indica. In Ayurvedic Formulary of India, Part II, page 338, Madhuka and Madhuuka, both are synonyms of Glycyrrhiza glabra.

In Bhavaprakasha, 99 formulations contain Madhuka; 10 Madhuuka; 9

Yashtimadhu (Madhuyashti, Madhuyashtika), 6 Yashtimadhu; 7 Yashti-madhuka; 16 Yashtyaahva (synonym of Yashtimadhu). Even in 100

bc. Madhukaahva (synonyms: Klitaka, Madhuyashtikaa, Madhuyashti, Yashtimadhu, Yasti, and Yashtaahva) was mentioned at more than 100

places in Charaka Samhita. In Charaka Samhita (Su, 1.80) Klitaka is a synonym of Glycyrrhiza glabra ( Ayurvedic Formulary of India, page

154 Legacy and logical steps

317). It has been included among the purgative fruit drugs (there is no record of the use of Glycyrrhiza glabra fruits and seeds in literature.) Two varieties of Klitaka, terrestrial and aquatic, and the poisonous property of its root indicate that all classical formulations of Madhuka and its synonyms do not contain Glycyrrhiza glabra which was an imported drug.

There is a possibility that Taverniera cuneifolia, locally known as Jethimadh (a folk version of Yashtimadhu), found in the plains of Punjab, Gujarat and Deccan peninsula, was used during the classical period. Jethimadh is used by the tribes of Barda Hills of Jamnagar in Western India as a substitute of Licorice, the plant itself is considered to be G. glabra. It is known for its medicinal uses as an expectorant, blood purifier, antiulcer, anti-inflammatory and wound healing. Thus all formulations containing Madhuka are to be revalidated.

Further work should be done on Ganas, Vargas, and formulations on the basis of detailed research available in Reviews on Indian Medicinal Plants series, published by Indian Council of Medical Research, Medicinal Plant Unit.

References

1 Bhagwan Dasha V, Vaidya Lalitesh Kashyap, Materia Medica of Ayurveda (Based on Ayurveda Saukhyam of Todaraanda), Concept Publishing Company, New Delhi, 1987: 412–427.

2 Dravya Guna Vijnana, Vol. I, Prof. P.V. Sharma, Chaukhambha Bharati Academy, Varanasi, 1993: 41–65.

3 Chunekar Prof. KC, Dr NP Hota, Plants of Bhavaprakasha, National Academi Ayurveda, New Delhi, 1999.

4 Balwant Singh T, Glossary of Vegetable Drugs in Brhattrayi, Chaukhambha Amarab-harati Prakashana, Varanasi, 1999.

5 Ayurvedic Formulary of India, part I, second revised edn, 2003, Government of India.

6 Ray P, HN Gupta, M Roy, Sishruta Samhita: A Scientific Synopsis, Indian National Science, New Delhi, 1993.

7 Khare CP, Dictionary of Synonyms: Indian Medicinal Plants, IK International, New Delhi, 2012.

8 Kolhe R and Rabinarayan Acharya, Ayurpharm Int J Ayur Alli Sci., 2015, 4(10): 183–196.

9 Dhankhar S, Ruhil S, Balhara M, Dhankhar S, Chhillar A, Aegle marmelos (Linn.) Cor-rea: A potential source of phytomedicine. J Med Plant Res., 2011, 5(9): 1497–1507.

10 Gupta RC et al, Journal of Pharmacy Research, 2008, 1(1): 65–72.

11 Dr. Sonawane Suvarna Rambhau et al, International Journal of Ayurvedic & Herbal Medicine, September–October 2014, 4(5): 1615–1621.





12 Hidden secrets

of clinical success

Super power of “Sacred Word”

German Professor Rudolf Hansel wrote in the Preface of Rational Phytotherapy: Approximately two-thirds of phytomedicine prescriptions written by German doctors are for single-herb products. But 10 herbs accounted for approximately 80% of these prescriptions, and 20 herbs accounted for more than 90%.

This is surprising when we consider that German Commission E evaluated the therapeutic use of some 400 medicinal herbs from 1982 to 1944 and recommended approximately 250 of them. Clearly, the prescriptions written today no longer reflect the rich historical diversity of herbal remedies (in Germany).

We were surprised to see a 4-page text on “Drug Therapy and the Doctor’s Word”: Today the therapeutic benefit of drugs is assessed mainly by outcome measures that were established in the artificial realm of clinical double-bound studies. In the official drug official process and in most evaluation for setting therapeutic guidelines, the efficacy of pharmacologic treatment is considered equal to the difference between the true drug and the placebo. . . . A differentiated analysis of representative numbers from placebo-controlled studies has shown that the psychodynamic components of antidepressant therapy (the

“Herb Doctor,” measurable as the “placebo effect”) accounts for between two-thirds and one-third of the overall effect related to the pharmacodynamic components. This discovery is by no means limited to the treatment of depression. It is equally valid for a great many important indications in general. This is proven by quantitative analyses of the placebo contribution to the overall efficacy of pharmacologic therapies in controlled clinical studies. The pharmacodynamic properties of the active ingredients generally account for only about 20–40% of the overall therapeutic effect of the indications (insomnia, depression, anxiety states, gastric symptoms, symptoms from varicose veins, irritable bowel syndrome, headaches, BPH symptoms (IPSS), influenza syndrome, dysmenorrhea, widespread pains, rheumatic complaints, cardiac pain syndrome).

156 Legacy and logical steps

In India, Ayurvedic medicine has very deep roots in religion and rituals, even one pinch of “holy ash” will save a patient from “bhuuta-baadhaa” (ghost syndrome) or a few illegible Sanskrit shlokas (verses from holy texts) will cure a patient suffering from “graha-baadhaa” All “god-men” are prepraring and prescribing Ayurvedic medicines to millions of followers. Instead of “Doctor’s Word,” it can be said that indigenous Ayurvedic medicine combined with “sacred Word” is a panacea.

We have said earlier that Ganas and Vargas (classification of herbs based on their therapeutic properties) must be validated first before pruning polyherbal formulations. In many formulations “Doctor’s Word” or “Sacred Word” as placebo must be influncing the patient recovery. That also should be assessed. For example, if a patient is suffering from acute stress or depression, also with hyperacidity and irritable bowel syndrome, the holistic formulation will contain three Ganas or Vargas in the formulation. The drug or “Sacred Word” or “Doctor’s Word” or placebo will free the patient from acute stress or depression, and hyperacidity and irritable bowel syndrome will get cured on its own.

We will analyze a few such formulations in this chapter. While a number of drugs for psychological disorders contain validated herbs ( Saraswatarishta, Saraswata Churna, and Brahmi Ghrit, to name a few), there are drugs which contain components which are still unidentified. Once Sanskrit names are replaced with botanical names, formulations of Ayurvedic Formulary should be subjected to experimental or clinical trials. It is possible that a number of placebos may surface among popular drugs (adopting the method we recommended in “Pruning of Ayurvedic Formulations”) which survived for centuries. The best example will be that of drugs meant for epilepsy, insanity and psychological disorders, which contain only a few scientificlly validated herbs with a number of “supporting” herbs, which might be working like placebos.

Panch Gavya Ghrita contains filtered cow’s dung, cow’s milk, curd, urine and ghee.

Mahaa Panch Gavya Ghrit contains all the five constituents of Panch Gavya Ghrita, plus Dashamuula Gana, Trphala Gana, Tryuushna, plus 26 additional herbs from other Ganas and Vargas. Both are used for Unmaada (insanity), Apasmaara (epilepsy), Kaamalaa (jaundice) and fever.

Manasmitra Vataka contains Shankhpushpi ( Convolvulus pluricaulis) with 72

other herbs drawn from different Ganas and Vargas. Prescribed for Manodosha and Manovikaara (mental disorders), Unmaada insanity, Apasmaara (epilepsy) and Bhuuta baadhaa (Ghost-syndrome = psychological disorder).

There are drugs for Bhuutonmaada (insanity due to ghost influence = exog-enous psychosis), Kalyaanaka Ghrita and Maha Kalyaanaka Ghrita contain 27

and 32 plant drugs respectively. Kalyaanaka Ghrita contains Tagara ( Valeriana wallichii), Triplala and 24 other plant drugs from different Ganas and Vargas.

Maha Kalyaanaka Ghrita does not contain Tagara ( Valeriana wallichii) and included Kapikachhu ( Mucuna prurita). Vacha ( Acoras calamus) is common to both.

Hidden secrets of clinical success 157

1 For Graha dosha (Planetary evil influnce syndrome), Arvinda Asava and Panch Mahagavya Ghrita have been identified. Arvinda Asava contains Jataamaamsi ( Nardostachys jatamansi), Vacha ( Acorus calamus) and Mura ( Salinium tenuifolium) with 22 herbs from different Ganas and Vargas.

2 For

Baala Graha Dosha (Child’s illness due to Planetary evil influnce), Kalyanaka, Maha Kalyaanaka Ghrita and Phala Ghrita are indicated. Phala Ghrita contains Tagara ( Valeriana wallichii) and Vacha ( Acorus calamus) with Triphala with 13 other herbs.

3 For Napunsakataa (impotency) Vishnu Taila has been identified. It contains seven herbs. In the original text of Bhaishajya ratnavali, it was a drug to be prescribed for age-related debility (not for Napunsakataa), and for Angina pectoris, Pthisis, Calculus, facial palsy and bleeding disorders. ( Ayurvedic Formulary of India, Part I and II.)

4 For epilepsy, 36 Ayurvedic herbal and mineral drugs have been identified in Ayurvedic Formulary of India, for insanity 24, for jaundice 48, for fever 97.

The impact of placebo

Now, we will elaborate on the impact of placebo in the treatments which survived for centuries.

Placebos have been shown to produce measurable physiological changes and exert therapeutic response in chronic pains, headache, depression, anxiety disorders, cough, erectile dysfunction, insomnia, dysmenorrhea, irritable bowel syndrome, Parkinson’s disease, epilepsy, benign prostatic hyperplasia symptoms and psycho-neurosis.

Brain imaging studies have found measurable changes in the neural activity of people experiencing placebo analgesia. Areas that have been implicated include

parts of the brain stem, spinal cord, nucleus accumbens and amygdala.1 Strong

placebo responses have also been linked to increases in dopamine and opioid receptor activity. Both of these chemicals are involved in reward and motivation pathways in the brain.

Conversely, nocebos have been found to reduce dopamine and opioid receptor activity.

Some of these neurological changes occur in areas of the brain that are often targeted by antidepressant drugs. This might account for the 50% to 75% placebo response rate in antidepressant trials.

The following conditions have demonstrated positive responses to the placebo effect:1

Pain: A placebo’s ability to reduce pain is referred to as placebo analgesia.

Either the placebo initiates the release of natural painkillers and endorphins or they change the individual’s perception of the pain.

Additionally, genuine analgesics have been found to be more effective if a person knows they are being given the drug, rather than the drug being

158 Legacy and logical steps

given without the person’s knowledge. In this case, the placebo effect can be viewed as assisting a genuine intervention.

Depression: The effect of antidepressants is believed to be largely reliant on the placebo effect. One overview of eight studies found that over a 12-week period, placebo antidepressants were effective, demonstrating the potentially long-lasting impact of placebos.

Anxiety disorders: The placebo effect is particularly prevalent in trials for anti-anxiety drugs and significantly interrupts the discovery and trials of new forms of medication.

Coughs: A review of cough medication trials found that “85 percent of the reduction in cough is related to treatment with placebo, and only 15 percent attributable to the active ingredient.”

Erectile dysfunction: In one study, participants were split into three groups.

The first group was told they would receive treatment for erectile dysfunction, the second group was told they would receive either a placebo or an actual treatment, and the third group was told they would receive a placebo.

All three groups were, in fact, given placebo starch tablets, but the erectile dysfunction in all three groups improved significantly without any differences between the three groups.

Irritable Bowel Syndrome: A meta-analysis found that the placebo response rate in people with Irritable Bowel Syndrome (IBS) ranged from 16.0% to 71.4%. It was also noted that the placebo effect is greater in trials where the participants are required to take medication less frequently, and individuals with lower anxiety levels appear to be more susceptible to the placebo effect. In a trial, even when the participants were aware they were taking a placebo, their IBS symptoms improved.

Parkinson’s disease: A review of 11 clinical trials found that 16% of participants with Parkinson’s disease in the placebo groups showed significant improvements, sometimes lasting for 6 months.

The effect seems to be partly due to dopamine release in the striatum.

Epilepsy: Participants in anti-epilepsy drug trials have a 0% to 19% placebo response. A “placebo response” for this trial was defined as a 50% decrease

in their normal seizure frequency.1

Critically reviewed placebo studies: There is increasing evidence that placebo interventions also affect end-organ functions regulated by the autonomic nervous system (ANS). After discussing three psychological models for autonomic placebo effects, a study provides an anatomical framework of the autonomic system and then critically reviews the relevant placebo studies in the field, thereby focusing on gastrointestinal, cardiovascular and pulmonary functions. The findings indicate that several autonomic organ functions can indeed be altered by verbal suggestions delivered during placebo and nocebo interventions. In addition, three experimental studies provide evidence for organ-specific effects, in agreement with the current knowledge on the central control of the ANS. It is suggested that the placebo effects on autonomic organ functions are best explained by the model

Hidden secrets of clinical success 159

of “implicit affordance,” which assumes that placebo effects are dependent on “lived experience” rather than on the conscious representation of

expected outcomes.2

Placebo response rates in clinical trials: A recent study investigated the impact of placebo response rates on the relative risk of response to drug versus placebo in randomized, double-blind, placebo-controlled clinical trials of pharmacological therapy in Bipolar Depression (BPD). Medline/

PubMed publication databases were searched for randomized, double-blind, placebo-controlled trials of oral drugs used as monotherapy for the treatment of BPD. The search was limited to articles published between January 1980 and September 2015. Data extracted from 12 manuscripts and one poster with yet unpublished results, representing a total of 17 clinical trials were pooled (n = 6,578). Pooled response rates for drug and placebo were 55.1% and 39.2%, corresponding to a risk ratio (RR) for responding to active treatment versus placebo of 1.29 (p < 0.001). Clinical response was defined as a 50% or greater reduction in depression scores, baseline to endpoint. A higher placebo response rate correlated with a significantly lower RR of responding to pharmacotherapy versus placebo (p = 0.002).

The pooled drug and placebo response rates for studies with a placebo response rate ≤30% were 50.5% versus 26.6%, while corresponding values from studies with a placebo response rate >30 were 55.0% versus 41.6%.

These results suggest that the relative efficacy of the active drug compared to placebo in clinical trials for BPD is highly heterogeneous across studies with different placebo response rates, with a worse performance in showing the superiority of the drug versus placebo for studies with placebo response rates >30%.

It is important to maintain placebo response rates below this critical threshold since this is one of the most challenging obstacles for new treatment develop-

ment in BPD.3

A more caring approach from clinicians (“Doctor’s Word”) was found to enhance the placebo effect. Psychodynamic effect of Ayurvedic medicines works miraculously because medicine carries a divine aura.

References

1 Summarized from the post by Tim Newman, News Editor at Medical News Today, September 7, 2017, Reviewed by Timothy J. Legg, PhD, CRNP.

2 Meissner K, The placebo effect and the autonomic nervous system: Evidence for an intimate relationship, Philos Trans R Soc Lond B Biol Sci., June 27, 2011, 366(1572): 1808–1817.

3 Nadia Iovieno et al, Relationship between placebo response rate and clinical trial outcome in bipolar depression, Journal of Psychiatric Research, March 2016, 74: 38–44.

Sciencedirect.com.





Part II

Defining

a new scientific path

by switching over to

modern pharmacognosy,

pharmacology and

research protocols





13 Identification of medicinal

plants by voucher specimen

In the pharmaceutical community, herbarium specimens are essential for documenting the source material used for drug discovery. A voucher typically consists of a herbarium specimen, a pressed and dried sample of an individual plant, containing aboveground structures (leaves, stems, flowers, and/or fruits) and below-ground structures when possible.

The use of vouchers for taxon identity is crucial in ethnobotanical research in which botanical information collected from native inhabitants of an area is frequently limited to common plant names, often in local dialects. Vouchers provide a verifiable means to identify and distinguish these plants from one another, especially if they share the same common name. Unknown plant species may also serve as the supporting material for published studies of the taxon.

The Oxford University Herbarium, the oldest in the UK and fourth-oldest in the world, was founded in 1621 to document plants from the Oxford Physic Garden.

Institutions worldwide now host herbaria whose collections, in their entirety, may house many different specimens from a particular species, collected at different times and places. Such holdings in total are the best record of morphological and

anatomical variation as well as the distribution of that species.1

In India, Indian Institute of Integrative Medicine (Formerly RRL) Jammu, Herbarium is the main source of the original collection from all over India by col. Sir R. N. Chopra, Shri R. L. Bhadwar and Dr. S. L. Nayar, which include specimens dated even prior to 1935, some of even dating back to nineteenth century.

Many journals focused on the plant sciences, including the Botanical Society of America’s journals, Applications in Plant Sciences ( APPS) and the American Journal of Botany, require submission of vouchers as a condition for publication of articles. This is not new, as there have been repeated calls for requiring voucher

citations within publications as a means to document scientific data.2.

The International Code of Botanical Nomenclature requires that a “holotype,”

a specimen that permanently fixes the identity of the new taxon, be prepared or designated from previously collected material and that the herbarium where it is conserved be named. Voucher specimens can serve as a source of plant tissue for DNA analyses. Most journals require that DNA and amino acid sequences used in publications be submitted to a database such as GenBank.

164 Defining a new scientific path

The United States Department of Agriculture (USDA) Forest Service in north-western states also requires that researchers conducting floristic surveys collect a voucher from each vascular plant species at each sampling site and that the speci-

men be placed in a public repository for verification of identification.3

The misidentification of a sample can dramatically hamper drug development.4

The classical example is that of Ashwagandha. Five forms of Indian Ashwagandha have been identified by CK Atal. Form I is the Ashwagandha of commerce which is cultivated in Madhya Pradesh. Form II grows in the sandy desert of Pilani (Rajasthan). Form III grows in Chandigarh and mountainous areas of Punjab and Uttar Pradesh. Form IV is found growing near Delhi, Form V grows wild near Delhi and Ahmedabad. A separate species status, W. ashwagandha, was suggested for the cultivated forms in the W. somnifera germplasm.

Now, Indian species of Withania has been identified as Withania ashwaganda sp. novo (Bilal Ahamad Mir and Sushma Kaul). A considerable degree of variation in bioactive withanolides, withanolide A (WS-1), withanone (WS-2) and withaferin A (WS-3) and morphological characters were detected among the populations. Plant height and plant biomass were the highest in plants collected from Manasa population followed by Hyderabad. Leaves were found to be the principle organ for WS-3 accumulation while roots mainly accumulate WS-1, suggesting a spatial variation of withanolides. Plants of Manasa population alone showed the presence of WS-2 accumulation was also the highest in Manasa population, with 1.312% WS-3 in the leaves and 0.083% WS-1 in roots.

Withanolide accumulation correlated positively with developmental stages and the highest content of these withanolides was found at maturity in both roots and leaves. Thus, all Ashwagandha products must specify the chemotype of Ashwagandha.

Same is the case of different chemo types of Acorus calamus. In literature, Acorus calamus has been classified into four chemo-types which are found in different locations worldwide. Type I: Acorus calamus L. var. americanus, a diploid American variety; Type II: var. vulgaris L. (var. calamus), a European triploid; Type III and IV: var. augustatus Bess. and var. versus L., subtropical tetraploids.

(Chief constituents of the volatile oil are heavily dependent upon the chemical strain (dis-, tri-, tetraploid.) North American chemo-type I is virtually isoasarone-free. Western European chemo-type II contains less 10% isoasarone. The two other chemo-types (III and IV) have been found to contain up to 96% isoasarone in the volatile oil.

All the 27 Indian genotypes of A. calamus were also analyzed for α and β-asarone contents, and percentage of essential oil. The genotype (Ac13) from Kullu (Himachal Pradesh) showed maximum (9.5%) percentage of oil, while the corresponding minimum (2.8%) was obtained from the genotypes from Pangthang (Sikkim). Similarly, the highest α and β-asarone contents (16.82% and 92.12%) were obtained from genotypes from Renuka (Himachal Pradesh) and Udham-pur (Jammu and Kashmir), while lowest α and β-asarone contents (0.83% and 65.96%) resulted from Auranwa (Uttar Pradesh) and Pangthang (Sikkim) genotypes, respectively.

Identification of medicinal plants 165

One more example of intraspecific variation in plants. Artemisia dracunculus has been used medicinally and as a culinary herb in many parts of its vast range (western North America, Asia, and Eastern Europe). The plant contains a wide array of phytochemicals but also presents an extensive series of polyploid cytotypes (diploid, hexaploid, octoploid, and decaploid), each distinct in phytochemical composition.

Studies of samples from many sources found that some cytotypes contain specific antidiabetic compounds while others do not. Vouchering of materials subjected to study made it possible to confirm that varying results were really due to variation

within a single species5 and not to misidentification of samples.Voucher specimens not only are a source for correct botanical identification but also can serve as a repository for the chemical compounds of a plant at any given time during its life cycle. Vouchers collected at different intervals and in different areas can thus clearly reflect compound composition as influenced by edaphic and harvest conditions.

Apart from providing a clear reference for a certain batch of material, voucher specimens also allow a follow-up in case taxonomic concepts change.

If processed or powdered material is purchased, it should be compared with chemical assays available is standard reference works or should be identified rigorously by morphological, chemical, or molecular analysis. For example, Curcuma longa should contain not less than 4.0% of volatile oil and not less than 3.0% of curcuminoids. Quantitative assay for total curcuminoids by spectropho-tometric or by high-performance liquid chromatographic methods.

Without identifying the fertile parts, no plant should be used in herbal medicine. The voucher must contain all plant parts (e.g. bark, roots, seeds) that are actually used for the herbal preparation.

The Janaki Ammal Herbarium

Indian Institute of Integrative Medicine (Formerly RRL),

Jammu, India

The original collection from all over India by col. Sir R. N. Chopra, Shri R. L.

Bhadwar and Dr. S. L. Nayar, include specimens dated even prior to 1935, some of them even dating back to the nineteenth century. The herbarium was further enriched through the collections made by Dr. L. D. Kapur, Dr. S. N. Sobti and Dr. B. K. Abrol. These collections represent mostly to the areas of Jammu and Kashmir and some parts of Himachal Pradesh. Dr. Y. K. Sarin joined as the full time Curator of the herbarium in 1961, who in collaboration with Shri A. K. Dutt, Dr. S. K. Kapur, Dr. B. M. Sharma, and Dr. B. K. Kapahi, reorganized the herbarium on contemporary lines. Further thousands of voucher specimens were collected, identified and housed in this herbarium. In 1994, the herbarium was named as Janaki Ammal Herbarium.

The collections in herbarium were further enriched by Dr. T. N. Srivastava in close collaboration with Dr. B. K. Kapahi and Dr. Virendra Singh. Currently, Dr. S. N. Sharma is managing the affairs of this herbarium.

The structure or organization of Janaki Ammal Herbarium is based on Bentham and Hooker system of classification. International code of Botanical nomenclature incorporating the latest changes has been used in naming the plants. In case of name change of taxon, the correct name is on the top followed by relevant

166 Defining a new scientific path

synonyms. If the correct name has a basionym, the basionym follows the correct name and other synonyms follow the basionym.

This herbarium is recognized internationally. The acronym RRLH has been assigned to it which is registered in Index Herbariorum at New York.

The preserved specimens in this herbarium include a large number of medicinal, aromatic and other economic plants from different parts of India and foreign countries, while the flora of the North-West Himalayan region is very well represented. The herbarium at present houses more than 21,500 specimens representing 3,254 species, 1,152 genera and 218 families of Angiosperms, Gymnosperms and Pteridophytes. Besides technical details, habit, habitat, flowering and fruit-ing time of every specimen has been recorded in this herbarium for making it a ready reference and for use by the herbal drug industry for authentication of plant material.

Plant Families6:

1 Acanthaceae

132

9 Brassicaceae

12

2 Aceraceae

52

10 Burseraceae

41

3 Agavaceae

179

11 Buxaceae

158

4 Aizoaceae

88

5 Alangiaceae

93

1 Cactaceae

89

6 Alliaceae



182

2 Caesalpiniaceae 60

7 Alismataceae

194

3 Campanulaceae

103

8 Amaranthaceae

138

4 Cannabaceae

161

9 Amaryllidaceae

178

5 Cannaceae

179

10 Anacardiaceae

56

6 Capparaceae

13

11 Apiaceae



93

7 Caprifoliaceae

97

12 Apocynaceae

115

8 Caryophyllaceae

21

13 Aquifoliaceae

46

9 Celastraceae

47

14 Araceae



199

10 Ceratophyllaceae

169

15 Arecaceae; Palmae 196

11 Chailleticeae

43

16 Araliaceae

94

12 Chenopodiaceae

142

17 Araucariaceae

174

13 Cochlospermaceae 16

18 Aristolochiaceae

145

14 Colchicaceae

190

19 Arecaceae

196

15 Combertaceae

74

20 Asclepidaceae

116

16 Commelinaceae

193

17 Convolvulaceae

124

1 Balanophoraceae

155

18 Cordiaceae

122

2 Balsaminaceae

38

19 Coriariaceae

57

3 Berberidaceae

7

20 Cornaceae

95

4 Betulaceae

165

21 Crassulaceae

68

5 Biebersteiniaceae

36

22 Cucurbitaceae

86

6 Bignoniaceae

132

23 Cupressaceae

171

7 Bixaceae



17

24 Cuscutaceae

125

8 Boraginaceae

121

25 Cyperaceae

203

Identification of medicinal plants 167

1 Datiscaceae

88

1 Lamiaceae/Labiata 137

2 Dilleniaceae

3

2 Leeaceae



51

3 Dipsacaceae

100

3 Lauraceae

148

4 Dipterocarpaceae

27

4 Lecythidaceae

77

5 Dioscoriaceae

185

5 Lemnaceae

78

6 Dracaenaceae

189

6 Lentibulariaceae

130

7 Droseraceae

69

7 Liliaceae



187

8 Linaceae



31

1 Ebenaceae

112

9 Loganiaceae

117

2 Ehretiaceae

123

10 Loranthaceae

154

3 Elaeagnaceae

152

11 Lythraceae

80

4 Elatinaceae

153

5 Ephedraceae

170

1 Magnoliaceae

4

6 Ericaceae

104

2 Malpighiaceae

33

7 Eriocauleaceae

201

3 Malvaceae

28

8 Erythroxylaceae

33

4 Martyniaceae

134

9 Euphorbiaceae

157

5 Melastomaceae

78

6 Meliaceae

42

1 Fagaceae



167

7 Menispermaceae

6

2 Ficoideae

90

8 Menyanthaceae

119

3 Flacourtiaceae

18

9 Mimosaceae

61

4 Flagellarieae

194

10 Molluginaceae

92

5 Fumariaceae

11

11 Monotropaceae

107

12 Moraceae

162

1 Gentianaceae

118

13 Morinaceae

101

2 Geraniaceae

35

14 Moringaceae

58

3 Gesneriaceae

131

15 Myricaceae

165

4 Grossulariaceae

67

16 Myristicaceae

147

5 Guttiferae

25

17 Myrsinaceae

110

18 Myrtaceae

75

1 Haemodoraceae

180

2 Haloragidaceae

71

1 Najadaceae

76

3 Hamamelidaceae

70

2 Nyctaginaceae

139

4 Hernandiaceae

149

3 Nymphaeaceae

9

5 Hippuridaceae

72

6 Hydrangeaceae

65

1 Olacaceae

44

7 Hydrocharitaceae

176

2 Oleaceae



114

8 Hypoxidaceae

182

3 Onagraceae

82

9 Hypericaceae

24

4 Orchidaceae

177

5 Orobanchaceae

129

1 Icacinaceae

45

6 Oxalidaceae

37

2 Illecebraceae

140

3 Iridaceae



181

1 Paeoniaceae

2

2 Pamanaceae

197

1 Juglandaceae

164

3 Papaveraceae

10

2 Junacaceae

195

4 Papilionaceae

59

168 Defining a new scientific path

5 Passifloraceae

85

1 Sabiaceae

55

6 Parnassiaceae

64

2 Salicaceae

168

7 Pedaliaceae

133

3 Samydaceae

84

8 Philadelphaceae

66

4 Santalaceae

156

9 Phytolacaceae

143

5 Sapindaceae

52

10 Pinaceae



175

6 Sapotaceae

111

11 Piperaceae

146

7 Saxifragaceaae

63

12 Pittosporaceae

19

8 Scrophulariaceae

127

13 Plantaginaceae

138

9 Selaginaceae

128

14 Platanaceae

163

10 Simaroubaceae

40

15 Plumbaginaceae

108

11 Solanaceae

126

16 Poaceae



204

12 Staphyleaceae

54

17 Podophyllaceae

8

13 Sterculiaceae

29

18 Polemoniaceae

120

14 Symplocaceae

113

19 Polygalaceae

20

20 Polygonaceae

144

1 Tamaricaceae

23

21 Potamogetonaceae 202

2 Taxaceae



173

22 Pontederiaceae

192

3 Taxodiaceae

172

23 Portulacaceae

22

4 Thymelaeaceae

151

24 Primulaceae

109

5 Theaceae

26

25 Proteaceae

150

6 Tiliaceae



30

26 Punicaceae

81

7 Trapaceae

83

27 Pyrolaceae

105

8 Trichopodaceae

186

9 Trilliaceae

191

10 Typhaceae

198

1 Ranunculaceae

1

2 Resedaceae

14

1 Ulmaceae

160

3 Rhamnaceae

48

2 Urticaceae

159

4 Rhizophoraceae

73

5 Rosaceae

62

1 Zygophyllaceae

34

6 Rubiaceae

98

2 Zingiberaceae

178

7 Rutaceae



39

3 Zanichelliaceae

5

Other Indian Herbariums

1 NBRI: LWH Virtual Herbarium7

2 Deccan Regional Herbarium:8 It houses approximately 11,000 herbarium specimens including 890 Mangrove specimens. About 1,250 specimens received as a gift from other institutions in Floristic work.

3 Central National Herbarium, Howrah:9 The Central National Herbarium, popularly known as CNH. It is one of the oldest and largest herbaria in the world, established in 1795 by Dr. William Roxburgh, the first regular Super-intendent of the East India Company’s Garden at Shibpore. Presently the Central National Herbarium possesses about 2.5 million of herbarium sheets belonging to nearly 350 families of plants.

Identification of medicinal plants 169

4 French Institute of Pondicherry (The Western Ghats Forest Biodiversity Portal):10 The herbarium of French Institute of Pondicherry known as HIFP (Herbier Institut Français de Pondichéry). HIFP houses a large number of collections from the Western Ghats, especially for tree species, the other parts of India and also from different parts of the globe. The herbarium has a collection of over 24,000 specimens belonging to 268 families and 4,659

species.

5 ENVIS Centre on Medicinal Plants (Digital Herbarium):11 It was established in 1993 is a specialized herbarium with a focus on medicinal plants used in Indian Systems of Medicine (ISM). It consists of 1,107 unique species.

6 Kerala Forest Research Institute (Herbarium):12 Kerala Forest Research Institute was started in the early 1980s. Presently it has a collection of 11,074

specimens and recognized internationally by the acronym “KFRI” by the International Association of Plant Taxonomists (IAPT). It has a collection of medicinal plants in South India. It has a collection of 11,074 specimens representing more than 2,200 species form 159 families.

The Museum of Materia Medica

Institute of Natural Medicine, Toyama, Japan

The museum was started in 1973 as a crude drug specimen room belonging to the Department of Development of Natural Drug Resources, Research Facilities for Wakan-Yaku under Faculty of Pharmaceutical Sciences, Toyama University. In In 1980, a crude drug specimen room in Research Institute for Wakan-Yaku, Toyama Medical and Pharmaceutical University was founded. Crude drug samples were moved from Toyama University.

In 1985, the ground floor of a preservation building for pharmaceutical materials was developed as the Museum of Materia Medica under the care of the Department of Development of Natural Drug Resources. Crude drug samples were moved from the Research Institute for Wakan-Yaku.

The Museum of Materia Media is also a natural drug resource for almost all important regions of the world:

European crude drugs (Herbs)

Tibetan crude drugs from Tibet

Tibetan crude drugs from Tibet and Qinhai Prov.

Tibetan crude drugs from India and Bhutan

Tibetan crude drugs from Nepal

Ayurvedic crude drugs from Nepal

Ayurvedic crude drugs from India

Ayurvedic crude drugs from Sri Lanka

Plant specimens from Nepal

Crude drugs from Myanmar

Unani medicines from Pakistan and Bangladesh

170 Defining a new scientific path

Medicinal Plant Names Services, Kew Garden, London

Medicinal Plant Names Services at Kew Gardens offer information service related to medicinal plants, nutraceuticals, and poisonous plants.

Dr. Bob Allkin, in a personal communication13:

Researchers are familiar with current confusions that the use of different plant names can cause for practitioners, manufacturers, suppliers, and regulators:

• Out of date or ambiguous names are being used in legislation.

• Organizations are failing to communicate with one another because they use different names for the same plant.

• Prescribing the wrong drug or manufacturers receiving the wrong plant material from their suppliers cause serious problems.

• It is becoming difficult to find previously published literature due to being unaware of the synonyms of that plant.

• The problem becomes acute to communicate with those working in different countries, different disciplines or using older literature. The situation becomes more complicated as 10,000 plant name changes are published each year.

Medicinal Plant Names Services (MPNS) is working to make people aware of these issues and to help overcome them. MPNS have been collecting pharmacopoeia names, common names (in alternative languages) and scientific (Latin) names used in the medicinal literature and mapping them onto the comprehensive global scientific nomenclatures managed by Kew. MPNS use this resource to offer information services addressing the problems faced by medicinal plant users and clients.

References

1 Eisenman SW, AO Tucker, L Struwe, Voucher specimens are essential for documenting source material used in medicinal plant investigations. Journal of Medicinally Active Plants, January 26, 2012, 1(1): 30–43.

2 Goldblatt P, PC Hoch, LM McCook, Documenting scientific data: The need for voucher specimens. Annals of the Missouri Botanical Garden, 1992, 79: 969–970.

Funk VA et al, The importance of vouchers, Taxon, 2005, 54: 127–129.

3 USDA Forest Service, Memorandum Regarding the Vouchering Policy for Bryophytes, Lichens, Fungi, Vascular Plants, Mollusks, and All Other Invertebrates, 2011.

4 Eisenman SW et al, Voucher specimens are essential for documenting source material used in medicinal plant investigations. Journal of Medicinally Active Plants, 2012, 1: 30–43.

5 Bilal Ahmad Mir (Indian Institute of Integrative Medicine, Jamu), Jabeena Khazir (Indian Institute of Integrative Medicine), Khalid R. Hakeem (Universiti Putra Malaysia), Withanolides array of Withania ashwagandha sp. novo populations from India, Industrial Crops and Products, 2014, 59: 9–13.

6 https://iiim.res.in/herbarium/introduction.h

Identification of medicinal plants 171

7 www.nbri.res.in LWH Virtual Herbarium

8 http://164.100.52.111/circles/Deccan/Herbarium.shtm

9 http://164.100.52.111/cnh/aboutus.shtm

10 www.ifpindia.org/biodiversityportal/index.php? option=com_content&view=article&i

d=58&Itemid=63&lang=en

11 http://envis.frlht.org.in/digital-herbarium-main.php

12 www.kfri.res.in/herbarium.asp

13 b.allkin@kew.org, August 28, 2018.





14 DNA barcoding

A breakthrough in authentication

of raw herbs

A recent (2015–2016) study by Sophie Lorraine Vassou, Stalin Nithaniyal, Balaji Raju, and Madasamy Parani (Department of Genetic Engineering, Center for DNA Barcoading, SRM University, Kattankulathue, Tamil Nadu, India) is the first attempt to DNA barcode the medicinal plants that are listed in Ayurveda Pharmacopoeia of India (API) so as to develop a molecular tool to identify them in fresh as well as raw drug form, and to generate API-Reference DNA Barcode Library

(API-RDBL).1

The monographs in the API contain the Sanskrit and botanical names of the plants. Since these monographs were written between the year 1990 and 2008

( Ayurvedic Pharmacopoeia of India Part I, Volumes I to VI), the name of the plants was updated by incorporating the currently accepted botanical names as given in Tropicos and The Plants List database. API plant list that contains the Sanskrit names, the botanical names used in the API and the currently accepted botanical names for the 395 plants has been placed after the introductory note.

Four medicinal plants in the API plant list are not available in India and hence imported as raw drugs from other countries. Some medicinal plants in the API plant list were difficult to collect due to their seasonal occurrence or distribution in the high altitude ranges of the Himalayas. Most of the fresh specimens of the medicinal plants were collected from open forests, cultivated fields and botanical gardens of research institutions. Some specimens were derived from the seedlings that were raised from seeds in the greenhouse. Altogether, the researchers collected fresh specimens for 347 medicinal plants in the API plant list. Name of the plant, Sample ID, Field ID, and the place of the collection are given in the main document which is in open access.

Genomic DNA was extracted from either 100 mg of fresh leaf tissue or 25 mg of raw drugs using the cetyl trimethyl ammonium bromide (CTAB) method.2 The

DNA was checked on 0.8% Agarose gel and quantified for PCR amplification.

Polymerase chain reaction (PCR) was performed using rbcLa F (ATGTCAC-CACAAACAGAGACTAAAGC), rbc Lajf634R (GAAACGGTCTCTCCAACG-

CAT) primers. The amplicons were checked on 1% agarose gel and purified using EZ-10 Spin Column PCR Purification Kit (Bio Basic Inc. Ontario, Canada). Samples were sequenced using 3,130 xl Genetic analyzer (Applied Biosystems, CA, USA). The sequences were manually edited using Sequence Scanner Software v1.0

174 Defining a new scientific path

(Applied Biosystems, CA, USA), and full-length sequences were assembled using local alignment algorithm of CodonCode Aligner, version 4.2.4 (CodonCode Corporation, MA, USA).

BLAST (Basic Local Alignment Search Tool) search was performed against

GenBank3 and BOLD (Barcode of Life Database) databases. TaxonDNA v. 1.6.2

(http://taxondna.sf.net/) was used to calculate pairwise divergence. Phylogenetic tree based on Neighbor-Joining (NJ) method was constructed using MEGA version 5.1 Best match method was used for the authentication of the raw drug mar-

ket samples.4 Unmatched samples were analyzed by BLAST search against the NCBI nucleotide database and BOLD database.

API-Reference DNA Barcode Library was created with high quality and authentic rbcL barcodes for 374 out of the 395 medicinal plants that are included in the API. The rbcL DNA barcode differentiated 319 species (85%) with the pairwise divergence ranging between 0.2 and 29.9%. PCR amplification and DNA sequencing success rate of rbcL marker was 100% even for the poorly preserved medicinal plant raw drugs that were collected from local markets. DNA barcoding revealed that only 79 of raw drugs were authentic, and the remaining 21% of samples were adulterated. Further, adulteration was found to be much higher with powders (ca. 25%) when compared to seeds (ca. 5%). This library was used to authenticate 100 medicinal plant raw drugs, which were in the form of powders (82) and seeds (18)

The study demonstrated the utility of DNA barcoding in authenticating medicinal plant raw drug and found that approximately one fifth of the market samples was adulterated. Powdered raw drugs, which are very difficult to be identified by taxonomists as well as common people, seem to be the easy target for adulteration. Developing a quality control protocol for medicinal plant raw drugs by incorporating DNA barcoding as a component is essential to ensure safety to the consumers.

395 medicinal plants of API were selected for barcoding. A number of botanical names were corrected before DNA barcoding.

Currently accepted Botanical names of

API medicinal plants1,5

Sanskrit name Botanical name as given in API

Currently accepted Botanical name

Kasturilatika

Hibiscus abelmoschus Linn.

Abelmoschus moschatus Medik.

Talisa

Abies webbiana Lindl.

Abies spectabilis (D.Don) Spach

Arimeda

Acacia leucophloea Willd.

Acacia leucophloea (Roxb.) Willd.

Babbula

Acacia nilotica (Linn.) Willd. ex

Acacia nilotica subsp. indica

Del. sp. Indica (Benth.) Brenan

(Benth.) Brenan

Kadara

Acacia suma Buch.-Ham.

Acacia polyacantha Willd.

Bijapatra

Adiantum cappillus-veneris L.

Adiantum capillus-veneris L.

Hamsapadi

Adiantum lunulatum Burm

Adiantum lunulatum Burm. f.

Bilva

Aegle marmelos Corr.

Aegle marmelos (L.) Corrêa

Sirisa

Albizzia lebbeck Benth.

Albizia lebbeck (L.) Benth.

Sanskrit name Botanical name as given in API Currently accepted Botanical name

Yavasaka

Alhagi pseudalhagi (Bieb.) Desv.

Alhagi pseudalhagi (M. Bieb.)

Desv. ex Keller & Shap.

Kanyasara

Aloe barbadensis Mill.

Aloe vera (L.) Burm.f.

Granthimula

Alpinia calcarata Rosc.

Alpinia calcarata (Haw.) Roscoe

Kulanjan

Alpinia galanga Willd.

Alpinia galanga (L.) Willd.

Matsyaksi

Alternanthera sessilis (Linn.) R. Br. Alternanthera sessilis (L.) R.Br. ex DC.

Surana

Amorphophallus campanulatus

Amorphophallus sylvaticus (Roxb.)

(Roxb.) Bl.

Kunth

Akarakarabha Anacyclus pyrethrum DC.

Anacyclus pyrethrum (L.) Lag.

Satahva

Anethum sowa Roxb. ex Flem.

Anethum graveolens L.

Dhava

Anogeissus latifolia Wall.

Anogeissus latifolia (Roxb. ex

DC.) Wall. ex Guill. & Perr.

Kitamari

Aristolochia bracteata Retz.

Aristolochia bracteolata Lam.

Danti

Baliospermum montanum Muell-Arg. Baliospermum solanifolium (Burm.) Suresh

Kancanara

Bauhinia variegata Blume

Bauhinia variegata L.

Kusmanda

Benincasa hispida (Thunb.) Cogn.

Benincasa hispida (Thunb.) Cogn.

Utingana

Blepharis persica (Burm.f.) O.

Blepharis ciliaris (L.) B. L. Burtt

Kuntze.

Svetapunarnava Boerhaavia verticillata Poir.

Boerhavia plumbaginea Cav.

Kunduru

Boswellia serrata Roxb.

Boswellia serrata Roxb. ex Colebr.

Sarsapa

Brassica campestris Linn.

Brassica rapa L.

Priyala

Buchanania lanzan Spreng.

Buchanania cochinchinensis

(Lour.) M. R. Almeida

Palasa

Butea monosperma (Lam.) Kuntze

Butea monosperma (Lam.) Taub.

Arka

Calotropis procera (Ait.) R. Br.

Calotropis procera (Aiton) Dryand.

Madana

Xeromphis spinosa (Thunb.) Keay

Catunaregam spinosa (Thunb.)

Tirveng.

Devadaru

Cedrus deodara (Roxb.) Loud.

Cedrus deodara (Roxb. ex D.Don)

G.Don

Brhat Dugdhika Euphorbia hirta L.

Chamaesyce hirta (L.) Millsp.

Kebuka

Costus speciosus

Cheilocostus speciosus (J. Koenig)

(Koerning ex Retz.) Smith.

C. D. Specht

Usira

Vetiveria zizanioides (Linn.) Nash

Chrysopogon zizanioides

(L.) Roberty

Karpura

Cinnamomum camphora

Cinnamomum camphora (L.) J.Presl

(L.) Nees & Eberm.

Tvak

Cinnamomum zeylanicum Blume

Cinnamomum verum J. Presl

Indravaruni

Citrullus colocynthis Schrad.

Citrullus colocynthis (L.) Schrad.

Nimbu

Citrus limon (Linn.) Burm. f.

Citrus limon (L.) Osbeck

Gandira

Coleus forskohlii Briq.

Coleus forskohlii (Willd.) Briq.

Amragandhi-

Balsamodendron caudata Mauch

Commiphora caudata Engl.

guggulu

Sankhapuspi

Convolvulus pluricaulis Choisy

Convolvulus prostratus Forssk.

Sukanasa

Corallocarpus epigaeus Benth.ex

Corallocarpus epigaeus (Rottler)

Hook. f.

Hook.f.

Slesmataka

Cordia dichotoma Forst. f.

Cordia dichotoma G.Forst.

Maramanjal

Coscinium fenestratum

Coscinium fenestratum

(Gaertn.) Colebr.

(Goetgh.) Colebr.

Jivak

Malaxis acuminata D.Don

Crepidium acuminatum

(D.Don) Szlach.

( Continued)

(Continued)

Sanskrit name Botanical name as given in API

Currently accepted Botanical name

Krsnasariva

Cryptolepis buchanani

Cryptolepis dubia

Roem. & Schult.

(Burm. f.) M. R. Almeida

Ervaru

Cucumis melo var. utilissimus

Cucumis melo L.

Duthie & Fuller

Bakuci

Psoralea corylifolia Linn.

Cullen corylifolium (L.) Medik.

Karcura

Curcuma zedoaria Rosc.

Curcuma zedoaria

(Christm.) Roscoe

Ajamoda

Apium leptophyllum

Cyclospermum leptophyllum

(Pers.) F.V.M. ex Benth.

(Pers.) Sprague

Simsapa

Dalbergia sissoo Roxb.

Dalbergia sissoo DC.

Salaparni

Desmodium gangeticum DC.

Desmodium gangeticum (L.) DC.

Tinisha

Ougeinia oojeinensis

Desmodium oojeinense

(Roxb.) Hochr.

(Roxb.) H.Ohashi

Kusa

Desmostachya bipinnata Stapf.

Desmostachya bipinnata (L.) Stapf

Tinduka

Diospyros peregrina Gurke

Diospyros malabarica

(Desr.) Kostel.

Bhrngaraja

Eclipta alba Hassk.

Eclipta prostrata (L.) L.

Rudraksa

Elaeocarpus sphaericus

Elaeocarpus serratus L.

Gaertn. K. Schum

Nahi

Enicostemma axillare

Enicostema axillare

(Lam.) A. Raynal.

(Poir. ex Lam.) A.Raynal

Paribhadra

Erythrina indica Lam.

Erythrina variegata L.

Dugdhika

Euphorbia prostrata W. Ait.

Euphorbia prostrata Aiton

Hingu

Ferula foetida Regel.

Ferula assa-foetida L.

Nandi

Ficus arnottiana Miq.

Ficus arnottiana (Miq.) Miq.

Phalgu

Ficus hispida Linn.

Ficus hispida L. f.

Sruvavrksa

Flacourtia indica Merr.

Flacourtia indica (Burm. f.) Merr.

Ksirakakoli

Fritillaria roylei Hook.

Fritillaria cirrhosa D.Don

Vrantamlaphala Garcinia pedunculata Roxb.

Garcinia pedunculata Roxb. ex

Buch.-Ham.

Pullani

Calycopteris floribunda Lam.

Getonia floribunda Roxb.

Gangeru

Grewia tenax

Grewia tenax (Forssk.) Fiori

(Forsk.) Aschers & Schwf.

Mesasrngi

Gymnema sylvestre R.Br.

Gymnema sylvestre

(Retz.) R.Br. ex Sm.

Sati

Hedychium spicatum Ham. ex Smith Hedychium spicatum Sm.

Sveta Sariva

Hemidesmus indicus (Linn.) R. Br.

Hemidesmus indicus

(L.) R. Br. ex Schult.

Madhavi

Hiptage benghalensis L.

Hiptage benghalensis (L.) Kurz

Kutaja

Holarrhena antidysenterica

Holarrhena pubescens

(Roth) A. DC.

Wall. ex G. Don

Kokilaksa

Asteracantha longifolia Nees

Hygrophila auriculata Heine

Darbha

Imperata cylindrica (Linn.) Beauv.

Imperata cylindrica (L.) Raeusch.

Siva-nili

Indigofera aspalathoides

Indigofera aspalathoides DC.

Vahl ex DC.

Vasa

Adhatoda vasica Nees

Justicia adhatoda L.

Granthiparni

Leonotis nepetaefolia R. Br.

Leonotis nepetifolia (L.) R. Br.

Jivanti

Leptadenia reticulata W.& A.

Leptadenia reticulata

(Retz.) Wight & Arn.

Dronapuspi

Leucas cephalotes Spreng.

Leucas cephalotes (Roth) Spreng.

Sanskrit name Botanical name as given in API Currently accepted Botanical name

Kapittha

Feronia limonia (Linn.) Swingle

Limonia acidissima Groff

Medasakah

Litsea chinensis Lam.

Litsea glutinosa (Lour.) C. B. Rob.

Aklari

Lodoicea maldivica Pers.

Lodoicea maldivica

(J.F.Gmel.) Pers.

Madhuka

Madhuca indica J. F. Gmel.

Madhuca longifolia

(J. Koenig ex L.) J. F. Macbr.

Champaka

Michelia champaca Linn.

Magnolia champaca

(L.) Baill. ex Pierre

Kampilla

Mallotus philippinensis Muell.-Arg. Mallotus philippensis (Lam.) Müll.

Arg.

Murva

Marsdenia tenacissima

Marsdenia tenacissima

Wight. & Arn.

(Roxb.) Moon

Grismachatraka Mollugo cerviana Seringe.

Mollugo cerviana (L.) Ser.

Indivara

Monochoria vaginalis Presl.

Monochoria vaginalis

(Burm.f.) C.Presl

Atmagupta

Mucuna prurita Hook.

Mucuna pruriens (L.) DC.

Vrscikakanda

Doronicum hookeri C. B. Clarke

Nannoglottis hookeri

(C.B. Clarke ex Hook. f.) Kitam.

Jatamansi

Nardostachys jatamansi DC.

Nardostachys jatamansi

(D.Don) DC.

Kadamba

Anthocephalus cadamba Miq.

Neolamarckia cadamba

(Roxb.) Bosser

Karavira

Nerium indicum Mill.

Nerium oleander L.

Utpala

Nymphaea stellata Willd

Nymphaea nouchali Burm. f.

Syonaka

Oroxylum indicum Vent.

Oroxylum indicum (L.) Kurz

Ketaki

Pandanus tectorius

Pandanus tectorius

Soland. ex Parkinson

Parkinson ex Du Roi

Kakajangha

Peristrophe bicalyculata Linn.

Peristrophe bicalyculata

(Retz.) Nees

Jalpippalika

Phyla nodiflora Greene

Phyla nodiflora (L.) Greene

Amalaki

Emblica officinalis Gaertn.

Phyllanthus emblica L.

Nikocaka

Pinus gerardiana Wall.

Pinus gerardiana Wall. ex D.Don

Karkatasrngi

Pistacia chinensis Burgo

Pistacia chinensis Bunge

Parnayavani

Coleus amboinicus Lour.

Plectranthus amboinicus

(Lour.) Spreng.

Rasna

Pluchea lanceolata Oliver & Hiem. Pluchea lanceolata (DC.) C. B. Clarke

Mahameda

Polygonatum cirrhifolium Royle

Polygonatum cirrhifolium (Wall.)

Royle

Karanja

Pongamia pinnata (Linn.) Merr.

Pongamia pinnata (L.) Pierre

Sami

Prosopis cineraria Druce

Prosopis cineraria (L.) Druce

Elavaluka

Prunus avium Linn. f.

Prunus avium (L.) L.

Padmaka

Prunus cerasoides D.Don

Prunus cerasoides

Buch.-Ham. ex D.Don

Raktacandana Pterocarpus santalinus Linn.

Pterocarpus santalinus L. f.

Vidari

Pueraria tuberosa DC.

Pueraria tuberosa (Willd.) DC.

Bharangi

Clerodendrum serratum Linn.

Rotheca serrata

(L.) Steane & Mabb.

Ashoka

Saraca asoca (Rosc.) DC. Willd.

Saraca asoca (Roxb.) Willd.

Kustha

Saussurea lappa C. B. Clarke

Saussurea lappa

(Decne.) Sch. Bip.

( Continued)

(Continued)

Sanskrit name Botanical name as given in API

Currently accepted Botanical name

Gajapippali

Scindapsus officinalis Schoott.

Scindapsus officinalis

(Roxb.) Schott

Mura

Selinium candollei DC.

Selinum wallichianum

(DC.) Raizada & H. O. Saxena

Bhallataka

Semecarpus anacardium Linn.

Semecarpus anacardium L. f.

Svarnapatri

Cassia angustifolia Vahl.

Senna alexandrina Mill.

Prapunnada

Cassia tora Linn.

Senna tora (L.) Roxb.

Itkata

Sesbania bispinosa W. F. Wight

Sesbania bispinosa

(Jacq.) W.Wight

Kantakari

Solanum surattense Burm. f.

Solanum virginianum L.

Patalai

Stereospermum suaveolens DC.

Stereospermum colais (Buch.-

Ham. ex Dillwyn) Mabb.

Kiratatikta

Swertia chirata Buch.-Ham.

Swertia chirata

Buch.-Ham. ex Wall.

Aranya-surana Synantherias syeatica

Synantherias sylvatica

Schott Gen.Aocja

(Roxb.) Schott

Lavanga

Syzygium aromaticum (Linn.)

Syzygium aromaticum

Merr. & M.Perry

(L.) Merr. & L. M. Perry

Saka

Tectona grandis Linn.

Tectona grandis L. f.

Masaparni

Teramnus labialis Spreng.

Teramnus labialis (L. f.) Spreng.

Arjuna

Terminalia arjuna W. & A.

Terminalia arjuna (Roxb. ex DC.)

Wight & Arn.

Bibhitaka

Terminalia belerica Roxb.

Terminalia bellirica

(Gaertn.) Roxb.

Guduci

Tinospora cordifolia (Willd.) Miers. Tinospora sinensis (Lour.) Merr.

Tuni

Cedrela toona Roxb.

Toona ciliata M. Roem.

Yavani

Trachyspermum ammi

Trachyspermum ammi

(Linn.) Sprague ex Turril

(L.) Sprague

Visala

Trichosanthes bracteata

Trichosanthes tricuspidata Lour.

(Lam.) Voigt

Prsniparni

Uraria picta Desv.

Uraria picta (Jacq.) DC.

Tagara

Valeriana wallichii DC.

Valeriana jatamansi Jones

Asphota

Vallaris solanacea Kuntze

Vallaris solanacea (Roth) Kuntze

Vanyajiraka

Centratherum anthelminticum

Vernonia anthelmintica (L.) Willd.

(L.) Kuntze

Sahadevi

Vernonia cinerea Lees.

Vernonia cinerea (L.) Less.

Mudga

Phaseolus radiatus Linn.

Vigna radiata (L.) R. Wilczek

Kesaraja

Wedelia calendulacea

Wedelia calendulacea Rich.

Less non Rich.

Asvagandha

Withania somnifera Dunal.

Withania somnifera (L.) Dunal

Laghupatra-

Trianthema decandra L.

Zaleya decandra (L.) Burm.f.

varsabhu

Ghonta

Ziziphus xylopyrus Willd.

Ziziphus xylopyrus (Retz.) Willd.

Kola

Zizypus jujuba Lam.

Ziziphus mauritiana Mill.

Source: Madasamy Parani and Sophie Lorraine Vassou conceived and designed the experiment. Stalin Nithaniyal SN and Balaji Raju performed the experiments. Madasamy Parani, Sophie Lorraine Vassou, Stalin Nithaniyal, and Balaji Raju analyzed the data. Madasamy Parani and Sophie Lorraine Vassou wrote the Text.

DNA barcoding 179

Views of Indian researchers

Views of DB A. Narayana, Member, Expert Working Group, Phytopharmaceuticals Group of Indian Pharmacopoeia Commission, Member Expert Committee (Non Specified Food and Food Ingredients) of Food Safety and Standards Authority of India, New Delhi, India; and T Sudhakar Johnson, Department of Biotechnology and Center for Innovation, Incubation and Entrepreneurship; Coordinator, DST-NIDHI-Technology Business Incubator, K.L.E.F deemed to be University, Green Fields, Guntur, Andhra Pradesh, India:

Several conventional techniques such as macroscopy, powder microscopy, and other pharmacognostic testing; organoleptic methods; chemotaxonomy; and chemical methods such as thin layer chromatography, high-performance liquid chromatography, Fourier-transform infrared spectroscopy, and liquid chromatography/mass spectrometry (LC/MS) have their own advantages as well as disadvantages. Due to the dearth of trained taxonomists, botanists, and pharmacognosists with the competency to authenticate botanical identity is shifting from the scientific approach to molecular-level studies. This led to the emergence of DNA barcode testing for botanicals as well for their identity.

DNA barcode makes use of short (<1 kb) region of the genome (a barcode) from either nuclear or organelle genome that evolves fast enough to differentiate between closely related species. However, the barcoding of plants evolved at a much slower pace. It became evident that the mitochondrial genome evolves far too slowly in plants to allow it to distinguish between species. A barcode must be flanked by conserved regions that can function as a primer-binding site during polymerase chain reaction amplification. An ideal plant barcode needs to be amplifiable with only a single set of primers so that it can be efficiently retrievable from any of the over 200,000 plant species. Thus, a single barcode fulfilling these two requirements has not been found in plants, and a combination of two or more will be required to approach the level of species discrimination and universality.

Several gene candidates matK, rbcL, trnH-psbA, ITS, trnL-F, 5S-rRNA, and 18S-rRNA have been tested for use in plants with respect to discrimination capacity. However, it was concluded that no single plant barcode exists.

Two international initiatives working toward the development of DNA barcodes include the consortium for the barcode of life (CBOL) and international barcode of life project, after several consultations with stakehold-ers, and evaluating seven chloroplast genomic regions across plant kingdom proposed the use of matK-rbcL combination as a potential barcode for land plants, but with an option to supplement it with one or two other markers, psbA-trnH or ITS. A combination of these two can help achieve maximum species discrimination.

Later, China Plant BOL Group proposed the addition of nuclear ITS to the matK-rbcL combination as a barcode to achieve maximum identification

180 Defining a new scientific path

rates even in closely related species. ITS is by far the most widely sequenced locus for angiosperms compared to 30,325 entries for rbcL, which is most frequently sequenced plastid gene. This should make it the most suitable barcoding region if quick identifications are desired. On the other hand, ITS is discredited due to its nonlinear pattern of evolution in some groups of plants.

However, the presence of universal primer for the ITS region and its evolu-tionary divergence rate suggests that its use as barcode should perhaps be considered, not discrediting it entirely. A number of researchers have studied and published DNA barcode data of raw botanicals, substitutes, and adulterants available in the market in ITS2 region, and these studies have concluded that barcode can successfully be used to differentiate the species and adulterants. Combining barcode data with nuclear magnetic resonance (NMR) have been shown to clearly determine adulteration, for example, in most often used Indian plant for treating women’s disorders, namely Saraca asoca.

United States Pharmacopoeia, British Pharmacopoeia, and Indian Pharmacopoeia have in recognition of this technique included general monographs providing detailed guidance and test methods for using either barcode in ITS or other regions or testing for an intact nucleic acid base. Indian Pharmacopoeia has even prescribed a DNA barcode test as a final alternative when other tests for identity fail for Asparagus racemosus(Shatavari).

However, DNA testing cannot be a final answer as it has its limitations in detecting the authenticity of processed products and finished formulations due to the degradation of DNA fragments. At the same time, DNA barcode is incapable of identifying chemical constituents or plant parts or quantify of plant material used in the product. In such cases, DNA barcode authentication has to be supplemented with NMR, LC-MS, or even metabolomics.

Validated test methods to extract DNA from varying matrix of products, viz., food matrix, pharmaceutical matrix, and cosmetic matrix are not available and pose its own challenges basis proportion of the botanical in the matrix.

In addition, many of the bioinformatic databases which were freeware are becoming chargeable adding to the cost of testing.

Pharmacognosists need to learn and build competency in this area so that their role continues to be relevant and contribute to the growing sector.

Further, authors propose that the manufacturers of products, dietary supplements, and extracts may develop DNA mini-barcodes of shorter than 300

bp to test finished formulations and dietary supplements and validate before

being made available to buyers.6

A study on 203 herbal trade samples

In a recent study, the extent of adulteration in raw herbal trade of 30 important medicinal plants in South India was analyzed. Biological reference material (BRM) consisting of taxonomically authenticated samples of each of the 30 species along with 14 other co-occurring and congeneric allied species that are likely to be used in adulteration was established. DNA barcode signatures of 124 BRM

DNA barcoding 181

using two candidate regions, nr-ITS and psbA-trnH were identified. A total of 203

herbal trade samples representing the 30 medicinal plant species were collected from 34 locations in South India. Using the DNA barcode sequences of the BRM

as reference, the analysis indicated that the substitution ranged from 20 to 100%.

Overall, approximately 12% of the market samples were adulterated.7

A study in Oslo

A number of studies in India have surveyed herbal raw drug markets and tested the authenticity of the herbal drugs using DNA barcoding. These studies reported that 24% of raw drug samples of Phyllanthus amarus Schumach. & Thonn.

were substituted with other phenotypically similar Phyllanthus species. Similar substitution was reported for other species, such as Sida cordifolia L. (76%), Cinnamomum verum J. Presl (70%), Myristica fragrans Houtt. (60%), Senna auriculata (L.) Roxb. (50%), Senna tora (L.) Roxb. (37%) and Senna alexandrina Mill. (8%). Furthermore, 21% of raw drugs in Indian herbal markets were unauthentic. One researcher found that 60% of 93 herbal products sold in the form of capsules and plant powders in local stores in India were adulterated. Studies that combined spectroscopic methods, such as NMR, with DNA barcoding or microscopy to authenticate herbal products, reported 80% adulteration in Saraca asoca, 80% in Berberis aristata, and 22% in Piper nigrum. All these studies utilizing DNA barcoding and metabarcoding have highlighted the concerns over the

quality and good labeling practices of herbal products.8

References

1 Cordial acknowledgment. Synopsis based on the paper, Creation of reference DNA barcode library and authentication of medicinal plant raw drugs used in Ayurvedic medicine, published as part of BMC Complementary and Alternative Medicine, 16(1), 2016: Proceedings of the Indian Genetics Congress, 2015: Complementary and Alternative Medicine. The full contents of the supplement are available online at http://bmccom-

plementalternmed.biomedcentral.com/articles/supplements/volume-16-supplement-1,

doi:10.1186/s12906-016-1086-0.) PMCID: PMC4959393 PMID: 27454470.)

2 Phytochem Bull., 1987, 9: 11–15.

3 http://blast.ncbi.nlm.nih.gov/Blast.cgi

4 Meier R, K Shiyang, G Vaidya, PKL Ng. DNA barcoding and taxonomy in diptera: A tale of high intraspecific variability and low identification success. Syst Biol, 2006, 55: 715–728, doi:10.1080/10635150600969864.

5 The first part of the botanical name refers to the genus, second part to its species, followed by the name of the author who identified the species. For full names of the authors, see Maberley’s Plant Book, latest edition, published by Cambridge University Press. DJ

Maberley has elaborated one sample entry: Anisodus stramoniifolius (Wallich) G. Don f.

The species was first described in another genus by Nathaniel Wallich (or Nathan Wolf), and first referred to Anisodus by George Don. Now we give three Indian examples to highlight the importance of the author of the species: Ziziphus jujuba (Lam) Gaertn.

non Mill. is common jujube or Kola of Ayurvedic medicine, while Ziziphus jujuba Mill.

182 Defining a new scientific path

is Chinese Tsao (Unnaba of Unani medicine). Capsicum frutescens sensu Clarke, non Linn. and Capsicum frutescens Linn. are two different species of capsicum. Carum carvi Linn. and Carum carvi Linn. forma gracile (Lindl.) Wolf are two different species.

6 DNA Barcode testing in the authentication of botanical raw material coming of age, Phcog Mag, 2018, 14(Suppl S1): 1–2.

7 Santhosh Kumar JU et al., Biotech, 2018, 3(8): 135.

8 Seethapathy GS et al, Front. Plant Sci., February 5, 2019.





15 Modern extraction methods

and standardization of

extracts

Vikram Andrew Naharwar

The current rationale for producing extracts in India as determined by the Ayurvedic Pharmacopoeia of India (API, Part I, Vol. IX) is counterproductive to the advancement of quality/clinically validated ingredients. The API permits extraction of herbs with either an aqueous or a hydroalcoholic medium ignoring the nonpolar constituents of herbs that have proven pharmacological activity. A case in point is Commiphora mukul that can only be extracted efficiently using Ethyl Acetate. This chapter discusses the various methods of extraction and goes beyond the limited scope of the API. Several important biologically actives compounds require nonpolar extraction, often phase separation and even multiple solvent extractions. The type of extraction process employed for producing the most natural and efficient product are discussed here:

Some of the commercial methods of extraction

1 Decoction: Herbs are heated in an aqueous solution for a period of time determined by individuals conducting the extraction. Generally, the extraction stops when the herb no longer yields any color in the menstruum. The decoction can be presented in a liquid form, concentrated to a paste, or further concentrated to a dry powder form. Dried decoctions were developed in Japan in the 1950s and have become a major method of providing herbs in Japan, Taiwan, the United States, and Europe.

2 Forced Extraction: This is conducted under pressure in a closed vessel usually made of food grade stainless steel. Herbs are loaded to an inner chamber that is suspended within the main vessel. The extraction menstruum is introduced at a ratio determined by the technologist. The menstruum is heated to the desired temperature and circulated for a period of time-based on each technologist’s experience. The menstruum is removed and distilled off under vacuum to yield a liquid/thick paste which is either presented as is or dried by various methods to yield a powder.

3 Countercurrent extraction: This involves a liquid-liquid extraction process and principles are similar to those of droplet countercurrent chromatography and partition chromatography. A lower stationary phase is combined in a series of tubes and an upper immiscible liquid is shaken and allowed to

184 Defining a new scientific path

separate between each transference. The mixture to be fractionated is placed in the first tube containing the immiscible liquid and the apparatus is agitated.

The layers are allowed to separate. The compounds in the mixture will be distributed between the two layers according to their partition coefficient.

4 Microwave-assisted extraction (MAE): The application of microwave-assisted extraction process for isolation and extraction of phytoconstituents from plant material has gained increasing importance. The conventional techniques used for extraction have limitations of requiring longer extraction times, large solvent volumes and cause degradation of thermo-labile components. MAE technique requires less solvent volume, gives high and fast extraction performance and offers protection to thermo-labile constituents.

Microwaves possess electric and magnetic fields which are perpendicular to each other. The electric field causes heating via two simultaneous mechanisms, namely, dipolar rotation and ionic conduction. Dipolar rotation is due to the alignment on the electric field of the molecules possessing a dipole moment in both the solvent and the solid sample. This oscillation produces collisions with surrounding molecules leading to the liberation of thermal energy into the medium. With a frequency of 2.45 GHz, this phenomenon occurs 4.9 × 109 times faster and thus the resulting temperature increase is rapid. The larger the dielectric constant of the solvent, the more rapid the heating. Consequently, unlike classical conductive heating methods, microwaves heat the whole biomass uniformly. In the case of extraction, the advantage of microwave heating is the disruption of weak hydrogen bonds promoted by the dipole rotation of the molecules.

The target for heating dried plant material is the minute microscopic traces of moisture that occurs in plant cells. The effect of microwave on the plant cells is a rapid increase in temperature rupturing the cells and releasing the compound(s) of interest in the menstruum.

5 Ultrasonic Extraction (UAE): UAE involves the application of high-intensity, high-frequency sound waves and their interaction with materials. UAE

is a potentially useful technology as it does not require complex instruments and is relatively low-cost. It can be used both on a small and large scale.1

UAE involves ultrasonic effects of acoustic cavitations. Under ultrasonic action, solid and liquid particles are vibrated and accelerated and, because of that solute quickly diffuses out from solid phase to solvent.2 Several probable mechanisms for the ultrasonic enhancement of extraction, such as cell disruption, improved penetration, and enhanced swelling, capillary effect, and hydration process have been proposed. If the intensity of the ultrasound is increased in a liquid, then it reaches a point at which the intramolecular forces are not able to hold the molecular structure intact, so it breaks down and bubbles are created, this process is called cavitation.3 The collapse of bubbles can produce physical, chemical and mechanical effects which result in the disruption of biological membranes to facilitate the release of extractable compounds and enhance penetration of solvent into cellular materials and improve mass transfer.2,4 The beneficial effects of sound waves on extraction

Modern extraction methods & standardization 185

are attributed to the formation and asymmetrical collapse of microcavities in the vicinity of cell walls leading to the generation of microjets rupturing the cells. The pulsation of bubbles is thought to cause acoustic streaming which improves mass transfer rate by preventing the solvent layer surrounding the plant tissue from getting saturated and hence the enhancement of convection.

6 Supercritical fluid extraction (SFE): Supercritical fluid extraction (SFE) is the process of separating one component (the extractant) from another (the matrix) using supercritical fluids that is CO as the extracting solvent. CO

2

2

is the major supercritical fluid for extraction of botanicals. Extraction conditions for supercritical CO are above the critical temperature of 31°C and 2

critical pressure of 74 bar. Supercritical fluids are highly compressed gases, which have combined properties of gases and liquids in an intriguing manner.

Supercritical fluids can lead to reactions, which are difficult or even impossible to achieve in conventional solvents. It is a fast process completed in 10

to 60 minutes. A supercritical fluid can be separated from analyte by simply releasing pressure, leaving almost no trace and yields a pure residue. However the extraction is mainly for nonpolar compounds such as oils, fats, resins, and this process is now the first choice for extraction of spice oleoresins, floral oils etc.

7 Drying of extracts: There are various methods employed for drying of extracts, these are discussed briefly:

Tray drying: The most basic form of drying involves placing liquid extracts in trays and placing them in an oven (steam or electric). The heat evaporates the latent moisture and results in a hard dry mass that is pulverized to yield a powder.

Vacuum tray drying: This is much the same process as tray drying with the addition of a vacuum system that helps dry faster and removes any oxygen from the drying chamber resulting in a better quality powder.

Rotary vacuum drying: Liquid extracts are injected into a vacuum sealed chamber that rotates at a slow speed distributing the heat evenly. This is the preferred system of drying extracts that are thermo-labile.

Spray drying: This method involves a continuous feed of liquid extract into an atomizer that spins at a very high speed. Hot air (typically over 180°C) is injected into a chamber and blasts the water molecules in the liquid extract resulting in instant evaporation of water. The fine dried powder is collected in a collection chamber. This system has an advantage of high throughput, however, suffers from high temperature, injection of oxygen that can oxidize bioactive compounds, the continuous exposure to high heat during the collection process can degrade thermo-sensitive compounds and a very low bulk density makes capsule filling challenging.

Freeze drying: Freeze drying uses a process called lyophilization to gently freeze the product, and then the water is extracted in the form of vapour using high-pressure vacuum. The vapour collects on a condenser below the freezing chamber, returns to ice and is removed. A gradual

186 Defining a new scientific path

temperature rise extracts all remaining “bound” moisture from the product. This process retains the chemical structure of the product and preserves it indefinitely. The freeze dried products can be re-hydrated at any time by adding water or can be consumed in their dried format.

Strength and limitation of various extraction

techniques

• Decoction method: This method is only suitable for extracting heat-stable polar compounds. This method does not permit the use of nonpolar solvents thereby restricting the spectrum of naturally occurring compounds.

• Forced extraction method: This method allows the use of polar, nonpolar and a mixture of solvents. This method is the most popular in commercial scale due to efficiency, cost, quality of extract and flexibility of extraction potential. The downside is the time taken to produce an extract.

• Countercurrent extraction method: This is a highly selective method as it yields selective compounds, however, this method is extremely expensive and utilized for research purposes rather than commercial extraction.

• Microwave assisted extraction: This method is fast and efficient in extracting most compounds, however, suffers from scalability and the potential of fire due to highly flammable solvents used to extract herbs. This method is best suited to polar extraction.

• Ultrasonic extraction: This method is by far the most promising in commercial production as it produces high yields with a short extraction time. The current challenges are the cost and the safety as the ultrasonic generators need to be enclosed in a flameproof enclosure which leads to a loss of efficiency.

However polar extraction is certainly a very viable process by Ultrasonic method.

• Supercritical fluid extraction: This method has become extremely popular for the production of oleoresins, oils, lipid soluble compounds. It is recycled without much loss with good solvent characteristics for nonpolar compounds and is easily removed from the product. The dissolving power and selectively can be controlled by selection of suitable pressure/temperature combination.

Extractions are carried out at comparatively low temperature (often as low as 40°C or 50°C), decreasing the risk of damage of thermalabile compounds.

Most of the volatile components, which tend to be lost in hydrodistillation, are retained by SFE.

• Soxhlet extraction: Evaluation of Soxhlet extraction for Moringa olief-era leaves resulted in lower yield, phenolics and flavonoids content.5 Opti-

mization of Centella asiatica extraction using Soxhlet extraction showed to achieve optimum metal chelating activities at the temperature of 25°C, the sample-solvent ratio of 1:45, at 200 rpm agitation speed and for 1.5 hours.

Soxhlet extraction has been used to remove lypodial materials from powdered Clitorea ternata flowers using petroleum ether at 60°–80°C resulted in a 2.2% yield w/w.5 Further extraction of the marc with ethanol ascertained

Modern extraction methods & standardization 187

the presence of alkaloids and saponins, but the major component of Clitorea ternate flowers, the anthocyanin was absence, suggesting oxidation and degradation had occurred.

Soxhlet extraction comes with disadvantage such as exposure to hazardous and flammable liquid organic solvents, with potential toxic emissions during extraction. This procedure is considered not environmental friendly. The ideal sample for Soxhlet extraction is also limited to a dry and finely divided solid.

• Evaluation on Microwave assisted extraction (MAE) as a new method to extract triterpene from Centella asiatica showed an increase in yield, twice of Soxhlet extraction with extraction condition; absolute ethanol as solvent, at 75°C and irradiation power at 600 W for four cycles. Enzymolysis (e.g., cellulase) has been combined with MAE to improved extraction, and optimum condition of sample-solvent ratio at 1:36, the temperature of 45°C for 30 minutes enzyme pretreatment, with irradiation at 650 W for 110 s resulted in 27.10% yield.

MAE with 100 W for 20 minutes on Dioscorea hispida yielded the highest extraction using 85% ethanol at 1:12.5 sample–solvent ratios. Decreased in yield was observed when the optimum value of each parameter on Dioscorea hispida MAE is exceeded. Extraction time and irradiation power are as critical as solvents type in MAE. Effect of 119.7 W and 39.9 W reached their optimum yield at 5 minutes and 17.5 minutes respectively in Andrographis paniculata extraction.

• The benefits of Ultrasound-assisted extraction (UAE) or sonication extraction is mainly a due reduction in extraction time and solvent consumption.

However, the use of ultrasound energy more than 20 kHz may have an effect on the active phytochemicals through the formation of free radicals. UAE

of Withania somnifera by water solvent at 15 minutes showed maximum yield, 11.85% compared to ethanol and water-ethanol at different 5, 15 and 20 minute extraction period.

• Accelerated solvent extraction (ASE) is an efficient form of liquid solvent extraction compared to maceration and Soxhlet extraction as the method uses a minimal amount of solvent. Similar to other solvent technique, ASE also critically depends on the solvent types. Cyclohexaneacetone solution at the ratio of 6:4 v/v with 5 minutes heating (50°C) showed to yield the highest bixin from Bixa orellana with 68.16% purity. High recoveries (~94%) of flavonoids from Rheum palmatun were observed using 80% aqueous methanol by ASE, suggesting the suitability of this method for quality control evaluation.

• Supercritical fluid extraction (SFE) or also called as dense-gas is a substance that shares the physical properties of both gas and liquid at its critical point.

Supercritical-CO (SC-CO ) has poor solubility for polar compounds, modi-2

2

fication such as adding small amount of ethanol and methanol enable it to extracts polar compounds. A major drawback of this method is the initial cost

of the equipment is very high.5

188 Defining a new scientific path

Importance of natural configuration of compounds

Standardization of herbs is based on the premise that isolated/concentrated compounds are responsible for the action of an herb. However, this kind of extract no longer resembles a natural extract but is a concentrated phytochemical. Herbs are not known for just a single function. In fact, plants contain a complex blend of phytochemicals and possess the unique ability to address a multiplicity of problems simultaneously based on complexing with other herbs or even by changing the dose.

The medicinal value of a plant is due to its natural configuration of compounds.

Nature in its infinite wisdom has given each plant a unique chemical fingerprint; all plants have dozens if not more naturally occurring phytochemicals, most of which remain unknown even today. Many compounds are found across a vast range of plants, and this leads to the question of whether a specific phytochemical is responsible for the pharmacological activity or the entire spectrum of compounds? The answer is clearly the latter. This led to the establishment of what is now known as Full Spectrum Extracts. A company in India pioneered this process in the 1960s.

A Full Spectrum Extract is one that reflects the natural chemical profile of the original plants without manipulation or selective extraction of one or more components. These extracts are a concentrated form of the original plant, produced by eliminating inactive material, such as fiber. These extracts are developed by exhaustive research on the entire spectrum of naturally occurring compounds by chemical fingerprinting across the range of polarity. These extracts typically contain polar and nonpolar compounds. The qualitative analysis is done by TLC to demonstrate the chemical profile of the extract. While most extracts are produced to show a higher concentration of one compound. This trend is dangerous since plants contain synergetic compounds that potentiate the activity of others and or provide a safety mechanism for compounds that in isolation or high concentration can be toxic.

Consequently, standardization may concentrate one constituent at the expense of other potentially important ones, while changing the natural balance of the herb’s chemical profile. While immense progress has been made in identifying plant chemistry, the true chemical profile of each plant and the medicinal value of each of its components in isolation or in their natural configuration is unknown and therefore the Full Spectrum Standardized Format represents the closest man can get to nature.

There is also a risk involved in “standardization” of selective compounds.

Several herbs contain poisonous substances. Atropa Belladonna is a poisonous plant, known as deadly nightshade. Its roots, leaves, and fruits contain alkaloids: atropine, hyocyamine, and scopolamine. The risk of poisoning in children is important because of possible confusion with other berries. If the extract is not standardized for its natural Full Spectrum of compounds, the toxic compounds can be enhanced and vary from batch to batch making the extract extremely dangerous. In this case, the standardization must always be expressed in terms of % of

Modern extraction methods & standardization 189

atropine, hyocyamine, scopolamine, and total alkaloids and a chemical fingerprint produced for every batch.

Understanding the concept of standardization

The industry uses the term “standardization” with a great deal of liberty without understanding the concept or science. There are different forms of standardization: The first and simplest form is a level of concentration (quantity of crude herb processed to yield a kilo of extract; as an example, Glycyrrihza glabra extracts typically are in the 5:1 ratio indicating that 5 kilos of dried crude root are used to produce 1 kilo of extract).

The strength of herbal extracts is generally expressed as a ratio of dry plant material to the final extract quantity, also known as the drug extract ratio (DER).

It is expressed in the following format:

X:Y

X = weight of dry plant material

Y = weight or volume of extract (depending upon whether the extract is a solid/

dry or a liquid extract)

The concept here is that the essential activity of the dry plant material (X) is found in the quantity of extract (Y). Or in other words, Y quantity of the extract is equivalent to X quantity of the dry plant.

The second form is to state a level of bioactive value. (As an example, Glycyrrhiza glabra extract is usually stated as 24% glycyrrihizin by the Garret method).

The crude root yields approximately 4–5% crude glycyrrhizin, and a 5:1 concentration should give an extract with 20–25% crude glycyrrhizin. However, each extraction company has a different herb:extract ratio and a different level of marker compound. One of the major challenges is to establish industry-wide standards for raw herbal biomass to ensure that standardization of extracts is uniform.

The third and more scientific method is bioactivity guided assay. These are relatively simple at a basic level or can be extended to clinical studies that define dose response, safety and efficacy. Extracts are then expressed in terms of the activity of mg/kilo body weight for the indication prescribed. As an example, the antioxidant activity can be determined by the Ferric Reducing Ability of Plasma (FRAP) assay and 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) assay methods.

In order to establish a scientific basis for claiming standardization, extracts should bear the same biochemical identity as the original herb. By removing inert material such as fiber and substances like chlorophyll the extracts are concentrated to a logical degree and can be stated in terms of their concentration (5:1, 10:1, etc.). Further, a chromatographic fingerprint for each batch is essential to ensure batch to batch conformity, dose validation and completion of extraction.

Further, simple TLC can establish qualitative benchmarks that will ensure that a

190 Defining a new scientific path

herb extract reflects the naturally occurring primary metabolites and secondary metabolites.

A general principle of herbal medicine is that the activity of the medicine is due to a combination of active chemicals in the plant or the extract. Thus, in most cases, it is desirable to create an extract that most closely represents the chemical complexity of the dry plant material. Such extracts are often termed “Galenical Extracts,” and more recently “Full Spectrum Extracts.”

Extract equivalency and dosage calculations

With multiple dosage forms now being common in herbal medicine, it is essential that formulators can convert between extract and dry herb equivalency, and vice-versa. This process is very simple; however, it carries a risk if extract equivalency is not coupled with TLC fingerprint and marker compounds analysis (preferably analysis of the major class of compounds), and it is essential that all herbal formulators can do these conversions quickly and accurately.

For instance, the conversion between extract and herb is given here:

• An extract of Emblica officinalis tablet stated to contain 500 mg of a 4:1

extract, with a dose of 1 tablet three times daily, translates to a dose of 2,000

mg of crude dry fruit per dose or 6,000 mg per day. ( Bhavprakash nighantu recommends 3–12 g a day, while Ayurvedic Formulary of India recommends 3–6 g a day.)

• Therefore a scientific basis of the anti-oxidant activity or bio-guided assays are essential for clinical dose validation.

• To further establish the qualitative assay, TLC should be conducted to identify the major bioactive compounds present, and a HPTLC fingerprint to demonstrate the quantity of the major compounds present in the plant extract.

Chemical constituents identified in important

medicinal herb extracts

Botanical name

Part used

Chemical constituents

Abies webbiana

Leaves

Abiesin, betuloside, abietane

Abrus precatorius

Seeds

Aberin, hypaphorine, precatorin,

abridin, abrusin

Root

Precol, abrol, abrasine, precasine

Acacia Arabica

Gum

Galactose, aldobio uronic,

arobinobioses, calcium

Bark

Tannins, polyphynolic componds

Acasia leuocuphlosa

Stem bark

Tannins, n-hexacosanol, β-amyrin,

β-sitosterol

Achyranthus aspera

Root

Triterpenoid saponins, oleanolic

acid, achyranthine

Kshara (whole

plant)

Botanical name

Part used

Chemical constituents

Aconitum chasmanthum

Root

Alkaloids, pseudo aconitine,

chasmacontine, indaconitine

Aconitum palmantum

Root

Aconitin

Ailanthus excelsa

Stem bark

Ailanthic acid, melanthine,

β-sitosterol, quassinoids

Albizzia lebbek

Bark

Tannins, pseudotannins, friedelin,

β-sitosterol

Alhagi pseudhalhagi

Whole plant

Flavonoid glycosides kaempferol,

chrysoeriol, isorhamnetin,

Allium sativum

Bulb

Alliin, arinicacid, allinase,

allyalcohol, scordine

Aloe barbadensis

Leaves

Emodin, aloctin A, galactose,

aloesin, aloenin

Alstonia scholaris

Stem bark

Ditamine, echitenine, echitamine,

picrinine

Alternanthera Sessilis

Whole plant

Flavonoids, tannins, phenols,

saponins

Alternanthera triandra

Whole plant

Flavenoids, tannins, saponins,

phenols

Amaranthus tricolor

Whole plant

Fatty oils, sitosterol, calcium, and

magnesium

Anacyclus pyrethrum

Root

Anacycline, inulin, isobutylamide

Andropogon Citratus

Leaves

Citral, citronellal, citronellol,

geraniol, geranyl-Acetate

Anethum sowa

Seeds (oil)

α and β-pinene, sabinene,

myrcene, limonene

Angelica archangelica

Root

Limonene, S-phellandrene, pinene,

p-cymene, terpinolene

Angelica glauca

Root

Furocoumarins, dimeric latone,

lingusticum latone, volatile oils

Anogeissus latifolia

Bark

Tannins, quinic, shikmik acid

Anthocephalus cadamba

Bark

Alkaloids, steroids, tannins,

chichotannins

Arctocarpus lakoocha

Bark

Alpha amyrin, β-amyrin, tannins,

β-sitosterol

Aregyreia speciosa

Roots

Tannins, resin

Baliospermum montanum

Root

Baliospermin, montanin

Bambosa bambos

Dried resin

Silica, silicic acid, peroxide or

iron, potash, lime

Barringtonia acutangula

Bark

Tannins, dihydromuticetin, gallic

acid, bartogenic acid

Fruit, root

Triterpenoids, sapogenins,

glucosides

Bauhinia variegata

Stem bark

Flavones, flavenol glycosides,

tannins

Betulis utilis

Bark

Methyl salicylate, botulin, lupeol,

oleaonic acid

Blepharis dulis

Seeds

Allantonin, blepharin,

blepharigenin, β-Sitosterol

Leaf

Phenolics and flavonoids

Boerhaavia diffusa

Root

Hentriacontane, punarnavine,

punarnavoside, oxalic acis

( Continued)

(Continued)

Botanical name

Part used

Chemical constituents

Boerhaavia verticilata

Root

Punarnavosides, oxalic acid,

punarnavine 1 &2

Borassus flabellifer

Fruit

Vitamin C, carotene, protein,

minerals

Buchananta Lanzen

Seeds, nuts

Kaempferol

Caesalpinia crista

Seeds

phytosterenin, bonducin, saponin,

bonducella

phytosterol, fixed oil, starch

Caesalpinia sappan

Heartwood

Throconine, β-amyrin, glucoside

alarine

Cajanus cajan

Root

Saponins and reducing sugars,

flavonoids, terpenoids

Seeds

Hydrocyanic acid, coumarin,

amygdalin

Calycopteris floribunda

Stem

Octacesanol, sitosterol,

calycopterin,

Cardiospermum

Seed

Fixed oil

helicacabum

Careya arborea

Bark

lupeol, β-sitesterol, betulin,

Carthamus tinctorius

Seeds

Chalcone C-glucoside carthamin

Leaves

Hinesol-β-D-fucopyranoside,

1-pentadecene

Carum Carvi

Seeds

Volatile oils, cuminaldehyde,

cymene

Cassia Absus

Seeds

β-Sitosterol, hydnocarpin,

apigenin

Cassia tora

Whole plant

Fistacacidine, emodin,

rubrofusarin, isotoralactone

Cholorophytum tuberosum

Root

Sapogenins A & B, stigmasterol

Cicer arietinum

whole plant

Quercetin, isoquercetin,

kaempferol-3-glucoside,

astragalin

Cinnamomum tamala

Bark

Cinnamaldehyde

Leaf

Linalool, cinnamaldehyde,

limonene

Cinnamomum zeylanicum

Stem bark

Cinnamaldehyde, eugenol,pinene,

linalool, benzaldehyde

Cissampelos pariera

Root

Hayatin, hayatinin, menismine,

cissamine, cycleanine

Citrullus colocynthis

Root

Saponins, alpha-elaterin

Fruit

Colocynthin and Colocynthitin,

Citrullol, Pectin

Citrus limon

Fruit

Citric acid

Citrus medica

Fruit

Citric acid, glucose, limonin,

limonene, rutin

Clitoria ternatea

Root

Ternatins, alkaloids, flavonoids,

saponins, tannins,

Carbohydrates, proteins, resins,

starch, taraxerol

Seeds

Palmitic, stearic, oleic, linoleic

acid, cinnamic acid

Botanical name

Part used

Chemical constituents

Cocos nucifera

Fruit

Proteins, vitamin C, B, iron

Commiphora myrrha

Resin

Commiferin A & B, myrrhol,

murrhin, limonene

Coriandrum sativum

Seeds

β-sitosterol, D-maninitol,

coriandrinonediol, linalool

Coscinium fenestrstum

Roots

Calumbin, berberine, palmatine,

calumbic acid

Crocus sativus

Stigma

Terpenes, terpene esters, crocetin,

carotenoids

Crotalaria juncea

Seeds

Corchorin

Croton tiglium

Seed

Tinglinic acid, crotonic acid,

crotonol

Cryptolepis buchanani

Root

Alkaloids

Cucumis melo

Seeds

Oil and sugars

Cucumis sativus

Fruit

Rutin, ascorbic acid, β-sitesterol,

pristine

Seeds

Glucosides

Cuminum cyminum

Seeds

Cuminaldehyde, cymene,

terpenoids

Curculigo orchioides

Root

Saponins, phenolic glycosides,

sitosterol, sigmasterol

cyanodon dactylon

Whole plant

Ferulic, Phenolic phyto-toxins,

vannilictricin

Cymbopogon citratus

Leaf

Volatile oils, citral, citronella,

citronellol

cymbopogon Jawarancusa

Whole plant

Piperitone, borneol, cadinene,

camphene, camphor, farnesene

Cymbopogon martinii

Whole plant

Geraniol, geranyl acetate,

citronellol, linalool, geranyl

butyrate

Cyperus Rotundus

Tuber

Cineol, copaene, cyperol,

cyperolone, kodusone

Dalbergia sissoo

Heartwood

Dalbergipherol

Bark

Isotectorigenin

Leaves

Biochanin A, tectorigenin

Desmodium gangeticum

Roort

Hypaphorine, hordenin, caudicine,

gangetinin,demodin

Desmostachya bipinnata

Root

Cylindrin, arundroine, feninole

Dioscorea bulbifera

Tuber

Diosbulbinosides

Diospyros tomentosa

Stem bark, fruit

Lupeol, betulin, β-sitosterol

Dipterocarpus turbinatus

Bark

Dipterocarpol, betulonic acid

Oil

A-Cardiana, A-muurolene

Dolichos biflorus

Seeds

Protein, pantosan, genistein,

colliding

Elaeocarpus ganitrus

Seeds

Rudrakine, quercetin, gallic acid

Erythrina indica

Bark

Erythrinins A, B, C, erysotin,

erythratidine, alkaloids

Leaves

Ertybidine, alkaloids

Euphorbia dracunculgides

Whole plant

Glyco-alkaloid (euphorbine).

Euphorbia thynifolia

Whole plant

Glucoside, galactoside,

β-sitosterol, campesterol

( Continued)

(Continued)

Botanical name

Part used

Chemical constituents

Fagonia cretica

Whole plant

Sapogenin, nahagenin, oleanolic

acid, diterpenes

Ficus arnottiana

Root

Tannins

Ficus bengalensis

Bark

Glycosides

Leaves, latex

Triterpins, friedelin, sitosterol

Ficus hispida

Root

β-sitosterol, β-amyrin, hispidin,

psoralen

Ficus lacor

Bark

β-sitosterol, lanosterol, caffinic

acid, bergenin

Ficus racemose

Bark

Flavonoids, kaempferol and

coumarin, sterols

Fruit

Gluacol, β-Sitosterol, Lupeol,

Ceryl behenate

Ficus religiosa

Bark

β-Sitosterol, Vit K, methyl

oleanolate, stigmasteriol

Leaves

Carbohydrate, protein, lipid,

calcium, sodium, potassium

Forniculum vulgare

Seeds

β-carotene, calcium, iron, vitamin

C

Fritillaria roylei

Root

Catechin, gallic acid, ferulic acid,

vanillic acid, ferulic acid

Garcinia indica

Fruit

Garcinol, isogarcinol, comboginol

Garcinia Pendunculata

Fruit

Pendunculol, garcinol, cambogin

Garuga pinnata

Whole plant

Flavonoids, alkaloids, and tannins

Gentiana kurroo

Root

Secoiridoid, amarogentin,

alkaloids, gentianine,

gentoflovin

Gloriosa superba

Rhizome

Colchicine, gloriosine

Glycyrrhiza glabra

Root

Glycyrrhizin

Gmelina arbonea

Root

Cluytylferulate, n-octacosanol,

gmelinol, arboreol, stigmasterol

Fruit

Butyric and tartaric acids,

β-sitosterol, ceryl alcohol,

gmelinol

Grewia asiatica

Fruit

Alkaloids, sugars, tannin &

phenolic compound, flavonoids

Grewia populifolia

Stem bark

Sugar, tannin, and sterols

Gymmema Sylvestre

Leaf

Gymnemic acid, quereitol

Gynandropsis gynandra

Seeds

β-kitosterol, kaempferol,

glucocibrine, luteolin

Leaves

Carotenoids, cardiac glycosides,

flavonoids, saponins, tannins

Habenaria intermedia

Tuber

Alkaloids, coumarin glycoside,

phenolic compounds

Habeneria sarasiformi

Rhizomes

Taxol, starch

Hedychium spicatum

Rhizomes

Sitosterol, glucosides, furanoids

Hibiscus esculantus

Fruit (pods)

Quercetin, hyperin, D-glucose,

D-glucuronic

Hibuscus sabdariffa

Flowers

Sucrose, xylose, hibiscetin, h

ibiscin, pectin, oxalic acid

Botanical name

Part used

Chemical constituents

Hiptage benghalensis

Leaf, bark

Cellulose, lignin, hiptagin

Hordeum vulgare

Whole plant

Proteins, carbohydrate, free

Amino-acids, vitamins, tannins

Hydnocarpus laurifolia

Seed

Hypnocarpic acid, chaulmoorgic

acid, oleic acid

Imperata cylindrica

Root

Cylindrin, arundoin, fernenon,

isoburneol and simiarenol.

Indigofera Tinctoria

Root

Indican

Leaf

Indican

Inula racemose

Root

Alantolactone, isoalantolactone,

sitosterol, inunolise

Ipomoea pelaloidea

Tuber

β-sitosterol, stigmasterol, puerarin,

duidzein

Jasminium officinale

Flowers

Pyridine, n icotinate, benzyl

acetate, linalool

Leaves

Ascorbic acid, anthranilic acid,

glucoside

Jatropha glandulifera

Seeds

Jatrophin, jatropholone A,

fraxetin, coumarino-lignan (I)

Jugulas Regia

Fruit

Vitamin A, B, ascorbic acid

Leaves

Volatile oils, terpenoid substances,

eugenol

Bark

Bisjuglon, oligomeric juglons

Lagenaria sinceraria

Fruit

Curcurbitacin B, aglycones

Leaves

Curcurbitacin B

Lens culinaris

Seeds

Flavonoids and vitamins.

lepidium sativum

Seeds

Calcium, Iron, glutamic acid,

leucin, linolinic acid, folic acid

Leucas cephalotes

Whole plant

Laballenic acid, β-sitosterol,

stigmasterol

Lillium polyphyllum

Root

Catechin, gallic acid, ferulic acid,

vanillic acid, ferulic acid

Linum usitatissimum

Seeds

Campesterol, sitosterol,

cycloarthenol

Seed oil

Omega 3 and 6 fatty acids, alfa-

linoleic acid

Lippia nodiflora

Whole plant

Nodiflorin A & B, nodifloretin

Liquidambar orientalis

Exudate

Cinnamic acid, benzoic acid

Lodoicea maldivica

Fruit

Sugars and sterols

Madhuca indica

Flowers

Sugars

Mangifera indica

Fruit ripe

Carotenoids, vitamin B, calcium,

potassium

Unripe

Vitamin C, carotenoids, vitamin B,

calcium, potasium

Young leaves

Tannins, flavonoids, alkaloids,

steroids

Bark & Root

Mangiferolic acid, indicenol,

mangiferin

Seed & kernal

Palmitic, linoleic, arachidonic and

behenic acids

Marsdenia tenacissima

Root

Glycosides

( Continued)

(Continued)

Botanical name

Part used

Chemical constituents

Melia azedarch

Stem bark

Tannins and alkaloids

Michelia champaca

Bark

Liriodenine, macheline,

lanuginosine

Flowers

Champacene, linalool

Microstylis wallici

Tubers

Carbohydrates, total sugars,

proteins, phenols

Microstylus muscifera

Psudo bulb

Piperitone, citronella, eugenol,

limonene, β-sitosterol

Mimosa pudica

Root/leaves

Mimosine, turgorin,

c-glycosylflavones

Mimusops elengi

Bark

Tannins, saponins, taraxerone,

taraxerol

Flowers

D-mannitol, β-sitesterol,

D-glycoside

Musa paradisiaca

Fruit

Starch, albuminoids, glycosides,

vitamin C

Stem

Hexoses, uronic acid

Myrica nagi

Bark

Myricanol, proanthocyanidin

Myristica Fragrans

Seeds

Beta pipene, alpha-teroinene,

safrole, myristicin, myristic acid

Myristica malabarica

Seed

Isoflavones, diarylnonanoids,

tannins,

Nelumbo nucifera

Seeds

Palmitic, myristic, oleic and

linoleic acid

Nerium indicum

Root

Karabin, neriodin, neriodorin,

obandrin

Nymphaea stellata

Flowers

Nymphalin, quercetin, kaempferol

Root

Luteolin

Onosma bracteatum

Leaf

Lycopsamine, supindine

viridiflorate

Flowers

Cholin, glucose, fructose

Oroxylum Indicum

Root

Baicalein, teluin, oroxindin,

chysin, prunetin

Oryza sativa

Fruit

Starch

Osmanthus fragrans

Fruit

Ketones, alcohols, asters,

aldehydes, 1,3,5-trioxepane

Ougeinia dalbergoides

Heartwood

Isoflavinoids, hemoferitin,

urgenin, oujenin

Bark

lupeol, botulin, tannins

Parmelia perlata

Whole plant

Lichenin, lecanoric acid, atraric

acid, gum

Pentatropsis microphylla

whole plant

n-octacosanol, alpha-amyrin,

friedelin, β-sitosterol

phaseolus mungo

Seeds

Calcium, potassium, iron,

magnesium, copper, manganes

Phaseolus radiatus

Seeds

Saponin, starch, albuminoids and

oil.

Phaseolus trilobus

Whole plant

Vitexin, lutcolin, quercetin

Botanical name

Part used

Chemical constituents

Phoenix dactylifera

Fruit

Vitamin A, thiamine, xylose,

tannin, galactose, ribose

Pinus roxburghii

Bark

Turpentine, pinene, abietic acid,

careen

Piper betle

Leaf

Essential Oil, amino Acids,

vitamins and enzymes.

Piper chaba

Root

Piperine, sitosterol piplartine

Piper cuboba

Fruit

Cubebine, kinokinin, cubebic acid,

cyclohexanes

Pistacia integerrima

Gall

n-decan-3′-ol-yl-n-eicosanoate,

n-octadecan-9,11-diol-7-one

Plumbago zeylanica

Root

Chitranone, plumbagin,

plumbagicacid, elliptinone

Polygonatum cirrhifolium

Rhizome

Glucose, sucrose

Polygonatum cirrhifolium

Root

Glucose, sucrose

Punica granatum

Fruit

Tannins, falvonoids, alkaloids

Quercus infectoria

Gall

Gallotannic acid, gallic acidellagic

acid, rubric acid

Randia dumetorium

Fruit

Itric and tartaric acid, Randialic

acid, ursosaponin

Rosa centrifolia

Petals

Saponins, citronellol, geraniol,

nerol

Saccharum munja

Root

Cellulose, lignin, pantosoms

Saccharum officinarum

Stem

Glucose, fructose, amino acids

Saccharum spontansum

Root

Alkaloids, glycosides, phenolic

compounds, saponins

Salix caprea

Flower

Cyanidin, pipecolic acid, salicin,

salicortin, salireprocide

Salmalia

Bark

Lupeopl

Gum

Gallic and tannic acid

Root bark

Monoclinic sulphur, salvadourea

Salvadora persica

Leaves

Isotymol, thymol, eugenol,

eucalyptol

Saraca indica

Bark

Tannins, catechol, catechin,

epicatechin, procyanidin

Scindapsus officinalis

Fruit

Scindepsin A and B, fructose,

glucose, xylose

Selinium tenuifolium

Root

Dihydropyrano-coumarines,

sucrose, and mannitol.

Sesbania grandiflora

Bark

Tannins and gum

Leaf

Tannins, flavonoids, coumarins,

steroids

Flowers

Calcium, iron and vitamin B

Root

Tannins, flavonoids, coumarins,

steroids

Sessamum indicum

Seeds oil

Vitamin E, copper, megnesium,

calcium, iron

Shorea robusta

Resin

Hydroxyanone, ursolic acid

Sida cordifolia

Root

Ephedrine, hypaphorine,

vasicinone, choline

( Continued)

(Continued)

Botanical name

Part used

Chemical constituents

Sida rhombifolia

Root

Alkaloids, vasicinone and

vasicine

Smilax china

Rhizome

Smilacin, cinchonin

Smilax Ornata

Root

Saponons, triterpenes,

sarsaparilloside, parillin

Solanum indicum

Root

Solanine, carotene, carpesterol,

canosterol

Solanum Indicum

Root

Solanine, carotene, carpesterol,

sitosterol, solasonin

Sphaeranthus indicus

Whole plant,

Sesquiterpene lactone,

sesquiterpene acid, β-eudesmol

Spondius pinnata

Fruit ripe

Beta-amyrin, oleanolic acid,

glycine, cystine, serine

Bark

Lignoceric acid, Saidinin,

pipecolic acid, fragilin, picein,

Salicin Salicortin, sitosterol,

glucosides

Leaves

Lignoceric acid, β-sitosterol,

glucosides

Strebulis asper

Bark

Cardiac glycoside, stebloside,

mansonin

Strychnos potatorum

Seeds

Mannogalactan, dibolin,

strychnine

Symplocos Racemosa

Bark

Alkaloids: Loturine, isoloturine,

and harmane

Phenolic Glycosides:

Benzoylsalireposide

Flavanol glucosides:

Symplocoside, symposide

Syzygium aromaticum

Flowers bud

Eugenol, vanillin, kaempferol,

β-caryophyllene

Tamarisdus indica

Fruit

Tamarindienol

Leaves

Tannins, saponins, alkaloids

Tecomella undulata

Bark

Tecomin, tecoside, β-sitosterol,

tecomelloside

Tectona grandis

Heartwood

Resin, essential oil, fatty Oil and

tectoquinone.

Teramnus labialis

Whole plant

Arginin, leucine, calcium,

magnesium, potassium

Trachyspermum ammi

Seeds

p-cymene, γ-terpinene, β-pinene,

thymol, linalool

Tragia Involucrata

Whole plant

Alkaloids, sterol and fixed oil

Trapa bispinosa

Fruit

Proteins, sulphur, calcium,

sodium, phosperous

Trianthema Portulacastrum

Root

Glycoside

Trichosanthes dioica

Leaves

Protein, carbohydrate, fiber,

phosperous

Typha elephantina

Root

β-sitosterol, cholestrol, quercetin

and lanosterol.

Uraria picta

Root

Isoflavanones, triterpenes,

steroids

Modern extraction methods & standardization 199

Botanical name

Part used

Chemical constituents

Valeriana wallichi

Root

Cyclopentapyrans, valtrote,

valepotriates, valerosidatum

Vateria indica

Resin

Oleoresin, limonene

Vaterial indica

Resin

Limonene, chamazulene, alpha-

β-pinene

Vetiveria zizanioides

Root

Allokhusiol, eugenol,

vanillin,vetivenic acid, vetiverol

Vitex agnus-castus

Seeds

n-tritriacontane, n-hentriacontane,

n-pentatriacontan

Zanthoxylum alatum

Leaves

Linalool, linolyl acetate, terpenes

Zingiber officinale

Rhizome

gingerol, shogaol, starch

Zizyphus jujba

Fruit

Vitamin C, jujubosides, zizogenin,

zeatin, saponin

Bark

Leucocyanidin, mauritines

Leaves

Rutin, yuzirin

References

1 Dai and Mumper, Molecules 2010, 15(10), 7313–7352

2 Cares MG et al., Physics Procedia, 2010, 3: 169–178.

3 Baig S, A Faroog, F Rehman, Sonochemistry and its industrial applications, World Applied Sciences Journal, 2010, 10(8): 936–944, ISSN 1818–4952.

4 Metherel AH et al, The application of ultrasound energy to increase lipid extraction throughput of solid matrix samples (flaxseed), Prostaglandins Leukotrienes Essent.

Fatty Acids, 2009, doi:10.1016/j.plefa.2009.07.003.

5 Azwanida NN, A review on the extraction methods use in medicinal plants, principle, strength and limitation, Med Aromat Plants, 2015, 4: 196, doi:10.4172/2167-0412.1000196.





16 Markers for quality control

of herbal drugs

WHO guidelines1

The main purpose of markers of characteristic constituents is the identification and quantification of herbal materials in herbal preparations and finished herbal products.

Markers used as chemical reference substances should be international chemical or pharmacopoeial reference substances. If others are used, markers for quantitative determination should be of high purity as required by national regulations, determined by validated analytical methods, including physical and chemical ones. These analytical methods may be different from those employed for quantifying herbal materials. For markers used for identification, lower purity may be suitable.

The general requirements for markers

• Identity, specificity and selectivity using the specified analytical method(s).

• Should be present in traceable quantity for the identification or sufficient quantity for assay.

• Should be easily obtained, stable under specified storage conditions.

• Should be easily detected and quantified analytically.

The criteria for selection of a marker

• The marker must be readily available (for example, as an international or pharmacopoeial reference substance). New markers may only be selected if no such reference substance is available. In that case, detailed documentation should be provided on the identity and properties of the selected markers.

• It should be relatively easy to separate or distinguish the marker analytically from other structurally similar herbal constituents.

• Markers should be detectable and quantifiable with available analytical instrumental methods (such as thin-layer chromatography (TLC), high-performance thin-layer chromatography (HPTLC), gas chromatography (GC) or high-performance liquid chromatography (HPLC)).

202 Defining a new scientific path

• Different marker substances may be selected for the same herbal medicines depending on the analytical instrumental methods available.

• Derivatives of the naturally occurring markers may be used where the latter is not easy to detect, are not stable or are not easily obtained.

• Different marker substances may be selected for the same herbal materials depending on the different forms of herbal preparations or finished herbal products.

• A group of markers may be selected if a single marker is not sufficient to identify and evaluate the herbal materials or finished herbal products. They could also be named “reference substances.” However, taking the complex nature of all kinds of herbal medicines into account, it is unlikely that one single compound would be solely responsible for the therapeutic action. Thus, substances of constituents with known therapeutic activity are generally also called “markers.”

• Markers for quantification: should be representative of the main therapeutic or pharmacological profiles of the herbal materials and finished products.

• Markers for identification: should be specific for one plant or for certain plant species and genera. If not, another marker(s) should be selected for specific identification.

Markers for toxic constituents

Marker substances for toxic constituents are used to define maximum acceptable concentrations of toxic constituents in herbal materials, herbal preparations or finished herbal products (such a limit test is needed). There should be a defined upper tolerable limit for the mode of application and posology intended (e.g., oral, topical, inhalation, short-term, subchronic or chronic application).

• Toxicological evaluation is required, but experience with traditional use should be taken into account.

• Genotoxicity, mutagenicity and carcinogenicity should also be considered when establishing toxicity criteria.

• An analytical detection procedure for the established tolerable limits should be available.

• These requirements should always be met by the finished herbal product destined for human use, since processing and conservation may alter toxicity.

• Highly sensitive instrumental analytical methods (such as TLC, HPTLC, GC, HPLC, GC/mass spectrometry (MS), liquid chromatography (LC)/(MS)) should be available for detection of toxic substances.

• Simple identification tests for groups of toxic substances, such as alkaloids or terpenoids, should be available.

• The toxicity may be assessed for control by the absence of a constituent or by establishing and testing allowable tolerable limit(s) for the toxic constituents

Markers for quality control of herbal drugs 203

using selected marker(s) and analytical methods. For example, the absence of thiaminase enzyme activity in horsetail ( Equisetum arvense) as well as a method or the detection of kavalactone (a hepatotoxic agent) in kava ( Piper methysticum) should be required. If it is not possible to exclude the toxic effect because there is no appropriate marker constituent or because of the lack of an analytical method or specific method of preparation, the herbal material or its herbal preparation should not be used in finished herbal

products.1

The European Medicines Agency (EMEA)2

According to the definition by the EMEA, analytical markers are the constituents or groups of constituents that serve solely for analytical purposes, while active markers are the constituents or groups of constituents that contribute to therapeutic activities.

Other categories of markers

In United States Pharmacopeia’s dietary supplement verification program, Srinivasan proposed the following four categories: (a) active principles, (b) active markers, (c) analytical markers and (d) negative markers.3 Active principles possess known clinical activities; active markers contribute to clinical efficacy; analytical markers have no clinical or pharmacological activities; negative markers demonstrate allergenic or toxic properties. All markers may contribute to the evaluation, standardization and safety assessment of herbal medicines.

Lin et al. expanded Srinivasan’s classification into seven categories: (a) active principles, (b) active markers, (c) group markers, (d) chemical fingerprints, (e) analytical markers, (f) “phantom” markers and (g) negative

markers.4

Group chemical markers have similar chemical structures and/or physical properties. The pharmacological activities of individual components are not necessarily known. Polysaccharides are classified under this category. This type of markers is not necessarily specific and can be easily masked by other components especially in proprietary products. “Phantom” markers are constituents that have known pharmacological activities; however, they can be undetectable in some

herbal medicines due to low quantities.4

Songlin Li et al., while discussing the pitfalls of the selection of chemical markers for the quality control of medicinal herbs, suggest a new classification of eight categories of chemical markers, namely (a) therapeutic components, (b) bioactive components, (c) synergistic components, (d) characteristic components, (e) main components, (f) correlative components, (g) toxic components and (h)

general components.5

204 Defining a new scientific path

Therapeutic components possess direct therapeutic effects of herbal medicine. Isosteroidal alkaloids of Bulbus Fritillariae, including verticine, verticinone and imperialine, were identified as the major therapeutic components that account for the antitussive effect. Therefore, isos-teroidal alkaloids were selected as the chemical markers for the quality assessment of Bulbus Fritillariae. ( Fritillaria roylei is Equated with Kshirakaakoli in API.)

Bioactive components, including isoflavonoids and saponins, were used simultaneously in the evaluation of the quality of Astragalus membranaceus.

Synergistic components act synergistically to reinforce the bioactivities of other components. Therefore, naphthodianthrones, phloroglucinols and flavonoids may be used as chemical markers for the quality control of Hypericum perforatum.

Flavonoids, terpene lactones including ginkgolides A, B and C, and bilo-balide are chemical markers for the quality control of Ginkgo biloba leave extracts.

Valerenic acids are the characteristic components of valerian derived from the roots of Valeriana officinalis. Valerenic acids are used as chemical markers to evaluate the quality of valerian preparations. Main components, triterpenoid saponins including ginsenoside Rg1, Re, Rb1 and notoginsenoside R1

are used as markers for Ginseng.

Correlative components may be the precursors, products or metabolites of a chemical or enzymatic reaction. Psoralen and isopsoralen are used as chemical markers for assessing the quality of Fructus Psoraleae, while they may be the enzymatic reaction products of psoralenoside and isopsoralenoside, respectively.

Toxic components of medicinal herbs, documented by toxicological studies are used as markers, for instance, aristolochic acids and pyrrolizidine alkaloids may cause nephrotoxicity and heptotoxicity, respectively. Specific components, present in a particular species, genus or family, may be used with

“fingerprints” for quality control purposes.5

In Chinese Pharmacopoeia (2005 edition), a total of 282 chemical markers are

listed for the quality control of Chinese herbal medicines.6

Reference Standards (RS) in The Ayurvedic

Pharmacopoeia of India

In India, for a large majority of botanical extracts, it is not known with certainty which of the various components is responsible for the reported pharmacological effect. It is generally believed that several constituents act synergistically to provide the reported effect.

Markers for quality control of herbal drugs 205

For the first time, on an experimental basis, API included Reference Standards of 15 Ayurvedic plant drugs. The Reference Standards, abbreviated as RS, of the following plant drugs were identified by Pharmacopoeial Laboratory of Indian Medicine (PLIM):

Achyranthes aspera (whole plant) RS:

Oleanolic acid.

Albizia lebbeck (stem bark) RS:

Catechin.

Berberis aristata (dried stem) RS:

Berberine chloride.

Boerhaavia diffusa (dried root) RS:

Boeravinone B.

Boswellia serrata (exudate) RS:

β-boswellic acid.

Cassia senna (dried leaflets) RS:

Sennoside A and Sennoside B.

Garcinia gummi-gutta (dried fruits) RS

(−)Hydroxycitric acid lactone and

(−)hydroxycitrate.

Gymnema sylvestre (dried leaf) RS:

Gymnemagenin.

Ocimum sanctum (dried leaf) RS:

Oleanolic acid Ursolic acid.

Picrorrhiza kurroa (dried rhizome) RS:

Picroside-I and Picroside-II.

Pterocarpus marsupium (heart-wood) RS:

Pterostilbene.

Rubia cordifolia (dried root) RS:

Rubiadin.

Trigonella foenum-graecum (seeds) RS:

4-Hydroxyisoleucine.

Vitex negundo (dried leaves) RS:

Negundoside and Agnuside.

Zingiber officinale (dried rhizome) RS:

6-Gingerol, 6-Shogaol, and

Capsaicin.

Problem of identifying a stable marker

in Ayurvedic compounds

Valtrate in Valeriana wallichii is its marker compound, but it degrades at high temperature. It becomes a problem for herbal drug preparations that go through high temperature, and also in its course of stability study.

Polyherbal formulations which contain a large number of herbs along with high percentage of sugar make it difficult for an analyst to extract the desired compound. This is because of the interference of the similar nature of other compounds which also get extracted. For example, estimation of piperine in Chayavan-avaleha samples or vitamins in asava/arishta samples, extraction get hindrance due to interference of complex nature of sugar moieties with target compounds. Moreover, quantification related to marker compounds are always costly than any other types of analysis. It will involve the use of sophisticated instruments like HPLC, GC, LC-MS along with considerable amount of solvents. Growing companies and small-scale industries will not be able to share

this additional burden.7,8

Markers, identified in Indian Pharmacopoeia, are being quoted in the following table:





2.0%)

, 20% w/w

1.0%), safrole (NMT

T 10.0% w/w

15.0% w/w of the stated

1.0%), linalool (1.5%–

& 1.5% w/w

NLA

10.0% w/w of the stated amount

T (not less than) 0.6% w/w

T 45% T 0.20% w/w

T 1.0% w/w

amount

L-carvone (27.0%), L-carvone (27.0%–35.0%) T 0.8% w/w T 0.1% w/w T 0.30%

T 1.0% w/w T 2.5% w/w

T 0.70% w/w T 0.50% w/w T 0.005% w/w T 1.0% w/w

T 0.25%

respectively T 1.0% w/w T 1.0% w/w

amount T 0.07% w/w T 0.50% w/w

T 0.7% w/w

90.0%), cinnamyl acetate (1.0%–6.0%), eugenol (nmt 0.5%), coumarin (1.5%–4.0%), trans-2- methoxycinnamaldehyde (3.0%– 15.0%) 3.5%), trans-cinnamic aldehyde (NMT 3.0%), beta-carryophyllene (1.5%– 7.0%), eugenol (70.0%–85.0%), coumarin (NMT 3.0%), cinnamyl acetate (NMT

Specification

NL 1.0% w/w NL NL

NL

90.0–120.0% w/w of the labeled

Cis-dehydro carvone (15.0%–25.0%)

NL NL NL 1.00% 1.00% NL NL

Bacoside

NL NL NL NL

90.0–120.0% w/w of the stated amount

NL 35.0%–45.0% and 48.0%–60.0%

NL NL 85.0% w/w–1

NL NL

90.0–1

0.1% w/v; 0.2% w/v of stated amount

NL trans-cinnamic aldehyde (70.0%–

Cineole (NMT



1,

& acetyl

1-keto-

1-keto-beta-

& acetyl 1

– IV

[sum of bacoside-A3,

& hyoscine & hyoscine

A

A

& carvone

12-didehydroandrographolide content shall not be more than one sixth of andrographolide 90.0–120.0% w/w of the labeled amount L-carvone (27.0%), L-carvone (27.0%–35.0%)

bacopaside-II, bacopasaponin-C, jujubogenin isomer of bacopasaonin-C]

11-keto-beta-boswellic acid

boswellic acid beta-boswellic acid, alpha and beta boswellic acids and alpha and beta acetyl boswellic acid]

aldehyde, beta-carryophyllene, eugenol, cineole, coumarin, safrole, cinnamyl acetate Marker Compounds

Vasicine Vasicine Aescin Alliin

Andrographolide

Andrographolides. 14-deoxy-1

Cis-dehydro carvone (15.0%–25.0%),

Artemisinin Shatavarin Hyoscyamine Atropine Atropine Rutin Bacoside Bacoside

Berberine Berberine Boeravinone B 11-keto-beta-boswellic acid

Boswellic acids [sum of 1

Capsaicin Limonene

Total sennosides as sennoside B Total sennosides as sennoside B Total sennosidesas calcium salts Rhein Asiaticoside

Total triterpenes [sum of asiaticoside, asiatic acid, madecassic acid as medecassoside] Emetine Chlorogenic acid Trans-cinnamic aldehyde, cinnamyl acetate, eugenol, coumarin, trans-2- methoxycinnamaldehyde Cineole, linalool, trans-cinnamic

ol. III

& flowering tops

& stems

& stems

& rhizomes

& seeds & young branches

bulbs

leaves and stems

leaves and stems

leaves

leaves

Part Used

Dried mature leaves Dried mature leaves extract Fruit Fresh or dried compound Dried aerial parts mainly

Dried aerial parts mainly

Mature seeds

Dried leaves Tuberous roots Flowering top and leaf Flowering top and leaf Flowering top and leaf Dried leaves Dried whole plant preferably Dried whole plant preferably

Dried roots Dried stems Dried roots Gum-resin

Gum-resin

Dried ripe fruits Ripe fruits

Dried compound leaves Dried compound pods Dried compound pods

Fruit pulp Dried aerial parts

Dried aerial parts

Roots

Fruits Leaves

Bark of the shoots





illd.

A.

W

ahal. ahal. ahal.

Blume

J. S.

Linn. Linn. Linn. A. Juss.

Linn.

V V V

Linn.

Nees Nees

(Linn.)

(Linn.)

DC DC

Roxb.

Roxb.

(Linn.)

(Linn.)

Linn.

L.

L.

Linn.

ographis paniculata

ographis paniculata

haavia diffusa

Nees

Nees

opa belladonna opa belladonna opa belladonna

Pennell

Pennell

Urban.

Urban.

Rich.

Presl.

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Adhatoda vasica Adhatoda vasica Aesculus hippocastanum Allium sativum Andr

Andr

Anethum sowa

Artemisia annua Asaragus racemosus Atr Atr Atr Azadirachta indica Bacopa monnieri Bacopa monnieri

Berberis aristata Berberis aristata Boer Boswellia serrata

Boswellia serrata

Capsicum annuum (Linn.) Carum carv

Cassia angustifolia Cassia angustifolia Cassia angustifolia Cassia fistula Centella asiatica

Centella asiatica

Cephaelis ipecacuanha

Cichorium intybus Cinnamomum cassia

Cinnamomum verum





)



2.0%)

, 20% w/w

( Continued

1.0%), safrole (NMT

T 10.0% w/w

15.0% w/w of the stated

1.0%), linalool (1.5%–

& 1.5% w/w

NLA

10.0% w/w of the stated amount

T (not less than) 0.6% w/w

T 45% T 0.20% w/w

T 1.0% w/w

amount

L-carvone (27.0%), L-carvone (27.0%–35.0%) T 0.8% w/w T 0.1% w/w T 0.30%

T 1.0% w/w T 2.5% w/w

T 0.70% w/w T 0.50% w/w T 0.005% w/w T 1.0% w/w

T 0.25%

respectively T 1.0% w/w T 1.0% w/w

amount T 0.07% w/w T 0.50% w/w

T 0.7% w/w

90.0%), cinnamyl acetate (1.0%–6.0%), eugenol (nmt 0.5%), coumarin (1.5%–4.0%), trans-2- methoxycinnamaldehyde (3.0%– 15.0%) 3.5%), trans-cinnamic aldehyde (NMT 3.0%), beta-carryophyllene (1.5%– 7.0%), eugenol (70.0%–85.0%), coumarin (NMT 3.0%), cinnamyl acetate (NMT

Specification

NL 1.0% w/w NL NL

NL

90.0–120.0% w/w of the labeled

Cis-dehydro carvone (15.0%–25.0%)

NL NL NL 1.00% 1.00% NL NL

Bacoside

NL NL NL NL

90.0–120.0% w/w of the stated amount

NL 35.0%–45.0% and 48.0%–60.0%

NL NL 85.0% w/w–1

NL NL

90.0–1

0.1% w/v; 0.2% w/v of stated amount

NL trans-cinnamic aldehyde (70.0%–

Cineole (NMT



1,

& acetyl

1-keto-

1-keto-beta-

& acetyl 1

– IV

[sum of bacoside-A3,

& hyoscine & hyoscine

A

A

& carvone

12-didehydroandrographolide content shall not be more than one sixth of andrographolide 90.0–120.0% w/w of the labeled amount L-carvone (27.0%), L-carvone (27.0%–35.0%)

bacopaside-II, bacopasaponin-C, jujubogenin isomer of bacopasaonin-C]

11-keto-beta-boswellic acid

boswellic acid beta-boswellic acid, alpha and beta boswellic acids and alpha and beta acetyl boswellic acid]

aldehyde, beta-carryophyllene, eugenol, cineole, coumarin, safrole, cinnamyl acetate Marker Compounds

Vasicine Vasicine Aescin Alliin

Andrographolide

Andrographolides. 14-deoxy-1

Cis-dehydro carvone (15.0%–25.0%),

Artemisinin Shatavarin Hyoscyamine Atropine Atropine Rutin Bacoside Bacoside

Berberine Berberine Boeravinone B 11-keto-beta-boswellic acid

Boswellic acids [sum of 1

Capsaicin Limonene

Total sennosides as sennoside B Total sennosides as sennoside B Total sennosidesas calcium salts Rhein Asiaticoside

Total triterpenes [sum of asiaticoside, asiatic acid, madecassic acid as medecassoside] Emetine Chlorogenic acid Trans-cinnamic aldehyde, cinnamyl acetate, eugenol, coumarin, trans-2- methoxycinnamaldehyde Cineole, linalool, trans-cinnamic

ol. III

& flowering tops

& stems

& stems

& rhizomes

& seeds & young branches

bulbs

leaves and stems

leaves and stems

leaves

leaves

Part Used

Dried mature leaves Dried mature leaves extract Fruit Fresh or dried compound Dried aerial parts mainly

Dried aerial parts mainly

Mature seeds

Dried leaves Tuberous roots Flowering top and leaf Flowering top and leaf Flowering top and leaf Dried leaves Dried whole plant preferably Dried whole plant preferably

Dried roots Dried stems Dried roots Gum-resin

Gum-resin

Dried ripe fruits Ripe fruits

Dried compound leaves Dried compound pods Dried compound pods

Fruit pulp Dried aerial parts

Dried aerial parts

Roots

Fruits Leaves

Bark of the shoots





illd.

A.

W

ahal. ahal. ahal.

Blume

J. S.

Linn. Linn. Linn. A. Juss.

Linn.

V V V

Linn.

Nees Nees

(Linn.)

(Linn.)

DC DC

Roxb.

Roxb.

(Linn.)

(Linn.)

Linn.

L.

L.

Linn.

ographis paniculata

ographis paniculata

haavia diffusa

Nees

Nees

opa belladonna opa belladonna opa belladonna

Pennell

Pennell

Urban.

Urban.

Rich.

Presl.

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Adhatoda vasica Adhatoda vasica Aesculus hippocastanum Allium sativum Andr

Andr

Anethum sowa

Artemisia annua Asaragus racemosus Atr Atr Atr Azadirachta indica Bacopa monnieri Bacopa monnieri

Berberis aristata Berberis aristata Boer Boswellia serrata

Boswellia serrata

Capsicum annuum (Linn.) Carum carv

Cassia angustifolia Cassia angustifolia Cassia angustifolia Cassia fistula Centella asiatica

Centella asiatica

Cephaelis ipecacuanha

Cichorium intybus Cinnamomum cassia

Cinnamomum verum





& decanal

1.0%),

0.5%),

& 0.20% of

1.0% w/w),

,

(0.02%–0.50%),

7.5%), cineole

T 1.50% w/w),

T 10% w/w

valencene

T 0.20% w/w), eicosanoic T 0.2% w/w)

3.0%), coumarin (NMT

0.30%), beta-myrcene

T 0.20% w/w), arachidic

T 1.0% w/w

aldehyde (55.0%–75%), beta- carryophyllene (1.0%–4.0%), eugenol (NMT (NMT 0.5%), safrole (NMT benzyl benzoate (NMT trans 2-methoxycinnamaldehyde (0.1%–1.0%) T 0.03% w/w terpinene (10.0%–20.0%)

(62.0%–69.0%), gamma-terpinene (8.0%–12.0%)

pinene (1.20%–2.0%), sabinene (NMT (1.50%–2.0%), p-cymene (NMT 1.0%), limonene (65.0%–75.0%), gamma-terpinene (16.0%–22.0%), methyl N-methyllanthranilate (0.30%–0.60%) pinene (0.02%–0.30%), sabinene (0.20%–1.10%), beta-myrcene (1.70%–2.50%), limonene (92.0%–97.0%), octanal (0.10%–0.40%), linalool (0.20%– 0.70%), neral (0.20%–0.10%), geranial (0.03%–0.20%) T 0.10%

gotoxine NLD 0.15% labeled amount

caprylic acid (5.0%–1 caproic acid (4.0%–9.0% w/w), lauric acid (40.0%–50.0% w/w), myristic acid (15.0%–20.0% w/w), palmitic acid (7.0%–12.0% w/w), stearic acid (1.5%–5.0% w/w), oleic acid (4.0%–10.0% w/w), linoleic acid (1.0%–3.0% w/w), linolenic acid NL acid (NL acid (NL T 0.40% w/w T 0.40% w/w 20% w/w

Specification

NL

Linalool (1.0%–6.0%), trans-cinnamic

NL D-limonene (45.0%–60.0%) alpha-

Beta-pinene (10.0%–16.5%), limonene

Alpha-pinene (1.60%–3.0%), beta-

Alpha-pinene (0.40%–0.60%) beta-

NL

Er

Caproic acid (NL

NL NL Forskolin NL

1.0% w/w–1.50% w/w 4.0% w/w–6.0% w/w

cineole,

eugenol,

& E) & E)

beta-carryophyllene, coumarin, safrole, benzyl benzoate, trans 2-methoxycinnamaldehyde terpinene

beta-myrcene, p-cymene, limonene, gamma-terpinene, methyl N-methyllanthranilate beta-myrcene, limonene, geranial, linalool, valencene, octanal, decanal, neral gotoxine

gotoxine

acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, arachidic acid, eicosanoic acid Marker Compounds

Cinnamaldehyde

Linalool, trans-cinnamic aldehyde,

Quercetin D-limonene, alpha-terpinene

Beta-pinene, limonene, gamma-

Alpha-pinene, beta-pinene, sabinene,

Alpha-pinene, beta-pinene, sabinene,

Er

Er

Caproic acid, caprylic acid, caproic

Chlorogenic acid Forskolin Forskolin

Guggulsterones (Z Guggulsterones (Z

ol. III

fee bean

endosperm

guggul resin

Part Used

Dried inner bark

Bark of the shoots

Stem Whole fruits

Epicarps of fresh fruits

Peel of fresh fruits

Fresh peel

Dried selerotia

Dried selerotia

Dried solid part of

Green cof Whole or cut dried roots Roots

Oleoresin exudation Ethyl acetate extractive of





Linn.

(Fries)

(Fries)

illd.Briq

Blanco

ea

ea

Briq W

Linn.

L.

Linn.

(L.) Burm.

eticulate

Blume

Nees

(Christman) Swingle.

tulasne.

tulasne.

(Continued)

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Cinnamomum zeylanicum

Cinnamomum zeylanicum

Cissus quadrangularis Citrus aurantiifolia

Citrus limon

Citrus r

Citrus sinensis

Claviceps purpur

Claviceps purpur

Cocos nucifera

Coffea arabica Coleus forskohlii Coleus forskohlii

Commiphora wightii Commiphora wightii





)





& decanal

( Continued

1.0%),

0.5%),

& 0.20% of

1.0% w/w),

,

(0.02%–0.50%),

7.5%), cineole

T 1.50% w/w),

T 10% w/w

valencene

T 0.20% w/w), eicosanoic T 0.2% w/w)

3.0%), coumarin (NMT

0.30%), beta-myrcene

T 0.20% w/w), arachidic

T 1.0% w/w

aldehyde (55.0%–75%), beta- carryophyllene (1.0%–4.0%), eugenol (NMT (NMT 0.5%), safrole (NMT benzyl benzoate (NMT trans 2-methoxycinnamaldehyde (0.1%–1.0%) T 0.03% w/w terpinene (10.0%–20.0%)

(62.0%–69.0%), gamma-terpinene (8.0%–12.0%)

pinene (1.20%–2.0%), sabinene (NMT (1.50%–2.0%), p-cymene (NMT 1.0%), limonene (65.0%–75.0%), gamma-terpinene (16.0%–22.0%), methyl N-methyllanthranilate (0.30%–0.60%) pinene (0.02%–0.30%), sabinene (0.20%–1.10%), beta-myrcene (1.70%–2.50%), limonene (92.0%–97.0%), octanal (0.10%–0.40%), linalool (0.20%– 0.70%), neral (0.20%–0.10%), geranial (0.03%–0.20%) T 0.10%

gotoxine NLD 0.15% labeled amount

caprylic acid (5.0%–1 caproic acid (4.0%–9.0% w/w), lauric acid (40.0%–50.0% w/w), myristic acid (15.0%–20.0% w/w), palmitic acid (7.0%–12.0% w/w), stearic acid (1.5%–5.0% w/w), oleic acid (4.0%–10.0% w/w), linoleic acid (1.0%–3.0% w/w), linolenic acid NL acid (NL acid (NL T 0.40% w/w T 0.40% w/w 20% w/w

Specification

NL

Linalool (1.0%–6.0%), trans-cinnamic

NL D-limonene (45.0%–60.0%) alpha-

Beta-pinene (10.0%–16.5%), limonene

Alpha-pinene (1.60%–3.0%), beta-

Alpha-pinene (0.40%–0.60%) beta-

NL

Er

Caproic acid (NL

NL NL Forskolin NL

1.0% w/w–1.50% w/w 4.0% w/w–6.0% w/w

cineole,

eugenol,

& E) & E)

beta-carryophyllene, coumarin, safrole, benzyl benzoate, trans 2-methoxycinnamaldehyde terpinene

beta-myrcene, p-cymene, limonene, gamma-terpinene, methyl N-methyllanthranilate beta-myrcene, limonene, geranial, linalool, valencene, octanal, decanal, neral gotoxine

gotoxine

acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, arachidic acid, eicosanoic acid Marker Compounds

Cinnamaldehyde

Linalool, trans-cinnamic aldehyde,

Quercetin D-limonene, alpha-terpinene

Beta-pinene, limonene, gamma-

Alpha-pinene, beta-pinene, sabinene,

Alpha-pinene, beta-pinene, sabinene,

Er

Er

Caproic acid, caprylic acid, caproic

Chlorogenic acid Forskolin Forskolin

Guggulsterones (Z Guggulsterones (Z

ol. III

fee bean

endosperm

guggul resin

Part Used

Dried inner bark

Bark of the shoots

Stem Whole fruits

Epicarps of fresh fruits

Peel of fresh fruits

Fresh peel

Dried selerotia

Dried selerotia

Dried solid part of

Green cof Whole or cut dried roots Roots

Oleoresin exudation Ethyl acetate extractive of





Linn.

(Fries)

(Fries)

illd.Briq

Blanco

ea

ea

Briq W

Linn.

L.

Linn.

(L.) Burm.

eticulate

Blume

Nees

(Christman) Swingle.

tulasne.

tulasne.

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Cinnamomum zeylanicum

Cinnamomum zeylanicum

Cissus quadrangularis Citrus aurantiifolia

Citrus limon

Citrus r

Citrus sinensis

Claviceps purpur

Claviceps purpur

Cocos nucifera

Coffea arabica Coleus forskohlii Coleus forskohlii

Commiphora wightii Commiphora wightii





1.0%),

& alpha-

0.1%), citronellyl 0.1%), neral (2.0%

1.0%), geranyl

3.0%), neral (NMT

T 50.0%)

(3.0%–7.0%), camphor (4.0%–6.0%)

p-mentha-1, 3-diene-7-al (14.0%– 18.0%), p-mentha-1, 4-dieneo-7-al (1.1%–2.0%), beta-pinene (12.0%– 16.0%), gamma-terpinene (20.0%– 28.0%), p-cymene (10.0%–15.0%) T 1.5% w/w amount T 0.1% w/w

methyl heptanoate (1.56% w/w– 8.0% w/w)

citronellal (NMT acetate (NMT w/w–5.0% w/w), geranial (2.0% w/w–5.0% w/w), geranyl acetate (5.0% w/w–10.0% w/w), citronellol (1.0% w/w–5.0% w/w), geraniol (NL

(30.0%–45.0%), citronellyl acetate (NMT geranial (NMT acetate (2.0%–5.0%), citronellol (9.0%–15.0%), geraniol (20.0%– 30.0%) T 0.1%

acetate (32.0%–42.0%) T 2.0% w/w T 1.0% w/w

pinene (10.0%–22.0%) T 0.10% w/w T 0.6% T 12.0% T 0.50% w/w

T 3.0% w/w

amount T 1.0% w/w

amount T 3.0%

Specification

0.10%–0.30%

Linalool (65.0%–78.0%), alpha-pinene

Cuminic aldehyde (18.0%–30.0%),

NL 95.0% w/w–102.0% w/w of stated

NL NA

Citral (70.0% w/w–90.0% w/w)

Limonene (1.0% w/w–5.0% w/w),

Limonene (1.0%–5.0%), citronellal

NL 1, 8-cineole (23.0%–33.0%), terpinyl

NL NL 40% w/w 1, 8-cineole (60.0%–80.0%)

NL NL NL NL 22.0% w/w–27.0% w/w NL

90.0% w/w–120.0% w/w of the stated

NL 90.0% w/w–120.0% w/w of stated

NL

10.0% w/w

& terpinyl acetate

& alpha-pinene

3-diene-7-al, p-mentha-1, 4-dieneo- 7-al, beta-pinene, gamma-terpinene, p-cymene acetate, neral, geranial, geranyl acetate, citronellol, geraniol acetate, neral, geranial, geranyl acetate, citronellol, geraniol edelolactone

Marker Compounds

Scopoletin

Linalool, alpha-pinene, camphor

Cuminic aldehyde, p-mentha-1,

Curcumin Curcuminoids

Quercetin Hydrocolloidal polysaccharide

Citral, methyl heptanoate

Limonene, citronellal, citronellyi

Limonene, citronellal, citronellyi

W 1, 8-cineole

Embelin Gallic acid Gallic acid; polyphenols 1, 8-cineole

trans-ferulic acid Anethole Hydroxycitric acid Flavone glycosides Flavonoids Glycyrrhizinic acid Glycyrrhizinic acid

Gymnemic acids (as gymnemagenin) Gymnemic acids (as gymnemagenin) Hederacoside C

Hederacoside C

ol. III

&

&

aerial parts

aerial parts

stolons

stolons

Part Used

Whole plant

Fruits



Dried rhizome Dried rhizome

Whole plant Ground endosperm of seeds

Leaves

Fresh and partially dried

Fresh and partially dried

Whole plant Fruits

Dried matured fruits Fruit pericarp Juice of fresh fruits Leaves Oleogum resin Dried fruit Dried deseeded fruit Dried leaves Dried leaves Dried unpeeled roots Dried unpeeled roots

Dried mature leaves Dried mature leaves

Leaves

Leaves





. .

Stapf.

.

L.

e Mill. Desr

Linn.

Linn.

dus

Gaertn. Gaertn.

e R. Br e R. Br

Linn. Linn.

Linn.

Burm.f.

Regel.

L. L.

(L.) Hassk damomum

L.

L.

eflexa

hiza glabra

hiza glabra

cinia cambogia

Choisy

cuma longa cuma longa

(Linn.)

(Continued)

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Convolvulus pluricaulis

Coriandrum sativum

Cuminum cyminum

Cur Cur

Cuscuta r Cyamopsis tetragonolobus

Cymbopogon flexuosus

Cymbopogon nar

Cymbopogon winterianus

Eclipta alba Elletaria car

Embelia ribes Emblica officinalis Emblica officinalis Eucalyptus globulous Ferula foetida Foeniculum vulgar Gar Ginkgo biloba Ginkgo biloba Glycyrr Glycyrr

Gymnema sylvestr Gymnema sylvestr

Hedera helix

Hedera helix





)

1.0%),

& alpha-

( Continued

0.1%), citronellyl 0.1%), neral (2.0%

1.0%), geranyl

3.0%), neral (NMT

T 50.0%)

(3.0%–7.0%), camphor (4.0%–6.0%)

p-mentha-1, 3-diene-7-al (14.0%– 18.0%), p-mentha-1, 4-dieneo-7-al (1.1%–2.0%), beta-pinene (12.0%– 16.0%), gamma-terpinene (20.0%– 28.0%), p-cymene (10.0%–15.0%) T 1.5% w/w amount T 0.1% w/w

methyl heptanoate (1.56% w/w– 8.0% w/w)

citronellal (NMT acetate (NMT w/w–5.0% w/w), geranial (2.0% w/w–5.0% w/w), geranyl acetate (5.0% w/w–10.0% w/w), citronellol (1.0% w/w–5.0% w/w), geraniol (NL

(30.0%–45.0%), citronellyl acetate (NMT geranial (NMT acetate (2.0%–5.0%), citronellol (9.0%–15.0%), geraniol (20.0%– 30.0%) T 0.1%

acetate (32.0%–42.0%) T 2.0% w/w T 1.0% w/w

pinene (10.0%–22.0%) T 0.10% w/w T 0.6% T 12.0% T 0.50% w/w

T 3.0% w/w

amount T 1.0% w/w

amount T 3.0%

Specification

0.10%–0.30%

Linalool (65.0%–78.0%), alpha-pinene

Cuminic aldehyde (18.0%–30.0%),

NL 95.0% w/w–102.0% w/w of stated

NL NA

Citral (70.0% w/w–90.0% w/w)

Limonene (1.0% w/w–5.0% w/w),

Limonene (1.0%–5.0%), citronellal

NL 1, 8-cineole (23.0%–33.0%), terpinyl

NL NL 40% w/w 1, 8-cineole (60.0%–80.0%)

NL NL NL NL 22.0% w/w–27.0% w/w NL

90.0% w/w–120.0% w/w of the stated

NL 90.0% w/w–120.0% w/w of stated

NL

10.0% w/w

& terpinyl acetate

& alpha-pinene

3-diene-7-al, p-mentha-1, 4-dieneo- 7-al, beta-pinene, gamma-terpinene, p-cymene acetate, neral, geranial, geranyl acetate, citronellol, geraniol acetate, neral, geranial, geranyl acetate, citronellol, geraniol edelolactone

Marker Compounds

Scopoletin

Linalool, alpha-pinene, camphor

Cuminic aldehyde, p-mentha-1,

Curcumin Curcuminoids

Quercetin Hydrocolloidal polysaccharide

Citral, methyl heptanoate

Limonene, citronellal, citronellyi

Limonene, citronellal, citronellyi

W 1, 8-cineole

Embelin Gallic acid Gallic acid; polyphenols 1, 8-cineole

trans-ferulic acid Anethole Hydroxycitric acid Flavone glycosides Flavonoids Glycyrrhizinic acid Glycyrrhizinic acid

Gymnemic acids (as gymnemagenin) Gymnemic acids (as gymnemagenin) Hederacoside C

Hederacoside C

ol. III

&

&

aerial parts

aerial parts

stolons

stolons

Part Used

Whole plant

Fruits



Dried rhizome Dried rhizome

Whole plant Ground endosperm of seeds

Leaves

Fresh and partially dried

Fresh and partially dried

Whole plant Fruits

Dried matured fruits Fruit pericarp Juice of fresh fruits Leaves Oleogum resin Dried fruit Dried deseeded fruit Dried leaves Dried leaves Dried unpeeled roots Dried unpeeled roots

Dried mature leaves Dried mature leaves

Leaves

Leaves





. .

Stapf.

.

L.

e Mill. Desr

Linn.

Linn.

dus

Gaertn. Gaertn.

e R. Br e R. Br

Linn. Linn.

Linn.

Burm.f.

Regel.

L. L.

(L.) Hassk damomum

L.

L.

eflexa

hiza glabra

hiza glabra

cinia cambogia

Choisy

cuma longa cuma longa

(Linn.)

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Convolvulus pluricaulis

Coriandrum sativum

Cuminum cyminum

Cur Cur

Cuscuta r Cyamopsis tetragonolobus

Cymbopogon flexuosus

Cymbopogon nar

Cymbopogon winterianus

Eclipta alba Elletaria car

Embelia ribes Emblica officinalis Emblica officinalis Eucalyptus globulous Ferula foetida Foeniculum vulgar Gar Ginkgo biloba Ginkgo biloba Glycyrr Glycyrr

Gymnema sylvestr Gymnema sylvestr

Hedera helix

Hedera helix

& w/w)

&

T 0.10%





T 0.20%) (NL1

1.2% w/w), trans-

T3.5%), p-cymene

T 15.0%), gamma-

Rb

T 10.0% w/w) codeine

1.5% w/w), alpha-

T 2.0% w/w)

T 0.8% w/w

T 0.02% w/w T 0.08% T 0.01% T 0.05%

50.0%), beta-pinene (1.0%–12.0%), limonene (2.0%–12.0%)

60.0%) linalool (25.0%–35.0%) T 1.5% w/w

sabinene (NL (0.5–12.0%), limonene (0.5–4.0%), alpha-terpinene (5.0–13.0%), cineole (NL terpinene(10.0–28.0%), terpinolene (1.5–5.0%) (17.0%–26.0%)

menthol (32.0% w/w–45.0% w/w) T 50.0% w/w T 0.30% w/w T 0.33% w/w T 3.0% w/w

pinene (13.0%–18.0%), sabinene (14.0%–29.0%)

limonene (15%–25%) T 0.40% w/w

ginsenosides T 4.0%

(NL

codeine (1.90% w/w–2.10% w/w)

stated amount of phyllanthin hypophyllanthin T 0.25% w/w

T 5.0% w/w

terpineol (NMT anethole (87.0% w/w–94.0% w/w) T 0.40% w/w

caryophyllene (12.0%–29.0%) T 2.50% w/w

Specification

NL

NL NL NL NL Alpha-pinene (20.0%–

Linalyl acetate (35.0%–

NL Alpha-pinene (1.0%–6.0%),

Menthol (33.0%–45.0%), Menthone

Menthone (13.0% w/w–28.0% w/w),

NL NL NL

NL Alpha-pinene(15.0%–28.0%), beta-

35.0%–50.0%

Methyl chavicol (50.0%–75%),

NL 0.10% w/w–0.20% w/w Ginsenosides Rg 1 (NL

NL Morphine (NL

Morphine (9.50% w/w–10.50% w/w)

90.0% w/w–120.0% w/w of

NL

NL

Linalol (NMT

NL Limonene (10.0%–17.0%), beta-

NL



& Ginsenosides

& limonene

& hypophyllanthin

& hypophyllanthin

& beta-caryophyllene

A

limonene, cineole, alpha-, gamma- terpinene, terpinolene

Rb 1

Marker Compounds

p-methoxycinnamic acid ethyl ester

Iso-vanillin Hypericins Hypericins Alantolactone Alpha-pinene, beta-pinene, limonene Linalyl acetate, linalool

Mangiferin Alpha-pinene, sabinene, p-cymene,

Menthol, menthone

Menthone, menthol

Menthol Mesuol Scopoletin

L-DOP Alpha-pinene, beta-pinene, sabinene

Total balsamic acid as cinnamic acid

Methyl chavicol

Eugenol Ursolic acid Ginsenosides Rg 1

Total ginsenosides Morphine, codeine

Morphine, codeine

Phyllanthin

Phyllanthin

Kutkin

Linalol, alpha-terpineol, trans-anethole

Piperine Limonene

Piperine

ol. III

& flower buds

& terminal branch

& crushed nuts

& flowering tops

Part Used

Dried rhizome

Root Flowering tops or aerial part Flowering tops or aerial part Dried roots Slightly dried ripe berries Flowers

Stem bark Foliage

Flowering tops

Flowering herb

Dried stamen Dried fruits

Dried seed Dried

Solid or semi solid balsum

Leaves

Leaves Leaves Dried roots

Dried roots Air dried latex

Air dried latex

Aerial part

Aerial part

Dried roots

Fruits

Fruit Dried unripe berries

Unripe fruits

.





Linn. (Linn). (Linn).

(Linn.)

Linn.

Linn.

Schum

Schum.

L.

Linn.

Linn. Houttuyn

Linn. Linn.

Royle ex

Linn

Hook. F

L.

oa

Linn.

Linn.

& Betch) Cheel.

L.

hiza kurr

oxylon balsamum

or

Buch.-Ham.ex Smith

P.Miller

(Maiden

Harms.

and Thom

and Thom.

Benth

(Continued)

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Hedychium spicatum

Hemidesmus indicus Hypericum perforatum Hypericum perforatum Inula racemosa Juniperus communis Lavendula angustifolia

Mangifera indica Melaleuca alternifolia

Mentha arvensis

Mentha piperita

Mentha sp. Mesua ferra Morinda citrifolia

Mucuna pruriens Myristica fragans

Myr

Ocimum basilicum

Ocimum sanctum Ocimum sanctum Panax ginseng

Panax ginseng Papaver somniferum

Papaver somniferum

Phyllanthus amarus

Phyllanthus amarus

Picr

Pimpinella anisum

Piper longum Piper nigrum

Piper nigrum

)

& w/w)

&

( Continued

T 0.10%





T 0.20%) (NL1

1.2% w/w), trans-

T3.5%), p-cymene

T 15.0%), gamma-

Rb

T 10.0% w/w) codeine

1.5% w/w), alpha-

T 2.0% w/w)

T 0.8% w/w

T 0.02% w/w T 0.08% T 0.01% T 0.05%

50.0%), beta-pinene (1.0%–12.0%), limonene (2.0%–12.0%)

60.0%) linalool (25.0%–35.0%) T 1.5% w/w

sabinene (NL (0.5–12.0%), limonene (0.5–4.0%), alpha-terpinene (5.0–13.0%), cineole (NL terpinene(10.0–28.0%), terpinolene (1.5–5.0%) (17.0%–26.0%)

menthol (32.0% w/w–45.0% w/w) T 50.0% w/w T 0.30% w/w T 0.33% w/w T 3.0% w/w

pinene (13.0%–18.0%), sabinene (14.0%–29.0%)

limonene (15%–25%) T 0.40% w/w

ginsenosides T 4.0%

(NL

codeine (1.90% w/w–2.10% w/w)

stated amount of phyllanthin hypophyllanthin T 0.25% w/w

T 5.0% w/w

terpineol (NMT anethole (87.0% w/w–94.0% w/w) T 0.40% w/w

caryophyllene (12.0%–29.0%) T 2.50% w/w

Specification

NL

NL NL NL NL Alpha-pinene (20.0%–

Linalyl acetate (35.0%–

NL Alpha-pinene (1.0%–6.0%),

Menthol (33.0%–45.0%), Menthone

Menthone (13.0% w/w–28.0% w/w),

NL NL NL

NL Alpha-pinene(15.0%–28.0%), beta-

35.0%–50.0%

Methyl chavicol (50.0%–75%),

NL 0.10% w/w–0.20% w/w Ginsenosides Rg 1 (NL

NL Morphine (NL

Morphine (9.50% w/w–10.50% w/w)

90.0% w/w–120.0% w/w of

NL

NL

Linalol (NMT

NL Limonene (10.0%–17.0%), beta-

NL



& Ginsenosides

& limonene

& hypophyllanthin

& hypophyllanthin

& beta-caryophyllene

A

limonene, cineole, alpha-, gamma- terpinene, terpinolene

Rb 1

Marker Compounds

p-methoxycinnamic acid ethyl ester

Iso-vanillin Hypericins Hypericins Alantolactone Alpha-pinene, beta-pinene, limonene Linalyl acetate, linalool

Mangiferin Alpha-pinene, sabinene, p-cymene,

Menthol, menthone

Menthone, menthol

Menthol Mesuol Scopoletin

L-DOP Alpha-pinene, beta-pinene, sabinene

Total balsamic acid as cinnamic acid

Methyl chavicol

Eugenol Ursolic acid Ginsenosides Rg 1

Total ginsenosides Morphine, codeine

Morphine, codeine

Phyllanthin

Phyllanthin

Kutkin

Linalol, alpha-terpineol, trans-anethole

Piperine Limonene

Piperine

ol. III

& flower buds

& terminal branch

& crushed nuts

& flowering tops

Part Used

Dried rhizome

Root Flowering tops or aerial part Flowering tops or aerial part Dried roots Slightly dried ripe berries Flowers

Stem bark Foliage

Flowering tops

Flowering herb

Dried stamen Dried fruits

Dried seed Dried

Solid or semi solid balsum

Leaves

Leaves Leaves Dried roots

Dried roots Air dried latex

Air dried latex

Aerial part

Aerial part

Dried roots

Fruits

Fruit Dried unripe berries

Unripe fruits

.





Linn. (Linn). (Linn).

(Linn.)

Linn.

Linn.

Schum

Schum.

L.

Linn.

Linn. Houttuyn

Linn. Linn.

Royle ex

Linn

Hook. F

L.

oa

Linn.

Linn.

& Betch) Cheel.

L.

hiza kurr

oxylon balsamum

or

Buch.-Ham.ex Smith

P.Miller

(Maiden

Harms.

and Thom

and Thom.

Benth

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Hedychium spicatum

Hemidesmus indicus Hypericum perforatum Hypericum perforatum Inula racemosa Juniperus communis Lavendula angustifolia

Mangifera indica Melaleuca alternifolia

Mentha arvensis

Mentha piperita

Mentha sp. Mesua ferra Morinda citrifolia

Mucuna pruriens Myristica fragans

Myr

Ocimum basilicum

Ocimum sanctum Ocimum sanctum Panax ginseng

Panax ginseng Papaver somniferum

Papaver somniferum

Phyllanthus amarus

Phyllanthus amarus

Picr

Pimpinella anisum

Piper longum Piper nigrum

Piper nigrum

T



and NLA

Alpha-pinene

Alpha-pinene

T 5.0% w/w), T 12.5% w/w)

ithaferin

T 0.30% w/w), T 0.75% w/w)

W

& 0.25%

T 1.0% w/w T 0.50% w/w T 0.30% w/w

0.15%T

(15.0%–40.0%) T 0.02% w/w

T 0.40% w/w T 0.40% w/w T 2.0% w/w T 0.016% w/w T 1.50% w/w T 30.0% T 0.14% T 7.0% w/w acetate (8.0%–15.0%)

acetate (0.5%–4.0%)

acetate (0.5%–4.0%) T 0.04% T 0.02% w/w

chebulinic acid (NL

(15.0%–40.0%) T 0.02% w/w

T 1.0% w/w

gallic acid (NL

T 0.50% T 0.10% w/w T 2.0% w/w T 0.02% w/w

T 0.30% w/w T 0.0004% w/w T 0.02% w/w

T 2.5% w/w 7.5% w/w total withanolides T 0.8% w/w

Specification

NL NL NL

NL

0.15% w/w-2.0% w/w

Borneol (2.0%–10.0%),

NL

NL NL NL NL NL NL NL NL

Eugenol (75.0%–85.0%), eugenyl

Eugenol (80.0%–92.0%), eugenyl

Eugenol (83.0%–92.0%), eugenyl

NL NL

60.0% w/w

Chebulagic acid (NL

15.0% w/w 40.0% w/w

Borneol (2.0%–10.0%)

NL

NL Ellagic acid (NL

7.0% w/w NL NL NL NL

0.02%

NL NL NL

NL

NL 5.0% w/w; 20.0% w/w

& chebulinic acid

& chebulinic acid

A

& withanoside iv

& gallic acid

& gallic acid

& ajmalicine

& ajmalicine

A

Alpha-pinene

ithanolide a

ithaferin

6-shogaol]

Marker Compounds

Piperine Psoralen Pterostilbene

Reserpine

Reserpine

Borneol, alpha-pinene

Rubiadin

Beta-sitosterol Schisandrin Schisandrin Ecdysterone Silymarin Silymarin as silibinin Epiafzelechin Eugenol Eugenol, eugenyl acetate

Eugenol, eugenyl acetate

Eugenol, eugenyl acetate

Paclitaxel Arjungenin

Arjunolic acid

Chebulagic acid

Chebulagic acid Total polyphenols including chebulic, gallic, ellagic acids Borneol, Cordifolioside

Thymol Ellagic acid

Ellagic acid Diosgenin Trigonelline Valproic acid Total squiterpenic acid as valerenic acid Total sesquiterpenic acid as valerenic acid Negundoside Resveratrol W

W

Total gingerols 6-gingerol, 8-gingerol, 10-gingerol and

ol. III

8 .

& blossoming tips

Part Used

Fruit Ripe fruit Heart-wood

Dried roots

Dried roots

Twigs

Dried stem

Stem bark Ripe fruit Ripe fruit Root Dried mature fruits Dried mature fruits Dried stem bark Dried flower buds Dried flower buds

Leaf

Stem

Dried leaves Stem bark

Stem bark

Dried fruit pericarp

Dried fruit pericarp Dried fruit pericarp

Flowering stem

Dried mature Stem

Fruit Fruit pericarp

Fruit Dried fruits Dried ripe seeds Dried rhizome Rhizome, roots and stolons Rhizome, roots

Dried leaves Dried mature fruits Mature root

Mature root

Dried rhizome Dried rhizome

L.



. Chandra Kant Katiyar

ahl





Linn.

Roxb. (L.)

L.

Mill.



Gaertn.

Gaertn.

DC.

DC.

V Linn.

L. or

L. or

Zucc (Roxb)

(Roxb)

Retz.

Retz. Retz.

L.





Roscoe. Roscoe.

Linn. Sensu

Roxb.

difolia

Linn.

omaticum

omaticum

(Loefl.) Linn.

estris

Linn.

ofractum

difolia

Burm.

and Arn.

and Arn.

etr

& L. M. Perry.

& Perry.

. & Perry

. & Perry

ocarpus marsupium

ight

ight

illd.) Miers

Roxb.

Bentham ex Kurz.

Bentham ex Kurz.

Hook.f.

Merr

Merr

Merr

Merr

W

W

(W

Valeriana wallichi

Valeriana wallichi

ithania somnifera (L.) Dunal ithania somnifera (L.) Dunal (Continued)

Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Piper r Psoralea corylifolia Pter

Rauwolfia serpentina

Rauwolfia serpentina

Rosmarinus officinalis

Rubia cor

Saraca asoca Schisandra chinensis Schisandra chinensis Sida acuta Silybum marianum Silybum marianum Symplocos racemosa Syzigium ar Syzygium ar

Syzygium aromaticum L.

Syzygium aromaticum L.

Taxus wallichiana Terminalia arjuna

Terminalia arjuna

Terminalia chebula

Terminalia chebula Terminalia chebula

Thymus zygis

Tinospora cor

Trachyspermum ammi Trerminalia bellirica

Trerminalia bellirica Tribulus terr Trigonella foenum-graecum Valeriana jatamansi Valeriana officinalis Valeriana officinalis

Vitex negundu Vitis vinifera W

W

Zingiber officinale Zingiber officinale

Source: Contributed by Dr

T



and NLA

Alpha-pinene

Alpha-pinene

T 5.0% w/w), T 12.5% w/w)

0.30% w/w),

ithaferin

T T 0.75% w/w)

W

& 0.25%

T 1.0% w/w T 0.50% w/w T 0.30% w/w

T 0.15%

(15.0%–40.0%) T 0.02% w/w

T 0.40% w/w T 0.40% w/w T 2.0% w/w T 0.016% w/w T 1.50% w/w T 30.0% T 0.14% T 7.0% w/w acetate (8.0%–15.0%)

acetate (0.5%–4.0%)

acetate (0.5%–4.0%) T 0.04% T 0.02% w/w

chebulinic acid (NL

(15.0%–40.0%) T 0.02% w/w

T 1.0% w/w

gallic acid (NL

T 0.50% T 0.10% w/w T 2.0% w/w T 0.02% w/w

T 0.30% w/w T 0.0004% w/w T 0.02% w/w

T 2.5% w/w 7.5% w/w total withanolides T 0.8% w/w

Specification

NL NL NL

NL

0.15% w/w-2.0% w/w

Borneol (2.0%–10.0%),

NL

NL NL NL NL NL NL NL NL

Eugenol (75.0%–85.0%), eugenyl

Eugenol (80.0%–92.0%), eugenyl

Eugenol (83.0%–92.0%), eugenyl

NL NL

60.0% w/w

Chebulagic acid (NL

15.0% w/w 40.0% w/w

Borneol (2.0%–10.0%)

NL

NL Ellagic acid (NL

7.0% w/w NL NL NL NL

0.02%

NL NL NL

NL

NL 5.0% w/w; 20.0% w/w

& chebulinic acid

& chebulinic acid

A

& withanoside iv

& gallic acid

& gallic acid

& ajmalicine

& ajmalicine

A

Alpha-pinene

ithanolide a

ithaferin

6-shogaol]

Marker Compounds

Piperine Psoralen Pterostilbene

Reserpine

Reserpine

Borneol, alpha-pinene

Rubiadin

Beta-sitosterol Schisandrin Schisandrin Ecdysterone Silymarin Silymarin as silibinin Epiafzelechin Eugenol Eugenol, eugenyl acetate

Eugenol, eugenyl acetate

Eugenol, eugenyl acetate

Paclitaxel Arjungenin

Arjunolic acid

Chebulagic acid

Chebulagic acid Total polyphenols including chebulic, gallic, ellagic acids Borneol, Cordifolioside

Thymol Ellagic acid

Ellagic acid Diosgenin Trigonelline Valproic acid Total squiterpenic acid as valerenic acid Total sesquiterpenic acid as valerenic acid Negundoside Resveratrol W

W

Total gingerols 6-gingerol, 8-gingerol, 10-gingerol and

ol. III

8 .

& blossoming tips

Part Used

Fruit Ripe fruit Heart-wood

Dried roots

Dried roots

Twigs

Dried stem

Stem bark Ripe fruit Ripe fruit Root Dried mature fruits Dried mature fruits Dried stem bark Dried flower buds Dried flower buds

Leaf

Stem

Dried leaves Stem bark

Stem bark

Dried fruit pericarp

Dried fruit pericarp Dried fruit pericarp

Flowering stem

Dried mature Stem

Fruit Fruit pericarp

Fruit Dried fruits Dried ripe seeds Dried rhizome Rhizome, roots and stolons Rhizome, roots

Dried leaves Dried mature fruits Mature root

Mature root

Dried rhizome Dried rhizome

L.



. Chandra Kant Katiyar

ahl





Linn.

Roxb. (L.)

L.

Mill.



Gaertn.

Gaertn.

DC.

DC.

V Linn.

L. or

L. or

Zucc (Roxb)

(Roxb)

Retz.

Retz. Retz.

L.





Roscoe. Roscoe.

Linn. Sensu

Roxb.

difolia

Linn.

omaticum

omaticum

(Loefl.) Linn.

estris

Linn.

ofractum

difolia

Burm.

and Arn.

and Arn.

etr

. & L. M. Perry

. & Perry

. & Perry

. & Perry

ocarpus marsupium

ight

ight

illd.) Miers

Roxb.

Bentham ex Kurz.

Bentham ex Kurz.

Hook.f.

Merr

Merr

Merr

Merr

W

W

(W

Valeriana wallichi

Valeriana wallichi

ithania somnifera (L.) Dunal ithania somnifera (L.) Dunal Ayurvedic Herb-markers in Indian Pharmacopoeia, 2018, V

Botanical name

Piper r Psoralea corylifolia Pter

Rauwolfia serpentina

Rauwolfia serpentina

Rosmarinus officinalis

Rubia cor

Saraca asoca Schisandra chinensis Schisandra chinensis Sida acuta Silybum marianum Silybum marianum Symplocos racemosa Syzigium ar Syzygium ar

Syzygium aromaticum L.

Syzygium aromaticum L.

Taxus wallichiana Terminalia arjuna

Terminalia arjuna

Terminalia chebula

Terminalia chebula erminalia chebulaT

Thymus zygis

Tinospora cor

Trachyspermum ammi Trerminalia bellirica

Trerminalia bellirica Tribulus terr Trigonella foenum-graecum Valeriana jatamansi Valeriana officinalis Valeriana officinalis

Vitex negundu Vitis vinifera W

W

Zingiber officinale Zingiber officinale

Source: Contributed by Dr

216 Defining a new scientific path

References

1 WHO Technical Report Series, No. 1003, 2017.

2 The European Medicines Agency Reflection paper on markers used for quantitative and qualitative analysis of herbal medicinal products and traditional herbal medicinal products, www.emea.europa.eu/pdfs/human/hmpc/25362907en.pdf.

3 Srinivasan VS, Challenges and scientific issues in the standardization of botanicals and their preparations: United States Pharmacopeia’s dietary supplement verification program – a public health program, Life Sci., 2006, 78: 2039–2043. [PubMed].

4 Chan SSK, SL Li, G Lin, Pitfalls of the selection of chemical markers for the quality control of medicinal herbs. J Food Drug Anal., 2007, 15: 365–371.

5 Li S et al, Chin Med., 2008, 3: 7. Published online June 28, 2008, doi:10.1186/1749-8546-3-7, PMCID:PMC2488332 PMID:18588699

6 Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China, Vol. 1, People’s Medical Publishing House, Beijing, 2005: 8–11, A123–125.

7 The Ayurvedic Pharmacopoeia of India (API): Part I, IX.

8 Chandra Kant Katiyar in Ayurveda at the Turning Point, 2018: 198.





17 Pharmacological actions of

chemical constituents

Chemical constituents of the herbs form an integral part of the research for herbal drug development. They are generally responsible for

• Herbs’ definite pharmacological actions

• Synergistic action of herbs

• Balancing factors

• Bioavailability of active principles

• Possible interactions with drugs of modern medicines

• Toxic components and potential risks

Alkaloids1

The first alkaloids for medicinal use were isolated at the beginning of the nineteenth century, by Derosne (opium salt, narcotine) and Sertürner (principium somniferum, morphine). The chemical identification of morphine was carried in 1923, by Robinson and Gulland. So far, there are more than 20,000 alkaloids identified and a number of them have been placed an important role in clinical practice.

They present numerous biological activities such as being emetic, anticholinergic, antitumor, diuretic, sympathomimetic, antiviral, antihypertensive, analgesic, antidepressant, muscle relaxant, anti-inflammatory, antimicrobial and antiulcer.

Based on reported biological activities alkaloids have emerged as potential agents for intestinal inflammatory disorders, central stimulants (strychinine), antispas-modics (atropine), antihypertensive (reserpine) or leukemics (vincristine).

In accordance with structural forms, the alkaloids are classified in diterpenoid alkaloids (14-O-acetylneoline, 14-O-veratroylpseudaconine, and hypaconitine), indole alkaloids (fumigaclavine C and isatin), indolonaphthyridine alkaloids (nigakinone), indoloquinazoline alkaloids (tryptanthin), isoquinoline alkaloids (berberine, boldine, cavidine, coptisine derivatives, EM012, papaverine, sangui-narine, sinomenine, tetrahydrocoptisine, and tetrandrine), phenanthroindolizidine alkaloids (NK-007 and W-8), piperidine alkaloids (piperine), purine alkaloids (caf-feine), quinoline alkaloids (skimmianine) and quinolizidine alkaloids (matrine, oxymatrine, sophocarpine, and sophoridine).

218 Defining a new scientific path

Flavonoids2

Medicinal efficacy of many flavonoids as antibacterial, hepatoprotective, anti-inflammatory, anticancer and antiviral agents is well established.

Flavonoids can be divided into a variety of classes such as flavones (e.g. flavone, apigenin, and luteolin), flavonols (e.g. quercetin, kaempferol, myricetin, and fisetin), flavanones (e.g. flavanone, hesperetin, and naringenin) and others.

Medicinal plants rich in flavonoids contents

Aloe vera

Luteolin

Acalypha indica

Kaempferol glycosides

Azadirachta indica

Quercetin

Andrographis paniculata

5-hydroxy-7,8-dimethoxyflavone

Bacopa monnieri

Luteolin

Betula pendula

Quercetrin

Butea monosperma

Genistein

Bauhinia monandra

Quercetin-3-O-rutinoside

Brysonima crassa

(+)-catechin

Calendula officinalis

Isorhamnetin

Cannabis sativa

Quercetin

Citrus medica

Hesperidin

Clerodendrum phlomidis

Pectolinarigenin,

Clitoria ternatea

kaempferol-3-neohesperidoside

Glyccheriza glabra

Liquiritin,

Mimosa pudica

Isoquercetin

Limnophila indica

3,4-methlenedioxyflavone

Mentha longifolia

Luteolin-7-O-glycoside

Momordica charantia

Luteolin

Oroxylum indicum

Chrysin

Passiflora incarnata

Vitexin

Pongamia pinnata

Pongaflavonol

Tephrosia purpurea

Purpurin

Tilia cordata

Hyperoside

Antioxidant activity: The best described property of almost every group of flavonoids is their capacity to act as antioxidants. Mechanisms of antioxidant action can include (1) suppression of ROS formation either by inhibition of enzymes or by chelating trace elements involved in a free radical generation; (2) scavenging Reactive Oxygen Species (ROS) and (3) upregulation or protection of antioxidant defenses. Some of the effects mediated by them may be the combined result of radical scavenging activity and the interaction with enzyme functions. Flavonoids inhibit the enzymes involved in ROS) generation.

Lipid peroxidation is a common consequence of oxidative stress. Flavonoid protects lipids against oxidative damage. Because of their capacity to chelate metal ions (iron, copper, etc.), flavonoids also inhibit free radical generation. Quercetin, in particular, is known for its iron-chelating and iron-stabilizing properties.

Pharmacological actions 219

A 3′,4′-catechol structure in the B ring firmly enhances inhibition of lipid peroxidation. This trait of flavonoids makes them most effective scavengers of peroxyl, superoxide and peroxynitrite radicals. Epicatechin and rutin are strong radical scavengers and inhibitors of lipid peroxidation in vitro. Because of oxidation on the B ring of flavonoids having catechol group a fairly stable orthosemiquinone radical is formed which is strong scavengers. Flavones lacking catechol system on oxidation lead to the formation of unstable radicals exhibit weak scavenging potential.

Hepatoprotective activity: Several flavonoids such as catechin, apigenin, quercetin, naringenin, rutin, and venoruton are reported for their hapatoprotective activities. Different chronic diseases such as diabetes may lead to the development of hepatic clinical manifestations. and ROS levels are reported to be decreased in the liver of diabetic mice. Anthocyanins have shown their preventive effect against various diseases. Anthocyanin cyanidin-3-O-β-glucoside (C3G) treatment lowers hepatic lipid peroxidation, inhibits the release of proinflammatory cytokines and protects against the development of hepatic steatosis.

Silymarin is a flavonoid having three structural components silibinin, silydia-nine, and silychristine extracted from the seeds and fruit of milk thistle ( Silybum marianum). Silymarin has clinical applications in the treatment of cirrhosis, ischemic injury and toxic hepatitis induced by various toxins, such as acetami-nophen and toxic mushroom.

Several clinical investigations have shown the efficacy and safety of flavonoids in the treatment of hepatobiliary dysfunction and digestive complaints, Antibacterial activity: Flavonoids are known to be synthesized by plants in response to microbial infection. They have been found in vitro to be effective antimicrobial substances against a wide array of microorganisms. Flavonoid rich plant extracts from different species have been reported to possess antibacterial activity. Several flavonoids including apigenin, galangin, flavone and flavonol glycosides, isoflavones, flavanones and chalcones have been shown to possess potent antibacterial activity. Catechins have been extensively researched due to their antimicrobial activity. These compounds are reported for their in vitro antibacterial activity against Vibrio cholerae, Streptococcus mutans, Shigella, and other bacteria. Robinetin, myricetin and (−)-epigallocatechin are known to inhibit DNA synthesis in Proteus vulgaris.

A study demonstrated the inhibitory activity of quercetin, apigenin and 3,6,7,3′,4′-pentahydroxyflavone against Escherichia coli DNA gyrase. Naringenin and sophoraflavanone G have shown intensive antibacterial activity against methicilline resistant Staphylococcus aureus (MRSA) and streptococci.

5-hydroxyflavanones and 5-hydroxyisoflavanones inhibited the growth of S.

mutans and Streptococcus sobrinus.

Anti-inflammatory activity: A number of flavonoids such as hesperidin, apigenin, luteolin and quercetin are reported to possess anti-inflammatory and analgesic effects. Flavonoids may affect specifically the function of enzyme systems critically involved in the generation of inflammatory processes, especially tyrosine

220 Defining a new scientific path

and serine-threonine protein kinases. The inhibition of kinases is due to the competitive binding of flavonoids with ATP at catalytic sites on the enzymes. These enzymes are involved in signal transduction and cell activation processes involving cells of the immune system. It has been reported that flavonoids are able to inhibit expression of isoforms of inducible nitric oxide synthase, cyclooxygenase and lipooxygenase, which are responsible for the production of a great amount of nitric oxide, prostanoids, leukotrienes, and other mediators of the inflammatory process such as cytokines, chemokines, or adhesion molecules. Flavonoids also inhibit phosphodiesterases involved in cell activation. Much of the anti-inflammatory effect of flavonoid is on the biosynthesis of protein cytokines that mediate adhesion of circulating leukocytes to sites of injury. Certain flavonoids are potent inhibitors of the production of prostaglandins, a group of powerful proinflammatory signaling molecules.

Reversal of the carrageenan induced inflammatory changes has been observed with silymarin treatment. It has been found that quercetin inhibits mitogen stimulated immunoglobulin secretion of IgG, IgM and IgA isotypes in vitro. Several flavonoids are reported to inhibit platelet adhesion, aggregation, and secretion significantly at 1–10mM concentration. The effect of flavonoid on platelets has been related to the inhibition of arachidonic acid metabolism by carbon mon-oxide. Alternatively, certain flavonoids are potent inhibitors of cyclic AMP

phosphodiesterase, and this may in part explain their ability to inhibit platelet function.

Anticancer activity: Drugs inhibiting tyrosine kinase activity are thought to be possible antitumor agents without the cytotoxic side effects seen with conventional chemotherapy. Quercetin was the first tyrosine kinase inhibiting compound tested in a human phase I trial. Heat shock proteins form a complex with mutant p53, which allows tumor cells to bypass normal mechanisms of cell cycle arrest.

Heat shock proteins also allow for improved cancer cell survival under different bodily stresses. Flavonoids are known to inhibit the production of heat shock proteins in several malignant cell lines, including breast cancer, leukemia and colon cancer.

Recently it has been shown that the flavonol epigallocatechin-3-gallate inhibited fatty acid synthase (FAS) activity and lipogenesis in prostate cancer cells, an effect that is strongly associated with growth arrest and cell death. Quercetin is known to produce cell cycle arrest in proliferating lymphoid cells. In addition to its antineoplastic activity, quercetin exerted growth-inhibitory effects on several malignant tumor cell lines in vitro. These included P-388 leukemia cells, gastric cancer cells (HGC-27, NUGC-2, NKN-7, and MKN-28), colon cancer cells (COLON 320 DM), human breast cancer cells, human squamous and gliosarcoma cells and ovarian cancer cells. It has been postulated that tumor cell growth inhibition by quercetin may be due to its interaction with nuclear type II estrogen binding sites (EBS). It has been experimentally proved that increased signal transduction in human breast cancer cells is markedly reduced by quercetin acting as an antiproliferative agent.

Pharmacological actions 221

The anticancer effects of genistein on in vitro and in vivo models have been extensively reviewed. In a study to determine the effects of isoflavones genistein, daidzein and biochanin A on mammary carcinogenesis, genistein was found to suppress the development of chemically induced mammary cancer without reproductive or endocrinological toxicities. Neonatal administration of genistein (a flavonoid) exhibited a protective effect against the subsequent development of induced mammary cancer in rats. Hesperidin, a flavanone glycoside, is known to inhibit azoxymethanol induced colon and mammary cancers in rats. The anticancer properties of flavonoids contained in citrus fruits have been reviewed by Carroll et al. Several flavonols, flavones, flavanones and the isoflavone biochanin A are reported to have potent antimutagenic activity. A carbonyl function at C-4

of the flavone nucleus was found to be essential for their activity. Flavone-8-acetic acid has also been shown to have antitumor effects. In earlier studies, ellagic acid, robinetin, quercetin and myricetin have been shown to inhibit the tumorigenic-ity of BP-7, 8-diol-9 and 10-epoxide-2 on mouse skin. Higher consumption of phytoestrogens, including isoflavones and other flavonoids, has been shown to provide protection against prostate cancer risk.

Antiviral activity: Flavonoids inhibit various enzymes associated with the life cycle of viruses. Favan-3-o1 was more effective than flavones and flavonones in selective inhibition of HIV-1, HIV-2 and similar immunodeficiency virus infections. Baicalin, a flavonoid isolated from Scutellaria baicalensis, inhibits HIV-1

infection and replication. Baicalein and other flavonoids such as robustaflavone and hinokiflavone have also been shown to inhibit HIV-1 reverse transcriptase.

Catechins are also known to inhibit DNA polymerases of HIV-1. Flavonoid such as demethylated gardenin A and robinetin are known to inhibit HIV-1 proteinase.

It has also been reported that the flavonoids chrysin, acacetin and apigenin prevent HIV-1 activation via a novel mechanism that probably involves inhibition of viral transcription.

Various combinations of flavones and flavonols have been shown to exhibit synergism. Kaempferol and luteolin show synergistic effect against herpes simplex virus (HSV). Synergism has also been reported between flavonoids and other antiviral agents. Quercetin is reported to potentiate the effects of 5-ethyl-2-dioxy-uridine and acyclovir against HSV and pseudorabies infection. Studies have displayed that flavonols are more active than flavones against herpes simplex virus type 1 and the activity order was found to be galangin, kaempferol and quercetin.

The antidengue virus properties of quercetin, hesperetin, naringin, and daidzein at different stages of DENV-2 (dengue virus type-2) infection and replication cycle have been studied. Quercetin was found to be most effective against DENV-2 in Vero cells. Many flavonoids, namely dihydroquercetin, dihydrofi-setin, leucocyanidin, pelargonidin chloride and catechin, show activity against several types of virus, including HSV, respiratory syncytial virus, polio virus and Sindbis virus. Inhibition of viral polymerase and binding of viral nucleic acid or viral capsid proteins have been proposed as antiviral mechanisms of action. Some flavonoids and their efficacy against viruses are given here:

222 Defining a new scientific path

Quercetin:

Rabies virus, herpesvirus, parainfluenza

virus, polio virus, mengo virus, and

pseudorabies virus.

Rutin:

Parainfluenza virus, influenza virus, and

potato virus.

Apigenin:

Immunodeficiency virus infection, Herpes

simplex virus type, and Auzesky virus

Naringin:

Respiratory syncytial virus

Luteolin:

Auzesky virus

Morin:

Potato virus

Galangin:

Herpes simplex virus type

Terpenoids

The terpenoids are a group of compounds that occur mostly in plants. The functional diversity of chemicals within plants is best demonstrated by terpenoids.

More than 30,000 terpenoids have been identified. The monoterpenoides and sesquiterpenoids are the chief constituents of the essential oils. The diterpenoides and triterpenoides, which are not steam volatile, are obtained from plants, and tree gums and resins. The tetraterpenoids belong to a group of compounds which are known as carotenoids. Rubber is the most important polyterpenoid.

Monoterpenoids are major components of many essential oils – myrcene, geraniol, and linalool (acyclic compounds), and menthol, camphor, pinene and limonene (cyclic compounds). All terpenoids are synthesized from two five-carbon building blocks. Based on the number of building blocks, terpenoids are commonly classified as monoterpenes (C ), sesquiterpenes (C ), diterpenes (C ), and 10

15

20

sesterterpenes (C ). Artemisinin from Artemisia is a sesquiterpenoid. Taxol from 25

Taxus brevifolia is a diterpenoid. Triterpenoids produce several pharmacologically active groups, such as steroids, saponins, and cardiac glycosides. Azadirachtin (from the seeds of Azadirachtin) is a powerful insect antifeedant. Limonins and curcubitacins are other potent triterpenoids. More than 30,000 terpenoids have been identified.

Among these pharmaceuticals, the anticancer drug Taxol and the antimalarial drug Artimesinin are two of the most valued terpene-based drugs. Terpenoids display a wide range of biological activities against cancer, malaria, inflammation, and a variety of infectious diseases (viral and bacterial).

Bitters

Extracts of the following drugs have been used as bitter stomachic: gentian, quas-sia, calumba, cinchona, nux vomica (or strychnine), hops, centaury, condurago, quebracho and Taraxacum. Bitters are abundant in certain plant families especially Compositae, Labiatae, Gentianaceae and Umbellifereae.

Two major classes of bitters could be distinguished: the terpenoid or isoprenoid bitters and the nonterpenoid bitters.

Pharmacological actions 223

Terpenoid bitters include isoprenoid bitters of different structures: (a) monoterpenoids (C ) e.g., iridoids (aucubin), secoiridoids (gentopicrin), mostly in glyco-10

sidic forms; (b) sesquiterpenoids (C ) containing a lactone ring, sesquiterpenes 15

are responsible for the bitterness of wormwood blessed thistle ( Cnicus benedictus) and ginkgo ( Ginkgo biloba). (c) diterpenoids (C ) having labdane, kaurane 20

and pimarane structures e.g., marrubiin; (d) triterpenoids (C ) e.g., cucurbitacins 30

and quassinoids.

Nonterpenoid bitters are classified according to their chemical structure: (a) phenolic bitters e.g., humulone and lupulone; (b) chromone bitters e.g., khellin and visnagin; (c) coumarin bitters e.g., xanthotoxin, imperatorin and bergapten; (d) coumarone bitters e.g., rotenone; (e) anhydride bitters e.g., cantharidin.

Plant Steroids

Plant steroids constitute a diverse group of natural products. Biosynthetically, they are derived from S-squalene-2,3-epoxide via an acetate-mevalonate pathway.

Among the plant steroids, phytosterols are ubiquitous in the plant kingdom. It is significant that some phytosterols have been reported to possess hypocholester-olemic activity. Withanolides are a large group of steroidal lactones with various biological activities. Brassinosteroids are a small group of plant steroids exhibiting plant growth hormonal activity. Phytoecdysteroids are polyhydroxylated plant steroids, many of which are known to exhibit anabolic effects with no undesirable side effects. Steroidal alkaloids are nitrogen-containing plant steroids with an array of biological activities.

It is noteworthy that trace amounts of cholesterol and mammalian steroidal hormones including progesterone have been detected in some plants. Analyses of plant steroids mainly utilize chromatographic methods such as thin-layer chromatography (TLC), high performance liquid chromatography (HPLC), ultra high performance liquid chromatography (UHPLC), and gas liquid chromatography (GLC), while photodiode array (PDA), evaporative light scattering (ELS) and fluorescence (FL) detectors and mass spectrometry (MS) are commonly used for

their detection, quantification and identification.4

Ergosterol and stigmastrol are the principal plant sterols. Ergosterol occurs in yeast. There is a hydroxyl group present in ergosterol, which is a precursor of vitamin D.

Stigmasterol is an important constituent and has been isolated from plants.

It is involved in the synthesis of many hormones like progesterone, androgens, estrogens and corticoids. In addition to stigmasterol many of its derivatives like spinasterol, fucosterol, cyasterone, stigmasterol glucoside, fucosterol epoxide, stigma-4en-3one, 29-fluorostigmasterol, etc. have been isolated, and their phar-

macological aspects have been assessed.5

Stigmasterol has significant effect on serum cholesterol comparable with the antihypercholestrolemic activity of β-sitosterol.6 Stigmasterol present in bark of Butea monosperma showed a decrease in hepatic lipid peroxidation and increase

224 Defining a new scientific path

in the activities of catalase, superoxide dismutase and glutathione thereby suggesting its antioxidantproperty.7 Stigmasterol isolated from the bark of Butea monosperma revealed that administration of stigmasterol to mice for 20 days reduced serum triiodothyronine (T3), thyroxin (T4), glucose concentration and the activity of hepatic glucose-6-phosphate with a significant increase in insulin

indicating its thyroid inhibiting and hypoglycaemic property.7

The cytostatic activity of stigmasterol in the chloroform extract of Achillea ageratum was determined against Hep-2 and McCoy cells. It showed a high degree

of inhibition when compared with 6-Mercaptopurine against both cultures.8

Stigmasterol also is involved in the synthesis of many hormones like progesterone, androgens, estrogens and corticoids. Many of its derivatives, like spinasterol, fucosterol, cyasterone, stigmasterol glucoside, fucosterol epoxide, stigma-4en-3one and 29-fluorostigmasterol have been isolated, and their pharmacological aspects are being assessed.

Cardioactive glycosides

The cardiac glycosides are a group of saponins exhibiting cardiotonic properties in low concentrations, but toxic in higher concentrations. The cardiac glycosides exert their effect on two types of heart activities: inotropic (force of contraction) and chronotropic (rate and rhythm of contraction). Thus there is a reduction in the heart rate, but increase in the force of contraction, thereby an effective increase in the efficiency of the heart, so that cardiac output per unit of oxygen consumed is much improved. It is this effect that may be life saving in conditions such as congestive heart failure.

Digitalis leaves contain more than 40 cardiac glycosides based on four genins: digitoxigenin, gitoxigenin, gitaloxigenin and gitaligenin. Primary glycosides (tetraglycosides) and triglycosides form the major compounds in the leaves. Digi-toxin improves the rhythm of the heartbeat, making the contraction of the heart more powerful, and helping the heart to pump blood at the time of heart failure.

Gitalin and many other glycosides exhibit similar properties.

Cardiac glycosides are found in several plants, including foxglove ( Digitalis purpurea), lily of the valley ( Convallaria majalis), oleander ( Nerium oleander), yellow oleander ( Thevetia peruviana), Strophanthus kombe/gratis/gratus seeds, squill ( Urginea maritima/sea onion/indica bulbs), Digitalis lanata, dogbane ( Apocynum cannabinum) and Adonis vernalisare. Medical professions prefer foxglove, while most of the herbalists prefer lily of the valley. Due to structural differences, the glycosides in the lily of the valley have less potential for cumulative poisoning.

Cyanogenic glycosides

Common cyanogenic glycosides include amygdalin, found in bitter almonds and peach karnels, and prunasin, which occurs in wild cherry ( Prunus serotina) bark.

Cyanogenic glucosides are capable of generating hydrocyanic acid, which is a

Pharmacological actions 225

violent poison. But hydrolysis of the glycosides in the digestive tract or by the liver leads to a slow release of hydrocyanic acid, which can be detoxified by the body.

Addition of 10% apricot kernels to the diet of rats for 18 weeks showed only moderate toxic effects. Amygdalin, given orally to humans, at 500 mg three times a day produced no toxic effects and only moderately raised blood cyanide levels.

However, co-administration of beta-glucosidase with amygdalin to rats substantially increased its toxicity. However, amygdalin did not prove to be an effective anticancer agent either in animals or in humans, presumably because the beta-glucosidase activity of cancer cells is quite low.

Anthraquinones

Anthraquinones are phytochemicals based on anthracene (three benzene rings joined together). At each apex of the central ring is a carbonyl group (carbon double-bonded to oxygen), which is the quinone part. Not all anthraquinones are strictly quinones; for example, the sennosides are dianthrones consisting of two anthrone units, each bearing only one carbonyl group.

Anthraquinones usually occur in plants as glycosides; for example, the sennosides from senna ( Cassia species) are O-glycosides and the aloins from Aloe are C-glycosides. The cascarosides from cascara ( Rhamnus purshiana) are unusual molecules in that they are C,O-glycosides, having one glucose linked to a central anthrone via a carbon atom and a second glucose linked via oxygen. If aglycones do occur in dried herbs, they are always anthraquinones; anthrones are too unstable in the free state. Dianthrone glycosides such as the sennosides are not found in the living plant, being formed on harvesting and drying from monomeric anthrone glycosides. Anthraquinone derivatives do not appear to be teratogenic. No stimulating effect on uterine contractions or other side effects relevant to pregnancy were noted when senna laxatives were used in normal dose during pregnancy.

Long term use is not advised.

Natural anthraquinones in the form of chrysarobin have also been used topically in the treatment of psoriasis. Chrysarobin is only stable in a greasy base, irritates and stains the skin. It is suspected to have tumor promoting activity.

Hypericin and pseudohypericin are structurally related to anthraquinones. They have been shown to have antiviral activity. Several anthraquinone aglycones, including rhein, alizarin and emodin, also demonstrated antiviral activity against human cytomegalo virus.

Coumarins

Coumarins are benzo-alpha-pyrones (lactones of o-hydroxycinnamic acid) formed via the shikimic acid pathway. Parmacological properties such as anti-inflammatory, anticoagulant, antibacterial, antifungal, antiviral, anticancer, antihypertensive, antitubercular, anticonvulsant, antiadipogenic, antihyperglycemic, antioxidant and neuroprotective properties have been attributed to coumarins.

226 Defining a new scientific path

Dietary exposure to benzopyrones is significant as these compounds are found in vegetables, fruits, seeds, nuts, coffee, tea and wine.

Most coumarins occur in higher plants, with the richest sources being the Rutaceae and Umbelliferone. Although distributed throughout all parts of the plant, the coumarins occur at the highest levels in the fruits (Bael fruits (Aegle marmelos), Tetrapleura tetraptera TAUB, bilberry, and cloudberry), followed by the roots, stems and leaves. They are also found at high levels in some essential oils, particularly cinnamon bark oil (7,000 ppm), cassia leaf oil (up to 87,300 ppm) and lavender oil. Coumarin is also found in fruits (e.g., bilberry, cloudberry), green tea and other foods such as chicory. Environmental conditions and seasonal changes can influence the occurrence in diverse parts discovered in microorganisms. Some important coumarin members have been isolated from microbial sources, e.g., novobiocin and coumermycin from Streptomyces, and aflatoxins from Aspergillus species.

Coumarins are made of fused benzene and α-pyrone rings, on the basis of different substituents on coumarin nucleus, coumarins can be classified into four types: simple coumarins, furano coumarins, pyrano coumarins and other coumarins.

Ammoresinol, Ostruthin, Novobiocin, Coumermysin and Chartreusin belong to simple coumarins with anti-bacterial activity, and Osthole has the biological activity of anti-cancer. Furano coumarin consists of Imperatorin, Psoralen, Bergapten Marmalde and other compounds with anti inflammatory, anti-TB and antifungal activities. There are two types of pyrano coumarins, linear type including Grandivittin, Agasyllin and Aegelinol benzoate with the anti-bacterial activity and angular type including Inophyllum (A, B, C, E, P, G), Calanolide (A, B, F)[11], and Pseudocordatolide having the antiviral activity. In addition to the types previously mentioned, the structure of natural coumarins also have other types, such as

bicoumarins, which have the pharmacological activity of anticoagulant.9

Saponins

Saponins are glycosides. They can be divided into two categories on the basis of sapogenin: steroidal and triterpenoidal. Steroidal saponins are mainly found in monocotyledons, and triterpenoidal saponins are by far more common. There are some unusual classifications; for example, the ginsenosides in ginseng are grouped with triterpenoidal saponins even though they exhibit a steroidal structure. In licorice ( Glycyrrhiza glabra), glycyrrhic acid and glycyrrhizin are triterpenoid saponins. They have a strengthening effect upon the adrenal gland as they mimic the activity of adrenocorticotrophic hormone (ACTH). In India, other important plants yielding saponins are sarsaparilla ( Smilax spp. Roots), asparagus ( Asparagus racemosus) roots, randia (Randia dumetorum), soapnut ( Sapindus laurifolius) and ziziphus ( Ziziphus jujuba var. spinosa).

Saponins cause lysis of the blood cells, hemolysis and are toxic. On oral ingestion, hydrolysis readily occurs, splitting the glucoside into its sugar moiety and the aglycone or sapogenin. The sapogenin does not possess hemolytic properties and is quite safe. All saponins have useful topical effects, but it has been neglected in modern pharmacology.

Pharmacological actions 227

Tannins

Tannins are phenolic compounds rich in hydroxy (-OH) residues that impart their astringent properties. Tannins are divided into two classes: Hydrolyzable and Condensed.

Hydrolyzable tannins consist of numerous simple phenolics (e.g., gallic acid, ellagic acid) attached to a sugar molecule. These tannins can be broken down by

“hydrolysis” using an acid or base to release the phenolics from the sugar molecule. Hydrolyzable tannins are usually dark yellow to brown in color. Hydrolyzable tannins are often found in the bark and roots of many plants, including Witch hazel, Oak, Crane’s Bill and Tea.

Nonhydrolyzable tannins, also called condensed tannins, are most resistant to splitting. They are related to the flavonoid pigments such as flavins and catechin.

When heated in acid they tend to polymerize to form a red insoluble substance called tannin red or phlobaphenes. The phlobaphenes give a characteristic red color to some plant tissues. The final breakdown product after heating all the condensed tannins is catechol.

Hydrolyzable tannins are significantly more astringent than condensed tannins.

The hydroxyl groups on the tannins are capable of undergoing several different reactions and interacting with various proteins and enzymes in the body.

As astringents, when applied topically, tannins help heal venous leg ulcers, make the wound more resilient to micro-organisms because they have difficulties attaching and infecting it. Astringent herbs have long been used as hemostatics to stop bleeding. When applied topically, stop bleeding by forming cross-linking with the proteins present in the damaged tissue and this tight-ens the skin and close wounds. Astringent herbs help reduce inflammation by inhibiting a number of enzymes involved in inflammation. Both hydrolyzable tannins and condensed tannins (anthocyanins) exert significant anti-inflammatory effects. Free tannin is astringent, anti-inflammatory and antimicrobial to the oral cavity. Free tannin and tannin-protein complexes are astringent, anti-inflammatory, antimicrobial and hemostatic to the stomach. Tannins alter the permeability of the mucous membranes thereby exerting an antisecretory effect.

This reduces the influx of water into the lumen of the bowel and reduces watery stools. By altering the surface of the intestines, toxins and microorganisms have difficulties attaching to the cells. Furthermore, tannins neutralize protein-based exotoxins produced by diarrhea-causing micro-organism including Vibro cholerae and Esch. coli.

In general, phenolic compounds act as antioxidants. The hydroxyl groups catch free radicals and stabilize them in the phenolic ring. Tannins are made from either simple phenolics (hydrolyzable) or polyphenols (nonhydrolyzable) both of which have high antioxidant effects.

The main tannin in green tea is (−)epigallocatechin. Catechin inhibited carcinogenesis in small intestines when given during or after carcinogen treatment in experimental rats. (−)epigallocatechin gallate inhibited the infectivity of both influenza A and B virus in vitro.

228 Defining a new scientific path

Gum, mucilage, resin

In Indian medicine, mostly Gum Arabic ( Acacia Senegal) is used. It is a mucilaginous, demulcent and emulsifying agent used in compounds for the treatment of diarrhea and catarrh. On hydrolysis, it gives arabinose, galactose, rhamnose and glucuronic acid. The gum and mucilage are common constituents of plants, and have traditionally been distinguished by their physical properties. However, there is no clear chemical distinction between the two, as they are often found together. Both gums and mucilages are made of uronic acid and sugar derivatives.

From phytochemical point of view, mucilages are often considered to be a minor category of plant polysaccharides, a category that includes gums, various man-nans, hemicellulose and pectins. The key action of the mucilages is on the surface with which they are in direct contact. They produce a casting of slime that acts to soothe and protect the exposed surface.

Thus the mucilaginous plants have been used as wound remedies, soothing pain, irritation and itching, and for binding damaged tissues. The demulcent or emollient properties also provides temporary relief in inflammatory conditions in the digestive tract. The protective effect of mucilage isolated from Plantago ovata leaves against aspirin-induced gastric ulcers has been demonstrated in rats. The similar gastroprotective activity has also been shown by guar gum. Mucilages can also function as bulk laxatives, and most widely used in this regard is isapgula or psyllium husk. The mucilages from psyllium husk has been shown to be effective in lowering blood cholesterol level. Soluble fiber and mucilages in particular also act as a prebiotic, enhancing the population of beneficial organisms in the gut flora.

Resins are a complex group of solids (occasionally liquid), insoluble in water, but soluble in alcohol, ether, and chloroform. They are obtained from many plants either spontaneously or as a result of the injury. Resins are often associated with essential oils, gum resins or with oil and gum. The resin compounds which mainly comprise diterpenenes. The essential resin is a mixture of resin acids (resinols), resin alcohols (resinols) or resin phenols (resino-tannols), oleo resins and gum resins mixed with volatile oils and gums. Other resins are complexed with aromatic balsamic acids like benzoic and cinnamic acids (which partially increase their solubility in water) and are referred to as balsamic resins. The balsams have been used as antiseptic and wound dressing for several centuries. In Western herbal medicine, 90% of tinctures of myrrh and marigold ( Calendula officinalis) are used as an effective topical application for infection of mucosal surfaces.

Polysaccharides

Polysaccharides are polymers based on sugars and uronic acids. They are found as a component of a plant’s cell wall. In experimental studies, plant polysaccharides have been shown to possess anti-oxidant, anti-inflammation, cell viability promotion, immune-regulation and antitumor functions in a number of disease models. The natural sources of several common plant polysaccharides include

Pharmacological actions 229

Aloe vera, Angelica sinensis, Astragalus membranaceus, Bupleurum falcutum, Dendrobium spp., Dimocarpus longan, Ginkgo biloba, Lycium barbarum, Panax ginseng, Zizyphus Jujuba and cactus fruits.

Any herbal extract prepared in 50% or more ethanol will not contain significant quantities of polysaccharides. The extraction methods of plant polysaccharides mainly include water extraction, alcohol precipitation, acid-base assistance, enzymatic hydrolysis, ultrasonic and microwave assisted extraction, enzymatic extraction and gel column chromatography. Among them, ultrasonic assisted extraction is a widely used method and is easy to spread. The multiple physical effects of ultrasound can accelerate the diffusion and release of the active components in the solvent, which is beneficial to the extraction of polysaccharides. Ultrasonic extraction can shorten the extraction time and improve the extraction rate. In a study, Purslane polysaccharides were extracted using water, ultrasonic and microwave.

The results showed that the extraction yield of ultrasonic was 35.42%, microwave method was 32.12%, and water method was 31.22% under the optimal conditions.

Essential oils

Essential oils have been widely used for bactericidal, fungicidal, antioxidant, allelochemical, medicinal, cosmetic applications, pharmaceutical, sanitary, agricultural and food industries. The most common compounds found in essential oils are hydro-carbons, alcohols, aldehydes, ketones, phenols, oxides and esters.

These compounds determine the pharmacology and toxicology of the essential oils. Ketones are more active and toxic than alcohol, and alcohols and phenols are more potent as antimicrobial agents. Due to vast chemical diversity, essential oils exhibit a wide variety of pharmacological activities: antimicrobial, spasmolytic, stimulant, sedative, diuretic, expectorant, or anti-inflammatory. Essential oil composition varies quite dramatically within a species, and often distinct chemotypes are recognized. The essential oil obtained usually contains a number of terpenoids, and these are separated by fractional distillation.

From a biosynthetic perspective, the components of essential oils can be classified into two major groups: the terpenoid and phenylpropanoids. The simple mono- and sesquiterpenoids are the chief constituents of essential oils. The monoterpenes identified in essential oils are limonene, geraneol, borneol and thu-jone, while bisabolol is a sesquiterpene. Polypropanoids are far less common as essential oil components. They are formed by the shikimic acid biosysthetic pathway, for example, anethole and eugenol.

References

1 Ana Cristina Alves de Almeida et al, Recent Trends in pharmacological activity of alkaloids. Evidence-Based Complementary and Alternative Medicine, 2017. Cordial acknowledgement.

2 Kumar S, Abhay K. Pandey, Chemistry and biological activities of flavonoids: An overview, The Scientific World Journal, 2013. Cordial acknowledgement.

230 Defining a new scientific path

3 Wang G, Weiping Tang, Terpenoids as Therapeutic Drugs and Pharmaceutical Agents, in book Natural Products, January 2005. https://www.researchgate.net/225850706-

terpenoids.

4 Gunaherath H, Plant steroids: Occurrence, biological significance and their analysis plant steroids: Occurrence, biological significance and their analysis, In book: Encyclo-pedia of Analytical Chemistry, 2014.

5 Kaur et al., IJPSR, 2011, 2(9): 2259–2265, www.researchgate.net/publication/264420218_

Stigmasterol_A_Comprehensive_Review, accessed February 11, 2019.

6 Chandler RF, et al., Antihypercholesterolemic studies with sterols: Beta-sitosterol and stigmasterol, J Pharm Sci., 1979, 68(2): 245–247.

7 Panda S et al, Thyroid inhibitory, antiperoxidative and hypoglycemic effects of stigmasterol isolated from Butea monosperma, Fitoterapia, 2009, 80(2): 123–126.

8 Gómez MA, García, Cytostatic activity of Achillea ageratum Linn., Phytotherapy Research, 2001, 15(7): 633–634.

9 Ling Xu, Yan-Ling Wu, The Study on Biological and Pharmacological Activity of Coumarins, ResearchGate, https://www.researchgate.net/publication/300617793_The_

Study_on_Biological_and_Pharmacological_Activity_of_Coumarins, accessed on February 13, 2019.





18 Pharmacological screening

of Ayurvedic drugs by

experimental studies

R. C. Saxena

The use of drugs of any system of medicine, may it be Ayurvedic system of medicine, must be based on properly done pharmacodynamic, pharmacokinetic, toxicity studies and chemical evaluation of monoherbal, dual herbal or polyherbal drugs, preferably performed by using modern parameters of clinical evaluation that give clear insight and will support evidence-based medicine. Pharmacodynamic activities cover both the desirable and undesirable aspects of drugs.

This is an era of safer surgery, but of dangerous medicine. This holds true for modern drugs but seems equally important for Ayurvedic preparations. Today a large number of experimental methods of evaluations are being used which are facing two problems: (1) Since law against the cruelty of animals has been introduced, preclinical animal data has become difficult to collect; however, proper procurement of permission by the duly constituted Animal Ethical Committees will solve the problem. The toxicity activities have to be done in two species: in rodent and nonrodent. (2) Toxicity studies that are acute, subacute and chronic are time-consuming, especially studies on mutagenicity, carcinogenicity and teratogenicity. Such studies do help in providing the safety profile of the drug under test.

Some toxicities cannot be detected with the help of animal studies, such as psychosis, drugs causing idiosyncrasy, and certain hematological toxicities like thrombocytopenia, due to variability in protein pattern in man and animals. To solve this problem, genetically modified animal models are being prepared, known as transgenic animals, in which new genes are inserted in DNA allow-ing them to mimic human disease. Now, one can take a human gene for a given protein and swap it for the original protein so as to make the mouse or any other animal model similar to a human being. Thus differences in the binding sites seem not to be a problem.

By producing a specific type of proteins in the transgenic animals, one can know amino acid sequences in all proteinous structures (receptors, pumps, enzymes, carriers, channels), which can give a clue for efficacy and toxicity of Ayurvedic drug, will also explain the delay in action at the DNA level and give a clue for adaptogenic activity i.e., bringing back a pathological state to its physiological state. But this is a very cumbersome process for exploring new avenues in Ayurveda.

232 Defining a new scientific path

Biological assays are also done for observing pharmacological effects of the drug or its chemical components on some animals or animal tissues, in vivo as well as in vitro. The graded assay is proportional to the dose, and response may lie between no response and maximum response. Graded responses are measured responses in isolated tissues in particular, but also in whole animals. Such graded assays include studies on contractions of muscle, blood pressure, blood sugar concentrations, etc.

In India, in general, pharmacological screening on intact animals, as well as on tissues and organs isolated from their bodies, is done. Guinea-pigs, albino rats, rabbits, frogs, and dogs are commonly used animals. The organs usually employed are rabbit and frog heart, isolated as well as intact. Among the isolated tissues (both skeletal as well as smooth muscles), the most readily available are rectus abdominis muscle of frog, guinea-pig ileum and rabbit intestine.

Experiments on anaesthetized animals involve carrying out a series of standard tests after injecting the test drug in the animals. These include vagal stimulation, carotid artery occlusion, injecting acetylcholine (Ach), adrenaline or noradrenaline. Toxicity tests are generally carried out in inbred rats and mice (in vertebrates or nonvertebrates).

A brief review of models adopted for screening biological activities of herbs demonstrates how India is now consolidating its position on the scientific platform: 1. Activity on autonomic nervous system (ANS):

Effect on mammalian blood pressure.

Effects on frog heart.

Effect of aconitine induced arrhythmias in dogs.

Effect of herbal drugs on isolated guinea pig ileum or the isolated ileum of the rabbit.

Effect of herbal drugs on the estrogen-primed uterus of female rats.

Effect of herbal drugs on the eyes of rabbits.

2. Activity on muscles:

Effect of drugs on cat’s polysynaptic lingo-mandibular reflex for central muscle relaxant activity.

Frog’s rectus or rat phrenic nerve diaphragm for effects on the neuromuscular junction for peripheral muscle relaxants.

Sciatic nerve gastrocnemius preparation of frog or of a cat.

3. Activity on central nervous system (CNS):

Anesthetic and hypnotic activity:

Rabbit or dog by giving inhalational or general inhalational anesthetic (not used with herbal drugs).

Rabbit’s cornea for assessing local anesthetic activity.

Hypnotic activity model of rats or mice to assess various righting, pinna, sound reflexes or motor activity.

Pharmacological screening of Ayurvedic drugs 233

Antiepileptic activity:

Supramaximal electroshock seizure pattern test in rats.

Metrazol-induced seizure threshold test in rats.

Analgesic activity:

Hardy Woolfe and Goodel method.

Stimulation of tooth pulp in dogs, rabbits or even in man.

Mechanical (Tail Clip method using analgesiometer), thermal (Eddy’s hot plate method) or mechanical (Hollander’s method), chemical stimulation by using acids, croton oil, 2phenyl 4benzo quinine, bradykinin or by producing an aconitine-induced writhing response in mice or rats.

Tranquilizing activity:

(a) Effect on gross behavior:

Decrease of spontaneous locomotor activity.·

Catalepsy.

Hypothermia.

Prolongation of pentobarbital/hexobarbital sleeping time.

(b) Effect on unlearned behavior:

The taming effect on cats and monkeys.

Abolition of fighting behavior in beta spiendens (Siamese fighting fish).

Abolition of “Shamrage” in decorticated and diencephalic cats.

(c) Effect on learned behavior:

Impairment of performance in Maize, or skinner’s box or light discrimination box. Blockade of conditioned avoidance responses.

The decrease in lever pressing rate of rats with chronically implanted elec-trodes in “pleasure centers.”

(d) Effect on stress-induced behavior:

Conflict neurosis in rats and cats.

(e) Adaptogenic activity:

Mice and rats, swimming endurance test; stress-induced gastric ulcer in rats; milk-induced leukocytosis in mice; stress-induced increase in adrenal weight; rats in cold-hypoxia-restraint (C-H-R) model, recently developed by the scientists of the Defence Institute of Physiology and Allied Sciences, New Delhi (Dr. Srivastava KK and associates).

234 Defining a new scientific path

(f) Antagonism of CNS stimulants:

Amphetamine induced stimulation.

Methods used for assessing anti-depressant activity.

Reserpine reversal test.

Amphetamine potentiation test in rats.

Swimming despair test in mice.

(g) Anti-emetic effects:

Apomorphine induced vomiting in dogs.

Chemoreceptor trigger-zone ablated dogs.

4. Autacoid activity:

Anti-allergic/antihistaminic activity by –

Model: mast cell degranulation produced by diazoxide or compound 48/80 in rats, antigen or histamine-induced bronchospasm in guinea pigs, antigen induced histamine release from peritoneal mast cells sensitized rats in vitro, isolated guinea pig lung preparations, egg-induced passive cutaneous anaphylaxis (PCA) in albino rats.

5. Anti-inflammatory and anti-pyretic activity:

Carrageenan and cotton pellet-induced edema in rats and mice, formalin or adjuvant induced arthritis akin to that of human rheumatoid arthritis, croton oil-induced edema in rats, edema induced by chemical mediators like histamine, serotonin, bradykinin, etc. Brewer’s yeast-induced pyrexia in rats for anti-pyretic activity.

6. Activity on gastrointestinal tract (GIT):

Anti-ulcerogenic activity:

Prednisolone or histamine or aspirin/phenyl-butazone or stress-induced ulcers in guinea pigs, rats respectively. Gastric pouch studies and analysis of gastric juices.

Antiemetic activity models in dogs or cats, as previously described.

Spasmolytic activity, as previously described.

7. Hepatoprotective activity:

Model: carbon tetrachloride-induced hepatotoxicity in rats and rabbits; stimulated viral hepatitis; fatty infiltration and cirrhosis; alcohol-induced liver damage on nonhepatectomized and partially hepatectomized rats; galactosamine-induced hepatic damage in rats.

Pharmacological screening of Ayurvedic drugs 235

8. Metabolic disorders:

Hypoglycaemic activity:

Model: normal and alloxan – induced diabetic rats, rabbits, guinea pigs and dogs; streptozotocin-induced diabetic rats; pancreatectomized dogs; hormone-induced diabetic models in rats, guinea pigs and rabbits; insulin deficient models using insulin antibodies in guinea pigs; viral-induced diabetic model and in spontaneous diabetic mice, transgenic animals.

Hypolipidemic activity:

Model: Cholesterol fed rabbits or guinea pigs, albino rats or dogs.

9. Urinary activity:

Diuretic and anti-diuretic activity on the urinary flow in rats.

10. Antifertility activity:

Female rats for estrogenic/anti-estrogenic activity; male rats for inhibition of spermatogenesis.

11. Antimalarial activity:

Antimalarial activity in malarial mice and rhesus monkeys (testing of current herbal drugs).

12. Anti-infective activity:

Plant (alcoholic, ethanolic and aqueous) extracts, essential oil and seed extracts tested in vitro for their antibacterial, antifungal, antiviral and anthelmintic activity.

13. Anticancer or effects on genomic structure:

Besides routine toxicity studies (mostly not done with herbal drugs), studies are being done by using cell lines or even human cancerous or rat’s tissue using Western Blotting technique and other similar methods to find changes in genomic proteins and the cell dividing enzymes. Occasionally, Amese test is used for toxicity studies.

On the basis of pharmacological and toxicological studies, a new classification of Indian medicinal plants has emerged. This has facilitated further research in the right direction and paved the way for appropriate clinical trials. Adaptogenic, anti-inflammatory, cardio-protective, CNS active, CVS active, hypolipidemic, hepatoprotective, hypoglycaemic, ulcero-protective, chemoprotective and

236 Defining a new scientific path

cytoprotective activities of Indian medicinal plants have been explored, but scientific validation will depend upon the results of clinical trials.

But research scientists point toward a paradoxical situation:

The practitioners of Ayurvedic system of medicine, in general, are neither keen nor motivated to subject the age-old remedies to scientific appraisal.

On the other hand, clinicians of modern medicine traditionally suffer from

skepticism and are averse to such clinical studies.1,2

References

1 Das PK et al, Clinical studies on medicinal plants of India, Current Research on Medicinal Plants of India, Indian National Science Academy, New Delhi, 1986.

2 CCRAS, General Guidelines for Safety/Toxicity Evaluation of Ayurvedic Formulations, Volume II, 2018.





19 An enigmatic approach in

Ayurvedic Pharmacopoeia

of India

From holistic approach to

disease-specific concepts

Excerpts from Special Introduction to

Ayurvedic Pharmacopoeia of India, Part I, Vol. IX: Since the last half a century, Ayurveda has had to compete with modern medicines, which are proven to be quick-acting, strong and effective. Convenience and acceptability of these medicines by patients was another factor that necessitated the Ayurvedic fraternity to modernize. Many manufacturers shifted their traditional preparation like Vati and Gutikaa to compressed tablets and capsules. There were attempts to achieve greater shelf life for traditional medicines, by adopting newer techniques of extraction, chemical preservation, and application of modern principles in Ayurvedic pharmacy.

A recent trend in Ayurvedic manufacturing pharmacy aims at (1) enhancement of potency and reduction in bulk of dosage form (2) convenience in administering doses and (3) acceptability by improving palatability. This trend is an outcome of significant gains in knowledge of phytochemical contents of the source plant, and improved methods of assessing the pharmacological and therapeutic actions of such phytochemical contents. Direct development of this awareness is the introduction of extracts of plants as a more effective means of obtaining desirable results.

Extracts: The modernization of the Ayurvedic drug industry is experiment-ing with various extraction techniques. More and more capsules and tablets appearing in the market are based on products using extraction techniques.

Even liquids like syrups, medicated oils, and other oral suspensions depend on the extracts. Extraction is essential to reduce the bulk of the drug material and enhance its potency, acceptability, and convenience of administration of the drug. The purpose of standardized extraction procedures for crude drugs is to acquire the therapeutically desired portion and eliminate inert material, by treatment with a selective solvent known as the menstruum. The extract thus obtained is used as a medicinal agent directly, or further processed to be incorporated in any dosage form such as a tablet, capsule or syrup.

Standardized extract: Standardized extract for use in a pharmacopoeia indicates an extract having an acceptable limit of the given content, specified by a biomarker or chemical/analytical marker. The extract should specify the

238 Defining a new scientific path

defined range for the constituents (biomarker or chemical/analytical marker).

Dry extracts usually have a loss on drying or water content not greater than 5 percent w/w, unless specified otherwise in any monograph. In the cases of standardized extracts, the presence and content of the inert permissible excipients including preservatives, if any, should be declared on the label. Extracts shall be free from solvents used for the extraction and shall comply with the respective limits. Harmful and carcinogenic solvents shall not be used for extraction purposes. Extracts may be exposed to ethylene oxide for fumigation or low dose gamma radiation for the purpose of avoiding microbial contamination. In cases where the extracts are fumigated, the final extracts exposed shall meet residual levels of ethylene dioxide limits as applicable.

Herbs treated with a low dose of gamma radiations shall meet national regulations related to such treatment and shall be labeled as per law.

Phyto-chemical reference standards as markers: Extracts are usually complex mixtures of several chemical constituents. For a large majority of botanical extracts, it is not known with certainty which of the various components is responsible for the reported pharmacological effect. It is generally believed that several constituents act synergistically to provide the reported effect. For articles for which compendial monographs are provided, certain chemical constituents of the article are chosen and quantitative test procedures for determining their content are provided. The choice of such constituents, known generally as marker compounds, is based on certain considerations.

Currently, the following types of marker compounds are specified in compendial monographs and may be identified in raw materials: Active Principles that have proven clinical activity; Active Markers that have known pharmacological activity; Analytical Markers, where neither defined active principles nor active markers are known; and Negative Markers that may have toxic or allergenic properties.

Fifteen single plant drugs were selected for preparing aqueous and hydroalcoholic dried extracts. The work of preparing extracts using identical standard operating procedures was allotted to different extract manufacturers in two groups viz., Natural Remedies Pvt. Ltd., Bangalore, Chemolids Pvt. Ltd.

Vijayawada, and Green Chem Pvt. Ltd., Bangalore, in one group and Sanat Product Pvt. Ltd. Bulendashar, Arjuna Products Pvt. Ltd., Kochi, and Amsar Pvt. Ltd., Indore, in another group. Both the groups were coordinated by Natural Remedies Pvt. Ltd., Bangalore. The raw material was procured in one lot and distributed among the three collaborators. Data generated was shared on three batches of each. Comprehensive reproducible data has been incorporated in the monographs. The monographs on fifteen plant drugs have been already included in earlier volumes of API, Part I. They have now been upgraded by the addition of Thin Layer Chromatography, fingerprint profiling using Phyto-Chemical Reference Standard (PRS). The new addition of assay for the PRS has been also added to make the monograph comparable to international standards.

Approach of Ayurvedic Pharmacopoeia of India 239

In the light of this latest amendment in the Drugs and Cosmetics Rule 158 (B) clause IV, the Ayurvedic Pharmacopoeia Committee considered it appropriate to prepare monographs on 15 plant extracts, aqueous and hydroalcoholic, in Volume IX of the Ayurvedic Pharmacopoeia of India, Part I.”

( Excerpts end.)

Ayurvedic Pharmacopoeia of India also approved thin-layer chromatography (TLC) and High performance liquid chromatography (HPLC). TLC is a very easy way to separate the components. It is not an automatic process. Very few types of equipment are used. The components are separated in a very short time. It is feasi-ble to visualize all components of UV light. Only soluble components of the mixtures and nonvolatile compounds are separated by the TLC method. It gives only qualitative analysis, not quantitative, and can not remain stationary. Compared to TLC, HPLC offers a quick, automated and highly accurate method to identify certain chemical components in a sample, but it can be costly, complex and doesn’t work for all samples. It uses a pump, rather than gravity, to force a liquid solvent through a solid adsorbent material, with different chemical components separating out as they move at different speeds. The process can be completed in roughly 10 to 30 minutes, and it delivers a high resolution. It is accurate and highly reproducible. Because it is largely automated, basic HPLC runs can be performed with minimal training. HPLC is widely used for the isolation of natural compounds.

This has become the main choice for fingerprinting study.

The monographs on Hydro-alcoholic extract and Water extract were selected from earlier volumes of the Ayurvedic Pharmacopoeia. (Earlier volumes in brackets.)

1 Apaamaarga (Also in Vol. II and Vol. III.)

2 Asana (Also in Vol. I.)

3 Daaruharidraa (Also in Vol. II and Vol. VI.)

4 Dhaaraa Vrkshaamla (Vrantaamlaphala in Vol VI.)

5 Katukaa (Also in Vol. II.)

6 Manjishthaa (Also in Vol. III.)

7 Meshashringi (Also in Vol. V.)

8 Methi (Also in Vol. II.)

9 Nirgundi (Also in Vol. III and Vol. IV,)

10 Punarnavaa (Also in Vol. I and Vol. V.)

11 Shallaki (Also in Vol. IV as Kunduru.)

12 Shrisha (Also in Vol. III.)

13 Shunthi (Also in Vol. I.)

14 Svarnapatri (Also in Vol 1.)

15 Tulasi (Also in Vol. II and Vol. IV.)

First of all, before identifying a Reference Standard and chemical constituents, Ayurvedic Pharmacopoeia must verify that the classical Sanskrit name

240 Defining a new scientific path

of the plant has been correctly equated with the botanical name. Two varieties of Apaamaarga have been mentioned during the seventh century, Gaur-dand Apaamaarga and Rakta Apaamaarga. Gaur-dand Apaamaarga exhibited 100%

abortifacient activity experimentally, while it was used by Vagbhata (Ashtangahridaya, Sa 1, 39) for Punsavan prayoga (medication causing the birth of a male child). Achyranthes bidenatata Blume has been identified as Shveta (Gaur-dand) Apaamaarga. In Chinese medicine, its root, known as huai niu xi, is used for irregular menses, postpartum pain in the abdomen due to blood stasis, after-birth not being expelled. Cooked huai niu xi is effective for strengthening muscles and bones, promoting urination and strengthening the essence of the body.

Rakta Apaamaarga has been equated with Achyranthes rubra-fusca Hook. f.

and Achyranthes verschaffeltii Lam., syn. Irestine herbstii. Cyathula prostrata, equated with Rakta Apaamarga in South India, is abortifacient. The paste of root was applied on naval, pelvis and vulva to induce labor easily. Application of the root paste was used to give relief in pahaffin during puerperium.

Pupalia lappacea (L.) Juss., syn. Achyranthes lappacea L. = Pupalia atropur-purea (Lamk) Moq. is also known as Chirchatta (common name of Apaamaarga).

“Pupalia. lappacea ointments significantly (p < 0.05) accelerated wound healing with 20% ointment having the highest percentage wound contraction and rate of epithelialization. At 4, 7 and 14 days post-treatment, mean total viable bacterial count of excision wounds of the extract treated groups were significantly (p < 0.05) lower compared against the control. Wound breaking strengths and weights of granuloma tissues formed in the extract treated groups were significantly (p < 0.05) higher than those of the control group. The minimum inhibitory concentration values obtained for the Pupalia lappacea extract against Pseu-domonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis were 9mg/ml, 4mg/ml and 3mg/ml, respectively, while the corresponding minimum bactericidal concentrations were 10mg/ml, 8mg/ml and 7mg/ml.” ( BMC Complementary and Alternative Medicine, the official journal of the International Society for Complementary Medicine Research (ISCMR)2014 (14):157.)

This exercise will help scientists to investigate the right herb for validated drug development.

Now, we will give a summary of one revised monograph on Apaamaarga ( Achyranthes aspera Linn.) based on the hydro-alcoholic extract and water extract of the powdered dried plant. The monograph is in three parts: (1) Updated Apaamaarga monograph; (2) Apaamaarga Hydro-alcoholic Extract, which contained not less than 0.08% of oleanolic acid when assayed; and (3) Apaamaarga Water Extract, which contained not less than 0.01% of oleanolic acid when assayed. In Hydro-alcoholic and Water Extract sub-monographs, isolated constituents were skipped, but oleanolic acid was included as API reference standard (RS).

In the updated part, Apaamaarga dried whole plant was shown to contain not less than 0.002% of oleanolic acid. API reference standard (RS) oleanolic acid and following constituents were added after TLC and HPLC assays: Oleanolic acid glycosides; ecdysterone, ecdysone, betaine, tritriacontanone, pentatriacontan-17-ol,

Approach of Ayurvedic Pharmacopoeia of India 241

27-cyclohexylheptacosan7-ol, 16-hydroxy-26-methylheptacosan-2-one, 4-meth-ylheptatriacont-1-en-10-ol, etracontanol, beta-sitosterol, pentatriacontane, pentatriacontan-6-one, hexatriacontane, triacontane, hentriacontane, octacosan-10-one, triacosan-4-one; lauric, myristic, palmitic, stearic, oleic, linoleic, arachidic and behenic acids.

At this stage, biological activities of oleanolic acid and those of chemical constituents should have been investigated by experimental trials and already mentioned properties and formulations in earlier monograph should have been reviewed.

We hope it will be done in the next phase. The dose almost remained the same: Churna (powder): 3–6g (instead of 5–10 g, due to extraction). The herb-extract ratio should have been mentioned to validate the dose.

The monograph is on the whole plant. Charaka prescribed dried fruits alone or in prescriptions for hemicranias (cluster headache). (The alkaloidal residue obtained from the plant did not show analgesic activity in rats.) A decoction of the whole plant was given as a diuretic in renal dropsies and general anasarca and pneumonia. (In a clinical study, the decoction of the plant, its seed or saponin did not show a significant diuretic property, immediate or late diuresis, in cases of general anasarca.) An infusion in water was given in bronchial infection. The powdered plant was used for treating rheumatism.

In Ayurvedic medicine, Apaamaarga Kshaara (alkaline ash) and root were also used. In Maha Vishagarbha Taila ( Agastya Rasayana) the root was an important ingredient. Kshaara was used in medicated oils. Kshaara-sutra is used in a surgi-cal procedure for fistula-in-ano. Kshaara was a drug for gastrointestinal disorders, dyspepsia, intestinal parasites, piles, cough and also for promoting the growth of normal tissues after surgery.

Now that “Identity and Strength” of the powdered herb is known and “RS”

(Reference Standard) and “Constituents” give a clear picture of the biological activity and curative potential of the drug, the next step should be to compare them with the “Properties and Actions” attributed by classical parameters, Rasa, Guna, Veerya, Vipaaka and Karma.

We are adding quantitative analysis of Apaamaarga Kshaara (5 samples), on our own, as additional information:

Sodium as Na (wt.%)

0.34

0.29

0.27

0.29

0.3

Potassium as K (wt.%)

2.11

2.64

2.59

2.74

0.0001

Magnesium as Mg (wt.%)

0.03

0.03

0.02

0.02

0.05

Calcium as Ca (wt.%)

5.13

0.54

0.51

0.55

0.61

Alkalinity as CaCO ppm

3

Phenolphthalein

185528 211519

188730 163043 144284

Methyl orange

144592 81353

107845 122282 144284

Sulphate as SO (wt.%)

7.86

8.84

9.77

11.59

8.765

4

Carbonate as CaCO ppm

104106 258054 230250 198913 176026

3

Bicarbonate as CaCO

ppm

Nil Nil Nil Nil Nil

3

Source: Journal of Ayurveda Medical Sciences, 3 (1).

242 Defining a new scientific path

This exercise is a shift from a Holistic approach to disease-specific concepts. Thin Layer Chromatography, fingerprint profiling, Phytochemical Reference Standard (PRS) and assay for PRS can make the extract-based monographs comparable to international standards. It remains to be seen if these scientific parameters add some new findings to our classical knowledge.

We expect many new findings. A few examples:

• Nardostachys jatamansi DC. (Jataamaamsi), as a total herb (2–4 g powder or 5–10 g of the drug decoction) is to be used for Kushtha (obstinate diseases), Daaha (burning sensation), Visarpa (erysipelas), Maanasroga (mental diseases) and Anidraa (insomnia). (Ayurvedic Pharmacopoeia of I ndia,

Part I, Vol. I.) Hydrodistillation of the crude drug gave an oil (2.5% v/w) that contained d-nardostachone, valeranone and jatamansone. Experimentally, in rabbits, jatamansone was found to impair biosynthesis of serotonin in the brain leading to a reduction in brain level of 5-hydroxytryptamine.

Alcoholic extract of the roots caused an overall increase in the level of central monamines, 5-hydroxy indole acetic acid, and the inhibitory amino acids, gamma-aminobutyric acid (GABA), nor-epinephrine, dopamine and serotonin in rat brain.

• Detoxified seeds of Mucuna prurita Hook. are used in most of the aphrodisiac drugs of Ayurveda. When chemical constituents were isolated, the seeds were found to contain 1.5% L-dopa, the whole bean contained 3% to 6%, the endocarp of the pericarp contained about 5.3%. L-dopa was also found in the stem, leaves and roots. This research gave the drug Zandopa, standardized to contain 3.3% L-dopa and is used for Parkinson’s disease.

• Glycyrrhiza glabra Linn. was used in Ayurveda for cough, hoarseness of voice, now Deglycyrrhizinated Licorice (DGL) is used for acute cases of duodenal or gastric ulcers (2–4 380 mg, 4:1, DGL tablets, not capsules, to be chewed before meals).

• While investigating chemical constituents of herbs and screening their biological activities experimentally and clinically, a number of phytochemicals were found to exhibit possibly safer and better results than traditional herbal medicines. A number of bioactive phytoconstituents are emerging as a viable natural medicine all over the West.

• Bromelain, a proteolytic enzyme found in the stem and fruit of the pineapple plant ( Ananas comosus), is extracted from pineapple juice pulp. Its constituents are a mixture of basic glycoproteins similar to papain. Bromelain is used as a digestive aid and has been found to be an effective mucolytic agent, as well as an anti-inflammatory mediator. It reduces platelet aggregation, edema (from decreased vascular permeability) and other prostaglandin-related phe-nomena. (250–750 mg tablet, twice daily, is used between meals.)

• Capsaicin, the major component of Capsicum annuum is currently an investigational drug for migraine, osteoarthritis and other pain-related conditions.

For pain syndrome, including rheumatoid and osteoarthritis, neuropathy and fibromyalgia, creams containing 0.025% to 0.075% capsaicin are topically

Approach of Ayurvedic Pharmacopoeia of India 243

applied three to four times daily. For cluster headache, 0.1 mL of a 10 mM

capsaicin suspension, providing 300 mcg/day of capsaicin, applied to the ipsilateral nostril, has been used. For migraine headache, the application of capsaicin 0.075% to the nasal mucosa is recommended.

• Curcumin, the major yellow pigment of Turmeric ( Curcuma longa) exhibits anti-inflammatory activity, possibly by inhibiting cyclooxygenase-2 (COX-2), prostaglandins, and leukotrienes. But the bioavailability of curcumin is very low after oral administration. Oral administration of a single dose of 2 g of curcumin to eight human volunteers led to undetectable or very low serum concentration. Concomitant administration of 20 mg of piperine is being tried to increase the serum concentrations. In the USA, Curcumin added to the whole phytocomplex is preferred as an anti-inflammatory dietary supplement.

• Hesperidin is primarily derived from citrus fruits and is known as a citrus bio-flavonoid, closely related to quercetin, rutin and diosmin. Used for vascular conditions such as hemorrhoids, varicose veins and venous stasis. Hesperidin capsules contain hesperidin methyl chalcone 250 mg, bromelain 2,400

GDU/g and Vitamin C 9 mg. For hemorrhoids, hesperidin 150 mg plus diosmin 1,350 mg twice daily for 4 days, followed by hesperidin 100 mg and diosmin 900 mg twice daily for 3 days, has been used. For venous stasis ulcers, a combination of 100 mg hesperidin and 900 mg diosmin daily has been used up to 2 months. Diosmin and hesperidin, extracted from Rutaceae species, have been used in clinical trials.

• Lycopene is the most abundant carotenoid in tomatoes ( Lycopersicon esculentum). Raw tomatoes contain 3.1 mg per 100 g. Mechanical treatment with heat helps release lycopene from the tomato matrix, improving its bioavailability. Tomato sauce and ketchup contain lycopene 33 to 66 mg per 100 g.

Heat processing of tomato paste, juice, ketchup induces the isomerization of lycopene from trans- to cis-configuration. The cis isomer has better bioavailability. In North America, 85% dietary lycopene comes from tomato-derived products such as tomato juice or paste. One cup of tomato juice (240

ml) provides about 23 mg of lycopene. The majority of evidence supported the use of lycopene in cancer prevention. Lycopene absorption in humans is approximately 10% to 30%. It was used in clinical trials at dosages of 13 to 75 mg/day.

• Oligomeric proanthocyanidins are usually derived from grape ( Vitis vinifera) seeds. The highest concentration of proanthocyanidins is found in the skin or membrane of the grape seed. Total proanthocyanidin content consumed in 100 g of dry grape seed is approximately 3,500 mg. Grape seed extract has shown positive results in the treatment of peripheral venous insufficiency, varicose veins, capillary fragility, also in diabetic retinopathy, edema, ocular stress, premenstrual syndrome, and for chronic venous insufficiency.

• Papaya ( Carica papaya) was introduced into India in the sixteenth century. It became a part of Ayurveda as Erandakarkati in the Ayurvedic Pharmacopoeia of India, Part I, Vol. VI to be used for treating worm infestation, cough, bleeding disorders, asthma and gout. None of these attributes could be confirmed

244 Defining a new scientific path

in experimental trials. In practice, the ripe fruit is used as a digestive aid in ethnomedicine. Current research revealed that the latex from unripe papaya is rich in two enzymes, papain and chymopapain. As the fruit ripens, papain and chymopapain dissipate and neither is present in the ripe fruit. Purified papain enzyme is poorly active in extremely acidic or basic media, can be digested by pepsin, and is poorly absorbed when ingested orally. The use of oral papain tablets is being evaluated in several controlled clinical trials for post-traumatic inflammation. Papaya proteolytic enzyme tablets appeared to reduce postoperative edema, inflammation or pain when compared to placebo. But the results of analgesic and anti-inflammatory effects are contradic-tory. The fibrinogenous effect has not been sufficiently proved.

• Both species, known as Chirchatta, Achyranthes aspera and Pupalia lappacea, have shown free radical scavenging activity. The ethanolic extract of Pupalia lappacea has IC50 value of 510 μg/ml, 410 μg/ml, 310 μg/ml of DPPH, nitric oxide and iron chelating activity, respectively. Their anti-proliferative and specific inhibitory activity against pancreatic cancer cells in preliminary studies are totally different from their traditional uses.

While concluding, we are confident that these changes in the Ayurvedic Pharmacopoeia, sooner or later, will inspire young Ayurvedic generation to revalidate the properties of Ayurvedic drugs, and much awaited scientific movement is bound to gather strength.





20 Unbiased research

Lifeline of evidence-based

Ayurveda

Contributions of young Indian scientists

to Ayurveda

Indian scientists are exploring new areas for further development of Ayurveda.

We are quoting the summary of selected research papers published in The Indian Journal of Pharmacology.

The Indian Journal of Pharmacology is an official publication of the Indian Pharmacological Society. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution. The journal is registered with the following abstracting partners: Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing’s Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data. The journal is indexed with or included in, the following: DOAJ, EMBASE/ Excerpta Medica, Index Copernicus, Indian Science Abstracts, IndMed, MedInd, MEDLINE/Index Medicus, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded, Web of Science.

The following studies demonstrate the positive growth of

research and development in India:

1 Hypoglycaemic effect of the aqueous extract of Boerhavia diffusa leaves: M. A. Chude, O. E. Orisakwe, O. J. Afonne, K. S. Gamaniel, O. H. Vongtau, E. Obi, Indian Journal of Pharmacology, 2001; 33: 215–216.

The study aims at investigating the effects of B. diffusa aqueous leaf extract on the blood sugar level of rats. The baseline plasma glucose levels were determined prior to administration. The alloxan-induced diabetic rats were divided into four groups of six male rats each. The test groups received 100, 200 and 400 mg/kg aqueous extract, while the control group received appropriate volumes of water orally respectively. At 0, 2, 4, 6, 8 and 24 hours, 0.5 ml of blood from the tail vein of the rats was dropped on the reagent pad of the one touch strip. The strip was

246 Defining a new scientific path

inserted into a one-touch brand meter and the reading noted. The aqueous extract was found to contain flavonoids, glycosides, tannins, saponins, and proteins. The extract showed non-dose dependent hypoglycemic activity. The peak activity of the extract was observed at 6h post drug administration. While the 400 mg/kg dose caused a maximum percent reduction of 21.56 in glucose level at 6h, the 100 and 200 mg/kg doses of the extract showed more hypoglycemic effects which were significant at p < 0.05 from the initial value, with percentage decreases of 38.07% and 51.95% respectively. The aqueous leaf extract of B. diffusa produced nondose related decreases in blood glucose level in alloxan-induced diabetic rats.

Thus the hypoglycemic effect produced by the extract of B. diffusa leaves may be due to the glycosides, flavonoids, tannins, and saponins present in the extract.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I: Dried matured whole plant is used for anemia and inflammations.

2 Effect of Pongamia pinnata flowers on blood glucose and oxidative stress in alloxan induced diabetic rats, Punitha R, Vasudevan K, Manoharan S, Indian Journal of Pharmacology, 2006; 38(1): 62–63.

Pongamia pinnata (Linn.) Pierre has been largely used in the traditional Indian system of medicine (Ayurveda) for bronchitis, whooping cough, rheumatic arthritis, and diabetes. This study was focused on the antihyperglycemic and antilipidperoxidative activities of aqueous extract of P. pinnata flowers (PpFAet) in alloxan-induced diabetic rats.

Albino Wistar male rats (7–8 week old, weighing 150–200 g) were used in the present study and housed in the Central Animal House with 12 h light/dark cycle. Standard pellet (Mysore Snack Feed Ltd, Mysore, India) was used as a basal diet during the experiment. The control and experimental animals were provided with food and water ad libitum. The Institutional Animal Ethics Committee of the Annamalai University, Annamalai Nagar, India, approved the experimental design. A total of 30 rats were divided into 5 groups of 6 each and treated as follows.

Group I: control (2 ml distilled water, orally).

Group II: diabetic control (alloxan, 150 mg/kg, i.p).

Group III: diabetic + PpFAet (300 mg/kg, orally).

Group IV: diabetic + glibenclamide (600 µg/kg, orally).

Group V: PpFAet + distilled water (300 mg/kg, orally).

The diabetic condition was assessed by determining the blood glucose concentration 3 and 5 days after alloxan treatment. The rats with blood glucose level above 260 mg/dl and urinary sugar (+++) were selected for study (Groups II–IV).

The dose (300 mg/kg, orally) was standardized after a pilot study with different doses of the PpFAet to assess the antihyperglycemic and antilipidperoxidative effects in alloxan-induced diabetic rats. After the experimental period, all animals were sacrificed by cervical dislocation and biochemical studies conducted

Unbiased research 247

in blood, plasma, and liver samples using colorimetric methods. Plasma insulin was assayed by the ELISA method using Boehinger Mannheim Gmbh kit. The data are expressed as mean ± SD. Statistical comparisons were performed by one-way anova followed by Dunnett’s test. The results were considered statistically significant if P ≤ 0.05.

A significant decrease in the level of blood glucose and glucose-6-phosphatase activity and a significant increase in the plasma insulin level and hexokinase activity was noted at the end of the experimental period in diabetic rats treated with PpFAet (300 mg/kg, orally). PpFAet also significantly reduced the thiobarbituric acid-reactive substances (TBARS) level and enhanced the antioxidants status in induced diabetic rats after 45 days of treatment. PpFAet showed antihyperglycemic and antilipidperoxidative effects in a manner similar to that of the reference drug glibenclamide in alloxan-induced diabetic rats.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I and II covered seed, leaf, stem bark, root and root bark, not flowers.

3 A study of the antidiabetic activity of Barleria prionitis: Dheer R, and Bhatnagar P, Indian Journal of Pharmacology, 2010; 42: 70–77.

Alcoholic extract of leaf and root of B. prionitis Linn. was tested for their antidiabetic activity. Albino rats were divided into six groups of six animals each. In three groups, diabetes was induced using alloxan monohydrate (150 mg/kg b.w., i.p.) and all the rats were given different treatments consisting of vehicle, alcoholic extract of leaves, and alcoholic extract roots of B. prionitis Linn (200 mg/kg) for 14 days. The same treatment was given to the other three groups, comprising non-diabetic (normal) animals. Blood glucose level, glycosylated hemoglobin, liver glycogen, serum insulin, and body weight were estimated in normal and alloxan-induced diabetic rats, before and 2 weeks after administration of drugs.

Animals treated with the alcoholic extract of leaves of B. prionitis Linn showed a significant decrease in blood glucose level (P < 0.01) and glycosylated hemoglobin (P < 0.01). A significant increase was observed in serum insulin level (P < 0.01) and liver glycogen level (P < 0.05), whereas the decrease in the body weight was arrested by the administration of leaf extract to the animals. The alcoholic extract of roots showed a moderate but non-significant antidiabetic activity in experimental animals.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. III: whole plant is used for obstinate skin diseases, pruritus, bleeding disorders, and graying of hair.

4 The effect of Allium sativum on ischemic preconditioning and ischemia reperfusion induced cardiac injury: Bhatti R, Singh K, Ishar MP, Indian Journal of Pharmacology, 2008; 40:261–265.

In this study, the effect of garlic ( Allium sativum) extract on ischemic preconditioning and ischemia-reperfusion induced cardiac injury has been studied. Hearts from adult albino rats of Wistar strain were isolated and immediately mounted on

248 Defining a new scientific path

Langendorff’s apparatus for retrograde perfusion. After 15 minutes of stabiliza-tion, the hearts were subjected to four episodes of 5 min ischemia, interspersed with 5 min reperfusion (to complete the protocol of ischemic preconditioning), 30 min global ischemia, followed by 120 min of reperfusion. In the control and treated groups, respective interventions were given instead of ischemic preconditioning. The magnitude of cardiac injury was quantified by measuring Lactate Dehydrogenase and creatine kinase concentration in the coronary effluent and myocardial infarct size by macroscopic volume method.

The study demonstrated that garlic extract exaggerates the cardio protection offered by ischemic preconditioning and per se treatment with garlic extract also protects the myocardium against ischemia reperfusion induced cardiac injury.

( Allium sativum is used in Ayurveda for worm infection, tympanitis, skin diseases, piles, cough, asthma, chronic rhinitis, rheumatism, obesity, and cardiac diseases.) Ayurvedic Pharmacopoeia of India (API), Part I, Vol. III: Bulb is used for chronic fever, worm infestations, tympanitis, obstinate skin diseases, piles, cough, asthma, chronic rhinitis/sinusitis, colic, earache, rheumatism, hiccup, obesity, diseases of the female genital tract, gastroenteritis, enlargement of spleen, emaciation, intermittent fever, epilepsy, insanity, edema, cardiac diseases, neuralgic pain, pain in sacral region, and ulcers.

5 Antiulcer activity of Tephrosia purpurea in rats: S. S. Deshpande, G. B.

Shah, N. S. Parmar, Indian Journal of Pharmacology, 2003; 35: 168–172.

The antiulcer activity of aqueous extract of roots of Tephrosia purpurea (AETP) was studied in different models of gastric and duodenal ulceration in rats. Antiulcer activity of AETP was studied in rats in which gastric ulcers were induced by oral administration of ethanol or 0.6 M HCl or indomethacin or by pyloric ligation and duodenal ulcers were induced by oral administration of cysteamine HCI.

AETP was administered in the dose of 1 to 20 mg/kg orally 30 min prior to ulcer induction. The antiulcer activity was assessed by determining and comparing the ulcer index in the test drug group with that of the vehicle control group. Gastric total acid output and pepsin activity were estimated in the pylorus ligated rats.

Omeprazole was used as a reference drug.

The ulcer index in the AETP treated animals was found to be significantly less in all the models compared to vehicle control animals. This antiulcer property was more prominent in animals in whom ulcers were induced by HCl, indomethacin and pyloric ligation. Omeprazole (8 mg/kg) produced a significant gastric and duodenal ulcer protection when compared with the control group. The anti-ulcer activity of AETP was, however, less than that of Omeprazole.

The results suggest that AETP possesses a significant antiulcer property which could be either due to cytoprotective action of the drug or by strengthening of gastric and duodenal mucosa and thus enhancing mucosal defense.

Tephrosia purpurea is used in Ayurveda for bleeding disorders, urinary disorders, blood disorders, obesity, wound-healing, inflammations, and skin diseases.

Unbiased research 249

Tephrosia purpurea attracted the attention of scientists all over the world for its use in Ayurvedic medicine for liver cirrhosis and splenomegaly.

6 Anticarcinogenic and antilipidperoxidative effects of Tephrosia purpurea

(Linn.) Pers. in 7, 12-dimethylbenz(a)anthracene (DMBA) induced hamster buccal pouch carcinoma: Kavitha K, Manoharan S, Indian Journal of Pharmacology, 2006; 38(3): 185–189.

This study investigates the chemopreventive potential and antilipidperoxidative effects of ethanolic root extract of Tephrosia purpurea (Linn.) Pers. (TpEt) on 7,12-dimethylbenz(a)-anthracene (DMBA)-induced hamster buccal pouch carcinoma.

Oral squamous cell carcinoma was developed in the buccal pouch of Syrian golden hamsters, by painting with 0.5% DMBA in liquid paraffin, thrice a week, for 14 weeks. The tumor incidence, volume, and burden were determined. Oral administration of TpEt at a dose of 300 mg/kg, b.w., to DMBA (on alternate days for 14 weeks)-painted animals significantly prevented the incidence, volume, and burden of the tumor.

TpEt showed potent antilipidperoxidative effect, as well as enhanced the antioxidant status in DMBA-painted animals. Further studies are needed to isolate and characterize the bioactive principle.

7 Effect of Tinospora cordifolia on learning and memory in normal and memory deficit rats: Agarwal A, Malini S, Bairy KL, Rao MS, Indian Journal of Pharmacology, 2002; 34: 339–349.

To study the effect of Tinospora cordifolia (Tc) on learning and memory in normal and cyclosporine-induced memory deficit rats, alcoholic and aqueous extracts of the whole plant of Tinospora cordifolia was administered orally for 15 days in two groups of rats. Cyclosporine 15, 25 mg/kg, i.p. was administered on alternate days for 10 days. Combination of cyclosporine 25 mg/kg, i.p. for 10 days and Tc alcoholic 200 mg/kg and Tc aqueous 100 mg/kg were administered in two different groups of rats. At the end of treatment, learning and memory were assessed using Hebb William maze and passive avoidance task. The locomotor activity was assessed using an open field chamber. The immune status was studied using DNCB

skin sensitivity test. Histopathological examination of hippocampus was done.

Both alcoholic and aqueous extracts of Tc indicated an enhancement of learning and memory. However, cyclosporine at both the doses suggested a memory deficit. The histopathological examination of the hippocampus in cyclosporine treated rats showed neurodegenerative changes which were protected by the Tc. Tc enhanced cognition (learning and memory) in normal rats. Cyclosporine induced memory deficit was successfully overcome by Tc.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I: Tinospora cordifolia stem is used for obstinate skin diseases, gout, fever, jaundice, anemia, and polyuria.

250 Defining a new scientific path

8 Possible anorectic effect of methanol extract of Benincasa hispida

(Thunb.). Cogn. Fruit: Kumar A, Vimalavathini R. Indian Journal of Pharmacology, 2004; 36: 348–350.

In this study, the anorectic effect of the methanol extract of Benincasa hispida (MEBH) in Swiss albino mice was investigated. Fasted mice were administered with various doses of MEBH (0.2–1 g/kg, i.p.), and the food intake was measured hourly for a period of 7 h. In another experiment, the percentage of gastric emptying at 4th h was determined after the administration of MEBH (0.2–1 g/kg, i.p.) in a different set of mice which had free access to preweighed food for either 1, 2 or 4 h.

MEBH significantly reduced the cumulative food intake over a 7 h period in a dose-dependent manner. The percentage reduction of cumulative food intake at 7th h for MEBH with 0.2, 0.6 and 1 g/kg was 27%, 38%, and 54% respectively.

The 4 h gastric emptying was not significantly influenced by MEBH when compared to control.

The study revealed for the first time a possible anorectic activity of Benincasa hispida, most probably mediated through the CNS without affecting the gastric emptying. However, further studies are required to find its potential as an antiobesity agent.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. IV: Benincasa hispida fruit is used in retention of urine, polyuria, dysuria, calculus, mental diseases, and constipation.

9 The effect of aqueous extract of Embelia ribes Burm on serum homocysteine, lipids, and oxidative enzymes in methionine induced hyperhomocysteinemia: Bhandari U, Ansari MN, Islam F, Tripathi CD, Indian Journal of Pharmacology, 2008; 40: 152–157.

The study was designed to evaluate the effect of the aqueous extract of Embelia ribes Burm fruits on methionine-induced hyperhomocysteinemia, hyperlipidemia and oxidative stress in albino rats. Adult male Wistar albino rats were fed with the aqueous extract of Embelia ribes (100 and 200 mg/kg, p.o.) for 30 days. Hyperhomocysteinemia was induced by methionine treatment (1 g/kg, p.o.) for 30 days and folic acid (100 mg/kg, p.o.) was used as a standard drug. The animals were evaluated for various biochemical parameters in serum and brain homogenates, followed by histopathological studies at the end of the study.

Administration of methionine (1 g/kg, p.o.) for 30 days to vehicle control rats produced significant increase (P < 0.01) in homocysteine, lactate dehydrogenase (LDH), total cholesterol, triglycerides, low density lipoprotein (LDL-C), very low density lipoprotein (VLDL-C) levels in serum and lipid peroxides (LPO) levels in brain homogenates, with reduction in high density lipoprotein (HDL-C) levels in serum, and glutathione (GSH) content in brain homogenates, as compared to vehicle control rats. Administration of the aqueous extract of Embelia ribes (100 and 200 mg/kg, p.o.) for 30 days, to hyperhomocysteinemic rats, significantly (P < 0.01)

Unbiased research 251

decreased the levels of homocysteine, LDH, total cholesterol, triglycerides, LDL-C, and VLDL-C and increased the HDL-C levels in serum. In addition, a significant (P < 0.01) decrease in LPO levels with an increase in GSH content was observed in hyperhomocysteinemic rats treated with the aqueous extract of Embelia ribes. The results were comparable to those obtained with folic acid, a standard antihyperhomocysteinemic drug.

The results provide clear evidence that the aqueous extract of Embelia ribes treatment enhances the antioxidant defense against methionine-induced hyperhomocysteinemia, hyperlipidemia and oxidative stress in the brain.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I: Embelia ribes fruit is used in worm infestation, flatulence, colic, and diseases of the abdomen.

10 Protective effect of aqueous extract of Embelia ribes Burm fruits in middle cerebral artery occlusion-induced focal cerebral ischemia in rats: Bhandari U, Ansari MN. Indian Journal of Pharmacology, 2008; 40: 215–220.

The study was carried out to evaluate the neuroprotective effect of the aqueous extract of Embelia ribes, in the focal ischemic brain. Adult male Wistar albino rats were fed with the aqueous extract of Embelia ribes (100 and 200 mg/kg, p.o.) for 30 days.

After 30 days of feeding, all the animals were anaesthetized with chloral hydrate (400 mg/kg, i.p.). The right middle cerebral artery was occluded with a 4–0 suture for 2 h. The suture was removed after 2 h, to allow reperfusion injury.

The animals were used for grip strength measurement, biochemical estimation in serum and brain tissue (hippocampus and frontal cortex) and cerebral infarct size measurement.

In the ischemic group, a significant (P < 0.01) alteration in the markers of oxidative damage (thiobarbituric acid reactive substances (TBARS); reduced glutathione (GSH); glutathione peroxidase (GPx); glutathione reductase (GR); and, glutathione-S-transferase (GST)) was observed in the hippocampus and frontal cortex, as compared to sham operated rats. It was observed that the animals treated with the aqueous extract of Embelia ribes had a significant (P < 0.01) increase in the poststroke grip strength activity. Further, supplementation with aqueous extract of Embelia ribes reversed the levels/activities of the above mentioned biochemical parameters significantly (P < 0.01) and also resulted in the decreased cerebral infarct area, as compared to the ischemic group.

The results of our study, for the first time, provide clear evidence that aqueous extract of Embelia ribes pretreatment ameliorates cerebral ischemia/reperfusion injury and enhances the antioxidant defense against middle cerebral artery occlusion-induced cerebral infarction in rats; it exhibits neuroprotective property.

11 Evaluation of the antidepressant-like activity of glycyrrhizin in mice: Dhingra D, Sharma A, Indian Journal of Pharmacology, 2005; 37: 390–394.

252 Defining a new scientific path

Glycyrrhizin (1.5, 3.0 and 6.0 mg/kg, i.p.) was administered once daily for seven successive days to separate groups of young male Swiss albino mice. The immobility periods of control and treated mice were recorded in the forced swim test (FST) and tail suspension test (TST). Effect of sulpiride (50 mg/kg, i.p.; a selective D2 receptor antagonist), prazosin (62.5 µg/kg, i.p.; an a1-adrenoceptor antagonist) and p-chlorophenylalanine (100 mg/kg, i.p.; an inhibitor of serotonin synthesis) on antidepressant-like effect of glycyrrhizin in TST was also studied.

The antidepressant-like effect of glycyrrhizin was compared to that of imipramine (15 mg/kg, i.p.) and fluoxetine (20 mg/kg, i.p.) administered for seven successive days.

Glycyrrhizin produced a significant antidepressant-like effect at a dose of 3.0

mg/kg administered for seven successive days, as indicated by a reduction in the immobility times of mice in both FST and TST. Glycyrrhizin did not show a significant effect on the locomotor activity of mice. The efficacy of glycyrrhizin was found to be comparable to that of imipramine and fluoxetine. Sulpiride and prazosin significantly attenuated the glycyrrhizin-induced antidepressant-like effect in TST. On the other hand, p-chlorophenylalanine did not reverse the antidepressant-like effect of glycyrrhizin. This suggests that the antidepressant-like effect of glycyrrhizin seems to be mediated by an increase in brain norepinephrine and dopamine, but not by an increase in serotonin.

12 Protective activity of Glycyrrhiza glabra Linn. on carbon tetrachlorideinduced peroxidative damage: Rajesh MG, Latha MS, Indian Journal of Pharmacology, 2004; 36: 284–287.

Peroxidative hepatic damage in rats was studied by assessing parameters such as thiobarbituric acid reactive substances (TBARS), conjugated dienes (CD), superoxidedismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione peroxidase (GSH-Px) and glutathione (GSH) in liver and kidneys.

The effect of co-administration of G. glabra on the above parameters and histopathological findings of the liver in experimental animals was studied.

The increased lipid peroxide formation in the tissues of CCl -treated rats 4

was significantly inhibited by G. glabra. The observed decreased antioxidant enzyme activities of SOD, CAT, GSHPx, GST, and antioxidant concentration of glutathione were nearly normalized by G. glabra treatment. Carbon tetrachloride-induced damage produces alteration in the antioxidant status of the tissues, which is manifested by abnormal histopathology. G. glabra restored all these changes.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I: G. glabra root is used for cough, hoarseness of voice, chest diseases, ulcers, and gout.

13 Pharmacological evaluation of the extracts of Sphaeranthus indicus flowers on anxiolytic activity in mice: Ambavade SD, Mhetre NA, Tate VD, Bodhankar SL, Indian Journal of Pharmacology, 2006; 38: 254–259.

Unbiased research 253

The study was to investigate the anxiolytic activity of petroleum ether, alcohol and water extracts, obtained from the flowers of Sphaeranthus indicus Linn, in mice.

Elevated Plus Maze (EPM), Open Field Test (OFT) and Foot-Shock Induced Aggression (FSIA) were the screening tests used to assess the anxiolytic activity of the extracts on mice. Diazepam (1 mg/kg) served as the standard anxiolytic agent.

The animals receiving extracts or diazepam (1 mg/kg) showed an increase in the time spent, percent entries and total entries in the open arm of the EPM; increased ambulation, activity at the centre and total locomotion in the OFT; and decreased fighting bouts in the FSIA, suggesting an anxiolytic activity. Petroleum ether extract (10 mg/kg), alcoholic extract (10 mg/kg) and water extract (30 mg/

kg) resulted in prominent activity in the mice. Petroleum ether extract (10 mg/kg) resulted in more prominent anxiolytic activity in the EPM and OFT than ethanolic or water extracts but was less than that produced by diazepam (1 mg/kg).

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. IV: Sphaeranthus indicus whole plant is used for scrofula, dysuria, worm infestation, bleeding disorders, anemia, diseases of the female genital organs, diarrhea, cough, filariasis, epilepsy, diseases of the spleen, obesity, ano-rectal diseases, polyuria, and emesis.

14 Hepatoprotective activity of Eugenia jambolana Lam. in carbon tetrachloride treated rats: Sisodia SS, Bhatnagar M, Indian Journal of Pharmacology, 2009; 41:23–27.

The study estimated the hepatoprotective effects of the methanolic seed extract of Eugenia jambolana in Wistar albino rats treated with carbon tetrachloride (CCl(4)).

Liver damage in rats treated with CCl (1 ml/kg/bw, administered subcutane-4

ously, on alternate days for one week) was studied by assessing parameters such as serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), alkaline phosphatase (ALP), acid phosphatase (ACP) and bilirubin (total and direct). The effect of co-administration of Eugenia jambolana (doses 100, 200 and 400 mg/kg p.o.) on the above parameters was investigated.

These biochemical observations were supplemented by weight and histological examination of liver sections. Liv.52 (Himalaya Drug Company) was used as positive control. Data were analyzed by one way ANOVA, followed by Scheff’s/

Dunnett’s test.

Administration of Eugenia jambolana (doses 100, 200 and 400 mg/kg p.o.) significantly prevented carbon tetrachloride induced elevation of serum SGOT, SGPT, ALP, ACP and bilirubin (total and direct) level. Histological examination of the liver section revealed hepatic regeneration, after administration of various doses of Eugenia jambolana. The results were comparable to that of Liv.52.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. II: Eugenia jambolana seed is used in polyuria and diabetes.

254 Defining a new scientific path

15 Evaluation of the hepatoprotective activity of Cissus quadrangularis

stem extract against isoniazid-induced liver damage in rats: Viswanatha Swamy AH, RV Kulkarni, AH Thippeswamy, BC Koti, A Gore, Indian Journal of Pharmacology, 2010, 42: 397–400.

The study was designed to investigate the hepatoprotective activity of methanol extract of Cissus quadrangularis (CQ) against isoniazid-induced hepatotoxicity in rats.

The successive petroleum ether (60–80°C) and methanol extracts of C. quadrangularis were used. Hepatic damage was induced in Wistar rats by administering isoniazid (54 mg/kg, p.o.) once daily for 30 days. Simultaneously, CQ (500

mg/kg p.o.) was administered 1 h prior to the administration of isoniazid (54 mg/

kg, p.o.) once daily for 30 days. Silymarin (50 mg/kg p.o.) was used as a reference drug.

Elevated levels of aspartate transaminase, alanine transaminase, alkaline phosphatase, and bilirubin following isoniazid administration were significantly lowered due to pretreatment with CQ. Isoniazid administration significantly increased lipid peroxidation (LPO) and decreased antioxidant activities such as reduced glutathione, superoxide dismutase, and catalase. Pretreatment of rats with CQ significantly decreased LPO and increased antioxidant activities.

The results of this study indicated that the hepatoprotective effect of CQ might be attributed to its antioxidant property.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. III and VI: Cissus quadrangularis stem (Vol. III) is used in worm infestation, piles, fractures, and dislocation of joint; aerial parts (Vol. VI) is used additionally in diseases of the eye, asthma, stiffness of thigh muscles, and ulcer.

16 Immunomodulatory effect of Tinospora cordifolia extract in human immuno-deficiency virus positive patients: Kalikar MV, Thawani VR, Varadpande UK, Sontakke SD, Singh RP, Khiyani RK, Indian Journal of Pharmacology, 2008; 40: 107–110.

Efficacy of Tinospora cordifolia extract (TCE) in HIV positive patients was assessed in randomized double blind placebo controlled trial. 68 HIV positive participants were randomly assigned to two groups to receive either TCE or placebo for six months. After clinical examination, TLC, DLC, ESR, platelet count, hemoglobin and CD4 count were done. The hematological investigations were repeated at bimonthly intervals and CD4 count was repeated at the end of the study. Patients were clinically reviewed at monthly intervals for compliance, refill and ADR monitoring. The drugs were decoded at the end of the trial.

TCE treatment caused a significant reduction in the eosinophil count and hemoglobin percentage. 60% of patients receiving TCE and 20% on placebo reported a decrease in the incidence of various symptoms associated with the disease. Some of the common complaints reported by patients on TCE were anorexia, nausea, vomiting, and weakness.

Unbiased research 255

Tinospora cordifolia extract significantly affected the symptoms of HIV. However, not all of the objective parameters studied.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I: Tinospora cordifolia stem is used for obstinate skin diseases, gout, fever, jaundice, anemia, and polyuria.

17 Immunosuppressive properties of Pluchea lanceolata leaves: Bhagwat DP, MD Kharya, S Bani, A Kaul, K Kour, PS Chauhan, KA Suri, NK Satti, Indian Journal of Pharmacology, 2010, 42: 21–26.

This study was designed to investigate the immunosuppressive potential of Pluchea lanceolata 50% ethanolic extract (PL) and its bioactive chloroform fraction (PLC).

Preliminary screening of the Pluchea lanceolata 50% ethanolic extract (PL) was carried out with basic models of immunomodulation, such as, the humoral antibody response (hemagglutination antibody titers), cell-mediated immune response (delayed-type hypersensitivity), skin allograft rejection test, in vitro (C. albicans method), and in vivo phagocytosis (carbon clearance test). The extract was then fractionated with chloroform, n-butanol, and water to receive the respective fractions by partitioning. These fractions were employed for flow cytometry to study the T-cell specific immunosuppressive potential of these fractions.

Oral administration of PL at doses of 50 to 800 mg/kg in mice, with sheep red blood cells (SRBC) as an antigen, inhibited both humoral and cell-mediated immune responses, as evidenced by the production of the circulating antibody titer and delayed-type hypersensitivity reaction results, respectively, and the immune suppression was statistically significant (P < 0.01) in Balb/C mice. PL

also decreased the process of phagocytosis both in vitro (31.23%) and ex vivo (32.81%) and delayed the graft rejection time (30.76%). To study the T-cell-specific activities, chloroform, n-butanol, and water fractions from P. lanceolata were tested for T-cell specific immunosuppressive evaluation, wherein only the chloroform fraction (PLC) showed significant (P < 0.01) suppression of CD8+/

CD4+ T-cell surface markers and intracellular Th1 (IL-2 and IFN-(Y)) cytokines at 25–200 mg/kg p.o. doses. PLC, however, did not show significant suppression of the Th2 (IL-4) cytokine.

The findings reveal that P. lanceolata causes immunosuppression by inhibiting Th1 cytokines.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. III: Pluchea lanceolata dried leaf is used in inflammation, neurological disorders, asthma, cough, fever, diseases of the abdomen, pityriasis versicolor, stiff joints, rheumatism, and gout.

18 Effect of Hemidesmus indicus (Anantmool) extract on IgG production and adenosine deaminase activity of human lymphocytes in vitro: Kainthla RP, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF, Indian Journal of Pharmacology, 2006; 38: 190–193.

256 Defining a new scientific path

The study was designed to investigate the effect of Hemidesmus indicus extract on activities of human peripheral blood lymphocytes in vitro.

The total extract of the raw herb was obtained by methanol: isopropyl alcohol: acetone extraction and used at different concentrations. Human peripheral blood lymphocytes (PBLs) were isolated, stimulated to proliferate using phy-tohaemagglutinin (PHA) or lipopolysaccharide (LPS), with and without different concentration of herbal extracts. Adenosine deaminase (ADA) activity and immunoglobulin (IgG) secretion from cultured PBLs were studied with the herbal extracts and appropriate controls.

Hemidesmus indicus extract stimulated the cell proliferation at 1 mg/ml concentration significantly, after 72 h in culture. Viability of extract-treated PBLs was also maintained after culture. The extract increased the IgG production from cultured PBLs when used at 1 mg/ml concentration. It also increased the ADA activity of PBLs after 72 h in culture.

An immunomodulatory activity of H. indicus, related to IgG secretion and ADA activity, is revealed during the study. The herbal extract has shown to promote the release of IgG by lymphocytes and also the ADA activity after 72 h of culture.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I: Hemidesmus indicus root is used for digestive impairment, diarrhea, cough, asthma, pruritus, obstinate skin diseases, fever, inflammation, neurological disorders, asthma, cough, fever, and diseases due to vitiated blood.

19 A study of the antimicrobial activity of Alangium salviifolium: Pandian MR, GS Banu, G Kumar, Indian Journal of Pharmacology, 2006, 38: 203–204.

The major phytochemical constituents of Alangium salviifolium Linn. are alang-ine A and B, alangicine, markindine, lamarckinine and emetine. The root of Alangium salviifolium has been used in the Indian system of medicine as an acrid, diuretic, astringent and antidote for several poisons. The fruits (mucosa) of the plant are useful in treating burning sensation and haemorrhages. However, no scientific evidence is available regarding its antimicrobial activity.

The shadow-dried root was macerated overnight with solvents butanol and ethanol in a 1:5 (drug to solvent ratio) x 3. Exhaustive extraction with the solvent was carried out by the cold extraction procedure. The respective extracts thus obtained were evaporated to dryness and stored in amber-colored storage vials at 4–5OC

until they were used for the experiment.

Ten Gram positive and Gram negative ATCC (American Type Culture Collection) bacterial isolates, were used in the present study: Bacillus cereus (11778), Bacillus pumilus (14884), Bacillus subtilis (6633), Bordetella bronchiseptica ca (4617), Micrococcus luteus (9341), Staphylococcus epider-midis (6538), Escherichia coli (10536), Klebsiella pneumoniae (10031), Pseu-domonas aeruginosa (9027) and Enterococcus faecalis (8043).

Agar dilution method with a working concentration of 1, 2 and 4 mg/ml of butanol and ethanol extracts, were used for the study. Standard antibiotic

Unbiased research 257

ciprofloxacin (Cadila Pharmaceuticals, India) at 4 µg/ml concentration, was used as positive control.

Butanol extract of the plant showed growth inhibitory effect at 4 mg/ml concentrations in all the bacterial isolates tested, except Klebsiella pneumonia, where it showed 75% inhibition. Lower concentration of the extract showed a concentration-dependent inhibition effect. At 2 mg/ml, 50% inhibition in all the cultures was seen, while at 1 mg/ml, it was completely ineffective, when compared with the positive control (ciprofloxacin) and control (nutrient medium without antibiotic or plant extract).

Inhibitory effect of the ethanol extract with all the three concentrations was not found on any of the cultures used for the experiment, except Micrococcus luteus, where it showed 50% inhibition at 2 mg/ml and complete inhibition at 4 mg/ml of the concentration. The results of the study confirm the antimicrobial potential of the butanol extract of Alangium salviifolium. However, further detailed studies are required.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. V: Alangium salviifolium leaf is used in rheumatism, fever, throat infections, inflammations, edema, colic, worm infestation, Graha badhaa (ailments due to evil influence of planets/fear psychosis), disorders due to vitiated blood, poisonous animal bites, spider poison, rat bites, dog bites, and disorders due to poisoning, also used as fish poison.

20 Effect of Aegle marmelos leaf on rat sperm motility-An in vitro study: Sur TK, S Pandit, T Pramanik, D Bhattacharyya, Indian Journal of Pharmacology, 2002, 34: 276–277.

Earlier studies of Aegle marmelos Corr. in the laboratory have been shown that ethanolic extract of A. marmelos leaf possesses anti-spermatogenic activity in rats. The present investigation has been carried out to find the activity of A. marmelos leaf on rat sperm motility through in vitro study. Fresh leaves of A. marmelos were used. Different dilutions (1, 2.5, 5 and 10%) were prepared in buffer saline (pH 7.4) before the experiment. Six healthy adult male albino Wistar rats (180 + 5 g) were used in this study. At least 80% initial normal sperm motility and 2.5 x 107cc sperm count was considered for the selection of samples. Wet drop technique was applied to study the motility of spermatozoa. The motility of sperm was observed at various time intervals up to 150 seconds. In control, 10 ml of buffer saline was used instead of plant extract. Initial motility of control sperm was 82.3%, which remained almost static (80.5%) up to 150

seconds. But, sperm motility appears to decrease with the time and significantly so with the increasing concentration of A. marmelos. Increases in the concentration of water extract of A. marmelos decrease the complete immobility time of sperms.

The study showed that A. marmelos leaf possesses antimotility action on spermatozoa in rats.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I, III, and IV covered fruit pulp, dried root, and stem bark, respectively.

258 Defining a new scientific path

21 Antiovulatory and abortifacient effects of Areca catechu (betel nut) in female rats: Shrestha J, T Shanbhag, S Shenoy, A Amuthan, K Prabhu, S

Sharma, S Banerjee, S Kafle, Indian Journal of Pharmacology, 2010, 42: 306–311.

To study the antiovulatory and abortifacient effects of ethanolic extract of Areca catechu in female rats, ethanolic extract of Areca catechu Linn. at 100 and 300

mg/kg doses were administered orally for 15 days. Vaginal smears were examined daily microscopically for estrus cycle. Rats were sacrificed on 16(th) day. Ovarian weight, cholesterol estimation, and histopathological studies were done. The abortifacient activity was studied in rats at 100 and 300 mg/kg doses administered orally from 6th to 15th day of pregnancy. Rats were laparotomised on the 19th day. The number of implantation sites and live fetuses were observed in both horns of the uterus.

The extract of A. catechu showed a significant decrease in the duration of estrus at 100 mg/kg (P = 0.015) and 300 mg/kg doses (P = 0.002) as compared with control. Metestrus phase was also significantly reduced at 100 mg/kg (P = 0.024) and 300 mg/kg doses (P = 0.002). There was a significant increase in proestrus (P

< 0.001) phase. However, the diestrus phase was unchanged.

Histopathological study of the ovaries showed mainly primordial, primary, and secondary follicles in the test groups as compared to control. There was also a significant (P = 0.002) decrease in ovarian weight and a significant (P = 0.021) increase in ovarian cholesterol level at 100 mg/kg dose. In the study to evaluate the abortifacient effect, the mean percentage of abortion with 100 and 300 mg/kg doses were 75.5% and 72.22%, respectively, which was significantly (P = 0.008

and P = 0.006, respectively) increased when compared with control.

The ethanolic extract of A. catechu at doses of 100 and 300 mg/kg showed antiovulatory and abortifacient effects.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. I: Areca catechu nut is used in diseases of the mouth, anorexia, vaginal atony, and leucorrhea.

22 Effect of methanolic extract of Benincasa hispida against histamine and acetylcholine induced bronchospasm in guinea pigs: Anil Kumar D, P

Ramu, Indian Journal of Pharmacology, 2002, 34: 365–366.

Benincasa hispida (Thunb.) Cogn. is employed as a main ingredient in Kush-manda lehyam in Ayurvedic system of medicine. The lehyam is used as a rejuvenative agent and in nervous disorders. This study was planned to investigate the methanol extract of Benincasa hispida (MEBH) fruit for possible antihistaminic or anticholinergic activity.

Adult guinea pigs of either sex (400–600 gms) were used for the experiment.

The methanol extract of Benincasa hispida (MEBH) was used for the pharmacological studies by dissolving each time with distilled water. Experimental bronchospasm was induced by exposing the animals to histamine acid phosphate

Unbiased research 259

0.25% or acetylcholine chloride. The mean increase in exposition time against histamine challenge was significantly (p < 0.001) increased with the increasing doses of methanol extract of Benincasa hispida (MEBH).

The methanol extract of Benincasa hispida (MEBH) showed excellent protection in guinea pigs against the histamine-induced bronchospasm even at a very low dose, 50 mg/kg, p.o. However, even at a higher dose level of 400 mg/kg, MEBH did not offer any significant protection against acetylcholine challenge.

Therefore, it can be deduced that MEBH is unlikely to have antimuscarinic action.

The results suggested that the protective effect against bronchospasm induced by histamine aerosol may be mediated by antihistaminic activity (H1 receptor antagonism).

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. IV: Benincasa hispida fruit is used in retention of urine, polyuria, dysuria, calculus, mental diseases, and constipation.

23 The antiasthmatic activity of Moringa oleifera Lam-A clinical study: Agrawal B, A Mehta, Indian Journal of Pharmacology, 2008, 40: 28–31.

The present study was carried out to investigate the efficacy and safety of seed kernels of Moringa oleifera in the treatment of bronchial asthma. Twenty patients of either sex with mild-to-moderate asthma were given finely powdered dried seed kernels in a dose of 3 g for 3 weeks. The clinical efficacy with respect to symptoms and respiratory functions were assessed using a spirometer prior to and at the end of the treatment. Hematological parameters were not changed markedly by treatment with M. oleifera. However, the majority of patients showed a significant increase in hemoglobin (Hb) values and Erythrocyte sedimentation rate (ESR) was significantly reduced. Significant improvement was also observed in symptom score and severity of asthmatic attacks.

Treatment with the drug for 3 weeks produced significant improvement in forced vital capacity, forced expiratory volume in one second, and peak expiratory flow rate values by 32.97 ± 6.03%, 30.05 ± 8.12%, and 32.09 ± 11.75%, respectively, in asthmatic subjects. Improvement was also observed in % predicted values. None of the patients showed any adverse effects with M. oleifera. The results of the present study suggest the usefulness of M. oleifera seed kernel in patients of bronchial asthma.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. IV: Moringa oleifera seed is used for worm infestation, diseases of the eye, inflammations, abscesses, scrofula, hyperliposis, abdominal lump (chlorosis), splenic diseases, goiter, ulcers, restricted movement of the jaw, diseases of the head, diseases of the nervous system, and insomnia.

24 Inhibitory concentrations of Lawsonia innermis dry powder for urinary pathogens: Bhuvaneswari K, S Gnana Poongothai, AB Kuruvilla, R Appala, Indian Journal of Pharmacology, 2002, 34: 260–263.

260 Defining a new scientific path

This study investigated the possibility of in vitro antimicrobial activity of Lawsonia Innermis Linn. (LI) leaves. Varying doses of LI suspensions (both powdered dried leaves and suspensions of fresh leaves) were tested for their antimicrobial activity against the urinary pathogens isolated from the patient’s urinary sample namely, E. coli, Pr. mirabilis, K. pneumoniae, Ps. aeruginosa, and Staph. aureus, using both tube turbidity standards and disc diffusion method, and their effects were observed.

Antimicrobial activity of LI dried leaves suspension, by Broth dilution method: Gram negative: 55–85 mg/ml, and for Gram positive: >95 mg/ml. By Disc diffusion method: >95 mg/ml for both Gram negative and Gram positive organisms.

Antimicrobial activity of LI fresh leaves suspension by Disc diffusion method: E.

coli: 10 mg/disc and for S. aureus: 25 mg/disc.

LI leaves showed definite antimicrobial activity against the common urinary pathogens.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. IV: Lawsonia Innermis leaves are used for fever, pruritus, bleeding disorders, jaundice, obstinate skin diseases, dysuria, vertigo, and ulcers.

25 Effect of ethanolic leaf extract of Ocimum sanctum on haloperidolinduced catalepsy in albino mice: Pemminati S, V Nair, P Dorababu, HN

Gopalakrishna, MRSM Pai, Indian Journal of Pharmacology, 2007, 39: 87–89.

Neuroleptic drugs used in the treatment of schizophrenia and other affective disorders are known to produce extrapyramidal side effects. Catalepsy induced by these drugs in animals has been used as a model for the extrapyramidal side effects associated with antipsychotic agents in human beings. This study attempted to evaluate the protective effect of the ethanolic leaf extract of Ocimum sanctum Linn. (OS) on haloperidol (1.0 mg/kg, intraperitoneal administration)-induced catalepsy in mice by employing the standard bar test. Mice were allocated to seven groups, each group containing six animals. The effects of the test drug OS

(at 1.75, 4.25 and 8.5 mg/kg doses) and the standard drugs, scopolamine (1.0 mg/

kg) and ondansetron (0.5 and 1.0 mg/kg doses) were assessed after single and repeat dose administration for seven days, 30 minutes prior to the haloperidol.

The results suggest that OS has a protective effect against haloperidol-induced catalepsy, which is comparable to the standard drugs used for the same purpose.

The study indicates that OS could be used to prevent drug-induced extrapyramidal side effects.

Ayurvedic Pharmacopoeia of India (API), Part I, Vol. II: Ocimum sanctum leaf is used for dyspnea, cough, coryza, intercostal neuralgia, worm infestation, and obstinate skin diseases. Seeds (Vol. IV) are used for gara vishaa (slow/accumulated poison).





21 Threat to classical reputation

by dubious herbs and

substitutes

Ashta varga

The Ashta varga of the classical period has been extinct since the sixteenth century, but the group is very much alive and kicking in commerce.

The substitute herbs and other (provisionally) identified herbs, when used as a composite drug, do not possess the therapeutic properties of Ashta varga of the classical period. The composite drug, containing all the eight herbs of Ashta varga, was included in rejuvenating tonics to alleviate sexual debility, to promote spermatogenesis and conception. It is unethical and misleading to promote substitute drugs as Ashta varga. In the era of evidence-based herbal medicine, dubious terminology should not be used in compound drugs of Ayurvedic Formulary of India and on the labels of Ayurvedic products.

Let us go back to the history of Ashta varga.

Following are the features and properties of Ashta varga drugs of the classical period, as described in Ayurveda Saukhyam.1

Riddhi:

Balya: Promotes strength.

Tridoshaghni: Alleviates all the three Doshas.

Shukralaa: Spermatopoetic, promotes spermatogenesis.

Madhuraa: Sweet.

Guru: Heavy, Difficult to digest.

Vriddhi:

Garbhpradaa: Promotes fertility, helps in conception.

Sheeta: Cooling.

Vrshyaa: Aphrodisiac and age-sustaining.

Kaasa kshaya kapha: Cures cough, bronchitis, and consumption.

Kaakoli and Kshirakaakoli:

Sheetam: Cooling.

Shukralam: Spermatopoetic, promotes spermatogenesis.

Madhuram: Sweet.

Guru: Heavy, difficult to digest.

262 Defining a new scientific path

Jayet Samira daaha asra pitta shosha, visha jwara: Both Kaakoli and Kshirakaakoli cure aggravated Vaayu, burning syndrome, bleeding disorders, consumption, poisoning (toxicity), and fever.

Medaa, Mahaa Medaa:

G uru: Heavy, difficult to digest.

Swaadu: Tasty, relishing.

Vrashym: Aphrodisiac and age-sustaining.

Stanyam: Galactogogue.

Kaphaapham: Alleviate Kapha.

Bramhanam: Nourishing, anabolic.

Sheetalam: Cooling.

Pitta rakta kshaya Samir-jit: Alleviate pitta, bleeding disorders or blood abnormalities, consumption, and vaayu.

Jivaka and Rshabhaka:

Balya: Strength promoting.

Sheeta: Cooling.

Shukra kaphaprada: Spermatopoetic, spermatogenic, aggravate kapha.

Haratah pitta daaha arsra kaarshya shosha kshaya: Cure aggravated Pitta, burning syndrome, piles, emaciation, cachexia, and phthisis.

Jivaka and Rshabhaka grow on Hemaadri-shikhara (in the peaks of the Himalayas), Rasona kanda-vat kanda (the underground part is like garlic bulb), sukshm patraka (leaves are thin and fine).

According to another text: jivaka has the shape of kuurchaka (brush). Rshbhaka is like Vrsha shranga-vat (like the horn of a bull in shape).

Riddhi and Vriddhi are the roots of creepers, shveta-lomaanvita kand (the roots covered with white hairs).

Riddhi is like a knot in the root and its fruit takes an anti-clockwise turn. On the other hand, Vriddhi has fruits which takes a clockwise turn.

Medaa is white. It can be cut with the help of finger nail, looks like fat tissues.

Mahaa Medaa root looks like a piece of dried ginger. It is unctuous, sweet and cooling. It has a foul smell of fat.

Kaakoli and Kshira kaakoli have roots like pivari ( Abroma augusta). Both contain a milky latex and they are fragrant. The lower part in known Kaakoli, whereas the upper part is used as Kshira Kaakoli. Kaakoli is white, whereas Kshira kaakoli is yellowish white.

All the eight herbs when taken together as a composite drug: Cooling, exceedingly spermatopoetic and nourishing. Alleviates aggravated Pitta, burning syndrome, piles, vitiated blood and consumption. Promotes lactation and conception.

Threat to classical reputation 263

According to Ayurveda Saukhyam, if Ashta varga drugs are not available, Yashti ( Glycyrrhiza glabra) in place of Medaa and Mahaa Medaa; Vidaari ( Pueraria tuberosa) in place of Jivaka and Rshabhaka; Ashwagandha in place of Kaakoli and Kshira kaakoli; and Vaaraahi ( Dioscorea bulbifera) in place of Riddhi and Vriddhi should be used. During the later period, Shatavari ( Asparagus racemosus) in place of Medaa and Mahaa Medaa and Musali syaah (C urculigo orchioides) in place of Riddhi and Vriddhi entered into Ashta varga as substitute drugs.

In Bhavaprakasha Nighantu commentary,2 by Prof. K. C. Chunekar and Dr. G.

S. Pandey, some more options have been incorporated. A few scholars, according to these commentators, found minimal properties of Ashta varga in substitute drugs, and following new substitutes were suggested by them:

Behman safed ( Centauria behen) or Guduchi ( Tinospora cordifolia) as Jivaka; Behman surkh ( Salvia haematodes) or Vansa-lochana (Bamboo-manna) as Rshbhaka;

Saleb misri ( Orchis latifolia) as Medaa; Shakaakul misri ( Pastinacea secacul) or Prasaarini ( Paederia foetida) as Mahaa Medaa;

Musali syaah ( Curculigo orchioides) as Kaakoli; Musali safed ( Chlophytum tuberosum) as Kshira Kaakoli; Uttangan seeds ( Blepharis edulis) or Balaa ( Sida cordifolia) as Riddhi; Saleb panjaa or Mahaa Balaa ( Sida rhombifolia) or Beejaband ( Rumex vesi-carium) as Vriddhi.

But substitutes are always of secondary importance in the eyes of the consumer.

So live Ashta varga plants started surfacing. These Ashta varga plants are endangered and rare, found only in high altitude areas from 2,000 to above 4,000 m above sea level in Himalaya northern valleys. Many plants were identified on the basis of superficial characters. Cultivars, suppliers and vendors are unqualified, and they are not familiar with authentic sources.

The manufacturers are not aware of chemical markers for Ashta varga plants, and regulatory authorities are not able to identify the exact location of authentic plants.

Hence, manufacturers take the liberty to use substandard drugs or substitutes.

Following are new botanical identifications of Ashta varga based on Ayurvedic Pharmacopoeia of India (API):

Malaxis acuminata ( Jivaka tuber) API, Part I, Vol. V.

M. muscifera ( Rshbhaka bulb)

Polygonatum cirrhifolium ( Mahaa Medaa, Medaa rhizome) API, Part I, Vol.

V and VI.

Polygonatum verticillatum ( Medaa rhizome)

Lillium polyphyllum ( Kaakoli rhizome) API, Part I, Vol. III.

Roscoea procera ( Kaakoli rhizome)

Fritillaria roylei ( Kshir-kaakoli) API, Part I, Vol. V.

Habenaria edgeworthii ( Vriddhi tuber)

Habenaria intermedia ( Riddhi tuber) API, Part I, Vol. V.

264 Defining a new scientific path

Malaxis acuminata ( Jivaka tuber) and M. muscifera

( Rshbhaka bulb)

The genus Malaxis is distributed in the Himalayas at altitudes of 1,500–2,800 m, also in Indo-China and Malesia.

Chemical constituents: Beta-sitosterol has been isolated from ethyl acetate extract of M. acuminata. Other reported compounds include piperitone, citronellal, eugenol, Limonene, 1, 8-cineole, p-cymene, O-methylbatatasin, and ceryl alcohol.

Polygonatum cirrhifolium ( Mahaa Medaa) Distributed in the temperate Himalayas from Kashmir (at an altitude of 2.000–

3,000 m) to Sikkim (at an altitude of 2,600–4,000 m above sea level, and in Uttarakhand at 1,600–3,500 m. Polygonatum verticillatum ( Medaa rhizome): Temperate Himalayas from Kashmir (at an altitude of 2,000–3,600 m) to Sikkim (at an altitude of 2,600–4,000 m), Himachal Pradesh and Uttarakhand (1,600–3,500 m).

Chemical constituents: Steroidal saponins sibiricoside A and B; n-butanol extract contained steroid terpenoid, polysaccharides, phenol, and tannin; alpha-L-rhamnopyranose, beta-D-glucopyranoside, daucosterol, beta-sitosterol-6-nonade-canoic acid, 6-stearic acid have also been identified.

P. verticillatum: Rhizomes contain lysine, serine, aspartic acid, threonine, beta-sitosterol, sucrose and glucose.

Lillium polyphyllum ( Kaakoli rhizome) Distributed in temperate Himalayas from Kumaun to Kashmir at 1,800–3,600 m.

Chemical constituents: The bulb contains linalool and alpha-terpineol. The methanolic extract of bulb yielded 3 steroidal glycerides: beta-sitosterol-3-glyceryl-2’-li-noleiyl-3’-linoleiate; glyceryl-1-n-octadec-9-enoyl-2-n-decanoyl-3-n-decanate; glyceryl-1-octadec-9’-enoyl-2-octadec-9”, 12”-denoyl-3-tetracosanoate.

Fritillaria roylei ( Kshir-kaakoli) The center of diversity for the genus Fritillaria is East Mediterranean region.

The possible center of evolution of the genus is Iran. According to Rix, the genus Fritillaria is represented by 165 species worldwide (Rix, M., 2001.). Tur-key represents the largest number of taxa (33) followed by China (30) Greece (24) and California (18). India represents only 6 taxa. Distributed in western temperate Himalayas from Kumaon to Kashmir at an altitude of 2,500–4,000 m. F.

roylei and F. cirrhosa) are found in Uttarakhand in different alpine meadows such as Kedarnath, Rudranath, Valley of flowers, Dayara, Dronagiri and Tungnath. In Jammu and Kashmir, the herb was found to thrive in Minimarg and Gurez valley.

Chemical constituents: The basic fractions of alcoholic extract of bulbs yielded a C-nor-D-homo steroidal alkaloid Kashmirine. T. Q. Chao ( Chinese J Physiol,

Threat to classical reputation 265

4, 1932; 265) isolated peimine and peiminine from the root of F. roylei (Chinese drug Pei-Mu), and K. K. Chen studied their pharmacology. Characterization was done by Chi, Kao, and Chang ( Chinese J Physiol, 7, 1933, 41); an entirely different active principle, fritimine was isolated.

Habenaria intermedia ( Riddhi tuber) Distributed through temperate Himalayan regions, including Meghalaya.

Chemical constituents: Scopoletin and gallic acid are marker compounds of the tuber. Scopoletin, a coumarin component, exhibits anticonvulsant, antioxidant, antimicrobial and hypotensive activities. Gallic acid possesses a wide range of biological activities, like antioxidant and cytotoxic.

When the properties of these Ashta varga plants were compared with those

mentioned in Classical texts, none is found genuine.2

Thus, Ashta varga is still a deceptive expression in the post-classical period.

Until finally validated by pharmacognosists and pharmacologists, its classical reputation should not be allowed for commercial exploitation.

Ashta varga, for the time being, should be removed from all compound formulations.

References

1 Ayurveda Saukhyam, compiled by Raja Todaramalla during the period of Mughal Emperor Akbar (sixteenth century), researched and edited by Vaidya Bhagwan Dash and published as Materia Medica of Ayurveda, 1987.

2 Prof. K.C. Chunekar and Dr G.S. Pandey, Bhavaprakasha Nighantu, 2010: 61.

Ashwagandha

The editors of The Wealth of India (Vol. X), while writing about Ashwagandha of ancient Indian literature, remarked, “It is difficult to say whether the source of the drug (classical Ashwagandha) is Withania somnifera.”

K.N. Kaul designated classical Ashwagandha as the “so-called Withania somnifera of Indian literature” in 1957.

Kaul was first to point out that cultivated Ashwagandha of commerce is different from the wild variety ( Ashwagandha of classical medicine) not only in therapeutic properties but also in morphological characters. Kaul named the cultivated variety as Withania ashwagandha.1

In “Ayurvedic Pharmacopoeia of India” (Part I, Vol. I), Ashwagandha (so-called Withania somnifera) has been recommended (on the basis of classical references) in the following conditions:

Klaibya (male impotence)

Kshaya (phthisis)

Daurbalya (weakness)

266 Defining a new scientific path

Vaataroga (diseases of the nervous system/neurological diseases) Shoth (inflammation, edema).

(English equivalents are quoted from

“The Ayurvedic Formulary of India, Part I,

Second Revised English Edn., 2003, 461–480)

“The Ayurvedic Formulary of India” recommends Ashwagandha as rasaayana and vaajikarana (rejuvenating and aphrodisiac agent). Bhaavaprakaasha (sixteenth century) promoted Ashwagandha as atishukrala (an effective drug for spermatogenesis) and as a vaajikarana dravya (aphrodisiac drug) ( Guduchyaadi varga, 189–190; Puurvaardha, 6/225). According to the Central Council for Research in Ayurvedic Sciences (CCRAS), vaajikarana therapy provides strength, potency, virility, sexual excitement, erection of sexual organ and pleasure during inter-course. The Council recommended the powder of Ashwagandha root (dose 1 to 3 g) as a vaajikarana drug.

In Shaarangadhara Samhitaa (thirteenth century)2 a paste prepared with the fresh root of Ashwagandha was recommended topically for increasing the size of the penis in males and for correcting vaginal laxity in females ( Uttar khanda 11.113 and 11.115). The root was also incorporated in Kaamdev Ghrit, an aphrodisiac tonic ( Madhya khanda 9.27).

“The Ayurvedic Formulary of India” (Part I, 2003 edn.) quoted one vaajikarana polyherbal formulation, Ashwagandhaadi Lehya, from Pharmacopoeia of Integrated Medicine, Chennai, section VIII, page 33, which contains Ashwagandha as the main drug. Other herbs, recommended by Central Council for Research in Ayurveda and Siddha for vaajikarana, including Mucuna prurita, Asparagus racemosus, Asparagus adescenden, Grewia populifolia, Pueraria tuberosa, Myristica fragrans nutmeg and mace, and Syzygium aromaticum, do not feature in the compound drug, while it contains Hemidesmus indicus and Smilax china, which are anti-inflammatory and antiseptic herbs, traditionally used against sexually transmitted diseases.

Now a few questions:

Is the root of Indian Ashwagandha an aphrodisiac drug?

Does it promote spermatogenesis?

Does it increase the size of the penis?

Does it remove vaginal laxity?

How far it is logical to equate Ashwagandha with Withania somnifera?

It is a common belief that Ashwagandha carries the body odor of the horse.

According to Shaarangdhara Samhita, the fresh root of Ashwagandha smells like horse’s urine.2 If Ashwagandha’s fresh root contained the smell of horse’s urine, then during the classical period Ashwamuutri should have been one of its synonyms. Ashwamuutri (of Sushruta Samhita) was equated with Shallaki (gum-resin of Boswellia serrata) by Dalhan (twelfth century).

In Charaka Samhita, Ashwagandha and Rshyagandhaa have been used as one composite drug. Rshyagandhaa was possibly a wild variety of Withania coagulens

Threat to classical reputation 267

or W. somnifera. Rshyagandhaa and Rshyaproktaa (Charaka Samhita) possessed similar medicinal properties. Later on, Dhanvantari Nighantu (thirteenth century) interpreted Rshyagandhaa as Shataavari ( Asparagus racemosus), Atibalaa ( Abutilon indicum) and Kapikachhu ( Mucuna prurita). One more herb, Ashwaarohikaa of Charaka Samhita, was interpreted by Chakrapaani (eleventh century) as Ashwagandha, Ashwakarna or Ikshuraka ( Astercantha longifolia Nees). In Nighantus (fourteenth century to seventh century) Ashwaarhohikaa was mentioned as a synonym of Ashwagandha.3

T he roots of Asparagus racemosus, Abutilon indicum, Mucuna prurita, and Astracantha longifolia are used in Indian medicine for their rejuvenating properties. (In “The Ayurvedic Pharmacopoeia of India, Part I, Vol. II, there is an independent monograph on Astracantha longifolia root, while most of the physicians use only seeds which are incorporated in sex tonics.)

This analysis clearly indicates that Ashwagandha of classical medicine is a controversial drug. Withania somnifera cannot be equated with Ashwagandha even if it contains the body odor of a rishi (hermit) or that of a horse or the smell of horse’s urine. Commercial samples are odorless.

Before concluding, we again go back to Bhaavaprakasha (sixteenth century) wherein Bhaavamisra advocated the used of the fresh root of Ashwagandha. Earlier, in the fourteenth century, Shaarangadhara also used the fresh root.

Bhaavamisra belonged to Gaya in Bihar. Let us see if it was possible for him to procure fresh root of naturally occurring Withania somnifera.

Five forms of Indian Ashwagandha have been identified by C. K. Atal. Form I is the Ashwagandha of commerce, which is now cultivated in Madhya Pradesh.

Form II grows in the sandy desert of Pilani (Rajasthan). Form III grows in Chandigarh and mountainous areas of Punjab and Uttar Pradesh. Form IV is found growing near Delhi, Form V grows wild near Delhi and Ahmedabad.4

The wild growth of Withania species has also been reported from Pakistan, Afghanistan, Palestine, Egypt, Jordon, Morocco, Spain, Canary Island, Madagascar, Eastern Africa and South Africa. In the Arabian Peninsula, Withania somnifera was never known as Asgandh or a similar name, it was known as Summ-al-far, Genegeneh, Haml balbul, Bulbul, Baabu, Shaukaran, ‘Ebab, Obeeb.

Research by Bilal Ahmad Mir, Sushma Koul, Amarjit Singh Soodan on the reproductive biology of Withania ashwagandha sp. novo supports the delineation of W.

ashwagandha from W. somnifera, based on morphology, chemical profiling, cross-ability features, AFLP fingerprinting and ITS analysis.5 Earlier, Kaul (1957) suggested that W. somnifera is an amalgamation of two or more taxa. Kaul (1957) proposed a separate species status, W. ashwagandha to the cultivated forms in the W. somnifera germplasm. Subsequently, anatomical, pharmacognostic and chemical studies on W.

ashwagandha confirmed its distinct nature from its ally W. somnifera, also the distinctness of cultivated types on the basis of AFLP and SAMPL studies was confirmed.

Three chemotypes of Withania somnifera have been defined in (Lawrence) Review of Natural Products (2005 edn.): Indian I, Israeli II and Israeli III. None of these chemotypes are known for their stimulating effect on the male reproductive system. Ashwagandha, though promoted as Indian ginseng, lacks the stimulating effect of Panax ginseng.6

268 Defining a new scientific path

Withania coagulans Dunal also does not qualify for the drug used in Bhaavaprakasha. It was not found in Bihar or Bengal.

From these facts, it can be inferred that the fresh root of Ashwagandha used by Bhaavamisra was not the one that has been identified as Withania coagulans or somnifera.

Now there are two possibilities:

Either the classical Ashwagandha was a different variety of Solanaceae, which could not be identified by botanical surveyors, or it is now extinct. Intraspecific variations are a common phenomenon in Solanaceae. For example, Capsicum, Lycopersicon and Solanum melongena do not possess the same features and properties.

Or Ashwagandha of the classical period was a related species of Mucuna. M.

cochinchinensis Cheval and M. nigricans Stend syn. M. imbricata DC. belonged to Bihar and Bengal. Not only the seeds but also the roots of Mucuna prurita are

used in Indian medicine.7,8 During the classical period, the root of some species

or subspecies of Mucuna were used as an aphrodisiac. Dalhan (twelfth century) identified Kaakaanda as Ashwaka. Vagbhat was of the opinion that Kaakaanda and Kapikachhu, syn. Aatmagupta belonged to the same ( Mucuna) family, and both were used as an aphrodisiac. P. V. Sharma opined that Kaakaanda (Ashwaka) should be equated with Mucuna monosperma DC.

Here, we would like to repeat that two Mucuna species, M. cochinchinensis and M. nigricans, were easily available in Bihar, the original place of Bhaavamisra.

M. monosperma is found in Nepal and eastwards up to Khasi hills.

Finally, if we accept Withania somnifera as Ashwagandha of classical medicine, it should be possible to substantiate its aphrodisiac activity by any clinical or experimental study.

Recently (in 2002), Dept. of Anatomy, Faculty of Medicine, University of Ruhuna, Sri Lanka, examined the effect of Ashwagandha root extract on the sexual behavior of male rats. Findings of this experimental study clearly indicated that the use of Ashwagandha roots may be detrimental to male sexual competence.

Male rats were orally administered 300 mg/kg/day of root methanolic extract for 7 days. Their sexual behavior was evaluated 7 days prior to treatment, on day 3 and day 7 of treatment and day 7, 14 and 30 post-treatment by pairing each male with a receptive female. The root extract induced a marked impairment in libido, sexual performance, and sexual vigor. It also caused penile erectile dysfunction.

These effects were partly reversible on cessation of treatment. These antimascu-line effects were not due to changes in testosterone levels or toxicity, but might be attributed to hyperprolactinemic, GABAergic, serotonergic or sedative activities

of the extract.9

Now, after a lot of research, Indian species of Withania has been identified as Withania ashwagandha sp. novo (Bilal Ahmad Mir and Sushma Kaul). A considerable degree of variation in bioactive withanolides, withanolide A (WS-1), withanone (WS-2) and withaferin A (WS-3) and morphological characters were detected among the populations. Plant height and plant biomass were the highest in plants collected from Manasa population followed by Hyderabad. Leaves

Threat to classical reputation 269

were found to be the principal organ for WS-3 accumulation while roots mainly accumulate WS-1, suggesting a spatial variation of withanolides. Plants of Manasa population alone showed the presence of WS-2. Withanolide accumulation was also the highest in Manasa population, with 1.312% WS-3 in the leaves and 0.083% WS-1 in roots. Withanolide accumulation correlated positively with developmental stages, and the highest content of these withanolides was found at

maturity in both roots and leaves.10

Cultivated Ashwagandha should not be used in any classical formulation until it is proven that its biological activities match with the Ashwagandha of the classical period.

References

1 Kaul KN, The Origin, Distribution, and Cultivation of the So-Called Withania Somnifera of Indian Literature. Symposium on the utilization of Indian medicinal plants, Lucknow; CSIR, 1957: 7–8.

2 Chunekar and Pondel, Shaarangdhara Samhita, Rashtriya Ayurveda Vidyapeeth, New Delhi, 1999.

3 Sharma PV, Dravyaguna Vigyaan, Vol. V: 72.

4 Pharmacognosy and Phytochemistry of Withania somnifera, CCRAS, 1979: 18.

5 Kumar A, BA Mir, D Sehgal, TH Dar, S Koul, MK Kaul, SN Raina, GN Qazi. Utility of multidisciplinary approach for genome diagnostics of cultivated and wild germplasm resources of medicinal Withania Somnifera, and status of new species, W. Ashwagandha, in the cultivated taxon. Plant Syst Evol., 2011, 291: 141–151, doi:10.1007/

s00606-010-0372-4.

6 Mills S, Kerry Bone, Principles and Practice of Phytotherapy, 2000: 595.

7 The Wealth of India, Vol. V: 442.

8 Ayurvedic Pharmacopoeia of India, Part I, Vol. IV.

9 Ilayperuma I, WD Ratnasoorya, TR Weerasoorya, Asian J Androl, December 2002, 4(4), 295–298. PMID: 12508132. PubMed: indexed for MEDLINE.

10 Withanolides array of Withania ashwagandha sp. novo populations from India, Industrial Crops and Products, August 2014, 59: 9–13.

Shilajatu

Shilajatu (Asphalt, Mineral Pitch) is being promoted as a sex stimulant and a vitality drug. This is an example of how Sanskrit names have been distorted and misconstrued. Shilajatu has been rechristened as Shilajeet, the drug that makes a person so full of virility that he can even break a rock.

In Ayurvedic texts, Shilajatu belongs to Ushakaadi gana, the group that contains drugs with curative properties for ashmari (stone in the urinary tract), sharkara (gravels in urine, diabetes). muutrakrchhra shuula (dysuria) and gulma (tumor).

According to Bhavaprakasha (sixteenth century), it is chedi (depleting) and yogavaha (enhances the properties of other drugs) and cures ( hanti) kaphameha (obstinate urinary diseases including diabetes), ashma sharkara (stones and gravel in the urinary tract), mutrakrcchra (dysuria), kshaya (consumption), svaasa

270 Defining a new scientific path

(asthma), aggravated Vaayu, arsha (piles), paandu (anemia), apasmaara (epilepsy), unmaada (insanity), kushtha (obstinate skin diseases, including leprosy), udara (abdominal diseases including ascites) and krmi (parasitic infections).1

(Iron Shilajatu, the blackish brown variety, is used in Ayurveda.) The people of Tajikistan, as part of their routine diet, use Shilajatu as a supplement. Many Shilajatu bioactive dietary supplements or food additives contain Shilajatu, which have been patented and are manufactured in Tajikistan. Shilajatu is used in the form of an aqueous extract for therapeutic applications, such as immunostimulants and anabolic food additives.2 Shilajatu is prescribed for varied disorders of different etiology in Russia, notably, a few of them are genitouri-nary diseases, diabetes, angina, jaundice, digestive disorders, nervous diseases, chronic bronchitis, asthma, anemia, amenorrhea, dysmenorrhea, menorrhagia,

eczema, anorexia, fracture of bones and osteoporosis.3

Fulvic acid and humic substances are important active principles of Shilajatu.

Shilajatu obtained from India in the region of Kumaon contains a higher percentage of fulvic acids (21.4%) compared with Shilajatu obtained from Nepal

(15.4%), Pakistan (15.5%) and Russia (19.0%).4

Fulvic acids are powerful antioxidants and have superoxide and hydroxyl radical scavenging properties.5 Fulvic acid from Shilajatu enhanced the production of reactive oxygen species and nitric oxide in murine peritoneal macrophages.2 Pro-

cessed Shilajatu (PS), consisting of resonance stabilized soft-spin semiquinone free radicals, has been shown to produce free radical scavenging and antioxidant effects against superoxide (SO) and hydroxyl radicals and the paramagnetic nitric oxide (NO) depending on the concentration of PS. Chemical polymerization by free radicals was measured with and without processed Shilajatu. Processed Shilajatu provided almost complete protection of MMA (methylmethacrylate) against hydroxyl radical-induced polymerization and significantly inhibited the polymerization of MMA by the SO free radical. Processed Shilajatu efficiently trapped NO free radicals. The antioxidant effects were concentration dependent. Higher concentrations of processed Shilajatu provided greater free radical protection.

Preclinical studies in adult male Wistar rats reveal that processed Shilajatu provided complete protection to methyl methacrylate (MMA) against hydroxyl radical-induced polymerization and acted as a reversible NO-captodative agent.

Shilajatu in the dose of 20 and 50 mg/kg/day, i.p., for 21 days induced a dose-related increase in superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX) activities in frontal cortex and striatum of rats when compared with the control. The resulting values were comparable to those of (−) depre-nyl 2 mg/kg/day, i.p., for 21 days in respect of SOD and CAT activities.6 Simi-

larly, the effect of Shilajatu on lipid peroxidation and glutathione content in rat

liver homogenates.7 Shilajatu inhibited lipid peroxidation induced by cumene hydroperoxide and ADP/Fe++ complex in a dose-dependent manner. In addition, Shilajatu also decreased the rate of oxidation of reduced glutathione content and inhibited the ongoing lipid peroxidation, which was induced by these agents immediately after its addition to the incubation system.8,9 Antiradical properties of Shilajatu extract can be attributed to the presence of fulvic acid.10

Threat to classical reputation 271

Reactive oxygen species (ROS) have now shown an indispensable role in controlling the growth of pathogens. Recent evidence also suggests that they can function as second messengers and modulators of the immune system. The immuno-modulatory effect in mice that were given either Shilajatu extract or placebo was evaluated. White blood cell activity was studied and monitored before and at intervals after receiving the Shilajatu extract or a placebo. Shilajatu extract increased white blood cell activity. The experimental activity was dose dependent and also related to the time of exposure of Shilajatu and its combined constituents which elicited and activated, to different degrees of murine peritoneal macrophages, and activated later stages of tumor growth.9,11 Moreover, Ghosal in 1990

evaluated the effect of Shilajatu in rats pertaining to the levels of brain monoam-ines. Shilajatu at a dose of 25 and 50 mg/kg i.p. for 5 days significantly lowered the level of 5-hydroxytryptamine and 5-hydroxy indole acetic acid and raised the level of dopamine, noradrenaline and its metabolites in rat brain. These changes in neurotransmitter levels are similar to those seen in cases of increased humoral (immune) activity.12 Shilajatu’s use causes the production of lymphocytes of cortical thymus layer and their intensive migration into thymus-dependent zones of lymph nodes and spleen. It is evident from the event that Shilajatu activates phagocytosis and thereby releases cytokines in mouse peritoneal macrophages.11,13

Shilajatu extract inhibited the proliferation of the Ehrlich ascites tumor cells significantly.10 Shilajatu and its combined constituents also elicited and activated, in different degrees, murine peritoneal macrophages and activated splenocytes of tumor-bearing animals at early and later stages (unresponsive) of tumor growth.

Shilajatu from USSR and its corresponding combined fractions acted essentially as cell-growth factors in both normal and tumor cells by maintaining membrane integrity.11 Moreover, Shilajatu did not increase the incidence of micronucleated polychromatic erythrocytes (PCE) in the bone marrow cell of mice. A mild reduction in RNA contents followed by a slight decrease in PCE/NCE (normochromatic erythrocyte) ratio. Shilajatu treatment reduced the increase in micronucleated PCE, caused by cyclophosphamide showing its anti-tumor property.12

Shilajatu is used in 20 Shastric (classical) formulations and 24 proprietary

drugs.14

Shilajatu must be validated by well-structured clinical trials before it is branded as a virility drug.

References

1 Bhavaprakasha, Dhatu-updhatu Varga, 8: 80–82.

2 Schepetkin Igor A et al, Characterization and biological activities of humic substances from mumie, J Agric Food Chem, 2003, 51: 5245–5254.

3 Schepetkin Igor A, Andrei Khlebnikov, Byoung Se Kwon, Medical drugs from humus matter: Focus on mumie, Drug Dev Res, 2002, 57: 140–159.

4 Agarwal SP, Rajesh Khanna, Ritesh Karmarkar, Md. Khalid Anwer, Roop K. Khar, Shilajit: A review, Phytother Res, 2007, 21: 401–405.

5 KORUS, Russia International Symposium on Science and Technology, Russia, Tomsk, June 26–July 3, 2004, 3: 352–355.

272 Defining a new scientific path

6 Bhattacharya SK, Ananda P. Sen, Effects of Shilajatu on biogenic free radicals, Phytother Res, 1995, 9: 56–59.

7 Ghosal S, Free radicals, oxidative stress, and antioxidant defense, Phytomedica, 2000, 1: 1–8.

8 Agarwal SP, Rajesh Khanna, Ritesh Karmarkar, Md. Khalid Anwer, Roop K. Khar, Shilajatu: A review, Phytother Res, 2007, 21: 401–405.

9 Tripathi YB, S Shukla, S Chaurasia, S Chaturvedi, Antilipid peroxidative property of shilajit, Phytother Res, 1996, 10: 269–270.

10 Schepetkin Igor A, Andrei Khlebnikov, Byoung Se Kwon, Medical drugs from humus matter: Focus on mumie, Drug Dev Res, 2002, 57: 140–159.

11 Bhaumik S, S Chattopadhyay, S Ghosal, Effects of Shilajit on mouse peritoneal macrophages, Phytother Res, 1993, 7: 425–427.

12 Ghosal S, Chemistry of Shilajit, an immunomodulatory ayurvedic rasayan, Pure Appl Chem, 1990, 62(7): 1285–1288.

13 Tiwari, Ramarao P, S Ghosal, Effects of Shilajit on the development of tolerance to morphine in mice, Phytother Res, 2001, 15: 177–179.

14 Wilson E et al, Journal of Ethnopharmacology, 136, 2011: 5 (Table 2).





22 Red list of medicinal plants

A threat to Ayurvedic formulations

Red list of Ayurvedic medicinal plants1

Botanical name:

Aconitum ferox Wall. ex Seringe

Family:

Ranuculaceae

Threat status:

critically endangered/North-West

Used in Ayurveda:

Ayurvedic Formulary of India, Part I

Distribution:

Distributed in the Himalayan region across India, Nepal, and Bhutan in an altitude range of 2,100–3,600 m. Within India, it has been recorded in Sikkim.

Botanical Name:

Aconitum heterophyllum Wall. ex Royle

Family:

Ranuculaceae

Threat status:

critically endangered/North-West

Used in Ayurveda:

Ayurvedic Pharmacopoeia of India ( API), Part I, Vol. I Distribution:

Distributed in the Himalayan region across Pakistan, India, and Nepal. In India, it has been recorded in Jammu and Kashmir, Himachal Pradesh, Uttar Pradesh in an altitude range of 2,400–4,500 m.

Botanical name:

Acorus calamus L.

Family:

Araceae

Threat status:

vulnerable/regional

Used in Ayurveda:

API, Part I, Vol. II

Distribution:

Globally distributed in the North temperate hemisphere and tropical Asia.

Within India, it has been recorded throughout, in marshes, wild or cultivated, ascending to an altitude of 2,200 m in the Himalayas.

Botanical name:

Adhatoda beddomei C. B. Clarke

Family:

Acanthaceae

Threat status:

critically endangered/global

Used in Ayurveda: API, Part I, Vol. IV

274 Defining a new scientific path

Distribution:

This species is endemic to India occurring in the Travancore hills of South Western Ghats, Valparai (South Arcot), Akkamalai (Coimbatore Dist.) and Mahendragiri (Kanniyakumari Dist.).

Botanical name:

Aquilaria malaccensis Lam. syn. A. agallocha Roxb.

Family:

Thymelaeaceae

Threat status:

critically endangered/North-East

Used in ayurveda: API, Part I, Vol. IV

Distribution:

Arunachal Pradesh, Assam, Meghalaya

Botanical name:

Berberis asiatica Roxb.

Family:

Berberidaceae

Threat status:

Endangered/North-West

Used in Ayurveda: API, Part I, Vol. II Distribution:

Thi

Botanical name:

Coscinium fenestratum (Gaertn.) Coleb.

Family:

Menispermaceae

Threat status:

critically endangered/regional

Used in Ayurveda:

API, Part I, Vol. V

Distribution:

This species is globally distributed across India, Nepal, Bhutan, Myanmar and South West China in an altitude range of 1,200–2,500 m. Within India, it has been recorded in the Himalayan region across Himachal Pradesh, Uttar Pradesh, Sikkim, and Arunachal Pradesh.

Distribution:

This species is recorded in Southern India and Sri Lanka. It has also been reported in Vietnam. Within India, the species is restricted to the Western Ghats of Karnataka (Coorg, Uduppi, Dakshin and Uttar Kannada districts), Kerala (Thiruvananthapuram, Wynaad, Thrissur, Idukki, and Palakkad) and Tamil Nadu (Kanniyakumari, Tirunelveli and Nilgiri districts) up to an altitude of 400m. The species is seen confined to the semi-evergreen and the wet evergreen forests.

Botanical name:

Curcuma caesia Roxb.

Family:

ZIingiberaceae

Threat status:

critically endangered/Central India

Used in Ayurveda:

Nisha, Rajani, Ratri of Ayurvedic texts Distribution:

The species is native of Bengal and distributed in the tropics. It is also cultivated to some extent.

Red list of medicinal plants 275

Botanical name:

Embelia ribes Burm. f.

Family:

Myrsinaceae

Threat status:

(low risk/near threatened)/regional

Used in Ayurveda:

API, Part I, Vol. I

Distribution:

It is an Indo-Malesian species, reported from India, Sri Lanka, Singapore, Malaysia, and Southern China. It is found to occur throughout India in Central Himalayas, Arunachal Pradesh, Assam, Maharashtra, Andhra Pradesh, Karnataka, Kerala, and Tamil Nadu. This species is globally distributed in Indo-Malesia.

Within India, it is found throughout up to an altitude of 5,000 ft.

Botanical name:

Embelia tsjeriam-cottam A. DC.

Family:

Myrsinaceae

Threat status:

vulnerable/regional

Used in Ayurveda:

substitute of Vidanga

Distribution:

Global distribution of this species is recorded in India, Myanmar (earlier Burma) and Sri Lanka. Within Indi, it is seen in the southern states of Maharashtra, Karnataka, Kerala, Tamil Nadu, and Andhra Pradesh up to an altitude of 1,600 m. This species is globally distributed in Indo-Malesia. Within India, it is found distributed throughout the greater part up to an altitude of 1,600 m.

Botanical name:

Fritillaria roylei Hook.

Family:

Liliceae

Threat status:

critically endangered/North-West

Used in Ayurveda:

Kshirakakakoli ( API, Part I, Vol. V) Distribution:

This species distributed in the Himalayan region across Pakistan and India.

Within India, it has been recorded in Jammu and Kashmir, Himachal Pradesh, and Uttar Pradesh in an altitude of 2,800–4,000 m.

Botanical name:

Gardenia gummifera L. f.

Family:

Rubiaceae

Threat status:

(low risk/near threatened)/global

Used in Ayurveda:

API, Part I, Vol. VI

Distribution:

This species is endemic to Peninsular India. It has been recorded in the drier parts of Maharashtra (Raighad district), Andhra Pradesh, Karnataka (Belgaum, Bellary, Bidar, Bijapur, Dharwad, Chitradurga, Kolar), Kerala (Marayur forest, Chinnar, Idukki districts) and Tamil Nadu (Chengalpattu, Coimbatore, Madurai, Nilgiri, North and South Arcot, Ramanathapuram, Tirunelveli). WOI – This species is found throughout the Deccan Peninsula extending northwards to Bun-delkhand and parts of Bihar.

276 Defining a new scientific path

Botanical name:

Gentiana kurroo Royle

Family:

Gentianaceae

Threat status:

critically endangered/North-West

Used in Ayurveda:

API, Part I, Vol. VI

Distribution:

This species is distributed in the Himalayan region across Pakistan, India, and Nepal. Within India, it has been recorded in Jammu and Kashmir, Himachal Pradesh and Uttar Pradesh between an altitude range of 1,800–2,700 m.

Botanical name:

Gloriosa superba L.

Family:

Liliaceae

Threat status:

(low risk/near threatened)/regional

Used in Ayurveda: API, Part I, Vol. III Distribution:

A Paleotropic species found in Africa, Madagascar, India to Indo-China and Malesia. It is found throughout tropical India. This species is globally distributed in the Paleotropics. Within India, it is found throughout the tropical region common in the moist deciduous forests.

Botanical name:

Hydnocarpus kurzii (King) Warb.

Family:

Flacourtiaceae

Threat status:

endangered/North-East

Used in

API, Part I, Vol. VI

Distribution:

This species is globally distributed across India, Bangladesh, and Myanmar.

Within India, it has been recorded in the evergreen forests throughout Arunachal Pradesh, Assam, Tripura in an altitude range of 200–1000 m. often forming gre-garious patches.

Botanical name:

Inula racemosa Hook. f.

Family:

Asteraceae

Threat status:

critically endangered/North-West

Used in Ayurveda: API, Part I, Vol. IV

Distribution:

This species is distributed in the Hindu-Kush Himalayan region across Afghanistan, Pakistan, India, Nepal. Within India, it has been recorded in Jammu and Kashmir, Himachal Pradesh and Uttar Pradesh in an altitude range of 2,800–3,200 m.

Botanical name:

Kaempferia galanga L.

Family:

Zingiberaceae

Threat status:

critically endangered/regional

Used in Ayurveda: substitute of Hedychium spicatum Ham. ex Smith

Red list of medicinal plants 277

Distribution:

Globally the species is distributed in South East Asia. Within India, it is found in Eastern and Southern India. This species is also largely cultivated. This species is globally distributed in South East Asia. Within India, it is found throughout the plains and cultivated for ornament and for its aromatic rhizome.

Botanical name:

Madhuca longifolia (Koen.) Macler

Family:

Sapotaceae

Threat status:

endangered/regional

Used in Ayurveda: South Indian madhuuka tree

Distribution:

Globally the species is distributed in India, Sri Lanka and doubtfully in Myanmar (earlier Burma). Within India, it is distributed in the peninsula region. This species is distributed in India, Sri Lanka and doubtfully in Myanmar. Within India, it is found in the warmer parts, tropical Himalayas and along the Western Ghats. It is often planted as an avenue tree along the road sides and in temples.

Botanical name:

Nardostachys jatamansi DC.

Family:

Valerianaceae

Threat status:

critically endangered/North-West

Used in Ayurveda

API, Part I, Vol. I

Distribution:

Sikkim, Eastern Himalayas

Botanical name:

Operculina turpethum (L.) S. Manso

Family:

Convolvulaceae

Threat status:

(low risk/near threatened)/regional

Used in Ayurveda: API, Part I, Vol. III Distribution

Africa, Tropical Asi, and Australia. Recorded throughout the warmer parts. In Karnataka and Tamil Nadu, recorded in the drier zones but nowhere abundant. In Kerala, recorded only in the disturbed forests of drier regions. (ravikumar) Botanical name:

Picrorhiza kurroa Royle ex Benth.

Family:

Scrophulariaceae

Threat status:

endangered

Used in Ayurveda: API, Part I, Vol. II Distribution:

This species is globally distributed in the Himalayan range across Pakistan, India, and Nepal. Within India, it is found in the alpine Himalayas of Jammu and Kashmir, Himachal Pradesh, Uttar Pradesh and Sikkim between an altitude range of 3,300–4,300 m.

278 Defining a new scientific path

Botanical name:

Piper longum Linn.

Family:

Piperaceae

Threat status:

(low risk/near threatened)/regional

Used in Ayurveda:

API, Part I, Vol. IV

Distribution:

It is a native of North East India. Globally the species is distributed in the Indo-Malesian region and Sri Lanka. Within India, its presence is reported from the lower hills of Central to Eastern Himalayas as well as Western Ghats of Kerala and Tamil Nadu. It has also been recorded in Nicobar Island. This species is probably native to North East India, globally distributed in Indo-Malesia. Within India, it is found in the hotter parts of India, from Central Himalayas to Assam, Meghalaya, Bengal, evergreen forests along the western ghats and Car Nicobar Islands.

Botanical name:

Polygonatum verticillatum (L.) All.

Family:

Liliaceae

Threat status:

endangered/North-West

Used in Ayurveda:

As Medaa, P. cirrhifolium Royle as Mahaa Medaa

Distribution:

This species is endemic to India occurring only in the temperate Himalayas of Jammu and Kashmir, Himachal Pradesh (Lahaul-Spiti: Frequent in Juniperus forest. Thirot-Udaipur), Uttar Pradesh, Sikkim, Arunachal Pradesh and Manipur between an altitude range of 1,800–3,900 m.

Botanical name:

Pueraria tuberosa (Roxb. ex Willd.) DC.

Family:

Fabaceae

Threat status:

(low risk/near threatened)/regional

Used in Ayurveda: API, Part I, Vol. V

Distribution:

Globally the species is distributed in India, Pakistan, and Nepal. Within India, it is distributed widely in the outer Himalayan region of Jammu and Kashmir, Himachal Pradesh, Uttar Pradesh, West Bengal, and Sikkim. It is also present in the hills of Southern and Eastern India.

Botanical name:

Rauvolfia serpentina (L.) Benth. ex Kurz

Family:

Apocynaceae

Threat status:

endangered/regional

Used in Ayurveda: API, Part I, Vol. V

Distribution:

Globally the species is distributed in the Indo-Malesian region and Sri Lanka. Within India, it is distributed in the sub-Himalayan tracts from

Red list of medicinal plants 279

Himachal Pradesh to Arunachal Pradesh. It is also recorded in the hills of Western and Eastern Ghats as well as Eastern and Central India. This species is globally distributed in Indo-Malesa. Within India, it is found almost throughout.

Botanical name:

Santalum album Linn.

Family:

Santalaceae

Threat status:

endangered/regional

Used in Ayurveda: API, Part I, Vol. III Distribution:

Globally the species is distributed in the Indo-Malesian region and Peninsular India. Though it is naturalized in many dry regions of India, the principal natural tracts of sandal trees are confined to areas of Karnataka, Andhra Pradesh, and Tamil Nadu.

Botanical name:

Saraca asoca (Rosc.) De Wilde

Family:

Caesalpiniaceae

Threat status:

endangered/regional

Used in Ayurveda: API, Part I, Vol. I Distribution:

Globally the species is distributed in the Indo-Malesian region and Sri Lanka. Within India, its distribution is confined to the moist zones of Western and Eastern Ghats (Peninsular India), sub-Himalayan tracts (Uttar Pradesh to Arunachal Pradesh) and Eastern India (Bihar, West Bengal, Orissa, and North Eastern states). This species is globally distributed in Indo-Malesia. Within India, its distribution is confined to the moist zones of Western and Eastern Ghats (Peninsular India), sub-Himalayan tracts (Uttar Pradesh to Arunachal Pradesh) and Eastern India (Bihar, West Bengal, Orissa, and North Eastern states).

Botanical name:

Saussurea costus (Falc.) Lipsch.

Family:

Asteraceae

Threat status:

critically endangered/North-West

Used in Ayurveda: API, Part I, Vol. I., syn. S . lappa C. B. Clarke Botanical name:

Taxus wallichiana Zucc.

Family:

Taxaceae

Threat status:

critically endangered/North-East

Used in Ayurveda: Himalayan yew. T. baccata Linn.: European yew ( API, Part I, Vol. III)

Distribution:

This species is endemic to India occurring only in the temperate Himalayas between an altitude of 2,000–3,000 m. It has been reported from Arunachal Pradesh.

280 Defining a new scientific path

Botanical name:

Terminalia arjuna (Roxb.) Wight & Arn.

Family:

Combretaceae

Threat status:

(low risk/near threatened)/regional

Used in Ayurveda:

API, Part I, Vol. II

Distribution:

Globally the species is found to be distributed in India and Sri Lanka. Within India, it is found in the Sub-Himalayan tracts, Madhya Pradesh, Bihar, and penin-sular India. This species has restricted global distribution occurring only in India and Sri Lanka. Within India, it is sub-Himalayan tracts, Madhya Pradesh, Bihar, and Peninsular India.

Botanical name:

Valeriana jatamansi Jones

Family:

Valerianaceae

Threat status:

critically endangered/North-East

Used in Ayurveda: API, Part I, Vol. I., syn. V. wallichii DC.

Distribution:

This species has a restricted distribution occurring in India and Bhutan between an altitude range of 3,000–5,000 m. Within India, it is found in the alpine Himalayas from Punjab to Sikkim.

Botanical name:

Vateria indica Linn.

Family:

Dipterocarpaceae

Threat status:

(low risk/near threatened)/global

Used in Ayurveda:

API, Part I, Vol. IV

Distribution:

Endemic to the Western Ghats of Karnataka, Tamil Nadu and Kerala. This species is endemic to Western Ghats of Karnataka (Dakshin and Uttar Kannada, Chikmagalur, Hassan), Kerala (Cannanore, Calicut, Palghat, Tiruvanantapuram) and Tamil Nadu (Coimbatore, Annamalai, Tinnaveli) up to an altitude of 800m. in the evergreen forests.

Threatened species2

(Identified through 14 Central Institute of Medicinal and Aromatic Plants (CIMAP) workshops covering 17 Indian States)

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

1

Aconitum chasmanthum Stapf ex Ranunculaceae

CR

Holmes

2

Aconitum heterophyllum Wall.

Ranunculaceae

CR

ex Royle

3

Adhatoda beddomei C. B. Clarke

Acanthaceae

CR

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

4

Alectra chitrakutensis (Rau)

Scrophulariaceae

CR

Prasad & Dixit

5

Amentotaxus assamica D. K.

Taxaceae

CR

Ferguson

6

Aquilaria malaccensis Lam.

Aquilariaceae

CR

7

Arnebia benthami (Wall. ex G.

Boraginaceae

CR

Don) Johns

8

Arnebia euchroma (Royle) John.

Boraginaceae

CR

9

Atropa acuminata Royle ex

Solanaceae

CR

Lindl.

10

Betula utilis D.Don

Betulaceae

CR

11

Chlorophytum borivillianum

Liliaceae

CR

Sant. & Fernandes

12

Cochlospermum religiosum DC.

Cochlospermaceae

CR

13

Commiphora wightii (Arn.)

Lauraceae

CR

Bhandari

14

Coscinium fenestratum (Gaertn.)

Menispermaceae

CR

Coleb.

15

Cycas beddomei Dyer

Cycadaceae

CR

16

Cycas circinalis L.

Cycadaceae

CR

17

Dactylorhiza hatagirea (D.Don)

Orchidaceae

CR

Soo

18

Embelia ribes Burm.f.

Myrsinaceae

CR

19

Eulophia cullenii (Wight) Blume

Orchidaceae

CR

20

Eulophia ochreata

Orchidaceae

CR

21

Gentiana kurroo Royle

Gentianaceae

CR

22

Gymnocladus assamicus

Caesalpiniaceae

CR

Kanjilal

23

Heliotropium keralense Sivar. &

Boraginaceae

CR

Manilal

24

Helminthostachys zeylanica (L.)

Ophioglossaceae

CR

Hook.

25

Holostemma ada-kodien Schult.

Asclepiadaceae

CR

26

Illicium griffithii Hook.f. &

Illiciaceae

CR

Thoms.

27

Janakia arayalpathra

Periplocaceae

CR

J.Joseph & V. Chandras.

28

Lilium polyphyllum D.Don ex

Liliaceae

CR

Royle

29

Litsea glutinosa (Lour.)

Lauraceae

CR

Robinson

30

Malaxis muscifera (Lindl.)

Orchidaceae

CR

Kuntze

31

Nardostachys grandiflora DC.

Valerianaceae

CR

32

Panax pseudoginseng Wall.

Araliaceae

CR

33

Paphiopedilum druryi (Bedd.)

Orchidaceae

CR

Pfitz.

34

Persea glaucescens (Nees) Long

Lauraceae

CR

35

Picrorhiza kurrooa Royle ex

Scrophulariaceae

CR

Benth.

( Continued)

(Continued)

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

36

Piper barberi Gamble

Piperaceae

CR

37

Podophyllum hexandrum Royle

Podophyllaceae

CR

38

Psilotum nudum (L.) P.Beauv.

Psilotaceae

CR

39

Pterocarpus marsupium Roxb.

Fabaceae

CR

40

Pterocarpus santalinus L.f.

Fabaceae

CR

41

Pueraria tuberosa (Roxb. ex

Fabaceae

CR

Willd.) DC.

42

Rauvolfia serpentina (L.) Benth.

Apocynaceae

CR

ex Kurz

43

Saraca asoca (Roxb.) W.J. de

Caesalpiniaceae

CR

Wilde

44

Saussurea costus (Falc.) Lipsch.

Asteraceae

CR

45

Saussurea gossypiphora D.Don

Asteraceae

CR

46

Saussurea obvallata (DC.)

Asteraceae

CR

Edgew.

47

Shorea tumbaggaia Roxb.

Dipterocarpaceae

CR

48

Smilax glabra Roxb.

Smilacaceae

CR

49

Swertia chirayita (Roxb. ex

Gentianaceae

CR

Flem.) Karst.

50

Symplocos racemosa Roxb.

Symplocaceae

CR

51

Taxus wallichiana Zucc.

Taxaceae

CR

52

Tribulus rajasthanensis

Zygophyllaceae

CR

Bhandari & Sharma

53

Utleria salicifolia Bedd.

Periplocaceae

CR

54

Valeriana leschenaultii DC.

Valerianaceae

CR

55

Vateria macrocarpa B. L. Gupta

Dipterocarpaceae

CR

56

Aconitum bisma (Buch.-Ham.)

Ranunculaceae

EN

Rapaics

57

Aconitum deinorrhizum Stapf

Ranunculaceae

EN

58

Aconitum ferox Wall. ex Seringe

Ranunculaceae

EN

59

Aconitum spicatum (Bruhl) Stapf

Ranunculaceae

EN

60

Acorus calamus L.

Acoraceae

EN

61

Alpinia calcarata Roscoe

Zingiberaceae

EN

62

Ampelocissus barbata (Wall.)

Vitaceae

EN

Planch.

63

Ampelocissus indica (L.) Planch.

Vitaceae

EN

64

Angelica glauca Edgew.

Apiaceae

EN

65

Angiopteris evecta (Forst.)

Marattiaceae

EN

Hoffm.

66

Anodendron paniculatum A.DC.

Apocynaceae

EN

67

Asparagus racemosus Willd.

Liliaceae

EN

68

Balanophora involucrata

Balanophoraceae

EN

Hook.f.

69

Blepharispermum subsessile

Asteraceae

EN

DC.

70

Boswellia ovalifoliolata Bal. &

Burseraceae

EN

Henry

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

71

Boswellia serrata Roxb. ex

Burseraceae

EN

Colebr.

72

Brucea mollis Wall. ex Kurz

Simaroubaceae

EN

73

Bunium persicum (Boiss.) Fedts.

Apiaceae

EN

74

Butea monosperma var. lutea

Fabaceae

EN

(Witt.) Maheshwari

75

Calligonum polygonoides L.

Polygonaceae

EN

76

Cayratia pedata (Lam.) Juss. ex

Vitaceae

EN

Gagnep. var. glabra Gamble

77

Celastrus paniculatus Willd.

Celastraceae

EN

78

Cephalotaxus griffithii Hook.f.

Cephalotaxaceae

EN

79

Chlorophytum arundinaceum

Liliaceae

EN

Baker

80

Chonemorpha fragrans (Moon)

Apocynaceae

EN

Alston

81

Cibotium barometz Link.

Cyatheaceae

EN

82

Cinnamomum cecidodaphne

Lauraceae

EN

Meissn.

83

Cinnamomum wightii Meisn.

Lauraceae

EN

84

Citrus macroptera Montr. var.

Rutaceae

EN

annamensis Tanaka

85

Clerodendrum serratum (L.)

Verbenaceae

EN

Moon

86

Coptis teeta Wall.

Ranunculaceae

EN

87

Cordia macleodii (Griff.)

Ehretiaceae

EN

Hook.f. & Thoms.

88

Corollacarpus epigaeus

Cucurbitaceae

EN

(Rottler & Willd.) Clarke

89

Datisca cannabina L.

Datiscaceae

EN

90

Decalepis hamiltonii Wight &

Periplocaceae

EN

Arn.

91

Dendrobium nobile Lindl.

Orchidaceae

EN

92

Didymocarpus pedicillata R. Br.

Gesneriaceae

EN

93

Dioscorea deltoidea Wall. ex

Dioscoreaceae

EN

Griseli

94

Dioscorea prazeri Prain &

Dioscoreaceae

EN

Burkill

95

Dipcadi ursulae Blatter

Liliaceae

EN

96

Dipterocarpus indicus Bedd.

Dipterocarpaceae

EN

97

Drosera burmannii Vahl

Droseraceae

EN

98

Drosera indica L.

Droseraceae

EN

99

Drosera peltata J. E. Sm. ex

Droseraceae

EN

Willd.

100

Dysoxylum malabaricum Bedd.

Meliaceae

EN

ex Hiern

101

Entada pursaetha DC.

Mimosaceae

EN

102

Ephedra foliate

Ephedraceae

EN

103

Ephedra gerardiana Wall. ex

Ephedraceae

EN

Stapf.

( Continued)

(Continued)

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

104

Eulophia herbacea Lindl.

Orchidaceae

EN

105

Eulophia nuda Lindl.

Orchidaceae

EN

106

Eulophia ramentacea Wight

Orchidaceae

EN

107

Flickingeria fugax (Rchb.f.)

Orchidaceae

EN

Seodemf.

108

Fritillaria cirrhosa D.Don

Liliaceae

EN

109

Fritillaria roylei Hook.

Liliaceae

EN

110

Fumaria indica Pugsley

Fumaricaceae

EN

111

Garcinia pedunculata Roxb.

Clusiaceae

EN

112

Garcinia travancorica Bedd.

Clusiaceae

EN

113

Gloriosa superba L.

Liliaceae

EN

114

Gymnema khandalense Santapau

Asclepiadaceae

EN

115

Gymnema montanum (Roxb.)

Asclepiadaceae

EN

Hook.f.

116

Gymnema sylvestre R.Br.

Asclepiacaceae

EN

117

Gynocardia odorata R.Br.

Flacourtiaceae

EN

118

Habenaria intermedia D.Don

Orchidaceae

EN

119

Homalomena aromatica (Roxb.)

Araceae

EN

Schott

120

Humboldtia vahliana Wight

Caesalpiniaceae

EN

121

Hydnocarpus macrocarpa

Flacourtiaceae

EN

(Bedd.) Warb.

122

Hyoscyamus niger L.

Solanaceae

EN

123

Iphigenia stellata Blatter

Liliaceae

EN

124

Juniperus polycarpos C. Koch.

Cupressaceae

EN

125

Jurinea dolomiaea Boiss.

Asteraceae

EN

126

Lamprachaenium

Asteraceae

EN

microcephalum Benth.

127

Lasia spinosa (L.) Thw.

Araceae

EN

128

Leptadenia reticulata Wt. & Arn.

Asclepiadaceae

EN

129

Luffa echinata Roxb.

Cucurbitaceae

EN

130

Lycopodiella cernua (L.) Pichi-

Lycopodiaceae

EN

Sermolli

131

Manilkara hexandra (Roxb.)

Sapotaceae

EN

Dubard

132

Meconopis aculeata Royle

Papaveraceae

EN

133

Mesua ferrea L.

Clusiaceae

EN

134

Michelia champaca L.

Magnoliaceae

EN

135

Mucuna pruriens (L.) DC.

Fabaceae

EN

136

Mucuna gigantea (Willd.) DC.

Fabaceae

EN

137

Nepenthes khasiana Hook.f.

Nepenthaceae

EN

138

Nervilia aragoana Gaud.

Orchidaceae

EN

139

Neurada procumbens L.

Rosaceae

EN

140

Nilgirianthus ciliatus (Nees)

Acanthaceae

EN

Bremek.

141

Nothapodytes nimmoniana

Icacinaceae

EN

(Graham) Mabber.

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

142

Operculina turpethum (L.) Silva

Convolvulaceae

EN

Manso

= Merremia turpethum (L.)

Shah & Bhat

143

Ophioglossum reticulatum L.

Ophioglossaceae

EN

144

Oroxylum indicum (L.) Vent.

Bignoniaceae

EN

145

Ougeinia oojeinensis (Roxb.)

Fabaceae

EN

Hochr.

146

Panax wangianus Sun

Araliaceae

EN

147

Paris polyphylla Sm.

Liliaceae

EN

148

Persea macrantha (Nees)

Lauraceae

EN

Kosterm.

149

Pimpinella tirupatiensis Bal. &

Apiaceae

EN

Subr.

150

Piper longum L.

Piperaceae

EN

151

Piper nigrum L.

Piperaceae

EN

152

Plectranthus barbatus Andr.

Lamiaceae

EN

153

Plectranthus nilgherricus Benth.

Lamiaceae

EN

154

Pleione maculata (Lindl.)

Orchidaceae

EN

Lindl. & Paxton

155

Plumbago indica L.

Plumbaginaceae

EN

156

Polygonatum cirrhifolium

Liliaceae

EN

(Wall.) Royle

157

Rhaphidophora decursiva

Araceae

EN

(Roxb.) Sch.

158

Rheum emodi Wall. ex Meissn.

Polygonaceae

EN

159

Rheum moorcroftianum Royle

Polygonaceae

EN

160

Rhododendron anthopogon

Ericaceae

EN

D.Don

161

Salacia reticulata Wight

Hippocrateaceae

EN

162

Santalum album L.

Santalaceae

EN

163

Semecarpus travancorica Bedd.

Anacardiaceae

EN

164

Sonneratia caseolaris (L.) Engl.

Sonneratiaceae

EN

165

Sterculia urens Roxb.

Sterculiaceae

EN

166

Stereospermum colais(Dillwyn)

Bignoniaceae

EN

Mabb.

167

Strychnos aenea A. W. Hill

Loganiaceae

EN

168

Strychnos colubrina L.

Loganiaceae

EN

169

Swertia lawii (Wight ex C. B.

Gentianaceae

EN

Clarke) Burkill

170

Syzygium alternifolium (Wight)

Myrtaceae

EN

Walp.

171

Syzygium travancoricum

Myrtaceae

EN

Gamble

172

Tacca integrifolia Ker-Gawl.

Taccaceae

EN

173

Tecomella undulata(Sm.) Seem.

Bignoniaceae

EN

174

Terminalia pallida Brandis

Combretaceae

EN

175

Thalictrum dalzellii Hook.

Ranunculaceae

EN

( Continued)

(Continued)

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

176

Trichopus zeylanicus Gaertn.

Trichopodaceae

EN

subsp. travancoricus (Bedd.)

Burkill

177

Tropidia curculigoides Lindl.

Orchidaceae

EN

178

Urginea nagarjunae Hemadri &

Liliaceae

EN

Swahari

179

Xylocarpus granatum Koenig

Meliaceae

EN

180

Zanthoxylum armatum DC.

Rutaceae

EN

181

Zanthoxylum rhetsa (Roxb.) DC.

Rutaceae

EN

182

Zingiber roseum (Roxb.) Roscoe

Zingiberaceae

EN

183

Aconitum balfourii Stapf

Ranunculaceae

VU

184

Aconitum violaceum Jacq. ex

Ranunculaceae

VU

Stapf

185

Adenia hondala (Gaertn.) W. J.

Passifloraceae

VU

de Wilde

186

Aegle marmelos (L.) Corr.

Rutaceae

VU

187

Allium stracheyi Baker

Alliaceae

VU

188

Amorphophallus commutatus

Araceae

VU

(Schott) Engl.

189

Amorphophallus paeoniifolius

Araceae

VU

(Dennst.) Nicolson

190

Amorphophallus sylvaticus

Araceae

VU

(Roxb.) Kunth

191

Ampelocissus araneosa (Dalz. &

Vitaceae

VU

Gibson) Planch.

192

Andrographis paniculata

Acanthaceae

VU

(Burm.f.) Wall. ex Nees

193

Aphanamixis polystachya

Meliaceae

VU

(Wall.) Parker

194

Arisaema tortuosum Schott

Araceae

VU

195

Aristolochia tagala Cham

Aristolochiaceae

VU

196

Artemisia maritima L.

Asteraceae

VU

197

Artocarpus hirsutus Lam.

Moraceae

VU

198

Baliospermum montanum

Euphorbiaceae

VU

(Willd.) Mull.Arg.

199

Barleria acanthoides

Acanthaceae

VU

200

Berberis aristata DC.

Berberidaceae

VU

201

Bergenia ciliata (Haw.) Sternb.

Saxifragaceae

VU

202

Bergenia stracheyi (Hook.f. &

Saxifragaceae

VU

Thoms.) Engl.

203

Blepharis sindica Stocks ex

Acanthaceae

VU

T.Anders

204

Buchanania lanzan Spreng.

Anacardiaceae

VU

205

Caesalpinia digyna Rottler

Caesalpiniaceae

VU

206

Calophyllum apetalum Willd.

Clusiaceae

VU

207

Canarium strictum Roxb.

Burseraceae

VU

208

Cerbera odollam Gaertn.

Anacardiaceae

VU

209

Ceropegia bulbosa Roxb.

Asclepiadaceae

VU

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

210

Chlorophytum tuberosum Baker

Liliaceae

VU

211

Cinnamomum bejolghota

Lauraceae

VU

(Buch.-Ham.) Sweet

212

Cinnamomum macrocarpum

Lauraceae

VU

Hook.f.

213

Cinnamomum sulphuratum Nees

Lauraceae

VU

214

Cinnamomum tamala (Buch.-

Lauraceae

VU

Ham.) Nees

215

Citrullus colocynthis (L.)

Cucurbitaceae

VU

Kuntze

216

Colchicum luteum Baker

Colchicaceae

VU

(Liliaceae)

217

Costus speciosus (J.Koenig ex

Costaceae

VU

Retz.) Sm.

218

Crateva magna (Lour.) DC.

Capparidaceae

VU

219

Curcuma angustifolia Roxb.

Zingiberaceae

VU

220

Curcuma pseudomontana

Zingiberaceae

VU

Graham

221

Curcuma zedoaria (Christ.)

Zingiberaceae

VU

Roscoe

222

Desmodium motorium (Houtt.)

Fabaceae

VU

Merr.

223

Dioscorea bulbifera L.

Dioscoreaceae

VU

224

Dioscorea hispida Dennst.

Dioscoreaceae

VU

225

Diospyros candolleana Wight

Ebenaceae

VU

226

Diospyros paniculata Dalz.

Ebenaceae

VU

227

Elaeocarpus sphaericus

Elaeocarpaceae

VU

(Gaertn.) K.Schum.

228

Embelia tsjeriam-cottam

Myrsinaceae

VU

(Roem. & Schult.) A. DC.

229

Eremostachys superba Royle ex

Lamiaceae

VU

Benth.

230

Euphorbia fusiformis Buch.-

Euphorbiaceae

VU

Ham.

231

Fagonia cretia L.

Zygophyllaceae

VU

232

Ferula jaeschkeana Vatke

Apiaceae

VU

233

Garcinia indica (Thouars)

Clusiaceae

VU

Choisy

234

Garcinia morella (Gaertn.) Desr.

Clusiaceae

VU

235

Garcinia xanthochymus Hook.f.

Clusiaceae

VU

236

Gardenia gummifera L. f.

Rubiaceae

VU

237

Gentiana quadrifaria Bl.

Gentianaceae

VU

238

Glycosmis macrocarpa Wight

Rutaceae

VU

239

Gnetum ula Brongn.

Gnetaceae

VU

240

Gymnadenia orchides Lindl.

Orchidaceae

VU

241

Hedychium coronarium Koenig

Zingiberaceae

VU

242

Heracleum candolleanum

Apiaceae

VU

(Wight & Arn.) Gamble

243

Heracleum lanatum Michx.

Apiaceae

VU

( Continued)

(Continued)

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

244

Hildegardia populifolia (Roxb.)

Sterculiaceae

VU

Schott & Endl.

245

Hippophae rhamnoides L.

Elaeagnaceae

VU

246

Hydnocarpus alpina Wight

Flacourtiaceae

VU

247

Hydnocarpus kurzii (King.)

Flacourtiaceae

VU

Warb.

248

Hydnocarpus pentandra (Buch.-

Flacourtiaceae

VU

Ham.) Oken

249

Hypericum perforatum L.

Hypericaceae

VU

250

Hyssopus officinalis L.

Lamiaceae

VU

251

Kingiodendron pinnatum (Roxb.

Caesalpiniaceae

VU

ex DC.) Harms

252

Limonia acidissima L.

Rutaceae

VU

253

Lumnitzera racemosa Willd.

Combretaceae

VU

254

Madhuca longifolia (Koen.)

Sapotaceae

VU

Macbr.

255

Madhuca neriifolia (Moon) H.

Sapotaceae

VU

J. Lam

256

Mahonia napaulensis DC.

Berberidaceae

VU

257

Michelia nilagirica Zenk.

Magnoliaceae

VU

258

Morinda citrifolia L.

Rubiaceae

VU

259

Moringa concanensis Nimmo ex

Moringaceae

VU

Dalz. & Gibson

260

Mucuna monosperma DC.

Fabaceae

VU

261

Myristica dactyloides Gaertn.

Myristicaceae

VU

262

Myristica malabarica Lam.

Myristicaceae

VU

263

Naringi crenulata (Roxb.)

Rutaceae

VU

Nicolson

264

Nypa fruticans (Thunb.) Wurmb.

Arecaceae

VU

265

Ochreinauclea missionis (Wall.

Rubiaceae

VU

ex G. Don) Ridsdale

266

Ocimum gratissimum L.

Lamiaceae

VU

267

Olax nana Wall.

Olacaceae

VU

268

Paederia foetida L.

Rubiaceae

VU

269

Peganum harmala L.

Zygophyllaceae

VU

270

Pericampylus glaucus (Lam.)

Menispermaceae

VU

Merr.

271

Peucedanum nagpurense

Apiaceae

VU

(C.B.Clarke) Prain

272

Phyllanthus emblica L.

Euphorbiaceae

VU

273

Phyllanthus indofischeri Benn.

Euphorbiaceae

VU

274

Physochlaena praealta (Walp.)

Solanaceae

VU

Miers.

275

Piper boehmeriaefolium Wall.

Piperaceae

VU

ex C.DC.

276

Piper mullesua Buch.-Ham. ex

Piperaceae

VU

D.Don

277

Piper pedicellatum C.DC.

Piperaceae

VU

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

278

Piper peepuloides Roxb.

Piperaceae

VU

279

Plumbago zeylanica L.

Plumbaginaceae

VU

280

Polyalthia simiarum (Buch.-

Annonaceae

VU

Ham.) Hook.f & Thoms.

281

Polygonatum multiflorum (L.)

Liliaceae

VU

All.

282

Polygonatum verticillatum (L.)

Liliaceae

VU

All.

283

Pseudarthria viscida (L.)

Fabaceae

VU

Wight & Arn.

284

Rhaphidophora pertusa (Roxb.)

Araceae

VU

Schott

285

Rheum nobile Hook.f. & Thoms.

Polygonaceae

VU

286

Rheum spiciforme Royle

Polygonaceae

VU

287

Rheum webbianum Royle

Polygonaceae

VU

288

Rhodiola heterodonta

Crassulaceae

VU

(Hook.f. & Thoms.) Boriss

289

Rhododendron campanulatum

Ericaceae

VU

D.Don

290

Rhodondendron lepidotum Wall.

Ericaceae

VU

ex D.Don

291

Roylea cinerea (D.Don) Baillon

Lamiaceae

VU

292

Rubia cordifolia L.

Rubiaceae

VU

293

Salacia oblonga Wall. ex

Hippocrateaceae

VU

Wight & Arn.

294

Salvadora oleoides Decne

Salvadoraceae

VU

295

Salvadora persica L.

Salvadoraceae

VU

296

Sarcostemma viminale (L.) R.Br.

Asclepiadaceae

VU

297

Schrebera swietenioides Roxb.

Oleaceae

VU

298

Scindapsus officinalis (Roxb.)

Araceae

VU

Schott

299

Smilax zeylanica L.

Liliaceae

VU

300

Stemona tuberosa Lour.

Liliaceae

VU

301

Strychnos nux-vomica L.

Strychnaceae

VU

302

Strychnos potatorum L. f.

Strychnaceae

VU

303

Swertia corymbosa (Griseb.)

Gentianaceae

VU

Wight ex C. B. Clarke

304

Symplocos paniculata (Thunb.)

Symplocaceae

VU

Miq.

305

Terminalia arjuna (Roxb. ex

Combretaceae

VU

DC.) Wight & Arn.

306

Terminalia chebula Retz.

Combretaceae

VU

307

Thalictrum foliolosum DC.

Ranunculaceae

VU

308

Tinospora sinensis (Lour.) Merr.

Menispermaceae

VU

309

Toona ciliata M. J. Roem.

Meliaceae

VU

310

Tragia bicolor Miq.

Euphorbiaceae

VU

311

Tylophora indica (Burm. f.)

Asclepiadaceae

VU

Merr.

312

Uraria picta (Jacq.) Desv. ex DC.

Fabaceae

VU

( Continued)

290 Defining a new scientific path

(Continued)

Sl. No

Name of species

Family

Conservation

Status as per

IUCN Categories

313

Urginea indica (Roxb.) Kunth

Liliaceae

VU

314

Valeriana hardwickii Wall.

Valerianaceae

VU

315

Valeriana jatamansi Jones

Valerianaceae

VU

316

Vateria indica L.

Dipterocarpaceae

VU

IUCN = International Union for Conservation of Nature and Natural Resources.

CR = Critically endangered. EN = Endangered. VU = Vulnerable.

Red Data Book series of the Botanical Survey of India

Based on the survey and exploration as well as herbarium and literature studies, about 1,500 species of flowering plants and few hundreds of Pteridophytes, Bryophytes, Lichens and Fungi have been identified as threatened. After careful and critical evaluation of their status and threat perceptions, the Botanical Survey of India has compiled Data Sheets on 1,182 species, 708 of which have already been published as Red Data Book of Indian Plants: volume 1–3 (vol. 4 and 5 are in press).

The intensification of search for some of the extremely rare plant species in their known localities, as well as in the areas having identical eco-climatic conditions, have led to the rediscovery of species like Belosynapsis kewensis, Byrsophyllum tetrandrum, Claoxylon hirsutum, Didymocarpus missionis, D. ovalifolia, Eugenia floccosa, E.singampatiana, Exacum courtallense, Humboldtia unijuga, Pogostemon travancoricum, Casearia andamanica, Lactuca cooperi, Carex pamirensis, Cyathopus sikkimensis, Dicranostigma lactucoides, Cotoneaster lambertii, Trachycarpus takil, Radula assamica, Conocephalum supradecompositum, Daedo-leopsis purpurea and Fistulina hepatica. Some even after more than a hundred years since the type of collection.

The Botanical Survey of India has also been instrumental in the establishment of Nepethes and Citrusgene Sanctuary in Meghalaya and Rhododendron and Orchid sanctuaries in Sikkim. (Last updated: 22 March 2019.)

K. Nisteswar, Gujarat Ayurved University, Jamnagar, Gujarat, while discussing the depleting plant resources, rightly wrote:

Fact of facts is that most popular Ayurvedic formulations like Chyavanap-rash, Dashamoolarishta, Ashokarishta, etc., are not genuinely prepared and marketed as per classical reference. It is generally observed that the manufacturer is substituting or deleting or incorporating the adulterated drugs in the place of original drugs while preparing classical formulations. Most of the metals and minerals also require herbs for their purification and incineration processes.

Depletion of forest area and medicinal plants finally lead to the disappearance of classical prescriptions from the clinical practices and industry is being subjected

to a critical situation to process even their proprietary medicines.3

Red list of medicinal plants 291

References

1 FRLHT’s ENVIS Centre on Medicinal Plants, Bengaluru, http://envis.frlht.org. Editors: D K Ved, Suma Tagadur Sureshchandra, Vijay Barve, Vijay Srinivas, Sathya San-geetha, K Ravikumar, R Kartikeyan, Vaibhav Kulkarni, Ajith S Kumar, SN Venugopal, BS Somashekhar, MV Sumanth, Noorunissa Begum, Sugandhi Rani, KV Surekha, Nikhil Desale. FRLHT’s ENVIS Centre on Medicinal Plants, Bengaluru. Copy Right: FRLHT, Bengaluru and MoEFCC, GoI, accessed August 11, 2017.

2 Workshops were organized between 1995–2007. Contributed by NB Brindavanum, former adviser, Bio Resources Development Group, Dabur India Ltd.

3 Nisteswar K, Depleting medicinal plant resources: A threat for the survival of ayurveda, Ayu, October–December 2014, 35(4): 349–350.





23 Ayurvedic education system

A path-breaking study

reflecting the elements of

evidence-based Ayurveda

Between 2005 and 2008, a nation-wide survey was planned and executed by an Ayurvedic teacher, Dr. Kishor Patwardhan, as his doctoral research work.

The objective of his study was to evaluate the “Relevance of current system of Ayurvedic education in the emerging global scenario” with special reference to graduate level Ayurvedic education in India leading to a BAMS (Ayurvedacharya) degree.

The method adopted in the study: Mailed Survey.

Population: The population for the study was defined in terms of students and teachers studying and teaching respectively in Ayurvedic educational institutions of India during the period of September 2005 to October 2008. Specifically, the population was as follows:

1 Students: All IRNS/house surgeons registered under BAMS course who had passed the third professional BAMS examinations successfully. • All Postgraduate students registered under Ayurveda Vachaspati-MD(Ay) or Ayurveda Dhanvantari-MS(Ay) programs in Ayurvedic colleges recognized by the Central Council of Indian Medicine.

2 Teachers: All teachers of Ayurvedic colleges/universities who possessed at least BAMS or equivalent degree.

Sample Frame: The sample frame that became available to the investigator constituted a list of 242 Ayurvedic colleges spread all over 28 states and 7 union territories of India. As the students and teachers in these colleges constituted the primary units of sampling, for random sampling it was essential to get a list of all the students and teachers. But as no such database was available, the investigator was compelled to accept the list of 242 Ayurvedic colleges as the sample frame for this study.

Sample: With the availability of this sample frame, it was decided to include at least 10% of institutions from each geographical zone of India (North, East, South, and West) while trying to include as many states as possible. Thus, a total of 32 colleges were included in the study through a random cluster sampling technique.

294 Defining a new scientific path

The tool used for the study was a semi-structured questionnaire consisting of eight sections. A total of 73 items were grouped into these eight sections which were as follows:

1 Problems related to the exposure of a BAMS graduate to basic clinical skills.

2 Problems related to job opportunities after the completion of the BAMS

program

3 Problems related to the relevance of the Curriculum of BAMS program 4 Problems related to Teaching methodology in the existing system of Ayurvedic education.

5 Problems related to Global Challenges being faced by the Ayurvedic system of medicine

6 Problems related to Entrepreneurship/Business opportunities after the completion of the BAMS program.

7 Perception regarding Ideal system of Medical Education for India.

8 Problems related to Personal relevance of Ayurveda to the teachers and students.

The tool was evaluated for its reliability and consistency after administering it to a sample of 100 respondents and subjecting the results to relevant statistical tests.

The questions were in the form of statements, and the responses were obtained in the form of a five-point Likert scale that ranged from “strongly agree” to “strongly disagree.”

The major points that emerged out of this study

Inadequate exposure to clinical skills

The study reported a general perception among students and teachers that the graduates were not equipped with the required essential skills to handle the clinical emergencies of the primary healthcare level through Ayurveda interventions.

There was also a tendency toward an agreement that they were not exposed sufficiently in carrying out clinical procedures such as catheterization, incision and drainage; conduction of normal deliveries; interpretation of common diagnostic tests; etc. The study reported an inadequate exposure to a wide variety of clinical conditions during the graduate level of Ayurveda education. Based on these findings, the investigator suggested that the tendency to practice and prescribe allopathic medicines, commonly seen among Ayurveda physicians, was probably because of this status, though the legality of such cross-prescription was debat-able. The study also showed that the students agreed to these statements more strongly than the teachers.

The study revealed a common perception that employability of Ayurveda graduates was limited as they were not treated on par with MBBS graduates, and also because they had limited options if they did not opt for pursuing postgraduation.

Ayurvedic education system 295

On scientific relevance of the curriculum of BAMS program

The study reported a general tendency toward an agreement, among both students and teachers, regarding the issues listed in this section. In most cases, it was observed that the students agreed with these issues more strongly than the teachers.

• Most of the topics in the subject “Ayurvedīya Itihāsa” had the least practical applicability.

• Most of the topics covered in the subject “Padārtha Vijnyāna” were philosophical, and their practical applicability was limited. Many topics in “Rachanā

Śārīra” such as “Marma,” “Sirā,” “Snāyu,” “Sandhi,” etc. were outdated as more advanced knowledge on these topics was available in the textbooks of modern anatomy/modern surgery. Interestingly, however, the students from West zone showed a tendency to disagree with this statement.

• The topics like “Assessment of Prakrti and Dhātu Sāra” were given undue importance in the subject “Kriyā Śārīra,” and the clinical applicability of these topics was not emphasized in clinical disciplines.

• An essential practical exposure to laboratory diagnostic methods in serology, immunology, histopathology, microbiology and parasitology was not emphasized in “Roga nidāna and Vikrti Vijnāna.”

• In “Dravyaguna,” essential basic information related to recent advances in pharmacodynamic/pharmacognostic/phytochemical attributes of various Ayurvedic herbs and methods of evaluation of their pharmacological effects was not emphasized.

• An essential basic knowledge related to various technologically advanced methods of “Drug Standardization” was not included in the curricula of either

“Dravyaguna” or “Rasa Śāstra.”

• An essential basic knowledge related to pharmaco-vigilance, safety profile, toxicity studies and Good Manufacturing Practice (GMP) should be included in “Rasa Śāstra.”

• Essential basic knowledge related to the methods of quantitative and qualitative analysis of chemical components of Ayurvedic preparations was not included in the curriculum of “Rasa Śāstra.”

• In “Agada Tantra,” most of the Ayurvedic topics describing the classifications/

numbers/varieties of poisons and their effects are outdated and impractical.

• The topics related to “Arishta Vijnāna” explained in “Indriya Sthāna” of

“Caraka Samhitā” are practically not useful because they do not fit into the present social scenario.

• Practical training related to the basics of medical jurisprudence, toxicology and forensic medicine was not emphasized in teaching, making a BAMS

graduate inefficient in handling the legal procedures.

• Essential information on recent studies/reports related to the efficacy of Ayurvedic medicines/procedures was not included in the curriculum of clinical disciplines, which they thought was required to be included.

296 Defining a new scientific path

• The curricula of clinical disciplines contained many outdated methods of treatment/management that were impractical (e.g. Dronī Prāveśika Rasāyana). Certain essential areas like clinical decision making, care of hos-pitalized patients, patient interviewing skills, ethical decision making and geriatric patient care were required to be included in the curricula of the clinical disciplines.

• Many modern technical terms were translated into “Sanskrit” in the curriculum (e.g. “Unduka Puccha Śotha” for Appendicitis, “Hrtkāryacakra” for the cardiac cycle, etc.), which did not serve any practical purpose.

• Many controversial topics (e.g. certain structures in Racanā Śārīra, certain herbs in Dravyaguna) were included in the curricula, which led only to confusion among students.

Radical changes suggested

Based on those observations, the investigator suggested that the curricula of BAMS course required a radical change. From classical textbook-oriented and literature-oriented learning, he said, the learning had to become more clinically oriented. The syllabi of all the subjects had to be radically reviewed and restructured. He suggested that problem-based teaching was required to be adopted in Ayurveda, too. His suggestion was also that impractical, redundant and controversial topics were to be removed from the curricula. He observed that translation of modern technical terms into “Sanskrit” didn’t enrich Ayurveda. Therefore, such a practice had to be stopped. Wherever modern knowledge was to be given, it had to be in a direct way and not in a camouflaged way, he suggested.

The study also suggested that recent advances in technology/research related to medicinal herbs were to be incorporated into the curriculum. Good Manufacturing Practice (GMP) were to be included. Essential basic knowledge related to the methods of quantitative and qualitative analysis of chemical components of Ayurvedic preparations was to be included. Essential basic information related to recent advances in pharmacodynamic/pharmacognostic/phytochemical attributes of various Ayurvedic herbs and methods of evaluation of their pharmacological effects had to be included. Basic knowledge related to various technologically advanced methods of “Drug Standardization” was to be included in the curriculum.

To achieve the goal, the investigator suggested that there had to be a multidisciplinary approach in the education system. Some teachers from analytical chemistry, phyto-chemistry, botany and pharmaceutical chemistry were required to be recruited in the Ayurveda colleges to impart the required training. This may prove helpful in conducting some research activities at the institution-level, he suggested.

Observations on teaching methodology that was followed in the

existing system of Ayurvedic education

A significant number of students and teachers showed a tendency toward an agreement that the teaching methodology was mostly unable to keep up the scientific

Ayurvedic education system 297

values and scientific spirit of a young student. Also, they agreed that the teaching methodology followed in Ayurvedic educational institutions did not encourage questioning among the young students.

It was a general perception that the interpretation of theories like “Tridosa” or

“Pancha Mahābhūta” varied largely from one teacher to another, making these theories even more confusing and vague.

A significant proportion of students also agreed that memorizing the classical “Sanskrit” verses was unduly emphasized in Ayurveda education. They also agreed that memorizing the reference number of a particular chapter/verse of any

“Samhitā” did not serve any practical purpose, but it was given undue importance in teaching and examination system. In the study, 86.9% of students and 70.3% of teachers showed a tendency toward an agreement that the examination system in Ayurveda did not assess the actual abilities and skills of a student; rather, it largely depended on the assessment of memorizing capacity of students.

There was a general tendency toward an agreement that memorizing the numbers of various structures/their measurements/various classifications of diseases (Sankhyā Samprāpti) as per different authors etc. did not serve any practical purpose, but was given undue importance in teaching and examination system.

Global challenges faced by the Ayurvedic system of medicine

More than 85% of students and more than 80% of teachers agreed that serious questions being raised on the safety profile of Ayurvedic preparations were posing a threat to the Ayurvedic system of Medicine. A very significant proportion of participants perceived the issue of standardization of Ayurvedic preparations to be a problem that still needed to be addressed. These observations indicated that the questions related to the safety profile of Ayurvedic preparations were posing a threat to the Ayurvedic system of Medicine. This issue required immediate attention, according to the investigator.

Also, as the study showed, there was a general tendency toward an agreement that Ayurvedic academicians did not figure anywhere in authoring the scientific and evidence based papers in reputed international journals, and they did not vol-untarily participate in international platforms to present their research data. There was a general perception that Ayurvedic academicians did not follow international standards while planning the protocols of research projects and while writing research reports.

More than 85% of students and teachers agreed that pharmacodynamic/pharmacokinetic properties/efficacy/safety profiles and chemical compositions of Ayurvedic formulations were yet to be established, making it difficult for experts in conventional medicine to accept Ayurveda.

Out of 32 institutions covered in the study, 23 were of governmental administration. Only 6 private and 3 semi-governmental institutions were covered in the study. Also, most of the participants were from governmental institutions (781).

Therefore, this study reflected the status of Ayurvedic education system more in governmental institutions than in private or semi-governmental institutions.

298 Defining a new scientific path

Considering the nature of the study (mailed survey) and the lengthy questionnaire, an overall 57.4% of response rate to this study was viewed as good. Therefore, it was said that there was a considerable level of willingness among the participants to participate in the study.

Impact of the study

Ten years have passed after the findings from this study were published. The Investigator (Dr. Kishor Patwardhan), in a personal communication, informed the Editor that Central Council of Indian Medicine (CCIM) in its vision document, which was released in 2016, admitted having taken note of this study. Many topics suggested by the investigator were added in the curricula. After results of the study were published, the trend in PG entrance tests has witnessed a change, and application- and analysis-based questions are now being incorporated. Dr.

Kishor Patwardhan and his team have developed and tested new integrative ways of teaching Ayurveda.

Dr. Kishor Patwardhan currently works for the Department of Kriya Sharir (Ayurvedic Physiology), Faculty of Ayurveda, Banaras Hindu University, Varanasi, India, as a professor. The text is based on his doctoral work, “Identifying issues, concerns and challenges of Ayurveda education in India.” Also refer to latest update: https://0000.0002-4992-5376. Kishor Parwardhan: Ayurvedic Education in India-Experiences and perspectives on contemporary debates, September, 2019.





Abbreviations

α

alpha

β

beta

γ

gamma

ACE

Angiotensin converting enzyme

AFI

Ayurvedic Formulary of India

API

Ayurvedic Pharmacopoeia of India

Bw

Body weight

Cm Centimeter

CCL

Carbon tetrachloride

4

CCRAS Central Council for Research in Ayurvedic Sciences

COX

Cyclooxygenase

CNS

Central Nervous System

CSIR

Council of Scientific & Industrial Research

CTC

Common toxicity criteria

CVS

Cardiovascular system

D

day(s)

DNA

Deoxyribonucleic acid

L-Dopa Levodopa

E. coli

Escherichia coli

ED

Median effective dose

50

FSH

Follicle stimulating hormone

GABA Gamma-amino butyric acid

g/gm

Gram(s)

kg kilogram

h Hour

Hb Hemoglobin

HDL

High density lipoproteins

HIV

Human immunodeficiency virus

HPLC

High pressure liquid chromatography

HPTLC High performance thin layer chromatography

HSV

Herpes simplex virus

5-HT

5-Hydroxytryptamine

ICMR

Indian Council of Medical Research

300 Abbreviations

i.m. Intramuscular

i.p. Intraperitoneal

i.v. Intravenous

IC

Median inhibitory concentration

50

IU

International Unit

ID

Median inhibitory dose

50

Kcal/kg Kilocalorie per kilogram

Kg

kilogram

LC

Median lethal concentration

50

LD

Median lethal dose

50

LDL

Low density lipoproteins

LH

Luteinizing hormone

M

Meter

MIC

Minimum inhibitory concentration

MTD

Maximum tolerated dose

µg

Microgram

mg

Milligram(s)

mg/kg

Milligram per kilogram

ml/mL Milliliter

NLT

Not Less Than

NMT

Not More Than

p.o.

Per oral

PMID

PubMed identifier unique number.

Ppm

Parts per million

RBC

Red blood corpuscles

s.c. Subcutaneous

SGOT

Serum glutamic oxaloacetic transaminase

SGPT

Serum glutamic-pyruvic transaminase

Sh.

Shigella

Sp. Species

Spp.

Multiple species

Staph.

Staphylococcus

Syn. Synonym

TLC

Thin layer chromatography

UV Ultraviolet

Var. Variety

Vib.

Vibrio

VLDL

Very low density lipoproteins

v/v

Volume per volume

v/w

Volume per weight

WBC

White blood corpuscles

Wk

Week(s)

WoI

The Wealth of India (CSIR/Niscair)

w/w

Weight per weight





Index

Aamalakyaadi Gana 144

Sphaeranthus indicus flowers on

Aamra Haridra 82

anxiolytic activity in mice” 252 – 253

Aaragvadhaadi Gana 133

America see United States

Abies webbiana see Taalisha

Amomum subulatum see Sthuula-aila

abiesin 94

Amuthan, A., “Antiovulatory and

Abrol, B. K. 165

abortifacient effects of Areca catechu

accelerated solvent extraction (ASE) 187

(betel nut) in female rats” 258

Aconitum heterophyllum see Atis

analytical markers 203

Acorus calamus 164; see also Vacha

Anand, Nitya 58

Active Controlled trials 17

Ancient Rome, herbal medicine in 47 – 55

add on studies 17 – 18

Angelica archangelica see Chandaa

additional doses design 18

Animal Ethical Committees 231

Adhatoda vasica 69; see also Vaasaa

Anjanaadi Gana 140 – 141

Adiantum lunulatum see Hamspaadi

Anogeissus latifolia see Dhava

Adiantum venustum 76

Ansari, M. N.: “The effect of aqueous

adrenocorticotrophic hormone (ACTH) 226

extract of Embelia ribes Burm on

Aegle marmelos 257; leaves 152

serum homocysteine, lipids, and

Aeschines 48

oxidative enzymes in methionine

Afonne, O. J., “Hypoglycaemic effect of

induced hyperhomocysteinemia”

the aqueous extract of Boerhavia diffusa

250 – 251; “Protective activity of

leaves” 245 – 246

Glycyrrhiza glabra Linn. on carbon

African Marigold 45

tetrachlorideinduced peroxidative

Agaru 77

damage” 251

Agarwal, A., “Effect of Tinospora

antaphrodisiacs 49

cordifolia on learning and memory in

anthraquinones 225

normal and memory deficit rats” 249

anticancer activity: of flavonoids 220 – 221;

Agrawal, B., “The antiasthmatic activity of

of terpenoids 222

Moringa oleifera Lam-A clinical study”

anti-inflammatory activity, of flavonoids

259

219 – 220

agrimony 43

antioxidant activity, of flavonoids 218 – 219

Alangium salviifolium 256 – 257

antiviral actvity, of flavonoids 221 – 222

alkaloids 217

Anupan 11

Allium sativum 247 – 248

anxiety disorders, response to placebo

Allkin, Bob 170

effect 158

allocation concealment 23 – 24

Apaamaarga 240 – 241

Aloe indica 69

Apaamaarga Kshaara 241; quantitative

Ambaashthaadi Gana 142

analysis 241 – 242

Ambavade, S. D., “Pharmacogical

Aparaajitaa 80

evaluation of the extracts of

aphrodisiacs 49, 52, 53, 242

302 Index

API-Reference DNA Barcode Library

Ayurvedic Formulary of India 35, 73, 81,

(API-RDBL) 173, 174

82, 94, 122, 151, 157, 261; permitted

Apollodorus 52

extraction methods 183

Appala, R., “Inhibitory concentrations

Ayurvedic Pharmacopoeia of India (API)

of Lawsonia innermis dry powder for

1, 60, 61, 62, 64, 65, 73, 173, 239, 244;

urinary pathogens” 259 – 260

Aamra Haridra 82; accepted botanical

Aquillaria agallocha see Agaru

names of medicinal plants 174 – 178;

Archelaus 48

Agaru 77; Aparaajitaa 80; Asana 91;

Areca catechu 258

Atis 75; Bhaarangi 80; Bhootakeshi Argyreia nervosa see Vriddhadaaru

92; Bhringaraaja 83; Braamhi 78;

Aristolochia indica see Naakuli

Chandaa 77; Chirbilva 86; collection of

Arka Prakasha 35

plants 173; Daaruharidra 78; Danti 78;

Arkaadi Gana 135 – 136

Dhatuura 83; Dhava 76; Dvipaantara

Artemisia absinthium see Dvipaantara

Damanaka 77; Gajapippli 92; Gandira

Damanaka

80 – 81; Gojihvaa 89; Hamspaadi Artemisia dracunculus 165

75 – 76; Hapushaa 86; Haridra 82;

Asana 91

Hingu 84; Jaatiphala 88; Jalapippali Ashokarishta 69

89; Jataamaansi 88; Jivaka 87; Jivanti Ashta varga 261 – 263; Jivaka 262, 264;

87; Kaaka-Naasikaa 88; Kaakoli 87;

Kaakoli 261, 264; Kshirakaakoli 261,

Kaaliyaka 81; Kakamaachi 92 – 93;

264 – 265; Mahaa Medaa 262, 264;

Kankol 89 – 90; Karanja 79; Karchura Medaa 262; Riddhi 261, 265; Rshbhaka

83; Kebuka 81; Kiraatikta 93; Kozuppaa

262; substitute drugs 263; Vriddhi 261

91; Krishna Saariva 82; Kshirakaakoli Ashwagandha 164

87; Kumkuma 81 – 82; Kushtha 92;

Asparagus recemosus see Shataavari

Kutaja 85 – 86; Laangali 84; Lodhra

astringents 227

93; Lonikaa 91; Madayanti 86 – 87;

Atis 75

Mahaa Balaa 92; Mahaa Medaa 91;

Atropa Belladonna 188

Maricha 89 – 90; markers of Ayurvedic

aurapten 123

herbs 206 – 215; Medaa 91; Munditikaa Axungia 44

93; Muurvaa 87 – 88; Naadihingu Ayurveda 2, 3, 11, 14, 15, 16, 21, 24, 27,

84; Naagakeshara 88; Naakuli 77;

29, 57, 70, 156, 231; “additional texts”

Paarsika Yavaani 86; Paashanabheda

35 – 36; aphrodisiacs 242; Bhaishaja-

76; Paathaa 79 – 80; Papata 89;

Kalpana 67; decline of 59; Doshas Parpata 84; Priyangu 79; Raasanaa

62 – 63; global challenges faced by

89 – 90; Rakta-Chandana 91; Rakta

297 – 298; “Important Resources” for

Chitraka 89 – 90; Rakta Punarnavaa 79;

MBBS students 36 – 37; impregnating

Reference Standards (RS) 204 – 205;

the herb 68 – 69; legal knowledge base

Riddhi 85; Rshbhaka 87; Sahachara

of 33 – 35; pharmacognosy 59; red list

78; Sarpagandhaa 91 – 92; Shaalparni

of medicinal plants 273 – 280; research

83; Shallaki 79; Shankhpushpi 81;

2, 121; and the “Sacred Word” 156;

Shataavari 78; Shathi 85; Shveta

threatened medicinal plants 280 – 290;

Saariva 82; Simshapaa 83; Sthauneya vaidyas 2, 73; see also Ayurvedic

94; Sthuula-aila 76; Taalisha 74;

education in India; Ayurvedic Formulary

Taalmuuli 82; Taamalaki 89 – 90; Vaasaa

of India; Ayurvedic Pharmacopoeia

75; Vacha 75; Vidang 84; Vishmushthi

of India; formulations; Sushruta’s

93; Vriddhadaaru 77; Yashti 85

Classification of Ayurvedic Drugs

AYUSH (Department of Ayurveda, Yoga,

Ayurveda Sangraha 35

and Naturopathy, Unani, Siddha and

Ayurveda Saukhyam 132, 263

Homeopathy) 2, 38, 59; Advisory from

Ayurvedic education in India 293 – 294;

(2019) 11 – 12; colleges 30; comments

BAMS program 295 – 296; exposure to

by eminent scientists 31 – 32; final

clinical skills 294; suggested curricula

report of the AYUSH task force 25 – 27;

changes 296; teaching methodology

industry regulation 26 – 27; services 27;

296 – 297

unqualified “experts” 29 – 30

Index 303

B. diffusa aqueous leaf extract 245 – 246

Bhatti, R., “The effect of Allium sativum

Baakuchi 64

on ischemic preconditioning and

Baala Graha Dosha 157

ischemia reperfusion induced cardiac

Bacon, Francis 42

injury” 247 – 248

Bacopa monnieri see Braamhi

Bhavprakasha Nighantu 132, 153;

Baicalin 221

Dhaanya Varga 151; Guduchyaadi

Bairy, K. L., “Effect of Tinospora

Varga 150; Haritakyaadi Varga 149;

cordifolia on learning and memory in

Karpuraadi Varga 150; Phalaadi Varga

normal and memory deficit rats” 249

150 – 151; Pushpa Varga 150; Shaaka Balachandran, I. 59

Varga 151

Baliospermum montanum see Danti

Bhootakeshi 92

BAMS program 295 – 296

Bhringaraaja 64, 83

Banerjee, S., “Antiovulatory and

bhuuta-baadhaa 156

abortifacient effects of Areca catechu

Bhuutonmaada 156

(betel nut) in female rats” 258

Bhuvaneswari, K., “Inhibitory

Bani, S., “Immunosuppressive properties

concentrations of Lawsonia innermis

of Pluchea lanceolata l eaves”

dry powder for urinary pathogens”

255

259 – 260

Banu, G. S., “A study of the antimicrobial

bicoumarins 226

activity of Alangium salviifolium”

bioactive components 204

256 – 257

bioactive value 189

Barcode of Life Database (BOLD) 174

bioactivity guided assay 189

Barleria prionitis, antidiabetic effect of

biological activities, of alkaloids 217

247; see also Sahachara

biological assays 232

Basic Local Alignment Search Tool

Bipolar Depression (BPD), placebo

(BLAST) 174

response rates in clinical trials 159

basil 49

bitters 222 – 223

basilien (sweet basil) 41

black-box designs 20

Baxi, A. J. 121

blind assessment 24

Benincasa hispida 250, 258 – 259

blinding 22 – 23

Berberis aristata see Daaruharidra

block randomization 22

Bergenia ciliata see Paashanabheda

blood: astringents 227; as medicine 47 – 48

Bhaarangi 80, 153

Bodhankar, S. L., “Pharmacogical

Bhadwar, S. R. L. 165

evaluation of the extracts of

Bhagwat, D. P. 255

Sphaeranthus indicus flowers on

Bhaishaja-Kalpana 67

anxiolytic activity in mice” 252 – 253

Bhandari, U.: “The effect of aqueous

Boerhaavia diffusa see Rakta Punarnavaa

extract of Embelia ribes Burm on serum

borage 41

homocysteine, lipids, and oxidative

Boswellia serrat see Shallaki

enzymes in methionine induced

botanical drugs: Aamra Haridra 82;

hyperhomocysteinemia” 250 – 251;

Agaru 77; Aparaajitaa 80; Asana 91;

“Protective activity of Glycyrrhiza glabra

Atis 75; Bhaarangi 80; Bhootakeshi 92;

Linn. on carbon tetrachlorideinduced

Bhringaraaja 83; Braamhi 78; Chandaa

peroxidative damage” 251

77; Chirbilva 86; Daaruharidra 78;

Bharat Bhaishajya Ratnakara 35

Danti 78; Dhatuura 83; Dhava 76;

Bhatagar, P. 247

Dvipaantara Damanaka 77; Gajapippli Bhatnagar, M.: “Hepatoprotective activity

92; Gandira 80 – 81; Gojihvaa 89;

of Eugenia jambolana Lam. in carbon

Hamspaadi 75 – 76; Hapushaa 86;

tetrachloride treated rats” 253; “A study

Haridra 82; Hingu 84; Jaatiphala 88;

of the antidiabetic activity of Barleria

Jalapippali 89; Jataamaansi 88; Jivaka prionitis” 247

87; Jivanti 87; Kaaka-Naasikaa 88;

Bhattacharyya, D., “Effect of Aegle

Kaakoli 87; Kaaliyaka 81; Kakamaachi marmelos leaf on rat sperm motility-An

92 – 93; Kankol 89 – 90; Karanja 79;

in vitro study” 257

Karchura 83; Kebuka 81; Kiraatikta

304 Index

93; Kozuppaa 91; Krishna Saariva Central Council for Research in Ayurvedic

82; Kshirakaakoli 87; Kumkuma

Sciences (CCRAS) 2, 35; General

81 – 82; Kushtha 92; Kutaja 85 – 86;

Guidelines for Clinical Evolution of

Laangali 84; Lodhra 93; Lonikaa 91;

Ayurvedic Intervention 12; general

Madayanti 86 – 87; Mahaa Balaa 92;

methodologies and guidelines of drug

Mahaa Medaa 91; Maricha 89 – 90;

development 13 – 14

Medaa 91; Munditikaa 93; Muurvaa Central Council of Indian Medicine

87 – 88; Naadihingu 84; Naagakeshara

(CCIM) 27

88; Naakuli 77; Paarsika Yavaani Chandaa 77

86; Paashanabheda 76; Paathaa

Charaka 68, 127, 241; Dashemaani 131;

79 – 80; Papata 89; Parpata 84;

see also Vargas

pharmaceutical names of Ayurvedic

Charaka Samhita 35, 68

plant drugs 94 – 95; Priyangu 79;

Chatusshashti Prahari Pippali 68

Raasanaa 89 – 90; Rakta-Chandana Chaudhury, R. R. 60

91; Rakta Chitraka 89 – 90; Rakta Chauhan, P. S., “Immunosuppressive

Punarnavaa 79; Riddhi 85; Rshbhaka properties of Pluchea lanceolata leaves”

87; Sahachara 78; Sarpagandhaa

255

91 – 92; Shaalparni 83; Shallaki 79;

chemical constituents 190 – 199, 238,

Shankhpushpi 81; Shataavari 78; Shathi

240 – 241; alkaloids 217; anthraquinones

85; Shveta Saariva 82; Simshapaa

225; bitters 222 – 223; cardioactive

83; Sthauneya 94; Sthuula-aila 76;

glycosides 224; categories of markers

Taalisha 74; Taalmuuli 82; Taamalaki

203 – 204; coumarins 225 – 226;

89 – 90; Vaasaa 75; Vacha 75; Vidang

cyanogenic glycosides 224 – 225;

84; Vishmushthi 93; Vriddhadaaru 77;

essential oils 229; flavonoids 218 – 222;

Yashti 85

Gum Arabic 228; natural configuration

botanical names 156, 173; equivalent

of compounds 188 – 189; plant steroids

pharmaceutical names 96 – 109,

223 – 224; polysaccharides 228 – 229;

110 – 120; and pharmaceutical names 94;

saponins 226; tannins 227; terpenoids

plant families 166 – 168; Sanskritization

222; toxic constituents, markers for

of 73 – 74, 239 – 240

202 – 203

Botanical Survey of India 290

chemotypes 164

Braamhi 63, 64, 78

China: herbal medicine 39 – 40; Institute

breaking the codes 23 – 24

for Medicinal Plant Development 40;

Brhatyaadi Gana 139

pharmaceutical drug names in 96 – 109;

Britain see United Kingdom

see also Classical Chinese Medicine

bromelain 242

(CCM); Traditional Chinese Medicine

Butea monosperma 223 – 224

(TCM)

Chinese Pharmacopoeia 204

cabbage 54

Chirbilva 86

calamus 75

Chirchatta 243 – 244

Callicarpa macrophylla see Priyangu

Chopra, A. 62

capsaicin 242 – 243

Chopra, Ram Nath 57, 121, 163, 165

cardioactive glycosides 224

Chrysippus 49, 51

Carica papaya 64

Chude, M. A., “Hypoglycaemic effect of

carotenoids 222

the aqueous extract of Boerhavia diffusa

case control studies 17

leaves” 245 – 246

case reports 17

Chunekar, K. C. 263

case-series studies 17

churna 67 – 68

catechins 219, 227

Chyavanpraasha 67

categories of markers 203 – 204

Cineraria lyrata 45

Cato 54

Cinnamomum tamala 74

cavitation 184 – 185

Cissampelos pareira see Paathaa

cedria 55

Cissus quadrangularis 254

Index 305

Classical Chinese Medicine (CCM) 39;

cross over trials 17

see also Traditional Chinese Medicine

cross sectional studies 17

(TCM)

Cryptolepsis buchanani see Krishna

classical formulations, pruning 156; see

Saariva

also formulations

cucumber 50 – 51

classical plant drugs 2

Culpeper, Nicholas: Art of Physick 42; A classification of Ayurvedic drugs,

Complete Herbal 42 – 43; The English Dashemaani 131

Physitian 42; The London Dispensatory

Cleophantus 53, 54

42

Clerodendron phlomoides 152

Curculigo orchioides see Taalmuuli

Clerodendrum serratum see Bhaarangi

Curcuma amada see Aamra Haridra

clinical studies: experimental 17 – 19;

Curcuma longa 153, 165; see also Haridra

observational 16 – 17; see also designs

Curcuma zedoaria see Karchura

amenable to test Ayurvedic therapies

curcumin 243

Clinical Trial Registry-India (CTRI) 14

curriculum of the BAMS program 295 – 296

clinical trials 124; human pharmacology

cyanogenic glycosides 224 – 225

1415; placebo response rates in 159;

therapeutic exploratory trials 15;

Daaruharidra 78

un-blinding 23; see also designs

Daginawala, H. F., “Effect of Hemidesmus

amenable to test Ayurvedic therapies

indicus (Anantmool) extract on IgG

Clitoria ternatea see Aparaajitaa

production and adenosine deaminase

Clownes Wound-wort 44

activity of human lymphocytes in vitro”

cohort studies 17

255 – 256

Coleus forskohlii see Gandira

Dalbergia sissoo see Simshapaa

collection of herbs 67 – 68, 173

Danti 78

colocynthis 51

Dash, Bhagwan 63

Commiphora wightii 124

Dashamuula complex 122

Commission E 47, 155

Dashamuula Kwaath 123

comparative trials 18

Dashamuula Kwaath Churna 121

comparison, of Classical Chinese Medicine Dashamuulaarishta 121, 122 – 123

and Traditional Chinese Medicine

Dashemaani 131

39 – 40

Dashmuulu Varga 145; suggested

compounds: identifying stable markers in

substitutions for classical formulations

205; Karvi Panchakadasha Kashaaya

151 – 152

123; natural configuration of 188 – 189;

data based studies 21

redundant herbs 121 – 122; trituration

data fudging 64 – 65

68, 69, 70

Datura metel see Dhatuura

condensed tannins 227

Deccan Regional Herbarium 168

consortium for the barcode of life (CBOL)

decoction 183, 186

179

Democritus 52

controls 21

Deopujari, J. Y., “Effect of Hemidesmus

Convolvulus pluricaulis see Shankhpushpi

indicus (Anantmool) extract on IgG

correlative components 204

production and adenosine deaminase

Coscinium fenestratum see Kaaliyaka

activity of human lymphocytes in vitro”

Costus speciosus see Kebuka

255 – 256

coughs, response to placebo effect 158

Department of Indian Medicine and

coumarins 225 – 226; marmin 123

Homeopathy (ISM&H) 27

Council of Scientific and Industrial

depression, response to placebo effect 158

Research (CSIR) 2, 32

Derosne 217

countercurrent extraction 183 – 184, 186

Deshpande, S. S., “Antiulcer activity of

cow’s milk, properties of 64

Tephrosia purpurea in rats” 248 – 249

critically renewed placebo studies 158–159

designs amenable to test Ayurvedic

Crocus sativa 152

therapies 20 – 23; black-box 20; blinding

306 Index

22 – 23; data based studies 21; meta

Drugs Technical Advisory Board 25

analysis 21 – 22; placebo controlled

drying of extracts 185 – 186

trials 20 – 21; randomization 22; Reverse Dvipaantara Damanaka 77

Pharmacology (RP) 20

Desmodium gangeticum see Shaalparni

early escape rescue treatment 18

Desmodium triflorum 76

Eclipta alba see Bhringaraaja

deterioration of herbs 67

Elaadi Churna 128

Dhaanya Varga 151

Elaadi Gana 137 – 138

Dhatuura 83

elaterium 50 – 51

Dhava 76

Embelia ribes 250 – 251; see also Vidang

Dhavan, B. N. 58

Emblica officinalis 67

Dheer, R., “A study of the antidiabetic

ENVIS Centre on Medicinal Plants 169

activity of Barleria prionitis” 247

Epicatechin 219

Dhingra, D., “Evaluation of the

epilepsy, response to placebo effect 158

antidepressant-like activity of

erectile dysfunction, response to placebo

glycyrrhizin in mice” 251 – 252

effect 158

diabetes: Barleria prionitis effect on 247;

ergosterol 223

Pongamia pinnata effect on 246 – 247

essential oils 222, 228, 229

dianthrone glycosides 225

Eugenia jambolana 253

Dieuches 53, 54

eugenol 74

Diodorus, Empirica 49

European Medicines Agency (EMEA) 203

DNA barcoding 173, 174; and adulteration

European Scientific Cooperative on

180 – 181; views of Indian researchers

Phytotherapy (ESCOP) 47

179 – 180

experimental studies 17 – 19; placebo

doctrine of signatures 42, 64

controlled trials 20 – 21

Doiphode, V. V. 62

external control 18

Dorababu, P., “Effect of ethanolic

extraction methods: accelerated solvent

leaf extract of Ocimum sanctum on

extraction (ASE) 187; countercurrent

haloperidolinduced catalepsy in albino

extraction 183 – 184; decoction 183;

mice” 260

forced extraction 183; microwave-

dosage calculations for extracts 190

assisted extraction (MAE) 184; Soxhlet

Doshas 1, 61, 62 – 63, 122; see also

extraction 186 – 187; strengths and

Prakriti

limitations of 186 – 187; supercritical

double blind studies 23, 24, 69

fluid extraction (SFE) 185; ultrasonic

Draksharishta 128

extraction (UAE) 184 – 185

Dravya Guna Vijnana 132

extracts 237; dosage calculations 190; dry

drug extract ratio (DER) 189

238; drying of 185 – 186; standardized

drugs 24; biological assays 232; general

237 – 238; strength of 189

methodologies and guidelines of

development (CCRAS) 13 – 14;

factorial trials 17

pharmacodynamic activities 231;

Ferula foetida see Hingu

phases of clinical trial for 14 – 16;

final report of the AYUSH task force

polyformulations 21; and scientific

25 – 27

inquiry 57 – 58; subtlety 68; therapeutic

“Five Elements” 39

benefit of 155; toxicity studies 231;

flavonoids 204, 218; antibacterial activity

see also botanical drugs; compounds;

219; anticancer activity 220 – 221;

formulations

anti-inflammatory activity 219 – 220;

Drugs and Cosmetics Act (1940) 1, 24,

antioxidant activity 218 – 219; antiviral

26 – 27, 35; Chapter 3(a) 7; Chapter 3(h)

actvity 221 – 222; hepatoprotective

7 – 8; see also Drugs and Cosmetics

activity 219

Rules (1945)

forced extraction 183, 186

Drugs and Cosmetics Rules (1945) 27;

formulations 156; Ashvagangha 152;

Part X A: 122 DAC 8; Part XVI: 158(B)

Bhaargi 153; Draksharishta 128;

8 – 11

Elaadi Churna 128; Kumaryaasava

Index 307

128; logistics of 128 – 129; Maha Panch Gardenia gummifera see Naadihingu

Gavya Ghrita 127 – 128; Mahaa Panch

garlic 42 – 43

Gavya Ghrit 156; Manasmitra Vataka

genistein 221

156; Napunsakataa 157; Navaayasa genomic DNA extraction 173 – 174

Churna 128; Nishaa 153; Panch Gavya Gerard, John, Herball, or Generall

Ghrita 156; Pancha Gavya Ghrita 127;

Historieof Plantes 43, 44

Phala Ghrita 157; pruning 121 – 124;

Gerardia 44

revalidating 153 – 154; suggested

Germany: Commission E 47, 155; Federal

substitutions 151 – 152; Triphala 127;

Institute for Drugs and Medical Devices

see also Ganas; Vargas

47; herbal medicine in 45 – 47

foxglove 43, 224

Ghosh, S. C. 69

freeze drying 185 – 186

ginger 41

French Institute of Pondicherry 169

global challenges faced by the Ayurvedic

Fritillaria roylei see Kshirakaakoli

system of medicine 297 – 298

Full Spectrum Extracts 188

Gloriosa superba see Laangali

Fumaria parviflora see Parpata

glycosides 225, 226

furano coumarins 226

Glycyrrhiza glabra 153 – 154, 252; see also

Yashti

Gajapippli 92

glycyrrhizin 226, 251 – 252

Galen 42

Gmelina arborea 123, 152

Gamaniel, K. S., “Hypoglycaemic effect of Gojihvaa 89

the aqueous extract of Boerhavia diffusa Good Clinical Practice (GCP) guidelines

leaves” 245 – 246

11

Ganas 27, 127, 128, 129, 131 – 132;

Gopalakrishna, H. N., “Effect of ethanolic

Aamalakyaadi 144; Aaragvadhaadi leaf extract of Ocimum sanctum on

133; Ambaashthaadi 142; Anjanaadi haloperidolinduced catalepsy in albino

140 – 141; Arkaadi 135 – 136;

mice” 260

Brhatyaadi 139; Elaadi 137 – 138;

Gore, A. 254

Guduchyaadi 143; Haridraadi 138;

Graha dosha 157

Kaakolyaadi 139 – 140; Kadambaadi

group chemical markers 203

147; Kaphahara 149; Karanjaadi Guduchyaadi Gana 143

147; Krishnaadi 137; Kshudra Guduchyaadi Varga 150

panchamuula 145; Lakshaadi

Gum Arabic 228

144 – 145; Mahat panchmuula 145;

Gunas 1, 61, 62, 65

Mushkakaadi 136 – 137; Mustaadi

143 – 144; Niroohana Dravya 148;

Habernaria intermedia see Riddhi

Nyagrodhaadi 142 – 143; Panch

Haimavati Vachaa 75

Kola 147; Panchakantaka 146;

Hamspaadi 75 – 76

Paruushakaadi 141; Patolaadi 139;

Hansel, Rudolf, Rational Phytotherapy

Pittahara 148; Priyangvaadi 141 – 142;

155

Rodhraadi  135; Saalsaaraadi  134;

Hapushaa 86

Saarivaadi 140; Shirsha virechaniya Haridra 63, 82

148; Shyaamaadi 138 – 139; Surasaadi Haridraadi Gana 138

136; Trapvaadi 144 – 145; Triphlaa Haritakyaadi Varga 149

143 – 144; Trna panchamuula 146;

Harvey, William 42

Tryuushana 144; Utpalaadi 143;

heart activity, cardioactive glycosides,

Uushakaadi 140; Vaatahara 148;

effect on 224

Vachaadi 138; Vallija panchamuula

heat shock proteins 220

145 – 146; Vamanaoushadha 147;

Hedychium spicatum see Shathi

Varunaadi 133 – 134; Vatsakaadi Hemaadri 68

146, 149; Vidaarigandhaadi

Hemidesmus indicus 255 – 256

132 – 133; Viratarvaadi 134 – 135;

hepatoprotective activity, of flavonoids 219

Virechanaoushdha 148

herbal medicine: categories of markers

Gandira 80 – 81

203 – 204; doctrine of signatures 42;

308 Index

dosage calculations for extracts 190;

Indian Institute of Integrative Medicine

European Scientific Cooperative on

163

Phytotherapy (ESCOP) 47; see also

Indian Journal of Pharmacology, The 245

extraction methods; extracts; herbs;

Indian Pharmacopoeia 25

medicinal plants

Indian System of Medicine (ISM) 27

herbal products: authenticity of 180 – 181;

Indication Pluralism 73

markers for toxic constituents 202 – 203

indigenous medicine 58

herbariums: Central National Herbarium

ingwer see ginger

168; Deccan Regional Herbarium 168;

Institute for Medicinal Plant Development

ENVIS Centre on Medicinal Plants 169;

40

French Institute of Pondicherry 169;

Institutional Animal Ethics Committee

Janaki Ammal Herbarium 165 – 166;

(IAEC) 14

Kerala Forest Research Institute 169;

Intellectual Property Rights (IPR) 14

LWH Virtual Herbarium 168

International Code of Botanical

Herbe Gerarda 44

Nomenclature 163, 165 – 166

herbs 45 – 46; collection of 67 – 68;

international pharmaceutical names

deterioration of 67; holotypes 163;

110 – 120

impregnating 68 – 69; properties

intraspecific variation in plants 164 – 165

and actions of 61; specimens 163;

Inula racemosa see Pushkara

standardization 65; see also Ayurveda;

Irritable Bowel Syndrom (IBS), response

Ayurvedic Pharmacopoeia of India;

to placebo effect 158

formulations; herbal medicine;

Ishar, M. P., “The effect of Allium sativum

medicinal plants; standardization;

on ischemic preconditioning and

vouchers

ischemia reperfusion induced cardiac

hesperidin 243

injury” 247 – 248

high performance liquid chromatography

Islam, F., “The effect of aqueous extract

(HPLC) 65, 84, 239

of Embelia ribes Burm on serum

Hippocrates 42

homocysteine, lipids, and oxidative

Holarrhena antidysenterica see Kutaja

enzymes in methionine induced

holistic medicine 1, 2, 27; see also

hyperhomocysteinemia” 250 – 251

Ayurveda; medicinal plants

Holoptelea integrifolia see Chirbilva

Jaatiphala 88

holotypes 163

Jalapippali 89

human pharmacology 1415

Janaki Ammal Herbarium 165 – 166

humors 40 – 41

Japan, Museum of Materia Medica 169

hydrocyanic acid 224 – 225

jarjarikaran 68, 69

hydrolyzable tannins 227

Jataamaansi 88

Hyoscyamus niger see Paarsika Yavaani

Jethimadh 154

hyssop 52

Jivaka 87, 262, 264

Jivanti 87

ICMR (Indian Council of Medical

Jnana Prabodhni Institute of Research in

Research) 129

Ayurvedic Medicines 69

identifying stable markers in Ayurvedic

journals, need for unbiased research 29 – 30

compounds 205

Juniperus communis see Hapushaa

“implicit affordance” 158–159

impregnating the herb 68 – 69

Kaakamaachi 92 – 93

Independent Ethics Committee (IEC) 14

Kaaka-Naasikaa 88

Independent Review Board (IRB) 14

Kaakoli 87, 261, 262 – 263, 264

India: BAMS program 295 – 296; Drugs

Kaakolyaadi Gana 139 – 140

and Cosmetics Act (1940) 7; Research

Kaaliyaka 81

Councils 11; survey of the Ayurvedic

Kadambaadi Gana 147

education system in 293 – 294

Kafle, S., “Antiovulatory and abortifacient

Indian Council of Medical Research,

effects of Areca catechu (betel nut) in

Reviews on Indian Medicinal Plants 2

female rats” 258

Index 309

Kainthla, R. P., “Effect of Hemidesmus

Krishna Saariva 82

indicus (Anantmool) extract on IgG

Krishnaadi Gana 137

production and adenosine deaminase

Kshaara 241

activity of human lymphocytes in vitro”

Kshirakaakoli 87, 262 – 263, 264 – 265

255 – 256

Kshirakaakoli 261

Kakamaachi 92 – 93

Kshudra panchamuula Gana 145

Kalikar, M. V. 254 – 255

Kulkarni, P. H. 69

Kankol 89 – 90

Kulkarni, R. V., “Hepatoprotective activity

Kant Katiyar, C. 32

of Cissus quadrangularis stem extract

Kapahi, B. K. 165

against isoniazid-induced liver damage

Kapha 1, 27, 61, 63, 64

in rats” 254

Kaphahara Gana 149

Kumar, A. 250; “Effect of methanolic

Kapur, L. D. 165

extract of Benincasa hispida against

Karanja 79

histamine and acetylcholine induced

Karanjaadi Gana 147

bronchospasm in guinea pigs” 258 – 259;

Karchura 83

“Possible anorectic effect of methanol

Karma 1, 61, 62, 64

extract of Benincasa hispida (Thunb.).

Karpuraadi Varga 150

Cogn. Fruit” 250

Kashyap, R. S., “Effect of Hemidesmus

Kumar, B. D. 32

indicus (Anantmool) extract on IgG

Kumar, G., “A study of the antimicrobial

production and adenosine deaminase

activity of Alangium salviifolium” 256 – 257

activity of human lymphocytes in vitro”

Kumaryaasava 128

255 – 256

Kumkuma 81 – 82

Kaul, A., “Immunosuppressive properties

Kuruvilla, A. B., “Inhibitory

of Pluchea lanceolata leaves” 255

concentrations of Lawsonia innermis

Kavitha, K., “Anticarcinogenic and

dry powder for urinary pathogens”

antilipidperoxidative effects of

259 – 260

Tephrosia purpurea (Linn.) Pers. in

Kushtha 92

7, 12-dimethylbenz(a)anthracene

Kutaja 85 – 86

(DMBA) induced hamster buccal pouch

carcinoma” 249

Laangali 84

Kebuka 81

Lakshaadi Gana 144 – 145

Kerala Forest Research Institute 169

large juniper 55

Kesara 81 – 82

Latha, M. S., “Protective activity of

Keshara 81 – 82, 152

Glycyrrhiza glabra Linn. on carbon

ketones 229

tetrachlorideinduced peroxidative

Khare, C. P.: The Ayurvedic

damage” 252

Pharmacopoeia of India and Ayurvedic

Lawsonia inermis see Madayanti

Pharmacopoeial Plant Drugs:

legal knowledge base of Ayurveda 33 – 35

Expanded Therapeutics 2; The Modern

leprosy 47 – 48

Ayurveda: Milestones beyond the

Leptadenia reticulata see Jivanti

Classical Age 2

Lilium polyphyllum 87, 281

Kharya, M. D., “Immunosuppressive

limited placebo period 18

properties of Pluchea lanceolata leaves” Linnaean system 1

255

linseed 50

Khiyani, R. K., 254 – 255

lipid peroxidation 218 – 219

Kiraatikta 93

Lodhra 93

Koti, B. C., “Hepatoprotective activity

Lodhrasava 69

of Cissus quadrangularis stem extract

logistics of Ayurvedic formulations

against isoniazid-induced liver damage

128 – 129

in rats” 254

Lonikaa 91

Kour, K., “Immunosuppressive properties

LWH Virtual Herbarium 168

of Pluchea lanceolata leaves” 255

lycopene 243

Kozuppaa 91

lyophilization 185 – 186

310 Index

Madayanti 86 – 87

extraction methods; herbal medicine;

Madhuuka 153 – 154

herbs

Maha Panch Gavya Ghrita 127 – 128

medicine 57; placebo effect 157 – 159; see Mahaa Balaa 92

also drugs

Mahaa Medaa 91, 262, 264

Mehta, A., “The antiasthmatic activity of

Mahaa Panch Gavya Ghrit 156

Moringa oleifera Lam-A clinical study”

Mahadihassan, S. 63

259

Mahat panchmuula Gana 145

Mesua ferrea 152; see also Naagakeshara

Malaxis acuminata see Jivaka

meta analysis 21 – 22

Malini, S., “Effect of Tinospora cordifolia

Mhetra N. A., “Pharmacogical evaluation

on learning and memory in normal and

of the extracts of Sphaeranthus indicus

memory deficit rats” 249

flowers on anxiolytic activity in mice”

Manasmitra Vataka 156

252 – 253

Manduukaparni 63

microwave-assisted extraction (MAE) 184,

Manoharan, K., “Effect of Pongamia

186, 187

pinnata flowers on blood glucose and

monoterpenoids 222

oxidative stress in alloxan induced

Moringa oleifera 259

diabetic rats” 246 – 247

mucilaginous plants 228

Manoharan, S., “Anticarcinogenic

Munditikaa 93

and antilipidperoxidative effects of

Museum of Materia Medica 169

Tephrosia purpurea (Linn.) Pers. in

Mushali 82

7, 12-dimethylbenz(a)anthracene

Mushkakaadi Gana 136 – 137

(DMBA) induced hamster buccal pouch

Muurvaa 87 – 88

carcinoma” 249

Myristica fragrans see Jaatiphala

mardanam gunavardhanam 68

Maricha 89 – 90

Naadihingu 84

markers 179, 180, 201; analytical 203; of

Naagakeshara 88

Ayurvedic herbs 206 – 215; categories

Naakuli 77

of 203 – 204; general guidelines for 201;

Naharwar, Vikram Andrew 3

phytochemical reference standards as

Nair, V., “Effect of ethanolic leaf extract of

238 – 244; problem of identification in

Ocimum sanctum on haloperidolinduced

Ayurvedic compounds 205; selection

catalepsy in albino mice” 260

criteria 201 – 202; for toxic consituents

Napunsakataa 157

202 – 203

Nardostachys jatamansi see Jataamaansi

marmin 123

National Formulary of Unani Medicine 74

Marsdenia tenacissima see Muurvaa

natural configuration of compounds 188 – 189

Martynia annua see Kaaka-Naasikaa

Navaayasa Churna 128

maximum tolerated dose 16

Nayar, S. L. 163, 165

Medaa 91, 262

Nehru, Pandit Jawahar Lal 58

Medicinal Plant Names Services (MPNS)

Nero, Emperor of Rome 48

170

Nirgundi 64

medicinal plants 45 – 46; African Marigold

Niroohana Dravya Gana 148

45; agrimony 43; basil 41, 49; borage

Nishaa formulations 153

41; cabbage 54; chemical constituents

Nithaniyal, S. 172

190 – 199, 217; classical names 73;

non-AYUSH researchers 29 – 30

Clownes Wound-wort 44; cucumber

non inferiority trials 17

50 – 51; doctrine of signatures 42;

nonhydrolyzable tannins 227

flavonoids 218; foxglove 43; garlic

nonterpenoid bitters 223

42 – 43; ginger 41; Herbe Gerarda 44;

no-treatment concurrent control design 18

large juniper 55; linseed 50; onion

Nyagrodhaadi Gana 142 – 143

44 – 45; radish 52; red list of 273 – 280;

Sanskritized names 73 – 74; stray parsnip Obi, E., “Hypoglycaemic effect of the

53 – 54; threatened species 280 – 290;

aqueous extract of Boerhavia diffusa

walnuts 50; see also botanical drugs;

leaves” 245 – 246

Index 311

observational studies 16 – 17

haloperidolinduced catalepsy in albino

Ocimum sanctum 260

mice” 260

oleanolic acid 241

phagedaenae 52

oligomeric proanthocyanidins 243

Phala Ghrita 157

onion 44 – 45

Phalaadi Varga 150 – 151

Onosma bracteatum see Gojihvaa

pharmaceutical names 94; of Ayurvedic

open blind studies 23

plant drugs 94 – 95; equivalent botanical

Orisakwe, O. E., “Hypoglycaemic effect of

names 96 – 109, 110 – 120; see also the aqueous extract of Boerhavia diffusa

international pharmaceutical names

leaves” 245 – 246

pharmacodynamic activities 231

Orpheus 48, 53

pharmacognosy 59, 63

Osthanes 49

pharmacological screening: activity on

Oxford University Herbarium 163

autonomous nervous system (ANS)

232; activity on central nervous

Paarsika Yavaani 64, 86

system (CNS) 232 – 234; activity on

Paashanabheda 76

gastrointestinal tract 234; activity on

Paathaa 79 – 80

muscles 232; anticancer or effects

Pai, M., “Effect of ethanolic leaf extract of

on genomic structure 235 – 236;

Ocimum sanctum on haloperidolinduced

antifertility activity 235; anti-

catalepsy in albino mice” 260

inflammatory and anti-pyretic activity

pain, response to placebo effect 157–158

234; antimalarial activity 235; autacoid

Panch Gavya Ghrita 156

activity 234; hepatoprotective activity

Panch Kola Gana 147

234; hypoglycaemic activity 235

Pancha Gavya Ghrita 127

Phase I trials 14 – 15

Panchakantaka Gana 146

Phase II trials 15

Panchakarma 21; Ganas for 147 – 149

Phase III trials 15 – 16

Panchbhuutas 62

Phase IV trials 16

panchmuula, suggested substitutions for

phenolic compounds 227

classical formulations 151 – 152

phenylpropanoids 229

Panchmuulu 151

Philistion 53, 54

Pandey, G. S. 263

Phyla nodiflora see Jalapippali

Pandian, M. R. 256 – 257

Phyllanthus fraternus see Taamalaki

Pandit, S., “Effect of Aegle marmelos leaf

Phyto-Chemical Reference Standard (PRS)

on rat sperm motility-An in vitro study”

238

257

phytochemicals 165, 242

Papata 89

phytoecdysteroids 223

papaya 243 – 244

Piper cubeba see Kankol

Paracelsus 41

Piper nigrum see Maricha

Parani, M. 172

Pita Chandan see Kaaliyaka

Parkinson’s disease, response to placebo

Pitta 1, 27, 61, 63, 64, 262

effect 158

Pittahara Gana 148

Parmar, N. S., “Antiulcer activity of

placebo controlled trials 17, 20 – 21

Tephrosia purpurea in rats” 248 – 249

placebo effect 156; on coughs 158; on

Parpata 84

depression 158; on epilepsy 158; on

Paruushakaadi Gana 141

erectile dysfunction 158; on Irritable

patent medicine 7 – 8, 24 – 25; phases of

Bowel Syndrome (IBS) 158; on pain

clinical trial for 14 – 16

157–158; on Parkinson’s disease 158;

Patis 75

response rate in clinical trials 159

Patolaadi Gana 139

plant steroids 223 – 224

Patwardhan, B. 59

Plantago ovata 228

Patwardhan, K. 293

Pliny the Elder, Natural History 47 – 55

Pavetta indica see Papata

Plistonicus 49

Pemmnati, S., “Effect of ethanolic

Pluchea lanceolata 255; see also leaf extract of Ocimum sanctum on

Raasanaa

312 Index

Plumbago indica see Rakta Chitraka

Raasanaa 89 – 90

Podagraria 44

radish 52

polyformulations 21; redundant herbs 122

Rajesh, M. G., “Protective activity of

Polygonatum cirrhifolium see Medaa

Glycyrrhiza glabra Linn. on carbon

polysaccharides 228 – 229

tetrachloride induced peroxidative

polyterpenoids 222

damage” 252

Pongamia pinnata, effect on blood glucose Raju, B. 172

levels 246 – 247; see also Karanja

Rakta-Chandana 91

Poongothai, S. G., “Inhibitory

Rakta Chitraka 89 – 90

concentrations of Lawsonia innermis

Rakta Punarnavaa 79

dry powder for urinary pathogens”

Ramu, D. P. 258 – 259

259 – 260

random allocation 22

Popaea 48

randomization codes 22, 23 – 24

Portulaca oleracea see Lonikaa

randomized withdrawal design 18

post marketing trials 16

Rao, M. S., “Effect of Tinospora cordifolia

Prabhava 64, 65

on learning and memory in normal and

Prabhu, K., “Antiovulatory and

memory deficit rats” 249

abortifacient effects of Areca catechu

Rasa tantra va siddha prayog sangraha 35

(betel nut) in female rats” 258

Rasas 1, 61, 62, 65

Prakriti 2, 11, 27, 62

rasayana 69

Pramanik, T., “Effect of Aegle marmelos

Rath, Satyajit 32

leaf on rat sperm motility-An in vitro

Rauwolfia serpentina see Sarpagandhaa

study” 257

rbcL DNA barcode 174

Praxagoras 52

recommendations: in the final report of the

preclinical animal data 231

AYUSH task force 25 – 27; suggested

Priyangu 79

substitutions for classical formulations

Priyangvaadi Gana 141 – 142

151 – 152

properties and actions 241 – 242

Red Data Book of Indian Plants 290

proprietary medicine 7 – 8, 24 – 25; phases

red list of Ayurvedic medicinal plants

of clinical trial for 14 – 16

273 – 280

prostaglandins 220

Reference Standards (RS) 204 – 205; as

pruning classical formulations 121 – 124, 156

markers 238 – 244

psoriasis 51

replacement studies 18

Pterocarpus marsupium see Asana

research 121; in Ayurvedic sciences 2;

Pterocarpus santalinus see Rakta-

biases 22 – 23; low-quality 29 – 30

Chandana

resins 228

Punitha, R., “Effect of Pongamia pinnata

revalidating formulations 151 – 154; see flowers on blood glucose and oxidative

also Ganas; Vargas

stress in alloxan induced diabetic rats”

Reverse Pharmacology (RP) design 20

246 – 247

Reviews on Indian Medicinal Plants

Purohit, H. J., “Effect of Hemidesmus

59 – 60

indicus (Anantmool) extract on IgG

Rhododendron anthopogon 74

production and adenosine deaminase

Riddhi 85, 261, 262, 265

activity of human lymphocytes in vitro“

Rodhraadi Gana  135

255 – 256

rotary tray drying 185

Pushkara 86

Rshabhaka 262

Pushpa Varga 150

Rshbhaka 87, 262

pyrano coumarins 226

rutin 219

quantitative analysis, of Apaamaarga

Saalsaaraadi Gana 133 – 134

Kshaara 241 – 242

Saarivaadi Gana 140

quercetin 218 – 219, 220

“Sacred Word” 156

quinsy 48

Sahachara 78

Index 313

Sahasrayoga 35

Shirsha virechaniya Gana 148

salts 41

shlokas 73, 74, 156

samhitas 69

Shrestha, J., “Antiovulatory and

sample surveys 17

abortifacient effects of Areca catechu

Sanskritized names 1, 73 – 74, 156,

(betel nut) in female rats” 258

239 – 240

Shri, R. L. 163

saponins 226

Shunthi Guggulu  124

Sarin, Y. K. 165

Shveta Saariva 82

Sarpagandhaa 91 – 92

Shveta Vachaa 75

Satti, N. K., “Immunosuppressive

Shyaamaadi Gana 138 – 139

properties of Pluchea lanceolata leaves” Sida rhombifolia see Mahaa Balaa

255

Siddha 11, 27

Sauer, Christopher, Sauer’s Herbal Cures 40

Siddhayoga Sangraha 35

Saussurea lappa see Kushtha

signatures 42

scientific journals, need for unbiased

Silymarin 219, 220

research 29 – 30

simple coumarins 226

Scindapsus officinalis see Gajapippli

simple random samples 22

screening biological activities of herbs:

Simshapaa 83

activity on gastrointestinal tract 234;

Singh, K., “The effect of Allium sativum

anticancer or effects on genomic structure

on ischemic preconditioning and

235 – 236; antifertility activity 235; anti-

ischemia reperfusion induced cardiac

inflammatory and anti-pyretic activity

injury” 247 – 248

234; antimalarial activity 235; autacoid

Singh, R. P. 254 – 255

activity 234; on autonomous nervous

single arm trials 17

system (ANS) 232; on central nervous

single blind studies 23, 24

system (CNS) 232 – 234; hepatoprotective Sisodia, S. S., “Hepatoprotective activity

activity 234; hypoglycaemic activity 235;

of Eugenia jambolana Lam. in carbon

on muscles 232

tetrachloride treated rats” 253

selinas 54

Sivarajan, V. V. 59

Selinum vaginatum see Bhootakeshi

Sobti, S. N. 165

Shaaka Varga 151

Solanum nigrum see Kaakamaachi

Shaalparni 83

Sontakke, S. D., 254 – 255

Shah, G. B., “Antiulcer activity of

Sowa Rigpa 27

Tephrosia purpurea in rats” 248 – 249

Soxhlet extraction 186 – 187

Shallaki 79

Sphaeranthus indicus 252 – 253; see also Shanbhag, T., “Antiovulatory and

Munditikaa

abortifacient effects of Areca catechu

spray drying 185

(betel nut) in female rats” 258

Srivastava, T. N. 165

Shankhpushpi 81

standardization 58, 65, 188, 189 – 190

Sharma, A., “Evaluation of the

standardized extracts 237 – 238

antidepressant-like activity of

Stereospermum suaveolens 152

glycyrrhizin in mice” 251 – 252

steroidal saponins 226

Sharma, B. M. 165

Sthauneya 94

Sharma, P. V. 64, 74

Sthuula-aila 76

Sharma, S., “Antiovulatory and

stigmastrol 223 – 224

abortifacient effects of Areca catechu

stratified randomization 22

(betel nut) in female rats” 258

stray parsnip 53 – 54

Shataavari 78

strengths and limitations of extraction

Shathi 85

methods 186 – 187

shelf-life of Ayurvedic herbs 67 – 68

Strychnos nux-vomica see Vishmushthi

Shenoy, S., “Antiovulatory and

Subramoniam, A. 122

abortifacient effects of Areca catechu

substitute drugs see suggested substitutions

(betel nut) in female rats” 258

for classical formulations

314 Index

subtlety 68

Swarge, J. M. 69

suggested substitutions for classical

sweet basil 41

formulations 151 – 152; Ashta varga 263

Swertia chirata see Kiraatikta

Sukshma Ayurvediya Aushadhi 69

Symplocos racemosa see Lodhra

sukshma churna 68

symptoms 57 – 58

sukshma medicines 69

synergystic components 204

sukshma suvarna bhasma 69

systematic reviews 21

supercritical fluid extraction (SFE) 185,

186, 187

Taalisha 74

Sur, T. K. 257

Taalmuuli 82

Surasaadi Gana 136

Taamalaki 89 – 90

Suri, K. A., “Immunosuppressive

tannins 227

properties of Pluchea lanceolata leaves” Taori, G. M., “Effect of Hemidesmus

255

indicus (Anantmool) extract on IgG

survey of the Ayurvedic education system

production and adenosine deaminase

in India 293 – 294; observations on

activity of human lymphocytes in vitro“

teaching methodology 296 – 297;

255 – 256

suggested curricula changes in the

tastes 61; see also Rasas

BAMS program 296

Tate, V. D. 252 – 253

Sushruta Samhita 80, 131

Taverniera cuneifolia 154

Sushruta’s Classification of Ayurvedic

Taxol 222

Drugs 68, 131, 132; Aamalakyaadi

Taxus baccata see Sthauneya

Gana 144; Aaragvadhaadi Gana 133;

Taxus wallichiana see Taalisha

Ambaashthaadi Gana 142; Anjanaadi

temperaments 41

Gana 140 – 141; Arkaadi Gana

Tephrosia purpurea: anticarginogenic

135 – 136; Brhatyaadi Gana 139; Elaadi

effect of 249; antiulcer effect of

Gana 137 – 138; Guduchyaadi Gana

248 – 249

143; Haridraadi Gana 138; Kaakolyaadi

terpenoid bitters 223

Gana 139 – 140; Kadambaadi

terpenoids 222, 229

Gana 147; Karanjaadi Gana 147;

Thawani, V. R. 254 – 255

Krishnaadi Gana 137; Kshudra

theory of Herbal Microcosm 69

panchamuula Gana 145; Lakshaadi

therapeutic benefit of drugs 155

Gana 144 – 145; Mahat panchmuula

therapeutic components 204

Gana 145; Mushkakaadi Gana

therapeutic confirmatory trials 15 – 16

136 – 137; Mustaadi Gana 143 – 144;

therapeutic exploratory trials 15

Nyagrodhaadi Gana 142 – 143; Panch

thin-layer chromatography (TLC) 239

Kola Gana 147; Panchakantaka

Thippeswamy, A. H., “Hepatoprotective

Gana 146; Paruushakaadi Gana 141;

activity of Cissus quadrangularis stem

Patolaadi Gana 139; Priyangvaadi

extract against isoniazid-induced liver

Gana 141 – 142; Rodhraadi Gana  135;

damage in rats” 254

Saalsaaraadi Gana 133 – 134; Saarivaadi threatened species 280 – 290

Gana 140; Shyaamaadi Gana 138 – 139;

three arms trial 17

Surasaadi Gana 136; Trapvaadi Gana Tinospora cordifolia 249, 254 – 255

144 – 145; Triphlaa Gana 143 – 144; Trna toxic constituents 204; markers for

panchamuula Gana 146; Tryuushana

202 – 203

Gana 144; Utpalaadi Gana 143;

toxicity studies 231

Uushakaadi Gana 140; Vachaadi

Traditional Chinese Medicine (TCM) 39

Gana 138; Vallija panchamuula Gana Trapvaadi Gana 144 – 145

145 – 146; Varunaadi Gana 133 – 134;

tray drying 185

Vatsakaadi Gana 146; Vidaarigandhaadi Tridoshas 1, 11, 61, 63

Gana 132 – 133; Viratarvaadi Gana Tripathi, C. D., “The effect of aqueous

135; see also Vagabhata

extract of Embelia ribes Burm on serum

Svarna-taali 74

homocysteine, lipids, and oxidative

Index 315

enzymes in methionine induced

Vaatahara Gana 148; Vachaadi Gana

hyperhomocysteinemia” 250 – 251

138; Vamanaoushadha Gana 147;

Triphala 127

Vatsakaadi Gana 149; Vidaaryaadi Gana Triphlaa Gana 143 – 144

132 – 133; Viratarvaadi Gana 134–135;

triple blind studies 23

Virechanaoushdha Gana 148

triterpenoidal saponins 226

vaidyas 2, 73, 129

triterpenoids 222

valerenic acids 204

trituration 68, 69, 70

Vallija panchamuula Gana 145 – 146

Trna panchamuula Gana 146

Vamanaoushadha Gana 147

Tryuushana Gana 144

Varadpande, U. K., “Immunomodulatory

Tulasi 63

effect of Tinospora cordifolia extract

in human immuno-deficiency virus

Udupa, K. N. 63

positive patients” 254 – 255

ultrasonic extraction (UAE) 184 – 185,

Vargas 27, 127, 129, 131 – 132; Dhaanya

186, 187

151; Guduchyaadi 150; Haritakyaadi Unani 11, 27; plant drugs 37 – 38

149; Karpuraadi 150; Phalaadi

unbiased research, need for 29 – 30

150 – 151; Pushpa 150; Shaaka 151;

un-blinding 23

Vataadi 150; see also Ganas;

United Kingdom: herbal medicine 42 – 45;

Vagabhata

Medicinal Plant Names Services

Varunaadi Gana 134

(MPNS) 170

Vassou, S. L. 172

United States: Food and Drug

Vasuedevan, K., “Effect of Pongamia

Administration 47; herbal medicine

pinnata flowers on blood glucose and

40 – 41; journals 163

oxidative stress in alloxan induced

United States Department of Agriculture

diabetic rats” 246 – 247

(USDA) 164

Vataadi Varga 150

Uraria picta 123

Vatsakaadi Gana 146, 149

Utpalaadi Gana 143

Vedic medicine 1

Uushakaadi Gana 140

Veerya 61

verapamil 123

Vaasaa 75

Vidaarigandhaadi Gana 132 – 133

Vaata 1, 27, 61, 63, 64

Vidang 84

Vaatahara Gana 148

Vimalavathini, R., “Possible anorectic

Vaayu 63

effect of methanol extract of Benincasa

Vacha 75

hispida (Thunb.). Cogn. Fruit” 250

Vachaadi Gana 138

Vipaka 1, 61, 62, 65

vacuum tray drying 185

Viratarvaadi Gana 134 – 135

Vagabhata 131, 132; Aaragwadhaadi

Virchow, Rudolf 46

Gana 133; Ambaashthaadi Gana 142;

Virechanaoushdha Gana 148

Anjanaadi Gana 141; Arkaadi Gana Virya 1, 62, 65

135 – 136; Asanaadi Gana 134; Elaadi Vishmushthi 93

Gana 137 – 138; Guduchyaadi Gana Viswanatha, Swamy A. H. 254

143; Haridraadi Gana 138; Jivantyaadi

Vitis pedata 76

Gana 140; Kaphahara Gana 149;

von Bingen, Hildegard, Physica 45 – 46

Mushkakaadi Gana 136 – 137; Mustaadi

Vongtau, O. H., “Hypoglycaemic effect of

Gana 144; Niroohana Dravya Gana 148;

the aqueous extract of Boerhavia diffusa

Nyagrodhaadi Gana 143; Paruushakaadi

leaves” 245 – 246

Gana 141; Pittahara Gana 148;

vouchers 163; intraspecific variation

Priyangvaadi Gana 141 – 142;

in plants 164 – 165; Janaki Ammal

Rodhraadi Gana 135; Saarivaadi

Herbarium 165 – 166; misidentification

Gana 140; Shirsha virechaniya Gana

of samples 164 – 165

148; Surasaadi Gana 136; Syaamnadi Vriddhadaaru 77

Gana 139; Uushakaadi Gana 140;

Vriddhi 261, 262

316 Index

walnuts 50

Yashti 85, 263

Wealth of India, The 129

Yellow Emperor’s Internal Classic, The 39

Withania Ashvagandha 152

Yin and Yang 39

withanolides 223

World Health Organization (WHO)

Zingiber officinale  124

47; criteria for selection of a marker

Zwinger, Friedrich 41

201 – 202; guidelines for markers 201

Zwinger, Theodor 40





Document Outline


Cover

Half Title

Series

Title

Copyright

Contents

List of contributors

Introduction: The thrust: why a new scientific path?

Part I The legacy and logical steps for a new therapeutic regimen 1 The need for liberal regulations for promoting evidence-based Ayurveda

2 Each and every step of AYUSH will have a far-reaching impact

3 To move with the times: expand the knowledge base of Ayurveda

4 The classical age in countries that are now leaders in herbal medicine

5 Avoiding scientific inquiry is not possible now

6 Ayurvedic pharmacognosy and pharmacology: in modern perspective

7 How classical procedures lost ground

8 Identification of proper herbs: a new scientific route

9 Pruning of classical formulations: suggested process

10 The pragmatic nature of Ayurveda: no restrictions on revising old formulations

11 Basic steps: for restructuring Ayurvedic formulations

12 Hidden secrets of clinical success: super power of “Sacred Word”





Part II Defining a new scientific path by switching over to modern pharmacognosy, pharmacology and research protocols 13 Identification of medicinal plants by voucher specimen

14 DNA barcoding: a breakthrough in authentication of raw herbs

15 Modern extraction methods and standardization of extracts

16 Markers for quality control of herbal drugs

17 Pharmacological actions of chemical constituents

18 Pharmacological screening of Ayurvedic drugs by experimental studies

19 An enigmatic approach in Ayurvedic Pharmacopoeia of India: from holistic approach to disease-specific concepts

20 Unbiased research: lifeline of evidence-based Ayurveda

21 Threat to classical reputation by dubious herbs and substitutes

22 Red list of medicinal plants: a threat to Ayurvedic formulations

23 Ayurvedic education system: a path-breaking study reflecting the elements of evidence-based Ayurveda





List of abbreviations

Index





